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Abstract 
This thesis aimed to examine service contact among children and young people with 
mental health problems, and has three complementary parts. The first is a secondary 
analysis of data from the British Child and Adolescent Mental Health Survey 
(BCAMHS) 2004, which explored mental health related service contact in relation to 
psychopathology over three years. The second and third parts focussed on young 
people with ADHD in transition from child services, which is a particularly challenging 
time. This involved a qualitative interview study of young peoples’ experiences, and 
an analysis of primary care prescribing of ADHD medication over the transition 
period using a cohort from the Clinical Practice Research Datalink from 2005-2013.  
Less than a third of children with a psychiatric disorder in BCAMHS reported contact 
with child mental health services. Instead, teachers were the most frequently used 
service, with two-thirds reporting mental health related contact. Interviews with young 
people with ADHD highlighted themes including concerns around medication 
management post transition and need for information. The prescribing analysis found 
that the majority of adolescents on ADHD medication at age 16 stopped during the 
transition period. This continuing disparity between estimates of symptom 
persistence and medication persistence suggests that many may be stopping 
medication from which they could still benefit; as various barriers have been 
identified to ongoing prescribing. 
In summary, the findings of these three linked studies suggest common themes in 
terms of unmet needs and gaps between policy and practice in mental health 
services for children and young people. One of the chief implications is the need for 
oversight and policy levers to ensure the implementation of best practice, 
accompanied by complementary efforts to better understand and overcome other 
barriers to providing optimal care, including research into knowledge and attitudes of 
different groups and the provision of targeted training. 
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Chapter One: Introduction 
My thesis focusses on two aspects of service provision for children and young 
people with psychiatric disorders in the UK. The first is mental health related service 
contact in school aged children and the trajectories of psychopathology over time of 
children in contact with services. The second is transition from child to adult services 
in young people with Attention Deficit Hyperactivity Disorder (ADHD). The following 
chapter briefly introduces the context and background necessary to understand both 
and presents the main aims and justification for the three constituent studies. The 
policy and research background to the topics is then reviewed and discussed in 
further detail in Chapter Two. 
1.1 Context 
 
1.1.1 Psychiatric disorders in children and adolescents:  
prevalence and impact 
According to the first and second British Child and Adolescent Mental Health 
Surveys in 1999 and 2004, approximately one in ten children aged 5-16 in the UK 
has a psychiatric disorder (Meltzer et al. 2000, Green et al. 2005), a figure which is in 
line with global estimates of prevalence (Costello et al. 2005). The most common 
disorders reported in the 2004 British survey were conduct disorders (5.8%) and 
anxiety disorders (3.3 %); with approximately a quarter of those with a disorder 
experiencing comorbidity (Green et al. 2005). Prospective analysis of children with 
psychiatric disorders in the Great Smoky Mountains Study by Copeland et al. (2009) 
also found childhood disorders to be predictive of adult disorders. This prediction 
occurred both homotypically, e.g. depression predicting later depression, and 
heterotypically, where childhood disorder predicted different adult disorders 
(Copeland et al. 2009). In retrospective analysis of the Dunedin cohort, 
approximately half of adults with a psychiatric disorder aged 26 had first met 
diagnostic criteria between the ages of 11-15 years, and almost three-quarters had 
symptoms by the age of 18 (Kim-Cohen et al. 2003). Adolescence is therefore a key 
time for the emergence of psychiatric disorders, which emphasises the importance of 
early identification and management as part of a life course approach. 
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In addition to the risk of psychiatric disorder in adulthood, young people with mental 
health problems are more likely to experience a range of other adverse outcomes, 
which are not only confined to those meeting criteria for a diagnosis but may also 
affect those with sub-threshold symptoms (Copeland et al. 2015). These include: 
exclusion from school, educational and occupational underachievement, relationship 
difficulties and poorer physical health (Fergusson and Woodward 2002, Fergusson 
et al. 2009, Richards and Abbott 2009, Gibb et al. 2010,  Klein et al. 2012, Costello 
and Maughan 2015, Parker et al. 2015). The association between socio-economic 
disadvantage and poorer mental health also means that these adverse impacts are 
more likely to affect children who are already vulnerable (Davis et al. 2010, Boe et al. 
2012, Reiss 2013). The costs to society in terms of perpetuated inequality and lost 
potential are substantial. In economic terms the costs of childhood psychiatric 
disorder to health, social care and education are estimated to reach over one billion 
pounds per year in the UK, with the majority of the cost falling on frontline education 
and special education services (Snell et al. 2013).  
1.1.2 Need for healthcare 
This thesis is concerned with the unmet mental healthcare needs of children and 
young people with psychiatric disorders. Acheson (1978) discusses two early 
definitions of needs for healthcare: firstly as being any ‘disturbance of health and 
wellbeing’ (the ‘humanitarian model’ first proposed by Donabedian); or secondly as 
existing only where there is some capacity to benefit from medical intervention ‘at 
reasonable cost’. The latter definition is one that is more commonly used, with or 
without the ‘reasonable cost’ caveat, which represents an entire field of health 
economic study and therefore may be highly subject to the context of resources and 
prioritisation. The World Health Organisation (2016) also uses three further 
definitions. Firstly, perceived healthcare needs, defined as: ‘the need for health 
services as experienced by the individual and which he/she is prepared to 
acknowledge’. Secondly, professionally defined health needs, defined as: ‘the need 
for health services as recognized by health professionals from the point of view of 
the benefit obtainable from advice, preventive measures, management or specific 
therapy’. Thirdly, scientific need, which was defined as need ‘considered to 
correspond to those conditions that can be classified in accordance with the 
International Classification of Diseases’. 
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Demand exists where needs are felt and expressed by the patient – i.e. where 
patients ask for or attend services (Wright et al. 1998). Demand is strongly 
influenced by individual and group illness behaviour, media attention, knowledge of 
services, and indeed the supply of services, and hence is not a proxy for need. The 
supply of services is dependent on professional interests, historical configurations, 
national and local resources and prioritisation, and is also affected by demand. 
Consequently, need, supply and demand are interdependent and overlapping 
concepts. 
The prevalence and impact of psychiatric disorders in childhood and the existence of 
effective interventions (see 1.1.4 below) indicates that there is a need for child 
mental healthcare in both a humanitarian sense and in terms of children’s capacity to 
benefit.  Healthcare is of course delivered by services, which will provide ‘service 
equivalents’ to meet a need where available such as therapy for an anxiety disorder 
(Acheson 1978). Unmet need in this case could therefore be simply defined as 
occurring where children who could benefit from a service providing healthcare do 
not receive such a service. This definition is complicated somewhat by the question 
of whether the service provided is also effective. Contact with services does not 
necessarily imply that all needs are met, depending on whether coming into contact 
with this service is beneficial for the patient, and in what way. This question is 
introduced briefly below, and discussed in more depth in Chapter Two.  
1.1.3 Services for children with mental health problems 
Services for children with mental health problems have traditionally been 
conceptualised as existing in four ‘tiers’ (NHS Health Advisory Service 1995) (see 
Figure 1.1 below).  The first consists of ‘universal services’ provided by GPs and 
teachers, and by other statutory or third sector practitioners such as youth workers, 
who to varying degrees will promote mental health and identify and manage less 
severe problems. Second-tier services involve ‘targeted services’ provided by single 
discipline teams and professionals such as primary mental health workers, school 
counsellors, or educational psychologists. Third-tier services are defined as 
specialist child mental health teams, which are community based and 
multidisciplinary (referred to as Tier 3 Child and Adolescent Mental Health Services 
or CAMHS). Finally, inpatient services and highly specialist teams, such as child 
eating disorders teams, constitute fourth tier CAMHS. 
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Figure 1.1: The tiered model of services for children with mental health 
problems  
1.1.4 Mental health related contact with services 
There has been a recent expansion in the collection of data regarding mental health 
service contacts in children, such as the CAMHS Benchmarking Reports introduced 
in 2011, and the forthcoming CAMHS Minimum Dataset, which will provide data on 
activity, evidence based interventions and outcomes in CAMHS from early 2016 
(Health and Social Care Information Centre 2016a). However, there remain as yet no 
integrated routine administrative datasets to describe and collate mental health 
related contacts across the breadth of services that children use such as schools, 
primary care, paediatrics and CAMHS. Estimates of the prevalence of contact with 
services have therefore historically come from parent reports of contact using 
population survey methods. The 1999 British Child and Adolescent Mental Health 
Survey (BCAMHS) found that a large minority (42%) of children meeting criteria for a 
psychiatric disorder had no contact with any services regarding their mental health 
over the three year follow up period (Ford et al. 2007b).  These figures imply a 
considerable degree of unmet need which has been increasingly acknowledged by 
reports including the Child and Adolescent Mental Health Review in 2008 
Tier 4: Tertiary: Inpatient and highly 
specialist teams 
e.g. CAMHS Tier 4, youth custody services 
Tier 3: Referred or specialist services 
e.g. CAMHS Tier 3, education psychology 
service 
Tier 2: Targeted services 
e.g. Parenting groups, Sure Start 
Tier 1: Universal services 
e.g. Education, primary care 
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(Department of Health 2008a). More recently, the House of Commons Health Select 
Committee (2014) report continued to highlight problems in access to services, high 
referral thresholds and considerable variations in service quality and delivery across 
England. The recommendations of these reports are considered further in Section 
2.1.8: Current policy and recommendations, alongside other recent policy. 
1.1.5 Effectiveness of services 
Even for children who do come into contact with services, the effectiveness of the 
care they receive is yet to be conclusively demonstrated. There is evidence of 
effectiveness from trials of certain specific interventions targeting child psychiatric 
disorders such as parent training programmes for conduct disorder, Cognitive 
Behavioural Therapy (CBT) for anxiety, and medication for children with ADHD, 
amongst others (Faraone and Buitelaar 2010, Furlong et al. 2013, James et al. 
2015). The Children and Young People’s Improving Access to Psychological 
Therapies (CYP IAPT) programme, introduced in 2011, aims to increase the delivery 
of evidence based interventions (NHS England 2016). However, data are currently 
lacking on whether evidence based interventions are being widely offered within 
services, and of their quality and outcomes (Davies 2013). The fidelity of adoption of 
interventions is likely to be highly variable, with a number of barriers to full 
implementation being identified including training, attitudes, resources, and the 
increasingly complex caseload in clinical practice (Novins et al. 2013).  Studies of 
local datasets from child mental health services suggest that children receiving 
‘usual care’ experience some improvement over the shorter term (Hurst et al. 2014, 
Deighton et al. 2015) but without a control group findings are likely to be affected to 
some extent by measurement phenomena such as attenuation and regression to the 
mean (see Chapter Two). To interpret data on the effectiveness of services and 
consider what ‘optimal outcomes’ might be, it is also necessary to understand the 
natural trajectories of childhood psychiatric disorders (Costello and Maughan 2015). 
Longitudinal research demonstrates that children with psychopathology follow a 
variety of trajectories over time; some experience chronic and severe difficulties, 
whilst others have more transient problems (Angold et al. 2000, Dekker et al. 2007, 
Pingault et al. 2011, Chaiton et al. 2013).  Surveys such as BCAMHS can help to 
describe the trajectories of psychopathology over time in children using services in a 
naturalistic setting. 
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1.1.6 Transition from child to adult services 
The term ‘transition’ is used to refer to the process of moving from child to adult 
services. This stage is characterised by multiple transitions within health and social 
care and education, against the backdrop of social and psychological change taking 
place in late adolescence. Indeed, the brain is still developing and carrying out 
activities such as pruning and myelination until the mid-twenties, leading to the 
introduction of the phase ‘emerging adulthood’ by Arnett (2000) to describe those 
between 18 and 25 years old. The difficulties of transition for young people with 
mental health conditions can be compounded by having to contend with multiple 
significant transitions during the emergence of new psychiatric disorders, for which 
adolescence is the peak time (Copeland et al. 2011), and by a marked cultural divide 
between child and adult mental health services (McLaren et al. 2013). 
1.1.7 Attention Deficit Hyperactivity Disorder and transition 
The second part of this thesis focusses on the needs of young people with Attention 
Deficit Hyperactivity Disorder (ADHD) in transition, for whom this period may be 
particularly challenging. ADHD has a multifactorial aetiology, with genetic and 
environmental risk factors, and is one of the most common childhood psychiatric 
disorders, with worldwide estimates of prevalence in children at 3.4% (Thapar et al. 
2012, Polanczyk et al. 2015). ADHD has previously been considered a condition 
affecting only children and younger adolescents, yet follow-up studies estimate that 
40-60% of those with the condition experience persistence of symptoms at age 25 
(Faraone et al. 2006).  Simon et al. (2009) in their meta-analysis of prevalence 
studies suggest that approximately 2.5% of adults may meet criteria for ADHD; but 
the accuracy and applicability of such estimates in adults are likely to be affected by 
questions about the validity of the diagnostic criteria for adults as well as the known 
decline in prevalence with increasing age. The latest fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5) defines ADHD as a persistent 
pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning 
or development (American Psychiatric Association 2013). In the International 
Classification of Diseases (ICD-10) the term ‘hyperkinetic disorder’ is used to refer to 
a more restrictive and severe definition of the equivalent condition; although often 
this is still referred to as ADHD (World Health Organisation 1992).  ADHD also has 
significant adverse impacts on a wide range of health, social and economic domains 
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(Hoare and Beattie 2003, Biederman and Faraone 2006, Barkley and Brown 2008, 
Groenman et al. 2013, Kang et al. 2013, Chang et al. 2014, Dalsgaard et al. 2015, 
Uchida et al. 2015, Cortese et al. 2016).  There are effective treatments for ADHD; 
with the National Institute for Health and Care Excellence (NICE, 2008b) 
recommending non-pharmacological management as a first line treatment for 
children with moderate impairment, and pharmacological treatment as a second line, 
and for those with more severe impairment. Medication is also effective in adults with 
ADHD, and is recommended by NICE as a first-line treatment for those affected 
(NICE 2008b, Faraone and Glatt 2010).  A systematic review by Shaw et al. (2012) 
of long term outcomes suggested that wider outcomes ranging from academic 
attainment to obesity and social functioning were worse in people with untreated 
ADHD compared to those on treatment, although such outcomes were still poorer 
than for people without ADHD. 
The historical perception of ADHD as a condition confined to children has meant that 
older adolescents and adults continue to face obstacles to support and treatment 
after the age of 16 or 18 years.  Identified barriers include  a lack of services for 
adults with ADHD where medication may be monitored (Marcer et al. 2008, Young et 
al. 2011, Hall et al. 2015), and attitudes amongst clinicians; recent research indicates 
that prescribing for adults with ADHD is still not well established and accepted 
amongst many professionals (Hall et al. 2013, Matheson et al. 2013). Previous UK 
studies of primary care prescribing found that the majority of young people with 
ADHD stopped medication before the age of 18 (Wong et al. 2009, McCarthy et al. 
2012a), and that the rates of cessation reported were greater than the estimated rate 
of persistence of ADHD according to Faraone et al.’s (2006) meta-analysis of follow-
up studies.  The TRACK study of transition also concluded that those with 
neurodevelopmental disorders were a group who were particularly likely to 
experience ongoing need but did not experience optimal transition (Singh et al. 
2010a). The impact of stopping treatment and/or disengaging from services may be 
increased by the vulnerability of adolescents during this crucial developmental stage, 
and little is known about how this transition is experienced by the young people 
themselves. 
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1.2 Aims and Justification 
 
1.2.1 Aims 
This PhD consists of three complementary studies, with the overarching aim of 
studying service provision and contact amongst children and young people with 
mental health problems. The second and third parts focus in particular on 
adolescents with ADHD who are in transition from child to adult services.  
The main aims of the three constituent studies are as follows: 
1. To analyse mental health related service contact and trajectories of 
psychopathology over three years in a cohort of school-aged children  
2. To examine primary care prescribing of ADHD medication and other 
psychotropic medication in people with ADHD over the transition period, and 
report on the time to cessation of medication from age 16 
3. To explore the experiences of young people with ADHD in transition from 
child to adult services  
 
1.2.2 Constituent studies and justification 
 
Study 1: Mental health related service contact and trajectories of 
psychopathology over three years in the British Child and Adolescent Mental 
Health Survey 2004 (Chapter Three) 
The first study is a secondary analysis of the British Child and Adolescent Mental 
Health Survey (BCAMHS) 2004 and its follow-up in 2007. It describes mental health 
related contact with services amongst children who did and did not meet criteria for a 
psychiatric disorder as well as exploring the predictors of contact. The study also 
examines the trajectories of psychopathology over time, including at interim points 
between the surveys, among children who did and did not use services, and 
analyses the association between service contact and outcome in terms of 
psychopathology at follow-up. The study design offers the opportunity to examine 
children’s trajectories in relation to ‘real-world’ service contacts in a community 
setting; a question not previously explored in the 2004-2007 survey data, and one 
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which may inform the future collection and interpretation of service outcomes data. It 
will also enable comparison with the previous BCAMHS 1999-2002, which used very 
similar methodology, adding to prior findings about which children do and do not use 
services and may be under served (see Chapter Two: Background). 
Study 2: Primary care prescribing of ADHD and psychotropic medication in 
young people with ADHD in the Clinical Practice Research Database 2005-2013 
(Chapter Four) 
Chapter Four presents the second study, which is an analysis of primary care 
prescribing of ADHD and other psychotropic medications in people with ADHD over 
the transition period up to the age of 27, using a cohort from the Clinical Practice 
Research Datalink (CPRD) from 2005-2013. The study also includes a survival 
analysis of the time to cessation of ADHD medication from age 16. As explored in 
more detail in Chapter Two, earlier studies of ADHD prescribing using general 
practice databases in the UK have covered the periods 1999-2006 in the CPRD 
(Wong et al. 2009) and 2003-2008 in the Health Improvement Network (McCarthy et 
al. 2012a & 2012b). Past research has concentrated on the prescribing of ADHD 
drugs rather than also examining other psychotropic medication, which is particularly 
relevant in ADHD due to the high prevalence of comorbidity that may be under-
treated or obscure the ADHD symptoms(Asherson et al. 2007).  New guidance on 
prescribing in transition and in adults was released by the British Association for 
Psychopharmacology in 2007 (Nutt et al. 2007), and later by NICE in 2008 (NICE 
2008b). No UK study has therefore to date examined prescribing and time to 
cessation using data collected since the introduction of the NICE guidance. 
Understanding more recent patterns both of prescribing of ADHD medication and of 
other psychotropic medications will therefore allow greater understanding of current 
practice in treating ADHD and its comorbidities in adolescents and adults, and 
contribute to recommendations for treatment and training. 
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Study 3:  Young people’s experiences of transition from child to adult services 
with ADHD (Chapter Five) 
The final study is a qualitative interview study of the experiences of transition of 
young people with ADHD recruited from CAMHS, paediatrics and Adult ADHD 
services. Transition for this group is acknowledged to be especially challenging, with 
a number of barriers identified by professionals (Wong et al. 2009, Belling et al. 
2011, Hall et al. 2013). Consequently, keeping young people engaged with existing 
services, and involved in developing appropriate care is crucial.  However, the 
perspectives of this ‘hard-to-reach’ population have not been well studied, with only 
one recent UK qualitative study by Swift et al. (2013) directly seeking their 
experiences. A clear gap in understanding therefore exists in understanding their 
vision of what services would help them and why might they disengage, which is 
directly relevant in creating functional and acceptable transition pathways. 
This chapter has provided a brief introduction to the research problem, and outlined 
the aims and justification for the constituent studies. In Chapter Two, the research 
and policy background is examined in more detail, to highlight the existing gaps in 
knowledge. 
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Chapter Two: Background 
Chapter Two presents a review of the research and policy background to the three 
studies in the PhD. This chapter begins with a discussion of current knowledge about 
service access and contact in children with mental health problems. It then examines 
the evidence for the effectiveness of services and methodological questions relating 
to outcome measurement. The chapter finishes by assessing the challenges of the 
transition period in young people with ADHD and the need to understand current 
prescribing practice in this group. 
2.1 Services for children with mental health problems 
 
Increasing recognition of the scale and significance of mental health problems in 
childhood has led to attempts to improve and expand prevention and provision over 
the last two decades in the UK. The National Service Framework for Children, Young 
People and Maternity Services in 2004 included a section on child mental health 
prioritising a comprehensive CAMH service and emphasising increased accessibility 
of services (Department of Health, 2004).  The final report of the National CAMHS 
Review in 2008 acknowledged that significant expansion of services had taken place 
over the intervening time, from 2005 to 2008, but expressed concern about 
unwarranted variation both in access to services and in the implementation of 
recommended interventions (Department of Health 2008a). More recent policy 
developments have included the introduction of the CYP IAPT programme, and the 
Future in Mind report published by the Department of Health (2015) which are 
described further in Section 2.1.8 below. 
2.1.1 Service activity data 
In the tiered system of services for children with psychiatric disorders, many children 
are seen in Universal or Targeted services, such as primary care, youth services, 
paediatric clinics or education. The diversity of these providers means that there is 
no aggregated source of activity data. In contrast, CAMHS Benchmarking Reports, 
recently introduced in 2011 by the NHS Benchmarking Network (2015), provide 
information about the numbers of children referred to and seen by services by 
mapping activity within CAMHS, covering 79 provider organisations at last report in 
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2015. Referral rates to Tier 1-3 averaged 3,051 referrals per 100,000 children aged 
0-18 years in this period but rates ranged from less than a hundred to over seven 
thousand referrals per 100,000 in different providers. The average figure for total 
contacts with CAMHS was 19,158 per 100,000, and again there was considerable 
variation from fewer than three thousand to more than 40,000 contacts per 100,000.  
The report concluded that such variation in referrals and activity were influenced not 
only by demand reflecting need, but by current and historic capacity levels, local 
service cultures and configurations, and of course funding (NHS Benchmarking 
Network 2015).  Figures for referrals, waiting times and contacts have all increased 
since the previous benchmarking in 2013/14; with referrals increasing by 11% and 
mean waiting time standing at 32 weeks compared to 22 weeks in 2013/14. 
2.1.2 Population surveys of service contact 
Whilst service activity data is essential to examine variation, and in understanding 
the demands on services, it is limited by being unable to capture data on children 
who are not referred for help. Comparisons of activity can be made with population 
estimates of prevalence, but this is a crude measure of unmet need.  Furthermore, 
the tiered system means that the majority of mental health related contacts may take 
place outside specialist child mental health services, for example in schools, GP 
surgeries and paediatric clinics.  As there is no integrated system that collates such 
activity together, population surveys therefore still remain key methods in estimating 
the proportion of those in need (i.e., who have a psychiatric disorder) who have 
contact with services.  
In the UK, the British Child and Adolescent Mental Health Surveys (Meltzer et al. 
2000, Green et al. 2005), which took place in 1999 and 2004,  are one of the chief 
sources of information on a population scale about mental health related contacts 
with public sector services. The surveys questioned parents about their child’s 
mental health related contact with a variety of public sector services and 
professionals, with the main categories being: teachers, special education, CAMHS, 
primary care, paediatrics and social workers. The results of a secondary analysis of 
the 2004 survey are discussed in the BCAMHS 2004 analysis in Chapter Three. The 
1999 survey reported that over a third of children who had a psychiatric diagnosis  
either at baseline or follow up had no contact with any services regarding mental 
health over the three year follow-up period (Ford et al. 2007b).  Almost a quarter of 
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those with a persistent disorder at both baseline and follow-up,  and two-fifths of 
those with an emerging disorder at follow up also reported no contact at all with 
services (Ford et al. 2007b).  
In terms of contact with specific services, a quarter of children with a disorder in 
BCAMHS 1999 had contact with specialist child mental health services (i.e. 
CAMHS), 28.9% reported contact with a GP, and 16% with paediatrics (Ford et al. 
2007b). Estimates of service contact amongst adults with psychiatric disorders from 
the 2007 Adult Psychiatric Morbidity Survey are not directly comparable due to 
different timescales, but again suggest a minority in contact with health services; 
39% of adults with a common psychiatric disorders had contact with any health 
service over the previous year; 38% with a GP and 18% with community mental 
health (National Centre for Social Research 2007).  For children, education 
professionals appear to be on the ‘front line’, accompanying an increasing focus on 
the role of schools in mental health promotion and intervention beginning with Every 
Child Matters in 2003 (HM Treasury 2003).Teachers were the most commonly 
contacted professional group regarding child mental health by parents of children 
with a psychiatric disorder in the 1999 BCAMHS – 41% reported contact (Ford et al. 
2007b). Contacts with education also constituted over 80% of all mental health 
related service activity in the US Great Smoky Mountains Study and often 
represented the common starting point for receiving other mental health services 
(Farmer 2003).  
Recent studies from the US, Australia and Europe report a minority of children and 
adolescents with mental health problems seeking help from or using any services, 
Whilst such estimates are not directly comparable to BCAMHS, due to varying 
service structures and definitions, the results imply that low levels of contact are not 
unique to the UK. For example, the 2012-2013 US National Comorbidity Survey 
found that fewer than half of adolescents with any mental health disorder had been 
in contact with any service during the twelve month period (Costello et al. 2014). In 
Australia, contact levels with primary care and with mental health services amongst 
young people aged 16-24 with a psychiatric disorder were lower than 25% in the 
national Survey of Mental Health and Wellbeing (Reavley et al. 2010). Similar 
estimates are reported by population surveys in European nations (Essau 2005, 
Zachrisson et al. 2006).  
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2.1.3 Predictors of service contact 
The majority of observational studies across Europe and the US report a higher 
proportion of children with ‘externalizing’ disorders in contact with services than 
children with ‘internalizing’ disorders (Zwaanswijk et al. 2003, Heiervang et al. 2007, 
Ford et al. 2008b, Costello et al. 2014). In the 1999 BCAMHS, 64% of children with 
hyperkinetic disorder and 49% of children with conduct disorders had mental health 
related contact with specialist services, in contrast with just 33% of those with 
anxiety disorders(Ford et al. 2008b). Findings on gender and service contact have 
been mixed. A number of studies have found boys to be more likely to have mental 
health related contact with various services than girls, even after adjusting for 
diagnosis or problem scores (Burns et al. 1995, Ford et al. 2008b, Merikangas et al. 
2010, Posserud and Lundervold 2013, Costello et al. 2014), whereas others report 
no association (Simpson et al. 2009, Wolfle et al. 2014). Interactions of age and 
gender have been reported whereby girls were reported to be less likely to use 
services in childhood and early adolescence but more likely to have contact than 
boys during the later adolescent years ( Young et al. 2011, Reijneveld et al. 2014)  
Severity and impact of psychopathology consistently predict mental health related 
contact with a variety of specialist and non-specialist services (Ford et al. 2008b, 
Reijneveld et al. 2014, Langer et al. 2015). Specific predictors of contact with 
specialist mental health services in previous studies include impact of 
psychopathology, stressful life events, neurodevelopmental disorders, parental 
socio-economic status, contact with primary care and  ‘reconstituted’ or other non-
traditional family types (Zwaanswijk et al. 2003, Ford et al. 2008b, Amone-P'Olak et 
al. 2010, Young et al. 2011). 
2.1.4 Service contact and unmet need 
Understanding how many children with disorders are not in contact with services 
provides an indication of the scale of unmet need. It cannot be assumed, however, 
that all children who do come into contact with services will have their needs met. 
Data remain lacking on exactly which psychological and pharmacological 
interventions children seen in services actually receive. This gap was highlighted in 
the recent Chief Medical Officer’s report, and may be addressed to some extent by 
the new CAMHS Minimum Dataset (Davies 2014). Furthermore, a variety of factors 
will influence children’s needs and outcomes including:  the existence of effective 
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treatment strategies in the first place, service variation in implementing evidence 
based practice, fidelity of adoption of such interventions, and the complexity and 
trajectory of any individual’s psychopathology and psychosocial context.  
2.1.5 Evidence based interventions in child mental health 
According to Hoagwood et al. (2001, p.1180) the term ‘evidence based’ is used to 
“differentiate therapies… that have been studied with varying degrees of rigor from 
therapies that are used but have not been studied or have not been studied well”. 
The authors argue that the multiple variables inherent in psychosocial interventions 
in particular create challenges in studying these therapies, which may be intensified 
by the nature of the changing stages of child development. Nonetheless, there has 
been increasing focus on developing appropriate methods to trial interventions such 
as parenting programmes, cognitive behavioural therapy and family therapy amongst 
others. In the UK, the CYP IAPT programme represents an initial attempt to widen 
the delivery of psychotherapies for which there is such an evidence base.  According 
to the programme, CYP IAPT now works with CAMH services covering 68% of the 
child population (NHS England 2016).  
There are well-recognised barriers and facilitators to the introduction and full 
implementation of evidence based interventions, which relate to clinicians, services, 
and individual patients (Garland et al. 2013, Novins et al. 2013). Clinician factors 
include differing attitudes towards interventions, preferences for delivery and skills to 
correctly provide the treatment. The perception from services may be that resources 
are too scarce to deliver the intervention at the required frequency and intensity, or 
to provide staff with time for training, although this might prove a false economy. The 
child and family constitute another variable in this process. Engagement with 
services can be challenging and linked to myriad socio-cultural influences; 
consequently children and their families may be unable or unwilling to complete a full 
course of treatment. Children seen in clinical practice often have more comorbidities, 
more severe disorders and face greater psycho-social adversities than those who 
take part in trials to establish the evidence base (Garland et al. 2013, Weisz et al. 
2013).These differences have implications not only for the successful 
implementation of interventions, but for the applicability of the results of clinical trials. 
Consequently, the innate superiority of evidence based interventions to ‘usual care’ 
has been called into question (Kazdin 2013, Weisz et al. 2013). Weisz et al. (2013) 
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in their meta-analysis of psychotherapies found that the advantages of evidence-
based psychotherapies compared to usual care were statistically and clinically non-
significant in samples of clinically referred and diagnosed young people. Deighton et 
al. (2015), using naturalistic service collected data similarly reported no significant 
difference in outcome between evidence based practice and non-evidence based 
practice in children with conduct disorders, but a significantly greater improvement 
according to child self report in children with emotional disorders. In contrast, Hurst 
et al. (2014) did report differences in pre- and post- intervention parent reported SDQ 
scores when using routine outcome measurements to examine evidence-based 
parenting programmes in children with conduct disorders. The increased use of such 
routine outcome measurements in UK CAMHS (see section 2.1.8 below) is likely to 
provide more clarity about the benefits of implementing evidence based practices in 
clinical settings, and is an evolving field. 
2.1.6 The effectiveness of ‘usual care’ 
Whilst individual evidence based interventions exist, the effectiveness of usual care 
in child mental health services has not been conclusively demonstrated. Evaluating 
usual care is an area fraught with difficulty in terms of measuring and interpreting 
outcome data. Usual care (sometimes referred to as ‘treatment as usual’ in trials) 
can be defined as the routine care as opposed to an intervention delivered in a trial 
setting  and may not consist of a single or specific intervention, but encompass a 
broad range of management as delivered by each individual clinical team and 
service configuration (Freedland et al. 2011).  Consequently, usual care is highly 
diverse and context specific, meaning trials using a usual care control group must be 
interpreted with care, as argued by Freedland et al. (2011). Similarly, statistical and 
measurement phenomena complicate attempts to measure change, and to attribute 
change to service use, particularly where there is no comparison group.  Regression 
to the mean occurs due to random error, so that large or small scores tend to be 
followed by measurements closer to the mean (Barnett et al. 2005). This can result 
in difficulty distinguishing change that is due to an intervention such as service use, 
from random change. Another phenomenon in repeated measurements is 
attenuation, whereby respondents in studies tend to report more problems in the first 
questionnaire or interview, and fewer thereafter, potentially due to respondent 
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fatigue. This may result in an improvement in scores without an accompanying 
improvement in symptoms (Jensen 1995, Ford et al. 2009). 
Some studies using datasets of children seen in community mental health care have 
reported improvement in behavioural and emotional symptoms and goal based 
outcomes over the shorter term (4-6 months), although symptom improvement effect 
sizes were small to medium (Trask and Garland 2012, Edbrooke-Childs et al. 
2015a). These studies suggest that children receiving ‘usual care’ experience some 
improvement, yet this cannot be directly attributed to the care itself without a control 
group, and can clearly be affected by attenuation as described above. Other studies 
of children and adolescents in receipt of usual care services report variable 
outcomes, with some cases deteriorating over the course of treatment and others 
experiencing no change (Manteuffel et al. 2008, Warren et al. 2010). A number of 
longitudinal observational studies, which analysed the association between reported 
contact with  mental health services and outcomes failed to detect any association 
between contact with usual care and improved outcomes (Zwaanswijk et al. 2006, 
Jörg et al. 2012). The TRAILS study in the Netherlands reported problem scores for 
those who had and had not had contact with mental health services, adjusted for 
baseline problem scores and common confounding factors. The authors found 
poorer outcomes in terms of problem scores in those in contact with services 
compared to those without contact; and outcomes were poorest in those who were in 
contact over a longer period (Jörg et al. 2012).  
There are a number of considerations in the interpretation of these results, which do 
not necessarily imply that services are not effective. Observational studies are 
complicated by inherent limitations such as residual confounding and confounding by 
indication when attempting to compare groups. Interpretation should be influenced 
by what ‘optimal outcomes’ might be for children with disorders and how outcomes 
will be influenced by the natural trajectories of childhood psychiatric disorders 
(Costello and Maughan 2015). Children with the same disorder and symptom 
severity when measured at one or two time points may still be on different 
trajectories. Subsets of children that meet the same diagnostic criteria have been 
shown to experience chronic and severe difficulties, whilst others have more 
transient problems (Pingault et al. 2011, Chaiton et al. 2013). For example, 
depressive and anxiety symptoms have been shown to follow stable high trajectories 
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in subgroups of adolescents (Van Oort et al. 2009, Broeren et al. 2013). Angold et al. 
(2000) in their analysis of specialist mental health service use in the multi-wave 
Great Smoky Mountains Study observed a positive effect of service use on 
symptoms only after controlling for pre-treatment trajectory. They also noted that 
children who would later receive treatment exhibited higher levels of 
psychopathology than those with untreated need and that these children 
demonstrated deterioration before using services. This underlines the importance of 
understanding trajectories in interpreting data on symptom change.  
2.1.7 Outcome measurement 
Despite the challenges discussed above, there is a clear move towards the routine 
collection of outcome data in CAMHS in England, which is already embedded within 
the CYP IAPT programme and supported by the work of the CAMHS Outcome 
Research Consortium.  The latest Benchmarking report found that outcomes data 
was routinely collected in 95% of participating CAMHS services in 2012/2013, 
increased from 88% in the previous year (NHS Benchmarking Network 2015). Whilst 
some initial datasets drawn from this routinely collected data have been analysed, 
such work is at an early stage, but has considerable potential (Edbrooke-Childs et al. 
2015a).  
There remains debate over the choice of appropriate outcome measures. Broad 
measures such as the well validated Strengths and Difficulties Questionnaire (SDQ) 
developed by Goodman (1997) have the benefit of allowing aggregation and 
comparison across teams and services (Lee et al. 2005, Edbrooke-Childs et al. 
2015a). Capturing a wide range of emotional and behavioural difficulties and 
measuring impact, the SDQ can also be applied throughout services including 
CAMHS, social services and education. On the other hand, it has been argued that 
the SDQ may underestimate the effectiveness of services, particularly in specialist 
services where specific, more focused outcome measures might be more relevant 
and where the SDQ has detected a smaller effect size than more specialist 
questionnaires (Lee et al. 2005). A case has also been made for the use of 
idiographic instruments such as the Goal Based Outcome tool, which aims to 
measure progress towards goals identified jointly by patient and clinician (Edbrooke-
Childs et al. 2015a). A clear advantage of such idiographic measures is their 
relevance to individual children and their families, but by the same token comparison 
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across groups may be less valid than for broader measures; and the question of 
subjectivity and vulnerability to manipulation when meeting targets should not be 
dismissed (Edbrooke-Childs et al. 2015a).   
2.1.8 Current policy and recommendations 
This section briefly summarises current policy and recommendations in three areas: 
service commissioning, service transformation and CAMHS data. 
Commissioning of Child Mental Health care 
The Health and Social Care Act of 2012 is the most recent reorganisation of the 
commissioning and delivery of care (HM Government 2012). Whereas previously 
Primary Care Trusts under the oversight of Strategic Health Authorities would be the 
primary commissioners of child mental health services, under the Act such 
responsibilities were largely devolved to Clinical Commissioning Groups (CCGs). In 
contrast to the top-down approach to implementation of the Act, one of the stated 
aims was to liberate clinicians to make decisions about the needs of their local 
population(Department of Health 2010a).  However, concerns were raised about a 
lack of expert public health and commissioning support to CCGs to assist the new 
bodies in this role (West 2012). There is some evidence to suggest that children with 
mental health problems may not be well served by the new system. Barely two years 
down the line in 2014 the House of Commons Health Select Committee report on 
CAMHS delivered this assessment of the situation: “demand for mental health 
services for children and adolescents appears to be rising, many CCGs report 
having frozen or cut their budgets. CCGs have the power to determine their own 
local priorities, but we are concerned that insufficient priority is being given to 
children and young people’s mental health” (House of Commons Health Select 
Committee 2014, p.4). Some of the most recent figures on budgets and waiting times 
are discussed in the context of the findings of the thesis in the final Overarching 
Conclusions chapter. 
The Select Committee report recommended national oversight of CAMHS; an 
increase in monitoring by NHS England and the Department of Health of spending 
levels on CAMHS by CCGs, and further support in order to address service variation 
and standards. There is  nonetheless likely to be tension between a commissioning 
structure set up to encourage local decision making and responsibility and increased 
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central oversight and intervention to ensure that mental health services do not 
remain overlooked and underfunded.  
Service transformation 
The Future in Mind report was published in 2015, and is based on the themes 
identified by the Child Mental Health and Wellbeing Taskforce (Department of Health 
2015). Although CAMH services were described in the previous section of this thesis 
as being largely conceptualised in tiers, the Future in Mind report advocates moving 
from a ‘tiered’ service to a pathway based service in order to remove artificial 
barriers to care. Linking with the Select Committee report, Future in Mind also 
envisages joint commissioning by CCGs and local authorities, as well as local 
transformation plans to act as a driver. However, at this early stage, the effects of 
planned service transformation on outcomes are yet to be seen.    
Data and outcomes measurement 
There has been an increasing policy consensus on the importance of data in 
improving child services. The 2013 Chief Medical Officer (CMO) report noted a lack 
of information on interventions currently offered to children and their outcomes 
(Davies 2014); and the need for more and better evaluations of interventions, whilst 
the Select Committee’s opinion was that: “those planning and running CAMHS 
services have been operating in a “fog”” (House of Commons Health Select 
Committee 2014, p4). More specifically, both the CMO and the Children and Young 
People's Health Outcomes Forum identified outcome measurement in services and 
the need for a regular prevalence survey as key priorities for the future (Department 
of Health 2012, Davies 2014).  
2.1.9 Summary 
The first study in this thesis uses the British Child Mental Health Survey 2004 to 
examine some of the questions discussed above, including mental health related 
contact with services, the trajectories of psychopathology over time among children 
using and not using services and the association between service contact and 
outcome in terms of psychopathology at follow-up. The second and third studies 
focus on ADHD, and specifically, young people with the disorder who are in 
transition from child to adult services. The second part of this Background chapter 
examines this topic in more detail. 
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2.2 Transition from child to adult services in young people 
with ADHD 
 
2.2.1 The importance of transition 
Young people in late adolescence and early adulthood constitute a distinct group 
with distinct needs, which may not be easily met by services catering to the wider 18 
to 65 year old ‘adult’ age range. The term ‘emerging adulthood’ has been used to 
describe this developmental stage (Arnett 2000). Whilst 18 years is considered the 
age of legal maturity, the brain is still developing and carrying out activities such as 
pruning and myelination until the mid-twenties (Johnson et al. 2009).  Furthermore, 
factors such as increasing time in education and the disproportionate impact of the 
global recession on the young mean that this age group also have different social 
and economic experiences to older adults (Arnett et al. 2014). 
There has been increasing recognition of the challenges involved in moving from 
child to adult services. The UK Department of Health Good Practice Guide ‘Getting it 
right for children and young people’ was one of the first to focus on transitions in 
health care. The report used the definition of transition as “a purposeful, planned 
process” of moving from child to adult services, as opposed to a single event of 
‘transfer’ of care (Department of Health 2006, p14). However, the 2010 Kennedy 
review of children’s services suggested that adolescents were still seen as a:  
“forgotten group, caught between services for children and adults and therefore also 
between bureaucratic barriers and professional spheres of influence” (Department of 
Health 2010b, p38). The report considered that transition in reality often therefore 
amounted to no more than a disruptive ‘transfer’ of care. 
Each condition presents its own challenges in negotiating this developmental stage, 
for example, taking increased responsibility for injections and glycaemic control in 
diabetes. Adolescence is also the peak time for new psychiatric disorders to develop 
(Copeland et al. 2011), and the difficulties for these young people may be 
compounded by cultural divides between child and adult mental health services and 
by the extent of persisting stigma surrounding mental ill-health. People with ADHD 
may be particularly affected by historical perceptions of the disorder as being a 
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childhood condition, which are still likely to shape their experience of transition in 
terms of attitudes, understanding and services provided. Two of the three studies in 
this thesis focus on transition in young people with ADHD; and the rationale and 
background to this research is therefore discussed further below. 
2.2.2 The impact and importance of ADHD and the 
effectiveness of treatment 
An extensive literature base describes adverse outcomes for children, adolescents 
and adults with ADHD over a wide spectrum of interlinked domains of function, 
including: education, occupation, comorbid psychiatric disorder, relationships, 
substance misuse, general health, obesity, criminality and accidents and injuries 
(Hoare and Beattie 2003, Biederman and Faraone 2006, Barkley and Brown 2008, 
Groenman et al. 2013, Kang et al. 2013, Chang et al. 2014, Dalsgaard et al. 2015, 
Uchida et al. 2015, Cortese et al. 2016).   Associated with this is the high cost to 
health, social and education services, estimated at over £5000 per adolescent in a 
12 month period in one UK study (Telford et al. 2013).  
There is evidence for the effectiveness of  pharmacological interventions in children 
and adults in terms of short term symptom reduction, but also across a wider range 
of outcomes including quality of life (Coghill 2010, Faraone and Buitelaar 2010, 
Faraone and Glatt 2010). A review of outcome studies suggested that people with 
treated ADHD experienced better outcomes than those with untreated ADHD in the 
categories of academic and occupational achievement, self-esteem, obesity, drug 
use and addictive behaviour and antisocial behaviour (Shaw et al. 2012). 
Pharmacological treatment has also been associated with a reduced risk of serious 
road traffic accidents and criminal convictions in males with ADHD and with reduced 
emergency department attendance and accidents and injuries in children (Dalsgaard 
et al. 2015,  Lichtenstein et al. 2012, Chang et al. 2014).   There is also evidence to 
suggest benefits from non-pharmacological management including parent training 
and school-based interventions (Fabiano et al. 2015, Richardson et al. 2015). 
In 2008 NICE recommended medication for adults with ADHD for the first time as a 
first line treatment, as well as psychological support such as Cognitive Behavioural 
Therapy (CBT) and also recommended re-assessment at the time of transition to 
ensure appropriate management could be provided (NICE 2008b). NICE estimated 
in their guidance that only 1-2% of adults with ADHD were receiving treatment 
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implying that at the time few young people continued their medication into adulthood 
(NICE 2008a). 
2.2.3 Persistence of ADHD into adulthood 
ADHD was previously considered to be a developmental condition, and therefore to 
affect only children and younger adolescents. Historically, services have reflected 
this and stopped working with young people at 16 or 18 years of age in the UK 
(Young et al. 2011). The findings of follow-up studies have naturally been influenced 
by how persistence of ADHD is defined: as meeting full, usually Diagnostic and 
Statistical Manual IV (American Psychiatric Association 2000) criteria, or as still 
experiencing symptoms or impairment of functioning. Similarly, the changing nature 
of ADHD symptoms into adulthood has also meant that persisting symptoms might 
go unrecognised, as earlier diagnostic criteria such as those in the DSM-IV were 
written for application to children (Kooij et al. 2010).   The 2006 meta-analysis by 
Faraone et al. (2006) attempted to analyse data from multiple follow-up studies and 
reported both persistence of meeting full diagnostic criteria and persistence of ‘partial 
remission’, where cases still experienced residual symptoms and impairment. 
Persistence of full symptoms at age 25 years stood at only 15%, but more strikingly 
the percentage experiencing partial remission was estimated at between 40% and 
60% (Faraone et al. 2006).  
More recent studies have yielded comparable results; an analysis of girls with ADHD 
in the US with a mean age of 22 years at follow-up found that two –thirds still met full 
or subthreshold diagnostic criteria (Biederman et al. 2010). Cheung et al.’s (2015) 
UK study had a lower mean age at follow-up (18.7 years) and reported that almost 
eight in ten participants continued to meet clinical criteria. There still remain relatively 
few studies which have followed participants into their thirties and beyond, and 
research into persistence in older adulthood has relied on retrospective self reports 
which is problematic in terms of recall bias and sample selection (Guldberg-Kjar et 
al. 2013, Semeijn et al. 2015). The Dunedin cohort study was able to administer 
adult ADHD diagnostic interviews to participants at the age of 38 and conduct both 
follow-forward and follow-back analyses (Moffitt et al. 2015). Surprisingly, they found 
little overlap between those meeting criteria at this age, and those who had earlier 
met DSM criteria as children, the authors concluding that, in this cohort, ‘the adult 
syndrome did not represent a continuation from a childhood-onset 
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neurodevelopmental disorder’ (Moffitt et al. 2015, p.6). This finding warrants interest 
and replication, however for the purposes of studying ADHD over the transition 
period its applicability is limited by the lack of ADHD assessments during the 
participants’ twenties.  
 Arguably, research into the outcomes of clinically referred samples may not be 
representative of all children with ADHD, but on balance the evidence is supportive 
of persistence of ADHD symptoms over the transition period and beyond in a 
significant proportion of cases studied.  Factors such as higher parent rated 
symptoms in childhood, lower IQ, lower socio-economic status, psychiatric 
comorbidity, family history of psychopathology, and school functioning at baseline 
have been linked with persistence of ADHD symptoms and poorer outcomes, adding 
to the vulnerability experienced by this group (Cheung et al. 2015, Uchida et al. 
2015). 
2.2.4 ADHD as a controversial diagnosis 
Transition may be a particularly difficult time for young people with ADHD, given past 
and present controversies surrounding the condition. Much debate has been 
provoked by questions regarding the validity of the ADHD diagnosis, and to what 
extent it represents the creeping ‘medicalisation’ of childhood (Moncrieff and Timimi 
2010, Singh and Wessely 2015). The existence of ADHD in adults has been even 
more controversial. It has been argued by Moncrieff and Timimi (2010, p.547) that 
adult ADHD represents little more than ‘aggressive marketing’ by pharmaceutical 
interests, and that medication represents ‘cosmetic psychopharmacology’.  Key 
aspects of this case revolve around the dimensional nature of ADHD, the 
‘subjectivity’ of a diagnosis and the multifactorial aetiology of the condition. None of 
these characteristics are exclusive to ADHD and apply to many other disorders; 
nonetheless the fact that ADHD medications are the most commonly prescribed 
psychotropic drugs in children (Steinhausen 2014) means that this is a sensitive 
subject that arouses concerns about over-diagnosis and over-treatment.  
Such anxieties are prominent in the minds of the public and parents, with surveys 
suggesting that many members of the public thought that ADHD was diagnosed and 
children treated too frequently (Bussing et al. 2012, Partridge et al. 2014).  Concerns 
have been raised by clinicians about the lack of a holistic approach and limited 
access to the non-pharmacological support recommended as first line treatment for 
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mild and moderate ADHD (Bowers 2014). The potential subjectivity of classifying the 
disorder as mild, moderate or severe may further contribute to fears about over-
reliance on medical treatment and to calls for conservative management (Thomas et 
al. 2013, Batstra et al. 2014) On the other hand, although the numbers of children 
treated with medication for ADHD has undoubtedly risen over time in the UK, 
estimates of rates of treated ADHD remain lower than estimates of 
prevalence(McCarthy et al. 2012b). Clinic and case note based studies have 
similarly found no evidence of over-diagnosis or inappropriately prescribed treatment 
within the CAMH services examined (Foreman and Ford 2008, Foreman 2010).  
Perhaps influenced by the media attention and controversy, attitudes from 
professionals towards ADHD are consequently also more variable than they might 
be for many other mental or physical disorders. A recent review of ADHD in schools 
suggested that many teachers held ‘polarised’ views on ADHD, believing it to be 
either of social or biological origin; and those attributing a social cause to ADHD 
widely believed that symptoms originated in the home with poor parenting 
(Richardson et al. 2015). This had a consequent effect on their views on whether 
assessment or interventions would be necessary or helpful. Research into attitudes 
and knowledge amongst health professionals so far has largely consisted of surveys 
of small (n<50) samples, which are likely to be prone to bias in terms of self-selection 
of respondents.  A recent UK survey of professionals working in adult mental health 
services reported that 73% thought ADHD was a valid diagnosis, although only 41% 
thought that treatment for ADHD was effective(Hall et al. 2013).  In terms of 
knowledge and confidence, Ahmed et al. found  that 50% of 38 adult psychiatrists 
surveyed were ‘confident’ in diagnosing ADHD  in adults and only 63% felt confident 
to prescribe medication, with most identifying a need for further training (Ahmed et 
al. 2009).  
2.2.5 Transition pathways in ADHD 
This section of the review concentrates on transition in the UK. The majority of 
children with ADHD in the UK are seen in Child and Adolescent Mental Health 
services although a significant minority are instead treated in paediatric medical 
services, depending on local service configurations (NHS Benchmarking Network 
2015). Young people with ADHD then undergo transition from child services to adult 
services at around the age of 18 in most parts of the country.  Their destination will 
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be influenced by multiple factors including their wishes, the persistence and severity 
of their symptoms, their comorbidities and the available services locally.  Possible 
pathways are illustrated in Figure 2.1 below and may involve referral to Adult Mental 
Health Services (AMHS), referral to a specialist Adult ADHD clinic, or transfer of all 
care back to the GP. Some may disengage or have their referrals to services 
rejected, but ultimately return to mental health services further down the line, for 
example, if they develop psychiatric co-morbidities or are assessed in the criminal 
justice system. Simultaneously, adolescents might be moving away for work or 
higher education, meaning there may also be a geographical shift in where their care 
is delivered. Maintaining continuity of treatment and engagement with services at this 
time is important, but often young people leaving CAMHS enter what has been 
described by Young et al. (2011) as a ‘twilight zone' gap in care. The factors 
contributing to this are explored in further detail below. 
 
Figure 2.1: Formal and informal transition pathways for young people with 
ADHD 
 
Child services: 
usually CAMHS or 
paediatrics 
Referral to Adult Mental 
Health Services 
(AMHS) 
Referral rejected: sub-
threshold, not severe or 
enduring, no service 
available 
Transfer  all care to 
primary care 
Adult ADHD clinic 
General AMHS 
Transfer all care to 
primary care 
Primary care manage 
ADHD with specialist 
input e.g. from ADHD 
clinic 
Primary care 
management only 
Disengagement with 
services  
Referral/involvement 
with other services: 
social services, criminal 
justice system 
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2.2.6: Transition from a professional perspective  
At an organisational and professional level, several key and inter-related barriers to 
transition between child and adult services for young people with ADHD emerge in 
the literature. One of these is resources, or lack of services to meet need. Belling et 
al. (2014) interviewed CAMHS and AMHS professionals about difficulties in transition 
for all mental health conditions, and found resources were a central theme. 
Workloads in AMHS were thought to contribute to an overly rigid interpretation of 
eligibility and age criteria for services, and to an emphasis on meeting the needs 
only of those with ‘severe and enduring’ mental disorders. A gap repeatedly 
identified was for provision for young people with Autism Spectrum Disorders (ASD) 
and ADHD. Findings from a recent national survey of mental health trusts also 
suggested that a high proportion of young people with ADHD were discharged 
prematurely from CAMHS due to a lack of suitable adult services (Hall et al. 2015); 
surveys of paediatricians have similarly identified ongoing needs for care in their 
patients with ADHD, but a gap in service provision (Marcer et al. 2008, Taylor et al. 
2010).  
Another, related difficulty in transition in mental health is the acknowledged 
organizational and cultural differences which exist between CAMHS and AMHS 
(McLaren et al. 2013). CAMHS and AMHS professionals interviewed by Belling et al. 
(2014) also cited differences including a lack of clarity on service eligibility and 
different thresholds between CAMHS and AMHS, with AMHS seen as prioritising 
only ‘serious’ psychosis and forensic risks. Hall et al. (2013), in their survey of East 
Midlands mental health professionals found a lack of consensus between child and 
adult services in their view of what should be provided post-transition for people with 
ADHD. Only 65% of AMHS respondents agreed that AMHS should provide services 
for this group, and furthermore, just 54% felt they possessed the skills to manage 
adult ADHD (Hall et al. 2013). Ambivalence amongst AMHS and even CAMHS 
professionals regarding the validity of adult ADHD as a diagnosis, and about the 
effectiveness of medication is also likely to influence organisational culture and 
practice (Ahmed et al. 2009, Hall et al. 2013, Belling et al. 2014). 
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2.2.7 Perspectives of young people in transition 
CAMHS and AMHS professionals also suggested that transition might be sub-
optimal where young people themselves did not engage with services over this 
period(Hall et al. 2013). The perspective of service users themselves is less studied 
than that of professionals, possibly because this group is generally understood to be 
‘hard to reach’, with difficulties in recruitment cited by various researchers (Wong et 
al. 2009, Hovish et al. 2012, Swift et al. 2013) (see also Chapter Four). The TRACK 
study included qualitative interviews with 11 service users undergoing transition from 
CAMHS (Hovish et al. 2012).  Participants reported varying experiences of transition, 
but highlighted a number of helpful (preparation, consistency, parallel processes) 
and unhelpful (key worker changes, waiting lists) practices. The simultaneous 
changes they were dealing with alongside CAMHS transition were described as 
being powerful influences on their experience. However, the TRACK study did not 
include any young people with ADHD diagnoses. The particular challenges faced by 
those with ADHD over the transition period mean that their experiences may be 
different. 
Swift et al. (2013) carried out qualitative interviews with ten young people with ADHD 
based in the Midlands on their experience of transition from CAMHS to AMHS. A 
number of findings resonated with those reported in the TRACK study, for example, 
the importance of clinician qualities and relationships. There were other themes 
which may have been more specific to this group, such as the importance of service 
thresholds and concerns about not being accepted by services if they ‘only’ had 
ADHD without co-morbid mental health problems. Responsibility for care and the 
role of the parent (who may be providing considerable practical support in terms of 
planning appointments and medication) were also reported as emerging themes 
which might be of particular relevance to adolescents with ADHD.  Thus far, this is 
the only published study of the experiences of young people with ADHD in transition 
in the UK, and the findings will necessarily be influenced by the specific local service 
configurations. Clearly, the perspectives of this vulnerable group merit further study 
in various service settings and constitute a gap in research.  Despite the challenges, 
understanding young peoples’ vision of what services would help them and why they 
engage or disengage is key to creating functional and acceptable transition 
pathways. 
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2.2.8 Prescribing in young people with ADHD over the 
transition period 
On leaving CAMHS or other child health services at the age of 16-18 years, young 
people may be referred to specialist services, return to primary care, or lose contact 
altogether with sources of help and support. Some may already have stopped 
medication and this may be entirely appropriate for a variety of reasons: personal 
preference, side effects, symptom reduction, using alternative coping strategies or a 
change in their daily environment e.g. from school to work (McCarthy 2014).  
However, for those preferring to remain on medication, arrangements for 
continuation of prescribing may be less clear, particularly where there is no specialist 
clinician in adult services willing to oversee or review primary care prescribing 
(Young et al. 2011).  Despite the publication of NICE guidance in 2008, in many 
localities prescribing for adults with ADHD may not be widely established and 
accepted (Hall et al. 2013, Matheson et al. 2013). A recent qualitative study of the 
experiences of adults with ADHD described participants’ perceptions of 
‘overwhelmingly negative and sceptical attitudes towards ADHD by health 
professionals’, including experiences where GPs or pharmacists were unwilling to 
prescribe or stock medication, causing problems with access and continuation of 
medication (Matheson et al. 2013) .  
Interviews with adolescents have highlighted some central themes regarding their 
perspectives on continuation of ADHD medication. Choosing to stop was interpreted 
as an exertion of autonomy by young people in a number of US and UK qualitative 
studies (Travell and Visser 2006, Wong et al. 2009, Brinkman et al. 2012). 
Participants interviewed by Brinkman et al. (2012) expressed doubt and uncertainty 
about their future use of medication; some saw academic success as the primary 
purpose of treatment and therefore saw no need to continue their medication after 
school. Another prominent theme was trade-offs, weighing up positive effects against 
diverse negative effects including loss of an ‘authentic self’, side-effects, and 
embarrassment at taking medication. The role of services in cessation was little 
mentioned, with the exception of three participants in one UK study who reported 
stopping their medication as they no longer had access to treatment (Wong et al. 
2009). 
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Young adults in the UK are most likely to stop treatment around the time of leaving 
CAMHS, according to database studies of primary care prescribing. The CADDY 
study (Cessation of Attention Deficit Hyperactivity Disorder Drugs in the Young) used 
survival analysis to examine rates of cessation of ADHD medication in 15-21 year 
olds over the period 1999 to 2006 in the General Practice Research Database, which 
is now known as the Clinical Practice Research Datalink or CPRD (Wong et al. 
2009). The steepest reduction in prescribing was between the ages of 16 and 17, 
and was a decrease far greater than the estimated rate of remission of ADHD related 
difficulties (Faraone et al. 2006). A study of persistence using the Health 
Improvement Network, another primary care database found 38.5% of those starting 
treatment before the age of 12 remained on treatment beyond the age of 18 
(McCarthy et al. 2012a). Of those starting between 13 and 17, the rate of persistence 
was 42.8%. Again, the rate of cessation reported exceeded the estimated rate of 
persistence of ADHD.  
Rates of prescribing in adults have historically been low. An increase in the 
prevalence of prescribing in adults was reported over the period 2003-2008 in one 
UK primary care database, potentially due to increasing awareness of adult ADHD 
(McCarthy et al. 2012b). However, by 2008 total prescribing in 18-24 year olds stood 
at 1.122 per 1000, and at 0.079 per 1000 in 25-45 year olds; even allowing for a 
preference for non-pharmacological management amongst adults, and the decline in 
ADHD symptoms with age, these figures are markedly lower than the expected 
prevalence of adult ADHD, which is in the region of 2.5% or 25 per 1000 (Boe et al. 
2012).  
2.2.9 Prescribing and psychiatric comorbidities in ADHD 
There are two ways in which the identification and treatment of psychiatric 
comorbidities in ADHD are particularly relevant over the transition period. Firstly, 
comorbidities in ADHD are common, affecting over half of people with ADHD (Kraut 
et al. 2013, Jensen and Steinhausen 2015). Furthermore, the peak age of 
emergence for many of these disorders is in adolescence and early adulthood 
(Kessler et al. 2007, Copeland et al. 2011). Comorbidities may contribute to overall 
impairment and adverse outcomes, necessitating identification and appropriate 
management (Kooij et al. 2010, Bolea-Alamanac et al. 2014).  
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Secondly, moving from adolescence to adulthood, the clinical presentation of ADHD 
may also lead to under-treatment if the symptoms are mistaken for the signs of other 
common psychiatric disorders. For example, mood instability may lead to diagnoses 
of mood or personality disorders, when this may instead be due to the patient’s 
ADHD (Asherson et al. 2007). Women and girls may be particularly affected by 
misdiagnosis due to the higher preponderance of inattentive-type ADHD which may 
be harder to identify(Quinn and Madhoo 2014). It could be theorised that other 
psychotropic medications might then become substituted for ADHD prescriptions 
when the young person moves into adult services, as clinicians may be more familiar 
with prescribing for depression or anxiety, or treat other conditions in preference to 
ADHD (Ginsberg et al. 2014). The result may be missed opportunities to treat ADHD 
and the use of ineffective management strategies (Asherson et al. 2007). 
Despite the significance of psychiatric comorbidities in ADHD, prescribing for such 
conditions has been little studied using large databases. The CADDY study did not 
report on the prevalence of comorbidity prescribing in ADHD, but did examine 
prescription of another psychotropic medication as a predictor of cessation of ADHD 
medication (Wong et al. 2009). In the Cox regression model such prescriptions were 
not associated with stopping medication for ADHD. Using the Health Improvement 
Network to identify cases, McCarthy et al. (2013) surveyed the GPs of three random 
samples of adult cases with ADHD who had either discontinued treatment before 
adulthood, continued treatment into adulthood, or newly started treatment as adults. 
Of those who continued treatment into adulthood, a quarter were receiving or had 
received treatment for comorbid psychiatric disorders. In contrast, the majority (18 of 
31) cases who had newly started treatment as adults had been treated with 
medication for other psychiatric disorders before being diagnosed with ADHD; and 
11 continued to be prescribed such medication alongside treatment for their ADHD. 
Such findings, albeit from a small sample of cases, suggest that professionals may 
look to identify and treat other psychiatric disorders first in newly-diagnosed adults 
with ADHD, but also raises the question of whether those diagnosed with ADHD as 
children might be under-treated for their comorbidities. 
 2.2.10 Current policy and recommendations 
The importance of transition has been well-recognised in policy for over two 
decades, yet progress has been limited. A Health Select Committee report as 
43 
 
recently as 2014 still referred to transition from CAMHS to adult services as a ‘cliff 
edge’(Health Select Committee 2014, p.51). Although the report of the Children and 
Young Peoples Outcome Forum (Department of Health, 2012) proposed the 
inclusion of age appropriate services and effective transition as new outcomes 
indicators, these have not so far been adopted into either the NHS or CCG 
Outcomes Frameworks. Objective national methods to monitor progress therefore 
remain lacking. 
More positively, NHS England (2015) recently produced a service model 
specification for transition, identifying young people with ADHD and Autism 
Spectrum Disorders as a particularly vulnerable group. The model incorporates 
many good practice points ranging from transition care pathways to transparent 
criteria for gaining access to adult services.  There is nonetheless acknowledgement 
from NHS England that there will be places: “where commissioned adult services are 
not equipped or/ appropriate to provide NICE evidence -based care”, for example in 
ADHD, and where this is the case “this should be brought to the attention of the 
commissioners of services”(NHS England 2015, p.13).  Consequently, clear 
mechanisms do not appear to exist to hold commissioners to account for these gaps, 
or to ensure the provision of new or extended ADHD services. Furthermore, planned 
savings within social care and competing crisis pressures within mental health 
services will influence the implementation of recommendations, particularly where 
they are perceived to carry extra costs. Research into service user experiences and 
prescribing practice is therefore especially relevant in ensuring that any investment is 
meeting clearly identified healthcare needs. 
2.2.11 Summary 
This second part of the Background Chapter has sought to describe the context for 
the second and third studies in this thesis, and to introduce the gaps in knowledge 
which they aim to fill.  The analysis of prescribing in young people with ADHD will be 
the first to use the Clinical Practice Research Datalink to examine prescribing and 
time to cessation of ADHD medication since the introduction of the NICE guidance 
on ADHD in 2008. It will be complemented by the third qualitative study, which will 
seek to address some of the gaps in understanding of the experiences of young 
people with ADHD in transition using services and their needs and concerns.  
44 
 
Chapter Three next presents and discusses the results of Study 1: Mental health 
related service contact and trajectories of psychopathology over three years in the 
British Child and Adolescent Mental Health Survey 2004  
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Chapter Three: Mental health related service 
contact and trajectories of psychopathology 
over three years in the British Child and 
Adolescent Mental Health Survey 2004 
3.1 Introduction 
 
This chapter presents and discusses the results of a secondary analysis of data from 
the 2004 British Child and Adolescent Mental Health Survey (BCAMHS) (Green et al. 
2005). It begins by briefly revisiting some of the background from Chapter Two in 
order to introduce the analysis, followed by the aims and research questions. The 
methods section starts by describing BCAMHS 2004 and subsequently details the 
procedure for the secondary analysis. The results for each research question are 
then presented. Finally, the discussion reviews the key findings in the context of 
existing literature and policy, as well as outlining the strengths and limitations of both 
the dataset and the secondary analysis. 
As described in Chapters One and Two, approximately one in ten children meet 
criteria for a psychiatric diagnosis at any point in time (Costello et al. 2005); and such 
disorders also predict the development of psychiatric disorders in adulthood (Kim-
Cohen et al. 2003, Copeland et al. 2009). Children with disorders are also at higher 
risk for other adverse social, psychological and educational outcomes (Fergusson 
and Woodward 2002, Fergusson et al. 2009, Gibb et al. 2010, Klein et al. 2012, 
Copeland et al. 2015, Parker et al. 2015). Survey data from across the US, UK, 
Australia and Europe suggest significant unmet need in that many children and 
adolescents who meet criteria for disorders or score highly in terms of 
psychopathology rating scales do not come into contact with services (Essau 2005, 
Zachrisson et al. 2006, Reavley et al. 2010, Costello et al. 2014).  In the UK, analysis 
of the earlier 1999 BCAMHS by Ford et al. (2007b) found that a large minority (42%) 
of children who met criteria for a psychiatric diagnosis either at baseline or follow up 
reported no contact with services regarding mental health over the three year follow 
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up period.  Three-quarters had no contact with specialist child mental health 
services. 
However, even where children with disorders do come into contact with services, 
there are questions about the degree of effectiveness of routine care in child mental 
health services. The extent to which evidence based interventions are incorporated 
into routine care is largely unknown, and there are acknowledged challenges to 
delivery in terms of skill mix, resources, and complexity of caseloads (Garland et al. 
2013, Novins et al. 2013, Davies 2014). Studies of outcome data from child mental 
health service local datasets suggest that children receiving ‘usual care’ experience 
some improvement, (Trask and Garland 2012, Deighton et al. 2015, Edbrooke-
Childs et al. 2015a); and some also report greater improvements in those receiving 
evidence based interventions compared to those in receipt of usual care, although 
this is an emerging field (Deighton et al. 2015). However, such designs do not 
include a control group who were not in contact with services. In contrast, a number 
of observational longitudinal studies of service contact have failed to find an 
association between mental health service contact and improved outcomes in terms 
of psychopathology at follow-up (Zwaanswijk et al. 2006, Jörg et al. 2012) although 
the influence of residual confounding cannot be discounted. The measurement and 
comparison of outcomes is a complex field, and influenced by multiple factors 
including choice and interpretation of measure and by phenomena such as 
regression to the mean and attenuation (Ford et al. 2009, Edbrooke-Childs et al. 
2015a). Furthermore, symptoms of psychiatric disorders often fluctuate over time, 
and subsets of children may follow different trajectories; i.e. some demonstrate 
chronic and severe difficulties, and others have more transient problems 
(Zwaanswijk et al. 2006, Van Oort et al. 2009, Pingault et al. 2011, Chaiton et al. 
2013). With the growth of outcomes monitoring within child mental health services, 
an understanding of the trajectories of children using services is highly relevant in 
the measurement and interpretation of such data. 
This secondary analysis examines mental health related contact with a broad range 
of services over three years in children in BCAMHS 2004, as well as exploring the 
predictors of contact. It will enable comparison with BCAMHS 1999, which used very 
similar methodology. The study also explores the trajectories of psychopathology 
over three years in children who did and did not have contact with services, and 
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examines the association between service contact and outcome in terms of 
psychopathology at follow-up.  Based on previous work, such as that by Angold et al. 
(2000) it was anticipated that children who would later access services would 
demonstrate deteriorating mental health. When taken in conjunction with the 
diversity of what real world service contacts represent, as well as the observational 
methodology, it was not predicted that a clear improvement over time would be 
observed amongst children in contact with services. 
 
3.2 Aims 
 
The overarching aim of this study was to analyse mental health related service 
contact in relation to psychopathology over three years in a community sample of 
children aged 5 to 16 years. 
There are three main questions which this secondary analysis addressed: 
1. What services do children with psychopathology have contact with over a 
three-year period (2004-2007)? 
2. Which factors predict contact with services over the study period? 
3. What are the trajectories of psychopathology over time in children who do and 
do not have service contact; and are there differences in outcome in 2007 
between children who have or have not been in contact with services? 
3.3 Methods 
 
3.3.1 Overview of BCAMHS 
The survey used a multi-informant model, involving a face-to-face interview with a 
parent (and with the child if aged 11-16), plus a teacher questionnaire.  The key 
mental health measures completed were the Development and Wellbeing 
Assessment (DAWBA) and the Strengths and Difficulties Questionnaire (SDQ) 
(Goodman 1997, Goodman et al. 2000).  
The 2004 BCAMHS was extended by follow-up waves at 6 months, 12 months and 
24 months that involved parental completion of the SDQ. In 2007, the three year 
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follow up survey repeated interviews with informants, collecting information on 
mental health and contact with services (Parry-Langdon 2008). The 2004 survey is 
detailed in Green et al.’s report (2005), and the 2007 follow-up in Parry-Langdon’s 
report (2008); procedures for both taken from the reports are described below. 
3.3.2 Subjects and recruitment 
Sample selection 
Children aged 5-16 living in private households in England, Scotland and Wales 
were included in the 2004 survey. The sample of 12,294 was drawn from the Child 
Benefit Register from 426 postal sectors selected by the Office for National Statistics 
(ONS). According to the Department for Work and Pensions, virtually all eligible 
families claimed Child Benefit, which at that time was a universal benefit, so that the 
register covered almost all children except for those in foster or residential care, or 
other non-private households (Green et al. 2005). These sectors were selected by 
stratifying by Government Office Region and then by socio-economic group. In each 
sector, 29 children were randomly selected except for in five sectors where all 
children were sampled due to the very small numbers in the sample frame.  
Parents were then sent invitations by the Child Benefit Centre on behalf of the ONS, 
to preserve confidentiality. Fifteen per cent of those selected in this way opted out or 
were not contactable. This left 10,496 families who were approached for interview.  
In all, 7,977 interviews with parents were achieved, constituting 76% of all cases 
approached. Teachers were asked to complete a questionnaire only if the child’s 
parents consented, which 96% did. Of those teachers contacted, 83% returned a 
questionnaire, meaning that teacher information was available for almost 80% of all 
children assessed. 
Follow-up contacts 
Parents were asked to consent at baseline to taking part in the six month follow up 
study involving a questionnaire only, which aimed to examine  the persistence of 
psychopathology, and therefore all children with a disorder at baseline whose 
parents consented (n=705) were included, along with a sample of those with no 
baseline disorder (n=926). Two-thirds of parents of children with a disorder returned 
the questionnaire, compared to 77% of those without, making a total follow-up 
sample of 1,174. Parent questionnaires were also collected on the whole sample at 
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12 months (n= 6,375) and 24 months from baseline (n= 5,794). 7329 children of the 
original 7977 were approached for interview in 2007, the remainder excluded as they 
had moved abroad, died, or withdrawn from the study. Almost three-quarters of this 
sample took part in the interview, resulting in a final number of 5,325 cases. Please 
see Figure 3.1 below for an overview of recruitment to the 2004 survey and 2007 
follow-up. 
Figure 3.1: Flow chart of recruitment to 2004 BCAMHS and 2007 follow-up 
 
 
 
Eligible children = 
12,294 
Approached for 
interview 2004 
=10,496 
Interviews achieved 
2004 = 
7,977 
'Keeping in touch' contacts: 6 , 
12 and 24 months from baseline 
Approached for 
interview 2007= 
7,329  
Interviews achieved 
2007 =  
5,325 
Lost to contact, refused or 
otherwise ineligible =  
2,004 
Excluded or 
withdrawn = 
648 
Refused or otherwise 
not contactable= 
2,519 
Opted out or not 
contactable = 1,798 
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3.3.3 Measures 
Socio-demographic measures 
Socio-demographic data collected included: age, ethnicity, gender, housing status, 
family type, parental education and employment and household income. The 
McMaster Family Assessment Device (Miller et al. 1985) was used to assess family 
functioning and the General Health Questionnaire (GHQ) (Goldberg et al. 1997) to 
assess parental mental health. Parents were asked whether the child suffered from a 
list of physical and neurodevelopmental disorders and how many stressful life events 
(out of 10 potential events) the child had experienced. Parental interviews also 
covered the child’s friendships and social aptitudes. 
 Measures used to assess psychopathology 
The Strengths and Difficulties Questionnaire 
Parents, teachers and children (if aged over 11) were asked to complete the one 
page Strengths and Difficulties Questionnaire (SDQ),  a screening tool which covers 
emotional and behavioural difficulties and their impact on the child and 
family(Goodman 1997). The SDQ has versions for completion by parents, teachers 
and 11-16 year olds, and asks about 25 positive and negative attributes over 5 
subscales: emotional symptoms, conduct problems, hyperactivity/inattention, peer 
problems and prosocial behaviour. The items are scored 0 (not true), 1 (somewhat 
true) or 2 (certainly true) or the reverse for positive items so that higher scores 
indicate greater difficulty. Items in the first four subscales are then added together to 
give the total difficulties score (possible range 0 to 40). In addition, there is a brief 
impact supplement, which asks the respondent whether they consider the child (or 
themselves if a self-rated questionnaire) to have a problem in terms of emotions, 
behaviour, concentration or relationships with others, and if so to rate the level of 
distress and impairment caused. The impact supplement is scored 0 (normal range), 
1 (borderline) or 2 or more (abnormal). 
The SDQ has been validated across various populations (Rothenberger et al. 2008, 
Stone et al. 2010, Gómez-Beneyto et al. 2013). The first BCAMHS (Meltzer et al. 
2000) also served to provide norms for SDQ scores for a community sample, shown 
in Table 3.1 below.  
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Table 3.1: Normative scores for British community population in 1999 and 
ranges for ‘caseness’ (taken from www.sdqinfo.com (Youth in Mind, 2016)) 
Informant and  
SDQ score 
Mean (SD) Normal range Borderline 
range 
Abnormal 
range 
Parent     
Total difficulty 
score 
8.4 (5.8) 0-13 14-16 17-40 
Impact score 0.4 (1.1) 0 1 2 
Teacher     
Total difficulty 
score 
6.6 (6.0) 0-11 12-15 16-40 
Impact score 0.4 (1.0) 0 1 2 
Self     
Total difficulty 
score 
10.3 (5.2) n/a n/a n/a 
Impact score 0.2 (0.8) n/a n/a n/a 
 
The Development and Wellbeing Assessment (DAWBA) 
The Development and Wellbeing Assessment (DAWBA) was used to determine 
psychiatric diagnostic status (Goodman et al. 2000). It has demonstrated high levels 
of agreement (93% for any disorder) between case notes and DAWBA diagnosis in 
clinic samples and differentiated clearly between the level of difficulty reported by 
those recruited from clinics and the community(Goodman et al. 2000). The DAWBA 
takes the form of a structured interview based on DSM-IV and ICD-10 criteria (World 
Health Organisation 1992,  American Psychiatric  Association, 2000), which can be 
administered by non-clinical researchers. Where the structured questions identify 
problem areas, open ended questions and prompts follow to allow the informant to 
describe the problem more fully – their words are then transcribed verbatim. There 
are also ‘skip rules’, allowing some sections to be missed out if initial screening 
questions indicate there is unlikely to be a problem, and if the relevant SDQ subscale 
score is within the normal range. Computer generated diagnoses arising from the 
interviews are then reviewed by a clinical rater who has access to all the data plus 
the verbatim transcripts. The clinician is subsequently able to either confirm or 
discard the computer generated diagnosis depending on their interpretation and 
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clinical judgement. In the validation study by Goodman et al. (2000) clinical raters 
judged 2.2% of those given a computer generated diagnosis not to have a 
psychiatric disorder and assigned 4.1% additional diagnoses. Transcripts also allow 
them to recognise confusion arising from erroneous reporting by any informant, to 
assign ‘not otherwise specified diagnoses’ to children who are clinically impaired yet 
do not fit a precise diagnostic category and to deal with disagreement between 
informants using complex and individually tailored clinical judgments as would occur 
in the clinic.  
Measures of service contact 
Parents were asked in 2004 and at the three-year follow up in 2007 whether they or 
their child had contact with a range of public sector services specifically in relation to 
concerns about the child’s mental health in terms of emotions, behaviour or 
concentration difficulties within the past 12 months. These reported contacts could 
involve the child or parent and encompass telephone advice, meetings, assessment, 
or interventions received by the child and family. Throughout the analysis the term 
‘service contact’ is therefore used to refer to contact with services in relation to their 
child’s mental health reported by a parent. The services and professionals included 
were: 
 Teacher 
 Primary care/GP 
 Specialist services 
o Educational psychology/special education 
o Paediatrics 
o Child mental health services (CAMHS) 
o Adult mental health services (AMHS) 
o Social workers/social services 
 
3.3.4 Collection of data in BCAMHS 
The key data from each group of informants collected at each stage is illustrated in 
the diagram below. 
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Figure 3.2: Data collection and informants in 2004-2007 BCAMHS 
 
3.3.5 Secondary analysis 
Ethical approval 
The Multicentre Research Ethics Committee provided the ethical approval for the 
survey, for which all participants including parents, teachers and children over 11 
gave informed consent. The Institute of Psychiatry Research Ethics committee then 
approved the initial secondary analysis (REC reference 103/00).  The Chair of the 
Peninsula College of Medicine and Dentistry ethics committee subsequently made 
the decision that separate ethical permission for subsequent secondary analysis 
within the Medical School was not required. 
Variables used in the secondary analysis 
The key measures from BCAMHS 2004 that were used in the secondary analysis 
are presented in Table 3.2 below 
Socio-demographic variables 
Variables relating to the child and family were selected to describe their association 
with service contact, and as covariates in the regression models. These key 
variables were pre-determined in the analysis plan and chosen due to the existing 
literature suggesting their association with both service use and mental health 
problems (see Chapter Two). All of these were baseline variables, measured in 
2004.  
 
2004 
• Parents, children over 11 and teachers 
• SDQ, DAWBA, socio-demographic information and service contact 
Interim 
contacts 
• Contacts at 6,12 and 24 months from baseline 
• Parents only 
• SDQ 
2007 
• Parents, children over 11 and teachers 
• SDQ, DAWBA, and service contact 
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Table 3.2: Baseline socio-demographic variables measured in 2004 
Variable Type Values 
Age Continuous  
Gender  Binary Male 
Female 
Ethnicity  Binary White 
Black and minority ethnic 
Child learning disability Categorical None 
Borderline 
Moderate 
Severe 
Child neurodevelopmental disorder (including 
epilepsy and cerebral palsy)  
Binary Yes 
No 
Child general health  Binary Very good or good 
Fair, poor, very poor 
Life events   Binary Three or more 
Two or fewer 
At least one parent in employment   Binary Yes 
No 
Housing status  Binary Rented 
Non-rented 
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Maternal  age at birth Continuous  
Parental education level Categorical No qualifications 
Poor GCSE 
Good GCSE or A-Level  
Degree or diploma 
Household income  Binary £200 or more per week 
Less than £200 per week 
Socio-economic status of household reference 
person (five category National Statistics Socio-
economic Classification, referred to as NS-SEC) 
Categorical Higher/lower managerial  
Intermediate/small employer  
Lower supervisory/ semi-routine  
Never worked/ long-term unemployed  
Full Time students/not stated  
Family size  Categorical Two or fewer children 
Three or more children 
Family type  Categorical Traditional ( 2 parent) 
Single parent 
Reconstituted 
Grandparent care/other 
Family functioning  
(using McMasters score)  
Binary Unhealthy (score <2) 
Healthy (score 2 or more) 
Parental General Health Questionnaire score  
 
Binary Case (score of 3 or more) 
Non case (score of 2 or fewer) 
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Diagnostic and psychopathology variables 
DSM-IV DAWBA diagnoses are presented throughout, as using ICD-10 criteria 
resulted in almost identical disorder prevalence; the only exception being 
hyperkinetic disorder/ADHD. The ICD-10 criteria for hyperkinetic disorder identify a 
slightly narrower group than the DSM-IV ADHD criteria, although there is substantial 
overlap in terms of clinical characteristics in validity studies (Tripp et al. 1999, Lee et 
al. 2008). Therefore, in order to capture a broader range of psychopathology, 
DAWBA diagnoses using DSM-IV were used throughout the secondary analysis. The 
main diagnostic groups were conduct disorder/Oppositional Defiant Disorder (ODD), 
(referred to throughout as conduct disorder), ADHD, anxiety disorder, depressive 
disorder and pervasive developmental disorder (PDD). 
Children’ characteristics and service contact were analysed according to their 
DAWBA diagnosis status, which was assessed in 2004 and 2007. Diagnostic status 
was categorised as follows:  any DAWBA diagnosis 2004 or 2007 (referred to as: 
“any disorder”), or no DAWBA diagnosis in 2004 or 2007. Disorder status was also 
examined according to the diagnostic status in 2004 and 2007; categorised as no 
disorder, resolving disorder, emerging disorder and persisting disorder. Table 3.3 
defines these diagnostic variables which were created for the secondary analysis, in 
more detail. 
The key SDQ scales selected for the secondary analysis were the total difficulty and 
total impact scores. The total difficulty score is a dimensional measure that 
represents a broad range of psychological difficulty, and so was particularly 
appropriate for capturing psychopathology across different psychiatric disorders. 
Impact as rated by the SDQ has been studied in BCAMHS 2004 by Stringaris and 
Goodman (2013) who found it to have stability and consistency as well as predicting 
future disorder. The impact supplement also asks whether respondents are 
concerned that the child has a problem in terms of emotions, behaviour, 
concentration or relationships with others; this binary variable was also selected for 
the analysis. The prosocial subscale score was included in the secondary analysis 
although was not included as an outcome in the linear and logistic regression 
models. Finally, although parent, teacher and self-rated SDQ scores are presented, 
only parent and teacher rated scores were included in the regression models as self-
rated scores were not captured for under-11s. Parent rated scores were used as the 
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outcome measure when analysing the relationship between service contact and 
outcome, as data from parents was available on more of the sample than scores 
from the other two informants (see Missing Data section). 
Service contact variables 
Service contact was categorised in various ways (see Table 3.3 for details). Firstly, 
as any service contact, reported in 2004 and/or 2007, with any of the main service 
types: teachers, special education, primary care, paediatrics, CAMHS, AMHS and 
social work. Secondly, a specialist service contact variable was created, defined as 
any contact in 2004 and/or 2007 with a specialist service – i.e. special education, 
paediatrics, CAMHS, AMHS or social work. Thirdly, service contact was also 
reported as contact in 2004 and/or 2007 by individual service type. Finally, variables 
were also created to describe both “any service contact” or CAMHS contact over 
time, defined as: no service contact, contact in 2004 only, contact in 2007, and 
contact at both time points (2004 and 2007). 
Variable management 
A number of new categorical and binary variables were created for the secondary 
analysis. This process is described in the table below. 
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Table 3.3: New variables created for the secondary analysis of BCAMHS 2004-2007 
New variable Description Values of new variable 
Socio-demographic   
Child’s general health Recoded from 5 categories (‘very good, good, fair, bad, or 
very bad’) to 2 
Very good or good 
Fair, bad or very bad 
Child’s ethnicity Recoded from 5 categories  (‘white, black, Indian, 
Pakistani/Bangladeshi, other’) to 2 
White  
Non-white/Black and Minority Ethnic 
Household income Recoded from categorical to binary £200 and above per week  
Less than £200 per week 
Family size Recoded from categorical to binary 2 or fewer children 
3 or more children 
Diagnosis and psychopathology   
Any disorder 2004 or 2007 
according to DAWBA 
New binary variable Any disorder 2004 or 2007 
No disorder 2004 or 2007 
Disorder status according to the 
DAWBA over the follow-up period 
New categorical variable No disorder 
Resolving disorder (2004 only) 
Emerging disorder (2007 only) 
Persisting disorder (2004 & 2007) 
Abnormal SDQ parental total 
difficulty score 
Continuous variable of parental total difficulty score in 04 
and 07 was recoded into a binary variable for each year, 
using the score of 17 which is the cut-off point for an 
abnormal score 
 
 
Parental total difficulty score below 
17   
Parental total difficulty score of 17 
and above 
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Service contact 
  
Any service contact 2004 or 2007 New binary variable No service contact 2004 or 2007 
Any service contact 2004 or 2007 
Any specialist service contact 2004 
or 2007 
New binary variable. Specialist service contact was defined 
as reported contact with any of the following: CAMHS, 
AMHS, special education, social work and paediatrics 
No specialist service contact 2004 
or 2007  
Any specialist service contact 2004 
or 2007 
Contact with services 2004-2007 New categorical variable No contact 
Contact 2004 only 
Contact 2007 only 
Contact 2004 & 2007 
Contact with specialist services 
2004-2007 
New categorical variable No contact 
Contact 2004 only 
Contact 2007 only 
Contact 2004 & 2007 
Type of service contact  New categorical variable Teacher 
CAMHS 
GP 
Paediatrics 
Special education 
Social work 
AMHS 
Other 
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Application of weights in the secondary analysis 
Weighting procedures used in BCAMHS 
The selection procedure described above for BCAMHS should have resulted in 
equal sampling probability for each child. However, there was some inequality due to 
a delay in sampling and the withdrawal of a very small number of children 
considered sensitive cases by the Child Benefit Centre. The second stage involved 
accounting for the regional variation in response rate, which ranged from 69% in 
London to 81% in the South West (Green et al. 2005). The BCAMHS team applied 
weights to correct for this so that the sample represented the total population 
age/sex/region structure. The BCAMHS 2004 report consequently used weighted 
bases when presenting figures from the survey. 
In the 2007 follow up, weighting was a three stage procedure involving firstly 
weighting the 2007 sample using the 2004 survey population weights. Subsequently, 
it was necessary to account for differential non-response at follow-up based on 
variables associated with non-response. These included region, age, sex, diagnosis, 
family type and SDQ score. The third stage was to weight to match the age, sex and 
region population structure according to the ONS figures (Parry-Langdon 2008). 
Weights in the secondary analysis 
As the current secondary analysis used the sample of children who were followed up 
in 2007, the 2007 weighting derived by the BCAMHS authors was used where 
appropriate. Descriptive analysis of sample characteristics was unweighted. Where 
prevalence of diagnoses and contact with services was analysed, as well as 
throughout the regression models, 2007 weights were applied. 
Missing data 
Completeness of dataset 
Missing data in 2004 and 2007 are shown in Table 3.4a & b below. Of the 2007 
follow-up sample used for the descriptive analysis, there were missing data for fewer 
than 4% of participants on all of the socio-demographic variables. As a completed 
interview was a prerequisite for inclusion in the sample, all participants had a 
completed DAWBA in 2004 and 2007, meaning that the disorder status was known 
for all participants. Similarly, over 99% had no missing data on parental rating of 
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concern or parental SDQ. The exception was self-rated and teacher-rated scores on 
the SDQ (Table 3.4). Teachers were only contacted when parents gave permission 
to do so; where teachers were contacted, 83% in 2004 and 74% in 2007 returned a 
completed questionnaire (1, 159). Approximately a fifth of cases in the study sample 
had teacher SDQ ratings missing in 2004, and approximately two-fifths had these 
variables missing in 2007. There was also a high proportion of missing data on self-
rating scores, even amongst the over-11s who were eligible to complete the SDQ.  
Table 3.4a Missing data in the 2004 and 2007 samples: Percentage with 
missing data on socio-economic and demographic variables  
Variable 
 2004 sample 
(n=7,977) % 
2007 sample 
 (n=5,326) % 
Age 0 0 
Gender 0 0 
Ethnicity 0.05 0.1 
Neurodevelopmental disorder 1.4 0 
Life events 2.5 0.7 
Learning Disability 0.6 0.1 
Parental unemployment 2.2 0.6 
Maternal age at birth 3.1 2.1 
Rented accommodation 0.1 0.04 
Parental education 2.7 0.7 
Family size 0 0 
Family type 0 0 
Household income 4.6 4.0 
Child general health 1.4 0 
Family functioning score 3.6 1.2 
GHQ score 3.0 1.0 
Social class (NS-SEC) 0 0 
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Table 3.4b Missing data in the 2004 and 2007 samples: Percentage with 
missing data on diagnosis and psychopathology variables  
Variable 
 2004 sample 
(n=7,977) % 
2007 sample 
 (n=5,326) % 
DAWBA diagnosis 0 0 
Concern at baseline 1.4 0 
SDQ Parental total difficulty score 2004 0.7 0.1 
SDQ Parental impact score 2004 0.6 0.04 
SDQ Parental prosocial score 2004 0.5 0.02 
SDQ Teacher total difficulty score 2004 25.0 22.3 
SDQ Teacher impact score 2004 25.2 22.6 
SDQ Teacher prosocial score 2004 25.0 22.3 
SDQ Self total difficulty score 2004 57.0 57.2 
SDQ Self- impact score 2004 82.8 57.4 
SDQ Self prosocial score 2004 57.0 57.2 
SDQ Parental total difficulty score 12 months  20.1 8.2 
SDQ Parental total difficulty score 24 months  27.4 12.3 
SDQ Parental total difficulty score 2007  33.8 0.9 
SDQ Parental impact score 2007 33.8 0.8 
SDQ Parental prosocial score 2007 33.8 0.8 
SDQ Teacher impact score 2007 60.8 41.3 
SDQ Teacher total difficulty score 2007 61.3 42.0 
SDQ Teacher prosocial score 2007 60.8 41.2 
SDQ Self total difficulty score 2007 57.2 35.9 
SDQ Self impact score 2007 57.4 36.3 
SDQ Self prosocial score 2007 57.2 35.9 
 
Distribution of missing data in the study sample 
The distribution of the missing data by diagnostic status was examined for the study 
sample for all variables where more than 2% of the data were missing. This is not 
presented for the self- rated scores as they were only used in the descriptive 
analysis. The table below (Table 3.5) displays the distribution of missing data by 
DAWBA disorder status in 2004 and 2007. Data were missing for a slightly higher 
proportion of children with disorders in 2004 and/or 2007 than without disorders on 
the teacher SDQ ratings in 2007 in particular; however 2007 scores were used only 
in descriptive analysis and were not included in the regression models. There was 
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also a less marked difference in missing data on household income at baseline, 
parental age at birth and service contact in 2007. 
Table 3.5: Distribution of missing data by DAWBA disorder status in the 2007 
follow-up sample 
Variable Percentage with missing data (%) 
(n=5,326) 
DAWBA diagnosis at baseline 
(2004) 
DAWBA diagnosis at follow-up 
(2007) 
Yes No Yes No 
SDQ Teacher total 
difficulty score 2004  
20.9 22.4 24.1 22.1 
SDQ Teacher impact 
score 2004 
21.2 22.8 24.5 22.4 
SDQ Teacher prosocial 
score 2004 
20.9 22.4 24.5 22.1 
SDQ Teacher total 
difficulty score 2007  
49.0 41.4 43.0 41.9 
SDQ Teacher impact 
score 2007 
48.3 40.7 42.3 41.2 
SDQ Teacher prosocial 
score 2007 
48.6 40.6 41.7 41.2 
Household income 5.1 3.9 4.4 4.0 
Parental age at birth 2.9 2.0 2.5 2.2 
Service contact 2007 1.4 2.5 2.7 1.2 
 
Data analysis 
Analyses were carried out using Stata SE version 14 (Statacorp 2015).For the initial 
descriptive analysis, the characteristics of the children in the sample were described 
in terms of socio-demographics, prevalence of disorders and contact with services, 
presented with percentages and 95% confidence intervals, or with means and 
standard deviations for continuous variables. SDQ total difficulty scores were 
summarised as means with standard deviations, and SDQ impact scores were 
examined using the median and interquartile range, as the distribution of impact 
scores is more skewed than total difficulty scores. Throughout, the term ‘statistically 
significant’ is used in the text as a shorthand to refer to a result with a p value lower 
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than 0.05. However, in tables, more exact p values are given i.e. <0.05 or <0.001, 
and 95% confidence intervals are also given to indicate the precision of the result. 
For the three main research questions, the analysis procedure is described below. 
 
Question 1: What services do children with psychiatric diagnoses have 
contact with over a three-year period (2004-2007)? 
Contact with any service was examined according to children’s DAWBA diagnosis, 
firstly, as the percentage of those with any disorder who had any service contact, 
and subsequently by disorder status over time (none, resolving, emerging, 
persisting) and by the type of diagnosis.  The analysis was then repeated for contact 
by service type and by service contact over time. Contact with any service was also 
examined by psychopathology according to whether the child had a parental total 
difficulty SDQ score in the abnormal range. In order to explore patterns of service 
contact, the percentage of those in contact with one service type with any disorder 
who also reported contact with another service type was tabulated. 
As these were categorical and binary variables, they were presented as percentages 
using cross-tabulation. The Chi-squared test for association between categorical 
variables was also performed where appropriate and p values were reported. To 
examine the odds of service contact in different disorder groups, odds ratios and 
confidence intervals were derived using logistic regression.  Contact with services 
was also described in the two age groups: children aged 5-10 at baseline and 
children aged 11-15 at baseline. Association between service contact and gender 
was explored further using logistic regression. Age as an effect modifier in the 
relationship between gender and service contact was initially examined by tabulating 
the percentages in contact and the odds of contact for each gender, with and without 
a diagnosis, for the 5-10 age group and the 11-15 age group. Tests for interaction 
were also performed using likelihood ratios. 
Finally, to examine the level of difficulty experienced by children who did have 
contact with services, the mean parent, teacher and self-rated SDQ total difficulty 
scores in 2007 were calculated for children by contact with any service, and by 
service type. 
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Question 2: What factors predict contact with services over the study period? 
Any service contact 
Logistic regression was used to firstly examine the association between contact with 
any service in 2004 and /or 2007 (binary outcome) and potential predictor variables. 
The baseline predictor variables fell into four groups: characteristics of the child, the 
family, disorder type at baseline on DAWBA and baseline parent and teacher SDQ 
total difficulty, impact and prosocial scores. Child SDQ scores were not included in 
the predictor variables as these were only completed by over 11s and over half had 
missing data. Consideration was given as to whether to include the teacher ratings of 
psychopathology on the SDQ as predictors in the models, due to the fact almost a 
fifth of participants had missing data for this variable (see Missing Data). Regression 
models were run with and without the variable and there was no significant 
difference in the results or the fit of the model as tested using Hosmer and 
Lemeshow's (1980) goodness-of-fit F-adjusted mean. However, given that teachers 
were often contacted regarding mental health problems, in this analysis and in the 
previous BCAMHS 1999-2002, teacher rating of difficulty appeared to be an 
important variable to include.  
The  child and family variables entered into each model were: age, gender, ethnicity, 
child learning disability, child neurodevelopmental disorder, child general health, life 
events, parental employment, housing status, parental age at birth, parental 
education level, household income, socio-economic status of household reference 
person, family size, family type, family functioning and parental GHQ in the case 
range. Details of these variables are given earlier under Socio-demographic 
variables. 
Models were fitted in three stages. First, each potential predictor was entered singly 
in separate models. Secondly, factors that were associated with contact at the 5% 
level of significance were then included in a multivariable model for each grouping of 
variables. Lastly, all factors that were still significant predictors at this stage were 
entered into a final multivariable model.   
Age (aged 10 or under versus aged 11 or over at baseline) was initially examined as 
a potential modifier of the relationship between gender and service contact, as this 
has been previously reported (Ford et al. 2008b, Young et al. 2011, Reijneveld et al. 
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2014) and likelihood ratios were therefore used to test for interaction between age 
and gender. In consideration of this interaction, and due to the differences between 
primary and secondary school aged children (e.g. many emotional disorders are 
more common in older children (Ford et al. 2003)), the predictors of contact were 
examined separately for children aged 5-10 at baseline and children aged 11-15 at 
baseline. 
Contact by service type 
Using the logistic regression methods described above, the analysis was repeated 
with any specialist service contact as the outcome variable; and subsequently for the 
four most commonly contacted services: teacher, GP, CAMHS and special 
education. Again, the predictors of contact were examined separately for children 
aged 5-10 at baseline and children aged 11-15 at baseline. 
Testing the models 
The fit of each final model was tested using the survey-adjusted version of Hosmer 
and Lemeshow's goodness-of-fit F-adjusted mean. 
 
Question 3: What are the trajectories of psychopathology over time in children 
who do and do not have service contact, and are there differences in outcome 
in 2007 between children who have been in contact with services and those 
who have not? 
Analysis of trajectories 
The parent rated total difficulty score of the SDQ was selected as the main measure 
for the analysis of trajectories and of outcomes, as it represents a validated 
dimensional measure of a broad range of psychological difficulty (Goodman and 
Goodman 2009). It is approximately normally distributed with a positive skew. 
Service contact was analysed as any service contact, or contact with CAMHS in 
particular, as this would capture both general mental health-related contact and 
contact with specific child mental health services. 
To analyse trajectories of psychopathology over time, tables were produced of mean 
parental total difficulty SDQ score at baseline, 12 and 24 months and in 2007, by 
service contact group; firstly for contact with any service, and then for contact with 
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CAMHS. Mean parental total difficulty scores were then plotted using line graphs to 
display the trajectories of psychopathology in groups with different levels of service 
contact. Parent rated SDQ impact scores over time were also examined in order to 
determine whether they would show similar trends. As the distribution of the impact 
score is skewed, tables were produced to show the median and interquartile range 
as the summary measure; and the impact scores were also displayed in box and 
whisker charts. 
Regression analysis of association between service contact and outcome 
Linear regression was used to examine the association between service contact and 
parental SDQ total difficulty score in 2007. This was done separately for children with 
and without a DAWBA diagnosis at baseline in 2004. The outcomes of children 
without a diagnosis at baseline were examined as, due to the categorical nature of 
assigning psychiatric diagnoses, it is possible for children to be developing or 
experiencing clinical levels of psychopathology, yet not meet criteria for a single 
diagnosis on the DAWBA, and similarly, symptoms may fluctuate over time. 
Separate models were fitted for any service contact and CAMHS contact. Contact 
was examined using the categories: no contact, contact 2004 only, contact 2007 
only, contact 2004 and 2007. This contact variable was firstly entered into an 
unadjusted linear regression model with 2007 parent SDQ total difficulty score as the 
outcome. Secondly, it was entered into an adjusted model with covariates which 
might act as confounders due to their association with service contact and outcome. 
These were:  age, gender, ethnicity, child learning disability, child 
neurodevelopmental disorder, child general health, life events, parental employment, 
housing status, parental education level, household income, parental socio-
economic status, family size, family type, family functioning and parental GHQ in the 
case range, as well as concern about child mental health, parent and teacher SDQ 
total difficulty and impact scores at baseline. The fit of the linear regression models 
were tested by examining the distribution of the standardised residuals and plotting 
them against the fitted values to check for heteroscedasticity. 
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3.4 Results 
 
The results are presented in two parts: firstly, there is a description of the sample 
and its characteristics, and secondly, the findings in relation to each of the research 
questions are described. 
3.4.1 Description of sample 
In this section, the basic characteristics of the whole sample are first described in 
terms of socio-demographic variables, disorder status and psychopathology. This is 
followed by a brief analysis of children’s characteristics firstly by DAWBA disorder 
status and then by service contact status. Finally, the prevalence of disorders and 
psychopathology in children reporting contact with services is presented. 
Whole sample characteristics 
The sample for the secondary analysis consisted of all the 5,326 children who were 
followed up in 2007. The mean age was 13. 44 (SD = 3.32). Ages of the children and 
young people in the sample ranged from 7 to 20; 51.5% were boys and 48.5% girls. 
Almost 90% were white, with the largest ethnic groups being children of mixed or 
other races (3.8%), and children of Pakistani/Bangladeshi origin (2.6%).  Just under 
2% were of Indian origin (1.9%) and black children made up the smallest group 
(1.8%). Other characteristics of the child and family are displayed in Table 3.6 below. 
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Table 3.6: Child and family characteristics of sample (unweighted) 
Characteristic at baseline in 2004 Percentage of sample (n=5,326) 
Parental unemployment (neither parent 
working) % 
15.4 
Living in rented accommodation % 38.9 
Single parent family % 24.5 
Family size 
2 or fewer children 
3 or more children 
 
64.2 
35.8 
Parental education 
No qualifications % 
Poor GCSE or equivalent % 
Good GCSE or A-Level % 
Degree or diploma % 
 
18.3 
13.7 
41.4 
26.7 
Household income under £200 per week 
% 
13.8 
Maternal age at birth, mean (SD) 28.3 (5.3) 
Parental GHQ score in clinical range % 22.6 
Unhealthy family functioning score % 17.5 
Child’s general health: fair, bad or very 
bad % 
5.1 
Child has a neurodevelopmental disorder 
(e.g. epilepsy, cerebral palsy etc.) % 
3.0 
Child general learning disability 
None % 
Borderline % 
Moderate % 
Severe % 
 
92.5 
5.8 
1.3 
0.39 
Socio-economic status (NS-SEC) of 
household reference person: 
Higher/lower managerial % 
Intermediate,small employer % 
Lower supervisory/ semi-routine % 
Never worked/ long-term unemployed % 
Full time students/not stated % 
 
 
39.8 
21.7 
35.2 
2.1 
1.3 
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Prevalence of psychiatric disorders  
Almost one in ten children met criteria for a DSM-IV diagnosis for a psychiatric 
disorder on the DAWBA at baseline and in 2007. The prevalence of the main 
diagnostic groups is presented in Table 3.7. Fewer than 0.4% met criteria for rarer 
disorders such as mutism, tics and eating disorders and therefore data on these 
groups was considered to be too small for further analysis(Green et al. 2005).The 
most common disorder at both time points was conduct disorder and the least 
common was pervasive developmental disorder. One in five of those with a disorder 
had more than one disorder in 2004(Green et al. 2005). 
Table 3.7: Prevalence of DAWBA – identified disorders in 2004 and 2007 
Development and Wellbeing 
Assessment diagnosis 
(DSM-IV) 
Percentage with the 
disorder in 2004* 
(weighted) 
 
Percentage with the 
disorder in 2007 
(weighted) 
Any disorder 9.6 9.1 
Any ADHD/hyperkinetic disorder 1.5 1.3 
Any conduct disorder or 
Oppositional Defiant Disorder 
5.8 4.4 
Any depressive disorder 0.9 1.1 
Any anxiety disorder 3.3 3.4 
Pervasive developmental disorder 0.9 0.8 
*Taken from 2004 survey report (Green et al. 2005)  
Disorder status 2004-2007 
Over 200 of the 5,326 children had at least one disorder in both 2004 and 2007, 
comprising four per cent of the total follow-up sample. This encompassed both 
homotypic and heterotypic persisting disorders – i.e. children who had the same 
disorder at both points and children who had different diagnoses in 2004 and 2007. 
Two hundred and seventy children developed a new disorder between 2004 and 
2007. 
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Table 3.8: DAWBA disorder status 2004-2007  
Disorder status N Percentage 
No disorder 4,640 87.1 
Resolving disorder (04 only) 204 3.8 
Emerging disorder (07 only) 270 5.1 
Persisting disorder (04 and 07) 212 4.0 
Total 5,326 100 
 
Psychopathology according to the SDQ 
The mean parent, teacher and self-rated total difficulty scores for the whole sample 
in 2004 and 2007 are presented in Table 3.9.  At both time points the mean scores 
were within the normal range. 
Table 3.9: Mean SDQ total difficulty scores in 2004 and 2007 
SDQ rater SDQ Total difficulty score 
Mean (SD) 
2004 2007 
Parent rated 7.97 (5.92) 7.56 (5.84) 
Teacher rated 6.48 (6.00) 5.67 (5.77) 
Child rated 10.01 (5.19) 9.68 (5.12) 
 
SDQ scores were then examined by DAWBA disorder status. These scores 
corresponded closely to disorder status, as demonstrated in Figure 3.3 below. 
Children with resolving, emerging and persisting disorders over the study period had 
significantly higher parental total difficulty scores in 2004 and 2007 than children who 
did not meet criteria for a DAWBA diagnosis at either point. Children with a 
persistent disorder had a mean score of 20 points at both time points, a score well 
into the abnormal range. Those who had a disorder in 2004 but not in 2007 (the 
resolving group) had a higher mean total difficulty score in 2004 than in 2007, 
whereas the emerging group who had a disorder in 2007 but not in 2004 had a 
higher score in 2007 than 2004. 
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Figure 3.3: Mean parental total difficulty score in 2004 and 2007 by disorder 
status, with 95% confidence intervals 
 
A similar pattern is seen in relation to the parent-rated SDQ impact scores (Figure 
3.4),  although in contrast to the total difficulty score, for children with persisting 
disorders the median impact score is lower in 2007 than 2004, possibly a result of 
attenuation, or adaptation to the disorder. 
Figure 3.4: Box and whiskers plot of median parental impact scores in 2004 
and 2007 by diagnostic status, showing median score and interquartile range 
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Characteristics by disorder status 
Boys made up nearly three-quarters (71.2%) of those with a persistent disorder (see 
Table 3.10 below). Almost one fifth of this group also had a neurodevelopmental 
disorder. The persisting disorders group also had the highest proportion of parental 
unemployment and were more likely to be living in rented accommodation. Just 
under one-third had experienced three or more stressful life events, in comparison to 
fewer than one in ten of the no disorder group, and 45% of the parents of these 
children scored in the ‘case’ range on the GHQ.   
The resolving disorders group had the highest proportion of children living in a single 
parent headed family (35.8%). In this group, a fifth had a household income lower 
than £200 per week and over a quarter had mothers with no qualifications.  
There were also significant differences between disorder groups in terms of family 
size, family functioning, and socio-economic status. Children without any disorder 
had healthier family functioning, better general health and came from families in 
higher socio-economic groups. 
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Table 3.10: Child and family characteristics by disorder status 2004-2007 (unweighted) 
Characteristics No disorder 
(n=4,640) 
Resolving 
disorder 
(n=204) 
Emerging  
disorder 
(n=270) 
Persistent  
Disorder 
(n=212) 
p value 
Age, mean (SD) 10.3 (3.3) 11.3 (3.4) 10.6 (3.3) 10.5 (3.1) NS* 
Male gender % 50.5 57.8 49.3 71.2 p <0.001 
White ethnicity % 89.6 94.1 90.7 92.9 NS* 
Neurodevelopmental disorder % 2.1 3.9 5.9 18.9 p<0.001 
Any Learning Disability % 5.6 18.4 13.0 33.5 p <0.001 
Three or more life events % 7.7 25.1 18.8 32.7 p <0.001 
Parental unemployment % (neither parent working) 10.1 22.7 20.5 27.8 p <0.001 
Living in rented accommodation % 21.5 38.2 35.3 44.3 p <0.001 
Single parent family % 19.0 35.8 25.6 31.1 p <0.001 
Family size: 3 or more children 35.1 37.3 40.7 43.4 p<0.05 
No parental qualifications 14.3 26.2 17.2 25.4 p <0.001 
Household income under £200 per week % 10.8 20.0 16.9 12.0 p<0.001 
Parental age at birth, mean (SD) 29.0 (5.2) 27.7 (5.4) 28.1 (5.4) 27.8 (5.6) NS* 
Parental GHQ score in clinical range % 19.2 41.1 30.1 45.4 p <0.001 
Unhealthy family functioning score % 14.6 23.8 17.8 34.6 p <0.001 
Child general health: Fair, bad or very bad % 4.0 11.3 10.0 17.5 p <0.001 
Socio-economic status (NS-SEC) 
Higher/lower managerial % 
Intermediate,small employer % 
Lower supervisory/ semi-routine % 
Never worked/ long-term unemployed % 
Students/not stated % 
 
41.6 
21.9 
33.5 
1.9 
1.1 
 
27.9 
17.2 
49.5 
3.4 
2.0 
 
31.1 
21.5 
42.6 
2.2 
2.6 
 
21.2 
23.1 
47.6 
4.3 
3.8 
p <0.001 
*NS = not significant at the p<0.05 level 
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Contact with services 
Almost 40% of all children in the sample had contact with any service regarding their 
mental health in 2004 or 2007. This included contact with a teacher or primary care, 
or with a specialist service such as CAMHS, AMHS, special education, social worker 
or paediatrics.  In contrast, only 15% had any contact with a specialist service, and 
only 3.6% had contact with a specialist service at both time points. 
Table 3.11: Contact with services 2004 and 2007: all children (unweighted) 
Contact status Any service Specialist services 
N Percentage N Percentage 
No contact 3,187 60.6 4,554 85.3 
Contact 04 
only 
489 9.3 175 3.3 
Contact 07 
only 
915 17.4 340 6.4 
Contact 04 and 
07 
666 12.7 188 3.6 
Total 5, 257 100 5,257 100 
 
Characteristics by service contact status 
There were significant differences in most characteristics examined between children 
in different service contact groups (see Table 3.12). Children who reported service 
contact at both time points were younger, and the majority were male (65%). In 
general this group also experienced more adverse circumstances, with 33% living in 
rented accommodation and 19% having no parent working, whereas only 9% of 
those with no service contact had neither parent employed. A fifth had experienced 
more than three life events, and over one in ten had a neurodevelopmental disorder, 
in contrast to one per cent of those who reported no contact. Just under a quarter 
had some degree of learning disability. Parental mental health was also poorer in 
this group – 38% scored in the ‘case’ range in the GHQ. 
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Table 3.12: Characteristics of children by service contact group 2004-2007  
Characteristics No service contact 
 (n= 3,187) 
Service contact 
04 only (n=489) 
Service contact 
07 only (n=915) 
Service contact 04 
and 07 (n=666) 
p value 
Age, mean (SD) 10.4 (3.4) 10.6 (3.3) 10.1 (3.3) 10.0 (3.2) p<0.05 
Male gender % 48.0 56.7 51.8 65.0 p<0.001 
White ethnicity % 88.5 92.6 93.3 93.8 p<0.001 
More than 3 life events % 6.4 14.5 11.8 20.1 p<0.001 
Neurodevelopmental disorder % 0.97 4.7 3.1 11.3 p<0.001 
Any learning disability %  3.9 11.7 7.4 21.3  
Parental unemployment % 9.3 11.0 14.3 19.1 p<0.001 
Living in rented accommodation % 20.8 27.4 23.5 33.2 p<0.001 
Single parent family % 17.2 25.8 23.8 26.9 p<0.001 
Family size: 3 or more children % 35.6 31.3 35.6 38.3 NS* 
No parental  qualifications % 15.0 15.8 13.1 17.7 p<0.05 
Household income under £200 per week % 10.8 12.5 11.9 13.8 NS* 
Parental age at birth, mean (SD) 29.1(5.1) 28.5 (5.3) 28.7 (5.4) 28.4(5.3) p<0.05 
Parental GHQ score in clinical range % 17.0 25.2 24.0 37.8 p<0.001 
Unhealthy family functioning score % 14.4 17.3 14.9 22.7 p<0.001 
Child general health:Fair, bad or very bad % 3.4 5.3 5.5 12.8 p<0.001 
Socio-economic status (NS-SEC)     p<0.05 
Higher/lower managerial % 41.4 38.7 40.2 35.0  
Intermediate,small employer % 22.7 20.7 20.0 20.0  
Lower supervisory/ semi-routine % 32.7 38.5 36.7 41.4  
Never worked/ long-term unemployed % 2.1 1.8 1.6 2.0  
Students/not stated % 1.1 0.4 1.4 1.7  
*NS = not significant at p<0.05 level 
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Contact with different service types 
Over the course of the survey, teachers were the most contacted service, with over a 
fifth of respondents reported having had mental health related contact with a teacher 
when questioned in 2004 and/or 2007 (Table 3.13).  The next most contacted 
service was primary care. The least commonly used service was adult mental health 
services, although as the majority of children in the sample were under 16 in 2007 
this would be expected. Consequently, when considering individual service types, 
the analysis focusses on contact with the five most commonly contacted health and 
education service types: teacher, GP/primary care, special education, CAMHS and 
paediatrics. 
Table 3.13: Contact with different service types, 2004 and/or 2007 (unweighted) 
Service type Contact with service, 2004 and/or 2007 
N ( total n=5,257) Percentage 
Teacher 1,523 29.0 
GP 590 11.2 
Special education 388 7.4 
CAMHS 293 5.6 
Paediatrics 214 4.1 
Social work 128 2.4 
AMHS 63 1.2 
 
Characteristics of children in contact with different service types 
The characteristics of children who reported contact with the most common health 
and education service types in 2004 and/or 2007 is reported in Table 3.14 below. 
Overall, children in contact with teachers and paediatrics had a lower mean age at 
baseline than those in contact with primary care and CAMHS. There was also a male 
preponderance amongst users of every service. This was especially marked for 
CAMHS (65% male) paediatrics (67%) and special education (64%). Almost one in 
four children in contact with paediatrics had a neurodevelopmental disorder, and 
16% reported fair, bad or very bad general health. Those in contact with CAMHS and 
special education services generally experienced the most adverse socio-economic 
circumstances – just under a fifth of children had no parent in employment. Children 
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in contact with CAMHS and special education also had the highest proportion of 
parents with poor mental health according to the GHQ, and those in contact with 
primary care the lowest. 
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Table 3.14 Characteristics of children by contact with service type in 2004 and/or 2007 (unweighted) 
Characteristics No service 
contact 
 (n= 3,187) 
Teacher 
(n=1523) 
GP (n=590) CAMHS  
(n=293) 
Special 
education  
(n=388) 
Paediatrics  
(n=214) 
Age, mean (SD) 10.4 (3.36) 9.9 (3.2) 10.4 (3.3) 10.4 (3.2) 10.2 (3.2) 9.5 (3.1) 
Male gender % 48.0 60.5 55.9 65.2 63.7 66.8 
White ethnicity % 88.5 93.6 93.2 94.2 93.8 92.5 
More than 3 life events % 6.4 15.2 22.5 28.8 22.3 15.1 
Neurodevelopmental disorder % 0.97 6.9 10.2 13.7 15.2 24.8 
Any Learning disability % 3.9 14.3 17.1 19.5 26.3 27.1 
Parental unemployment % 9.3 14.2 17.3 19.5 18.3 13.6 
Living in rented accommodation % 20.1 27.1 30.5 32.8 32.5 26.2 
Single parent family % 17.2 24.9 27.5 25.6 26.8 19.2 
Family size: 3 or more children % 35.6 35.8 37.5 38.9 39.2 41.1 
No parental qualifications % 15.0 14.8 18.4 18.9 23.1 18.9 
Household income under £200 per week % 10.8 11.5 14.7 13.8 12.6 12.4 
Parental age at birth, mean (SD) 29.1(5.1) 28.7 (5.3) 28.0 (5.3) 28.4 (5.4) 28.4 (5.1) 28.8 (5.5) 
Parent GHQ score in clinical range 17.0 29.0 34.6 40.2  36.9 33.8 
Unhealthy family functioning score % 14.4 18.1 22.3 22.6 21.1 20.7 
Child general health: Fair, bad or very bad % 3.4 8.3 14.6 14.0 12.6 16.8 
Socio-economic status (NS-SEC)       
Higher/lower managerial % 41.4 38.9 32.0 36.5 33.5 35.1 
Intermediate,small employer % 22.7 20.0 21.2 19.8 16.5 19.2 
Lower supervisory/ semi-routine % 32.7 38.2 43.2 40.3 45.1 42.1 
Never worked/ long-term unemployed % 2.1 1.7 1.5 1.4 2.8 2.8 
Students/not stated % 1.1 1.2 2.0 2.1 2.1 0.9 
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Psychopathology and psychiatric diagnoses amongst children in contact with 
services 
The prevalence of disorders was highest amongst children reporting CAMHS contact 
(69.2%) and lowest amongst children reporting teacher contact (32.1%)(Table 3.15). 
The most common disorders amongst children reporting contact with each service 
were conduct disorders, with anxiety disorders and then ADHD being the next most 
prevalent. This pattern was less marked in children in contact with paediatrics and 
special education. Figure 3.5 displays the mean SDQ total difficulty scores as rated 
by parents, teachers and children of those in contact with services at baseline. 
Again, these are highest for CAMHS (into the borderline and abnormal ranges) and 
lowest for teacher contact. The mean parent rated SDQ score was in the abnormal 
range for each type of service. 
Table 3.15: Prevalence of psychiatric disorders in children reporting mental 
health related service contact at any point (unweighted) 
Service contact 
2004 and/or 2007 
Percentage in contact with service with disorder at any time point 
 (2004 and/or 2007) 
Any 
disorder 
% 
Conduct 
disorder 
% 
ADHD  
% 
Anxiety 
disorders 
% 
Depressive 
disorders 
% 
PDD 
 % 
Teacher 32.1 19.7 8.6 11.8 3.9 2.8 
GP 49.8 28.7 13.6 22.5 7.6 4.7 
CAMHS 69.2 43.4 25.3 30.5 10.0 9.4 
Special education 55.1 35.4 21.4 21.2 7.9 7.4 
Paediatrics 43.4 24.2 16.7 16.4 2.9 8.8 
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Figure 3.5: Mean SDQ total difficulty scores of children in contact with 
services at baseline 
 
 
3.4.2 Research questions  
 
Question 1: What services do children with psychopathology have contact 
with over a three-year period (2004-2007)?  
 
In order to answer this research question, the results are presented in three sections: 
 Service contact in children with any psychiatric disorder 
 Service contact according to psychiatric diagnosis 
 Service contact by age and gender 
 
Service contact in children with any psychiatric disorder 
Any disorder and any service contact 
Of children with any disorder at baseline in 2004, 87.7% (95% CI 84.1-90.5%) had 
contact with any service at any time point (2004 and/or 2007). Having a disorder 
according to the DAWBA at any time point was associated with service contact 
(p<0.001). As displayed in Table 3.16 below, the vast majority (85%) of parents of 
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children with a disorder at any time point reported contact with a service regarding 
their child’s mental health.  A third of those who did not meet criteria for a diagnosis 
at either time point still reported mental health related contact with services. Such 
children may have difficulties despite not meeting criteria for a DAWBA diagnosis at 
either time point, which was borne out by the SDQ scores. On examination of SDQ 
scores of children without a DAWBA diagnosis but with mental health-related service 
contact, these children had higher mean parental total difficulty scores than children 
who had neither a disorder nor any mental health related contact with services 
(mean score at baseline 8.62 versus 5.84, p<0.001, in 2007, 8.82 vs 5.51, p <0.001). 
A third also had parents who reported concern about their child’s mental health at 
baseline (33.8%), compared to only 10.7% of children with neither diagnosis nor 
service contact. 
Table 3.16: Any service contact in children with a psychiatric disorder 2004 
and/or 2007 
Any  DAWBA 
disorder, 2004 or 2007 
Any contact with any service,  2004 or 2007 
No contact % 
(95% CI) 
Any contact % 
(95% CI) 
Total 
No disorder 66.5 
(65.1-68.0) 
33.5 
 (32.1-34.9) 
100% 
Any disorder 15.5 
(12.7-18.3) 
84.5 
 (81.7-87.3) 
100% 
Total 59.1 
(57.7-60.5) 
40.9  
(40.0-42.3) 
100% 
 
Disorder status and any service contact 
Almost all children with persistent disorders (96%) reported mental health related 
contact with services in 2004 and/or 2007 (see Table 3.17 below). Relative to 
children with no disorder, the odds ratio of being in contact for this group was 43.70 
(95% CI 22.04-86.68). Service contact was also significantly more common among 
children with a resolving disorder (OR 7.73, 95% CI 5.45-10.96) or an emerging 
disorder (OR 7.63, 95% CI 5.6-10.41) than children without a disorder. Just over a 
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fifth of children with a resolving or emerging disorder reported no contact with 
services in either 2004 or 2007. 
Table 3.17: any service contact 2004 or 2007 by disorder status, with odds 
ratio for service contact 
Disorder 
status 
2004-2007 
Percentage not in 
contact with any 
service 
(95% CI) 
Percentage with any 
service contact 2004 
or 2007 
(95% CI) 
Odds ratio for any 
service contact, 
adjusted for age 
and sex 
(95% CI) 
None 66.5 
(65.1-67.9) 
33.5 
(32.1-34.9) 
Reference 
Resolving 21.1 
(16.0-27.3) 
78.9 
(72.7-84.0) 
7.7 
(5.5-11.0) 
Emerging 21.1 
(16.5-26.7) 
78.9 
(73.3-83.5) 
7.6 
(5.6-10.4) 
Persistent 4.2 
(2.2-7.8) 
95.8 
(92.0-97.8) 
43.7 
 (22.0-86.7) 
 
Service contact corresponded to the timing of disorder; (Table 3.18); children with a 
resolving disorder had higher levels of contact with services in 2004 than children 
with an emerging disorder, and vice versa for contact in 2007. Almost three-quarters 
of children with a persisting disorder reported service contact in both 2004 and 2007, 
in contrast to 28% of those with an emerging disorder and 39% of those with a 
resolving disorder. 
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Table 3.18: Timing of service contact by disorder status 2004-2007 
Disorder 
status 
 Percentage with service contact (95% confidence interval) 
No service 
contact 
2004 only 2007 only 2004 and 
2007 
Total 
None 66.5 
(65.1-67.9) 
9.1 
(8.2-9.9) 
16.2 
(15.1-17.3) 
8.2 
(7.4-9.1) 
100% 
Resolving 21.1 
(16.0-27.3) 
27.1 
(21.3-33.9) 
13.3 
(9.2-18.7) 
38.5 
(32.0-45.5) 
100% 
Emerging 21.1 
(16.5-26.7) 
6.9 
(4.4-10.8) 
43.5 
(37.5-49.7) 
28.4 
(23.2-34.4) 
100% 
Persistent 4.2 
(2.2-8.0) 
6.3 
(3.6-10.6) 
16.5 
(11.9-22.5) 
73.0 
(66.4-78.8)  
100% 
 
Contact with services by psychopathology on the total difficulty score 
Examining service contact by psychopathology as measured by the SDQ total 
difficulty score produces a similar pattern to the previous analysis of disorder (Table 
3.19). A lower proportion of those with a persisting abnormal score were in contact 
with services at both time points than those with a persisting disorder; 64% reported 
both 2004 and 2007 contact as opposed to 73% of the persisting disorder group.  
Table 3.19: Contact with any service by abnormal parental SDQ total difficulty 
score (17 or above): 2004-2007 
Abnormal 
parental total 
difficulty 
score  
Percentage reporting contact with any service (95%CI) 
No service 
use 
2004 only 2007 only 2004 and 
2007 
Total 
None 66.2 
(64.7-67.5) 
9.1 
(8.3-10.0) 
16.4 
(15.3-17.5) 
8.3 
(7.6-9.2) 
100% 
2004 only 20.7 
(15.7-26.9) 
24.3 
(18.7-30.9) 
14.3 
(10.0-20.0) 
40.8 
(34.1-47.8) 
100% 
2007 only 18.5 
(13.9-24.3) 
6.1 
(3.5-10.4) 
42.0 
(35.6-8.6) 
33.4 
(27.5-40.0) 
100% 
2004 & 2007 11.2 
(7.6-16.1) 
7.6 
(4.6-12.1) 
17.5 
(12.7-23.5) 
63.8 
(56.9 -70.1) 
100% 
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Contact with individual services amongst children with a disorder 
Amongst children who had a  DAWBA disorder at any point, teachers were the most 
frequently contacted service, with 66.1% of respondents reporting having 
approached them regarding their child’s mental health. Just under half (41.9%) had 
contact with primary care. Specialist services were less commonly accessed; less 
than a third reported CAMHS contact (29.6%) or contact with special education 
(31.1%). The least frequently contacted health and education service as reported by 
participants with a disorder was paediatrics (13.1%). Contact with these services is 
presented in Figure 3.6 below. More detailed description of contact with individual 
health and education services by disorder and diagnostic status follows later. 
Figure 3.6: Contact with services amongst those with a disorder: percentage of 
children with any disorder reporting contact with individual services at any 
time point (with 95% confidence intervals) 
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reported teacher contact also reported contact with CAMHS. In contrast, 51.7% of 
those who had seen their GP reported CAMHS contact too. Of those seen by 
teachers, 48.9% reported also having contact with a GP; and of those seen in 
primary care, 77.2% reported mental health related contact with a teacher, which 
was the lowest figure for all service types. Unsurprisingly, as CAMHS is a specialist 
service, almost three-quarters of children seen by CAMHS also reported GP contact, 
and over half had also had contact with special education. 
Table 3.20: Contact with more than one service amongst those with a disorder: 
percentage of those in contact with one service at any point that also reported 
contact with another service 
Children with 
a disorder  in 
contact with: 
Percentage reporting  any contact with another service, 2004 or 2007  
(95% confidence intervals) 
Teacher Primary care Special 
education 
CAMHS Paediatrics 
Teacher n/a 48.9 
(44.2-53.7) 
40.0  
(35.4-44.8) 
38.1 
(33.5-42.9) 
16.9  
(13.6-20.9) 
Primary care 77.2 
(71.8-81.8.) 
n/a 46.6 
(40.7-52.7) 
51.7 
(45.7-57.7) 
21.3 
(16.8-26.7) 
Special 
education 
84.9  
(79.1-89.3) 
62.7 
(55.7-69.3) 
n/a 55.7  
(48.7-62.6) 
26.1 
(20.4-32.7) 
CAMHS 85.1  
(79.3-89.4) 
73.2 
(66.4-79.1) 
58.7  
(51.4-65.6) 
n/a 24.2 
(18.6-30.9) 
Paediatrics 84.9 
(75.4-91.2) 
67.7 
(56.7-77.1) 
61.5 
(50.6-71.5) 
54.3 
(43.4-64.8) 
n/a 
 
Any disorder and specialist service contact 
Specialist services were defined as CAMHS, AMHS, special education, paediatrics 
and social services for the purposes of this analysis. There was a significant 
association between psychiatric disorder and contact with specialist services (p 
<0.001). A smaller proportion of children were in contact with these services; just 
over half of those with a disorder and fewer than one in ten of those without a 
disorder reported contact at either time point (Table 3.21). 
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Table 3.21:  Specialist service contact in children with any disorder 2004 
and/or 2007 
Disorder 
status 
Percentage reporting contact with any specialist service,  
2004 or 2007 
(95% confidence interval) 
Any disorder, 
2004 or 2007 
No contact Any contact Total 
No disorder 91.5 (90.7-92.4) 8.5 (7.6-9.3) 100 
Any disorder 48.6 (44.7-52.4) 51.4 (47.6-55.3) 100 
Total 85.3 (84.2-86.3) 14.7 (13.7-15.8) 100 
 
Any disorder and CAMHS contact 
Fewer than 30% of children with a disorder reported any contact with CAMHS. 
Children without a disorder were very unlikely to be seen by CAMHS; only 2.2% 
reported such contact (Table 3.22). 
Table 3.22:  CAMHS contact in children with any disorder 2004 and/or 2007 
Disorder status Percentage reporting contact with CAMHS, 2004 and/or 
2007 
(95% confidence interval) 
Any disorder, 
2004 or 2007 
No contact Any contact Total 
No disorder 97.8 (97.3-98.2) 2.2 (1.8-2.7) 100 
Any disorder 70.4 (66.9-74.0) 29.6 (26.0-33.1) 100 
Total 93.7 (93.1-94.5) 6.2 (5.5-6.9) 100 
 
Type of service contact by disorder status 
Exploring contact in more detail, Table 3.23 displays contact with each individual 
service by disorder status over the 2004-2007 period. Teachers were again the 
most-contacted service.  Almost 80% of those with a persisting disorder and over 
half of those with emerging or resolving disorders reported contact. Even amongst 
those who did not meet criteria for a disorder, over 20% of parents reported contact 
with a teacher at some point regarding their child’s mental health. Amongst children 
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with a persisting disorder, the next most frequently used service was primary care 
(55% in contact) followed by special education (52%) and CAMHS (51%). 
Table 3.23: Type of service contact by disorder status 2004-2007 
Disorder 
status 
2004-2007 
Percentage of children reporting contact with each individual service 
over the 2004-2007 period (95% CI) 
Teacher GP CAMHS Special 
education 
Paediatrics 
None 
 
23.8 
(22.6-25.1) 
7.2 
(6.5-8.0) 
2.2 
(1.8-2.7) 
4.3 
(3.7-5.0) 
2.9 
(2.5-3.5) 
Resolving 
 
60.9 
(53.9-67.5) 
34.1 
(27.7-41.1) 
18.7 
(13.8-24.9) 
19.6 
(14.6-25.8) 
8.9 
(5.5-14.0) 
Emerging 
 
58.4 
(52.2-64.4) 
36.1 
(30.4-42.2) 
18.7 
(14.4-23.9) 
22.2 
(17.4-27.8) 
8.1 
(5.3-12.4) 
Persisting 
 
79.1 
(72.7-84.4) 
55.3 
(48.2-62.2) 
51.4 
(44.3-58.4) 
51.5 
(44.4-58.5) 
22.6 
(17.4-28.8) 
 
Service contact by psychiatric diagnosis 
Figure 3.7 displays contact with different health and education services amongst 
children who had DAWBA diagnoses at any point. The majority of children within all 
disorder categories (anxiety disorders, depressive disorders, ADHD, CD and PDD) 
had contact with a teacher about their mental health; with the highest levels of 
contact amongst those with ADHD (86.1%), CD (74.4%) and PDD (79.6%) and the 
lowest amongst children with anxiety disorders (58.4%).  Children with anxiety 
disorders had a markedly higher level of contact with primary care than with CAMHS 
(see Table 3.24 overleaf for estimates with confidence intervals); the same was not 
true for those with ADHD and PDD, who had the highest levels of CAMHS contact at 
over 50%. Children with more than one disorder at any time point formed 4.3% 
(n=184) of the sample, with almost all (95.0%, 95% CI 90.5 to 97.4%) reporting 
service contact in 2004 and/or 2007.  
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Figure 3.7: Service contact amongst children with psychiatric disorders at any 
point 
 
 
Table 3.24 below displays service contact by whether the child had a diagnosis at 
any time point or at both time points (persisting disorder). Over nine in ten children 
with a persisting diagnosis of any disorder reported mental health related contact 
with services. Children who met ADHD criteria at both time points had the highest 
levels of contact with every service except paediatrics, where contact was most 
frequent amongst those with a PDD. 
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Table 3.24: Contact with individual services by diagnosis and diagnostic status 
Disorder on 
DAWBA 2004/2007 
Timing of 
disorder 
Percentage in contact with each service at any time point (2004 and/or 2007)(95% confidence 
interval) 
Any service Teacher GP CAMHS Special 
education 
Paediatrics 
Anxiety disorders Any time 
point 
(n=279) 
80.8 
(75.6-85.1) 
58.4 
(52.3-64.3) 
45.3 
(39.3-51.4) 
31.3 
(25.9-37.3) 
28.8 
(23.6-34.6) 
12.0 
(8.6-16.4) 
Persistent 
(n=39) 
93.4 
(80.5-98.0) 
69.7 
(53.5-82.7) 
50.8 
(34.5-66.9) 
52.1 
(35.7-68.0) 
39.5 
(24.7-56.5) 
16.0 
(7.4-31.2) 
Depression Any time 
point 
(n=83) 
83.4 
(73.1-90.3) 
63.0 
(51.8-73) 
54.2 
(43.0-65.0) 
33.7 
(23.9-45.1) 
35.0 
(25.2-46.3) 
7.0 
(3.0-15.3) 
Persistent 
(n=4) 
n/a n/a n/a n/a n/a n/a 
ADHD Any time 
point (n=129) 
100 86.1 
(78.5-91.4) 
55.4 
(46.3-64.2) 
52.5 
(43.5-61.4) 
58.9 
(49.7-67.5) 
24.7 
(17.9-33.0) 
Persistent 
(n=53) 
100 85.5 
(73.6-92.6) 
59.9 
(45.4-72.9) 
66 
51.4-78.1) 
68.7 
(53.8-80.5) 
23.8 
(13.9-37.7) 
Conduct disorders Any time 
point 
(n=354) 
89.3 
(85.6-92.1) 
74.4 
(69.4-78.8) 
44.2 
(38.9-49.6) 
34.0 
(29.1-39.3) 
36.7 
(31.6-42.0) 
13.5 
(10.2-17.7) 
Persistent 
(n=91) 
97.7 
(91.0-99.5) 
80.6 
(70.1-88.0) 
54.3 
(43.5-64.7) 
56.4 
(45.5-66.6) 
55.9 
(45.1-66.2) 
18.3 
(11.6-27.6) 
Persistent 
Developmental 
Disorder 
Any time 
point 
(n=46) 
93.5 
(80.6-98.0) 
79.6 
(62.7-90.1) 
55.0 
(39.4-69.6) 
55.9 
(40.3-70.5) 
58.6 
(42.8-72.9) 
37.4 
(24.2-52.8) 
Persistent 
(n=35) 
91.7 
(75.8-97.5) 
82.4 
(61.7-93.2) 
50.0 
(32.6-67.3) 
51.2 
(33.6-68.4) 
57.7 
(39.3-74.1) 
38.4 
(23.2-56.3) 
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Service contact, age and gender 
Analysis by age group  
Service contact was analysed by age group at baseline in 2004, split into 
primary school- aged children and secondary school-aged children. Overall, 
42.2% (95% CI 40.3-44.1%) of children aged 5-10 at baseline, and 39.7% (95% 
CI 37.7-41.7%) of children aged 11-15 reported any mental health-related 
service contact. Service contact in children with a DAWBA disorder at any time 
point is displayed in Table 3.25 below. Fewer children in the older age group 
reported contact with CAMHS, special education and paediatrics, although 95% 
confidence intervals overlapped for all these estimates. However, the main 
difference in patterns of contact was in mental health-related contact with 
teachers; reported by 58.6% of older children and 76.0% of younger ones.  
Table 3.25: Service contact amongst children with psychiatric disorders at 
any point, by age group 
Children 
with a 
DAWBA 
disorder 
Percentage in contact with each service at any time point (2004 and/or 
2007) 
(95% confidence interval) 
Any 
service 
Teacher GP CAMHS Special 
education 
Paediatrics 
Children 
aged 5-
10 at 
baseline 
(n=305) 
87.6 
(83.4-90.8) 
76.0 
(70.8-80.5) 
41.7 
(36.1-47.5) 
34.1 
(28.8-39.8) 
33.6 
(28.3-39.3) 
17.2 
(13.2-22.0) 
Children 
aged 11-
15 at 
baseline 
(n=367) 
82.2 
(77.9-85.8) 
58.6 
(53.4-63.7) 
42.0 
(36.9-47.2) 
 
26.2 
(21.8-31.1) 
29.3 
(24.7-34.2) 
10.2 
(7.4-13.8) 
 
Analysis by age group and gender 
Amongst all children aged 5-10, only 35% of girls had service contact compared 
to 48.9% of boys (see Table 3.26). When analysis was confined only to those 
with a disorder, this pattern was still evident, with 77.2% of girls in contact 
versus 92.4% of boys. The gender difference was still present when including 
92 
 
only those with a persisting disorder (i.e. a disorder in 2004 and 2007) although 
the gap was narrower with more imprecise estimates related to the smaller 
numbers in this group. Unadjusted odds ratios were calculated for contact in 
females, with males being the reference group, which illustrate the pattern that 
girls were overall less likely to have contact with services in comparison with 
boys in this age group. 
Table 3.26: Contact with services by gender and disorder, weighted: 
children aged 5-10 at baseline 
 Gender Percentage in contact 
with any service 
(95% CI) 
OR for contact 
(95% CI) 
p value 
for OR 
All 
children 
aged 5-10 
at baseline 
Boys 
(n=1383) 
48.9 
(46.2-51.6) 
Reference p<0.001 
Girls 
(n=1324) 
35.0 
(32.4-37.8) 
0.56 
(0.48-0.66) 
Children 
aged 5-10 
at baseline 
with any 
disorder 
Boys 
(n=204) 
92.4 
(88.1-95.3) 
Reference p<0.001 
 
Girls 
(n=101) 
77.2 
(67.8-84.5) 
0.28 
(0.14-0.55) 
Children 
aged 5-10 
at baseline 
with any 
persisting 
disorder 
Boys 
(n=85) 
97.9 
(91.7-99.5) 
Reference  p =0.13 
Girls 
(n=19) 
90.5 
(65.4-98.0) 
0.21 
(0.26-1.64) 
 
In older children aged 11-15 at baseline (Table 3.27), the difference between 
genders was much smaller. Whilst 36.9% of girls aged 11-15 at baseline had 
service contact compared to 42.2% of boys, when examining only those with a 
disorder the corresponding figures were 80.6% and 83.6%. Among those with a 
persisting disorder, more girls than boys reported service contact. There was no 
statistically significant difference (at the p<0.05 level) in the odds of service 
contact between the genders in the disorder and persisting disorder groups, in 
contrast to the younger 5-10 age group. 
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Table 3.27: Contact with services by gender and diagnosis (any diagnosis 
2004 or 2007), weighted: children aged 11-15 at baseline 
 Gender Percentage in contact 
with any service 
(95% CI) 
OR for contact 
(95% CI) 
p value 
for OR 
All 
children 
aged 11-15 
at baseline 
Boys 
(n=1332) 
42.2 
(39.5-45.0) 
Reference p<0.01 
Girls 
(n=1218) 
36.9 
(34.2-39.8) 
0.80 
(0.68-0.95) 
Children 
aged 11-15 
at baseline 
with any 
disorder 
Boys 
(n=193) 
83.6 
(77.6-88.2) 
Reference p=0.47 
 
Girls 
(n=174) 
80.6 
(73.8-86.0) 
0.82 
(0.48-1.47) 
Children 
aged 11-15 
at baseline 
with any 
persisting 
disorder 
Boys 
(n=63) 
94.7 
(84.3-98.3) 
Reference  p =0.79 
Girls 
(n=40) 
95.8 
(83.7-99.0) 
1.28 
(0.20-8.31) 
 
This analysis suggests that in younger children, boys are more likely to be in 
contact with services than girls, even when both boys and girls have a disorder. 
It is possible that this reflects differences in the gender distribution of disorders, 
particularly the male preponderance of externalizing disorders. Analysis by 
disorder group was limited by the small numbers involved in each category. For 
example, when examining only the children with conduct and oppositional 
disorders aged under 11, girls were half as likely to report any service contact 
as boys (OR 0.51), but the confidence interval was very wide and crossed unity 
(95% CI 0.23 -  1.10). This effect is not seen in older children, which may 
indicate an interaction between age group and gender on service contact. This 
is supported by the results of the likelihood-ratio test for interaction, where p 
value for the Chi-squared test was 0.0019.  
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Question 2: What factors predict contact with services over the 
study period? 
This section presents the results of logistic regression models examining the 
predictors of service contact. Predictor variables and the procedure for analysis 
are described in the Methods section. Outcomes in the models were: contact 
with any service, contact with specialist services, and contact with the most 
common individual service types. In each table, only the predictors which were 
significant at the p<0.05 level in the fully adjusted model are displayed.  The p 
value for the Hosmer and Lemeshow's goodness-of-fit F-adjusted mean 
(Hosmer and Lemeshow 1980) was non-significant for each model, suggesting 
that the models fitted the data. 
Contact with any service over the study period 
In this analysis, the dependent variable was contact with any service over the 
study period – i.e. contact in 2004, or 2007, or both.  The model is displayed in 
Table 3.28 below, where the unadjusted odds ratios are also displayed.  
Increasing age, female gender, non-white ethnicity and lower socio-economic 
class all lowered the odds of service contact. However, the unadjusted 
association between lower socio-economic classes and service contact was in 
the opposite direction to the adjusted model. Other groups had increased or 
equal odds of contact in the unadjusted model compared to the highest baseline 
group, those in managerial or professional jobs. Having a neurodevelopmental 
disorder, experiencing three or more life events and coming from a non-
traditional family structure were all associated with increased odds of contact, 
as was parental GHQ score in the case range. Parental ratings of 
psychopathology at baseline on the total difficulty score and the impact score 
were also predictors of contact, as was teacher rating of total difficulty, which 
was associated with contact even after adjusting for parental ratings. Overall, 
the strongest predictors were neurodevelopmental disorder (OR 2.46) and 
concern about mental health at baseline (OR 2.50). 
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Table 3.28:  Final adjusted model predicting any service contact: all 
children (n=2,138) 
Variable at baseline Unadjusted OR 
(95% CI) 
Fully adjusted 
OR 
(95% CI) 
p value for 
adjusted 
OR 
Age 0.98 (0.96-1.00) 0.96 (0.94-0.98) p<0.001 
Female gender 0.67 (0.60-0.76) 0.85 (0.73-0.99) p<0.05 
Non- white ethnicity 0.55 (0.45-0.68) 0.54 (0.41-0.72) p<0.001 
3 or more life events 2.71 (2.24-3.28) 1.63 (1.23-2.16) p<0.001 
Neurodevelopmental 
disorder 
7.23 (4.82- 10.85) 2.46 (1.33-4.53) p<0.05 
Family type: traditional Reference Reference p<0.05 
Single parent 1.79 (1.55-2.06) 1.30 (1.07-1.59) 
Reconstituted 1.54 (1.28-1.85) 1.23 (0.96-1.58) 
Other  2.65 (0.44-15.97) 0.59 (0.11-3.36) 
Parent GHQ score in case 
range 
1.98 (1.73-2.27) 1.25 (1.04-1.51) p<0.05 
Socio-economic class: 
Higher/lower managerial  
 
Reference 
 
Reference 
 
p<0.05 
Intermediate,small employer  0.99 (0.85-1.15) 0.75 (0.62-0.92) 
Lower sup/ semi-routine  1.35 (1.18-1.53) 0.78 (0.65-0.93 
Never worked/ long-term 
unemployed  
0.87 (0.64-1.48) 0.42 (0.22-0.80) 
Students/not stated % 1.48 (0.87-2.52) 0.62 (0.26-1.49) 
Concern about mental health 6.39 (5.54-7.38) 2.50 (2.03-3.07) p<0.001 
Parental SDQ total difficulty 
score 
1.18 (1.16-1.19) 1.08 (1.06-1.99) p<0.001 
Parental SDQ impact score 2.03 (1.82-2.28) 1.23 (1.09-1.39) p<0.05 
Teacher SDQ total difficulty 
score 
1.12 (1.11-1.13) 1.04 (1.02-1.06) p<0.001 
 
Given the previous evidence discussed for an interaction between age group 
and gender, and the possible differences between primary and secondary 
school age children, models were also produced for the separate age groups, 
shown in Table 3.29 below. Corresponding to the findings in the descriptive 
analysis, gender was only associated with service contact in the younger age 
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group, with an odds ratio for contact in girls aged 5-10 of 0.74 (95% CI 0.61-
0.91).  In older children, gender was not a significant predictor. Socio-economic 
class and parental GHQ score were predictors of contact in younger children 
but not in the older age group. General learning disability was associated with 
contact in 5-10 year olds but not in 11-15 year olds and vice versa for 
neurodevelopmental disorder.  Concern about mental health at baseline 
remained a strong predictor of any service contact in both age groups, and odds 
ratios for parental and teacher total difficulty and parent impact scores remained 
very similar in both models, and very close to the initial all-children model above 
(Table 3.28). 
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Table 3.29: Model predicting any service contact 2004-2007, by age group at baseline* 
Variable Children aged 5-10 at baseline (n=2,138) Children aged 11-15 at baseline (n=1,797) 
Unadjusted OR 
(95% CI) 
Fully adjusted 
OR (95% CI) 
p value 
for 
adjusted 
OR 
Unadjusted OR 
(95% CI) 
Fully adjusted 
OR (95% CI) 
p value 
for 
adjusted 
OR 
Age    0.94 (0.89-0.98) 0.91 (0.84-0.97) p<0.01 
Female gender 0.56 (0.48-0.66) 0.74 (0.61-0.91) p<0.001    
Non- white ethnicity 0.49 (0.37-0.65) 0.52 (0.35-0.74) p<0.001 0.61 (0.46-0.87) 0.61 (0.38-0.97) p<0.05 
More than 3 life events 2.73 (2.01-3.71) 1.65 (1.08-2.52) p<0.05 2.81 (2.20-3.60) 1.56 (1.06-2.30) p<0.05 
Neurodevelopmental disorder    7.47 (4.24-13.17) 3.34 (1.43-7.81) p<0.01 
General Learning Disability: 
None 
 
Reference 
 
Reference 
 
p<0.05 
   
Borderline 3.30 (2.45-4.44) 1.24 (0.84-1.82)    
Moderate 7.91 (3.43-18.23) 2.73 (0.84-8.90)    
Severe 0.23 (0.03-1.82) 0.20 (0.05-0.77)    
Parental GHQ score in the case 
range 
1.98 (1.62-2.41) 1.32 (1.01-1.71) p<0.05    
Socio-economic class: 
Higher/lower managerial 
 
Reference 
 
Reference 
 
p<0.001 
   
Intermediate,small employer  0.89 (0.72-1.10) 0.68 (0.52-0.89)    
Lower sup/ semi-routine  1.20 (1.00-1.44) 0.68 (0.54-0.95)    
Never worked/ long-term 
unemployed  
0.86 (0.47-2.23) 0.43 (0.20-0.95)    
Students/not stated  1.02 (0.47-2.23) 0.28 (0.08-0.99)    
Concern about mental health 6.10 (4.97-7.50) 2.51 (1.90-3.32) p<0.001 6.84 (5.59-8.36) 2.58 (1.88-3.53) p<0.001 
Parental SDQ  total difficulty 
score 
1.17 (1.15-1.19) 1.09 (1.06-1.12) p<0.001 1.18 (1.16-1.20) 1.06 (1.03-1.10) p<0.001 
Parental SDQ impact score  2.01 (1.67-2.42) 1.24 (1.01-1.51) p<0.05 2.08 (1.80-2.41) 1.25 (1.07-1.46) p<0.01 
Teacher SDQ total difficulty 
score  
1.11 (1.09-1.13) 1.04 (1.01-1.07 p<0.01 1.13 (1.11-1.15) 1.04 (1.01-1.07) p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group  
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Contact with specialist services over the study period 
In the final model (Table 3.30), again, female gender was associated with lower odds 
of contact with specialist services (OR 0.69, 95% CI 0.50-0.94) in the younger age 
group. Life events and parental GHQ score were associated with service contact in 
younger children but not in older children, whilst neurodevelopmental disorder 
predicted specialist contact in both groups. Having an ADHD or PDD diagnosis at 
baseline was associated with specialist contact in younger and older children 
respectively. For both age groups, parent and teacher rated measures of 
psychopathology and concern again were predictive of contact. 
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Table 3.30: Model predicting any specialist service contact 2004-2007, by age group* 
Variable 
Children aged 5-10 at baseline 
(n=2,187) 
Children aged 11-15 at baseline 
(n=1,850) 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value 
for adjusted 
OR 
Female gender 0.45 (0.35-
0.57) 
0.69 
(0.50-0.94) 
p<0.05    
More than three life events 3.54 
(2.55-4.92) 
2.33 
(1.47-3.70) 
p<0.001    
Neurodevelopmental disorder 10.93 
(6.78-17.63) 
2.60 
(1.24-5.47) 
p<0.05 8.91 
(5.53-14.33) 
4.49 
(2.22-9.08) 
p<0.001 
Parental GHQ score in case 
range 
2.66 
(2.10-3.41) 
1.60 
(1.14-2.23) 
p<0.01    
ADHD at baseline 56.30 
(26.39-120.14) 
5.16 
(1.95-13.65) 
p<0.01    
PDD at baseline    30.14 
(10.1-90.1) 
10.9 
(1.45-81.9) 
p<0.05 
Concern about mental health 8.22 
(6.46-10.47) 
2.46 
(1.72-3.51) 
p<0.001 9.04 
(7.0-11.71) 
2.18 
(1.38-3.46) 
p<0.01 
Parent SDQ total difficulty 
score 
   1.19 
(1.17-1.22) 
1.04 
(1.01-1.09) 
p<0.05 
Parent SDQ impact score 1.95 
(1.74-2.19) 
1.23 
(1.08-1.42) 
p<0.01 1.79 
(1.65-1.94) 
1.26 
(1.10-1.45) 
p<0.01 
Teacher SDQ impact score 2.01 
(1.80-2.24) 
1.27 
(1.07-1.51) 
p<0.01 2.00 
(1.76-2.27) 
1.20 
(1.01-1.45) 
p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group
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Contact with individual services, 
Models for contact with the most commonly contacted front line (teacher and GP) 
and specialist (CAMHS and special education) services are displayed in Tables 3.31 
to 3.34 in the following pages, by age group. 
Teacher contact (Table 3.31) 
Age, gender and ethnicity were associated with teacher contact regarding mental 
health. Among children aged 5-10 at baseline, parents of girls and children from non-
white ethnic backgrounds were less likely to have approached a teacher for help and 
support. Being from a lower socio-economic group was also associated with lower 
odds of teacher contact in younger children. For older children, increasing age was 
also associated with reduced odds of teacher contact, whilst having a 
neurodevelopmental disorder was predictive of contact in the model. Again, parent 
and teacher rated psychopathology predicted service contact for both age groups. 
GP contact (Table 3.32) 
In contrast to other services, female gender in older children was associated with an 
increased odds ratio for contact with a GP (OR 1.82, 95% CI 1.30-2.57). Being in 
poor health or coming from a non-traditional family background also predicted GP 
contact in older children in this model, whilst experiencing more than three life events 
and having neurodevelopmental disorders were associated with contact in younger 
children. For both groups, parent rated psychopathology was associated with GP 
contact, but teacher rated psychopathology in the adjusted model was not. 
CAMHS contact (Table 3.33) 
As for teacher and specialist service contact, younger girls were less likely to be in 
contact with CAMHS than younger boys (OR 0.61, 95% 0.37-0.99). With increasing 
age, adolescents also had reduced odds of CAMHS contact. Experiencing three or 
more life events was associated with contact in both groups, as was parent rated 
psychopathology. In older children, anxiety disorders at baseline were also predictive 
of CAMHS contact in this model (OR 3.53, 95% CI 1.66-7.54). 
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Special education contact (Table 3.34) 
Once again, female gender was associated with lower odds of special education 
contact in younger children (OR 0.65, 95% CI 0.42-0.99) but not in older children. 
Neurodevelopmental disorder and learning disability predicted contact in older and 
younger age groups respectively. Unsurprisingly, given that teachers are key 
referrers into special education services, teacher ratings of impact were also 
associated with contact with this service.
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Table 3.31: Model predicting any teacher contact 2004-2007, by age group* 
Variable Children aged 5-10 at baseline (n=2,184) Children aged 11-15 at baseline(n=1,839) 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Age    0.87 
(0.82-0.92) 
0.85 
(0.78-0.92) 
p<0.001 
Female gender 0.50 
(0.42-0.59) 
0.66 
(0.53-0.81) 
p<0.001    
Non white ethnicity 0.51 
(0.36-0.69) 
0.53 
(0.37-0.77) 
p<0.01    
More than three life events 2.60 
(1.92-3.51) 
1.64 
(1.07-2.53) 
p<0.05    
Neurodevelopmental disorder    4.88 
(2.99-7.94) 
2.51 
(1.20-5.24) 
p<0.05 
Socio-economic class: 
Higher/lower managerial  
 
Reference 
 
Reference 
 
p<0.05 
   
Intermediate,small employer  0.86 
(0.69-1.08) 
0.73 
(0.56-0.97) 
   
Lower sup/ semi-routine  1.18 
(0.97-1.43) 
0.70 
(0.54-0.90) 
   
Never worked/ long-term 
unemployed  
0.90 
(0.50-1.64) 
0.52 
(0.21-1.28) 
   
Students/not stated  1.08 
(0.48-2.45) 
0.37 
(0.11-1.45) 
   
Concern about mental health 5.23 
(4.29-6.36) 
2.23 
(1.69-2.95) 
p<0.001 5.11 
(4.19-6.24) 
2.19 
(1.57-3.04) 
p<0.001 
Parent SDQ total difficulty 
score 
1.16 
(1.15-1.18) 
1.07 
(1.05-1.10) 
p<0.001    
Parent SDQ impact score 1.79 
(1.56-2.05) 
1.22 
(1.04-1.45) 
p<0.05 1.64 
(1.49-1.80) 
1.23 
(1.07-1.41) 
p<0.01 
Teacher SDQ total difficulty 
score 
1.12 
(1.10-1.14) 
1.05 
(1.02-1.08) 
p<0.001 1.92 
(1.68-2.20) 
1.04 
(1.01-1.07) 
p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group 
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Table 3.32: Model predicting any GP contact 2004-2007, by age group* 
Variable Children aged 5-10 at baseline 
(n=2,681) 
Children aged 11-15 at baseline 
(n= 2,524) 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Female gender    1.14 
(0.90-1.47) 
1.82 
(1.30-2.57) 
p<0.01 
General health: fair, bad or 
very bad 
   4.96 
(3.22-7.62) 
1.94 
(1.01-3.73) 
p<0.05 
More than three life events 3.64 
(2.56-5.16) 
1.95 
(1.24-3.05) 
p<0.01    
Neurodevelopmental disorder 6.88 
(4.27-11.1) 
2.37 
(1.20-4.70) 
p<0.05    
Family type: 
Traditional 
    
Reference 
 
Reference 
 
p<0.05 
Single parent    1.98 
(1.49-2.63) 
1.64 
(1.09-2.46) 
 
Reconstituted    1.83 
(1.29-2.60) 
1.54 
(0.95-2.50) 
 
Concern about mental health 6.73 
(5.16-8.78) 
2.35 
(1.59-3.47) 
p<0.001 7.25 
(5.57-9.45) 
2.75 
(1.76-4.30) 
p<0.001 
Parent SDQ total difficulty 
score 
1.17 
(1.14-1.19) 
1.05 
(1.01-1.10) 
p<0.01 1.15 
(1.12-1.17) 
1.05 
(1.01-1.10) 
p<0.05 
Parent SDQ impact score    1.55 
(1.45-1.67) 
1.20 
(1.01-1.26) 
p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group
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Table 3.33: Model predicting any CAMHS contact 2004-2007, by age group* 
Variable Children aged 5-10 at baseline 
(n=2,184) 
Children aged 11-15 at baseline 
(n=1,850) 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Age    0.88 
(0.79-0.97) 
0.80 
(0.69-0.94) 
p<0.01 
Female gender 0.33 
(0.23-0.49) 
0.61 
(0.37-0.99) 
p<0.05    
More than three life events 4.37 
(2.85-6.68) 
2.12 
(1.09-4.17) 
p<0.05 4.10 
(2.83-5.97) 
2.05 
(1.17-3.60) 
p<0.05 
Neurodevelopmental disorder 10.69 
(6.38-17.91) 
3.10 
(1.36-7.11) 
p<0.01    
Any anxiety disorder at 
baseline 
   8.88 
(5.42-14.56) 
3.53 
(1.66-7.54) 
p<0.01 
Concern about mental health 15.68 
(10.43-23.56) 
3.98 
(2.20-7.20) 
p<0.001 10.57 
(7.20-15.54) 
2.42 
(1.28-4.59) 
p<0.01 
Parent SDQ impact score 1.81 
(1.63-2.00) 
1.17 
(1.01-1.36) 
p<0.05 1.61 
(1.49-1.73) 
1.18 
(1.03-1.34) 
p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group 
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Table 3.34: Model predicting any special education contact 2004-2007, by age group* 
Variable Children aged 5-10 at baseline 
(n=2,176) 
Children aged 11-15 at baseline 
(n=1,845) 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Unadjusted 
OR 
(95% CI) 
Adjusted OR 
(95% CI) 
p value for 
adjusted OR 
Age    0.87 
(0.80-0.95) 
0.84 
(0.74-0.95) 
p<0.01 
Female gender 0.40 
(0.29-0.55) 
0.65 
(0.42-0.99) 
p<0.05    
Neurodevelopmental disorder    6.38 
(3.74-10.87) 
3.67 
(1.53-7.42) 
p<0.01 
Generalised Learning 
disability: None 
 
Reference 
 
Reference 
 
p<0.01 
   
Borderline 4.48 
(3.07-6.53) 
2.16 
(1.21-3.87) 
   
Moderate 14.47 
(7.30-28.69) 
4.48 
(1.33-15.1) 
   
Severe 2.23 
(0.28-18.03) 
4.69 
(0.97-22.62) 
   
Concern about mental health 9.37 
(6.78-12.95) 
2.77 
(1.71-4.47) 
p<0.001 10.35 
(7.28-14.72) 
2.74 
(1.49-5.01) 
p<0.01 
Parent SDQ impact score 1.76 
(1.60-1.94) 
1.24 
(1.07-1.44) 
p<0.01 1.62 
(1.51-1.74) 
1.25 
(1.09-1.44) 
p<0.01 
Teacher SDQ impact score 2.14 
(1.89-2.42) 
1.29 
(1.06-1.58) 
p<0.05 1.91 
(1.67-2.18) 
1.29 
(1.06-1.57) 
p<0.05 
*Grey shading indicates that this variable was not significant at the p<0.05 level in this age group 
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Question 3: Are there differences in the trajectories of psychopathology over 
time and in the outcome in 2007 between children who have been in contact 
with services and those who have not? 
This section first presents the findings of the analysis of children’s trajectories over 
time by service contact status. This is followed by the results of the regression 
models examining the association between service contact and outcome in terms of 
psychopathology in 2007. 
Trajectories of psychopathology over time by service contact 
Trajectories of children in contact with any service, 2004-2007 
Trajectories of children with disorders 
Figure 3.8 illustrates that those with a disorder who had any contact with services 
had consistently higher total difficulty scores over the three year study period than 
those with a disorder who reported no contact. In both groups, the mean score did 
not change significantly over time, suggesting that as a group their levels of difficulty 
as measured by the total difficulty score were largely sustained. 
Figure 3.8: Parent rated SDQ total difficulty scores over time by service 
contact status in children who had a disorder at any point (with 95% 
confidence intervals shown by error bars) 
 
Figure 3.9 shows that a similar pattern was detected for those with a disorder at 
baseline; those in contact with services had significantly higher mean total difficulty 
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scores than those who did not, suggesting that they experienced higher levels of 
psychopathology despite all meeting criteria for a diagnosis in 2004. The mean score 
of the service contact group was 18.2 (95% CI 17.4-19.0) at baseline, which is in the 
abnormal range of the SDQ, whereas the mean score of the no service contact 
group was only 12.4 (95% CI 10.5-14.2). Finally, whilst the mean scores of both 
groups decreased between 2004 and 2007, the score of those with service contact 
remained within the abnormal range in 2007 with a mean of 16.5 (95% CI 15.6-17.3) 
points on the total difficulty scale. 
Figure 3.9: Parent rated SDQ total difficulty scores over time by service 
contact status in children who had a disorder at baseline (with 95% confidence 
intervals shown by error bars) 
 
 
 Trajectories in all children  
The mean parental SDQ total difficulty scores are presented by service contact 
groups over the study period, in Figure 3.10 and Table 3.35 below.  Children with 
reported service contact at both time points (2004 and 2007) consistently 
demonstrated the highest scores over time, with no overall change for this group in 
the parental rating of difficulty between 2004 and 2007. Among children with service 
contact only in 2004, there was a decrease in mean score between 2004 and 2007, 
suggesting improvement. Similarly, the group who had contact with services only in 
2007 had a greater level of difficulty than those not using services at all, even at 
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baseline ‘pre-contact’ in 2004 and their scores clearly display an upward trajectory 
until follow-up in 2007 . 
Table 3.35: Mean parental SDQ total difficulty scores 2004-2007 by contact with 
any service, with 95% confidence intervals   
Service 
contact status 
Parental mean SDQ total difficulty scores 
(95% confidence interval) 
2004 12 months 24 months 2007 Mean 
change 
2004-2007 
No service 
contact 
6.0 
(5.9-6.2) 
5.7 
(5.6-5.9) 
5.5 
(5.3-5.7) 
5.7 
(5.5-5.8) 
-0.4 
(-0.5, -0.2) 
Contact in 
2004 only 
10.3 
(9.8-10.8) 
8.9 
(8.3-9.4) 
8.1 
(7.6-8.6) 
8.3 
(7.8-8.8) 
-2.0 
(-2.4, -1.5) 
Contact in 
2007 only 
8.4 
(8.0-8.8) 
8.8 
(8.4-9.2) 
9.4 
(8.9-9.8) 
10.3 
(9.9-10.7) 
1.8 
(1.5, 2.2) 
Contact in 
2004 & 2007 
14.3 
(13.7-14.9) 
13.3 
(12.7-14.0) 
13.51 
(12.8-14.2) 
14.0 
(13.4-14.6) 
-0.23 
(-0.8, 0.2) 
 
Figure 3.10: Trajectory of mean parental SDQ total difficulty scores 2004-2007 
by contact with any service, with 95% confidence intervals 
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The median and interquartile ranges of parent impact scores over time by contact 
with any service are shown below in a box and whiskers plot in Figure 3.11. The total 
impact scores can be seen to follow a similar pattern to the total difficulty scores over 
time. 
Figure 3.11: Box and whiskers plot of median and interquartile range of parent 
SDQ impact score over time by service contact 
 
 
Trajectories of children in contact with CAMHS, 2004-2007 
Repeating the analysis of trajectories over time for children in contact with CAMHS 
revealed a similar pattern, shown in Table 3.36 and Figure 3.12 below. However, the 
mean levels of difficulty were much greater among children who had access to 
CAMHS compared to those who had contact with any services, as might be 
expected. Children reporting contact with mental health services both in 04 and 07 in 
particular had mean scores well into the abnormal range for the total difficulty score 
of the SDQ (17 and above) at each time point. 
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Table 3.36: Mean parental SDQ total difficulty scores 2004-2007 by contact with 
any service, with 95% confidence intervals 
Contact 
with 
CAMHS 
Parental mean total difficulty scores 
(95% confidence interval) 
2004 12 months 24 months 2007 Mean 
change 
2004-2007 
No 
CAMHS 
contact 
7.46 
(7.30-7.62) 
7.06 
(6.90-7.23) 
6.96 
(6.79-7.13) 
7.31 
(7.14-7.47) 
-0.15 
(-0.28, -0.06) 
Contact in 
2004 only 
16.12 
(14.57-17.68) 
13.79 
(11.92-15.66) 
12.75 
(10.73-14.76) 
13.1 
(11.51-14.68) 
-2.97 
(-4.34, -1.60) 
Contact in 
2007 only 
12.77 
(11.53-14.02) 
14.03 
(12.65-15.40) 
14.49 
(13.16-15.82) 
15.66 
(14.39-16.93) 
2.89 
(1.90, 3.88) 
Contact in 
2004 & 
2007 
22.86 
(21.07-24.64) 
20.73 
(18.69-22.78) 
21.86 
(19.70-24.01) 
21.63 
(19.87-23.38) 
-1.23 
(-2.85, 0.39) 
 
Figure 3.12: Trajectory of mean parental total difficulty scores 2004-2007 by 
contact with mental health services, with 95% confidence intervals 
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Association of service contact with outcome in 2007 
Contact with any service 
Table 3.37 displays the model for contact with any service as a predictor of parental 
total difficulty score in 2007 for two groups of children: children who did not have a 
DAWBA diagnosis at baseline (on the left of the Table) and children who did have a 
diagnosis on the DAWBA at baseline in 2004 (on the right of the Table).   The 
reference group was children who had had no reported mental health related service 
contact. For both groups service contact at any point was associated with an 
increased unadjusted total difficulty score in 2007. Following adjustment for baseline 
covariates including socio-demographics, initial SDQ ratings of difficulty and impact, 
and DAWBA diagnoses, the coefficients became much smaller. However, the 
association between service contact as a categorical variable, and total difficulty 
score in 2007 remained (p<0.001). For children in both groups who had service 
contact in 2004 only, the 95% confidence interval for the coefficient crossed zero, 
indicating no significant improvement or deterioration at the p<0.05 level compared 
to those who did not have any service contact. For both groups, contact with 
services in 2007 only and at both time points, was associated with a higher total 
difficulty score in 2007. On checking both models by examining the distribution of the 
standardised residuals and plotting them against the fitted values, there was no 
evidence of significant heteroscedasticity. 
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Table 3.37: Association of any service contact 2004-2007 and parental total difficulty score in 2007 - results of linear 
regression analysis 
 
 
Predictor: 
Contact with 
any service 
Outcome: Parental SDQ total difficulty score in 2007, with 95% confidence intervals 
Children without a DAWBA diagnosis at 
baseline (n=3636 in adjusted model) 
Children with a DAWBA diagnosis at baseline 
(n=304 in adjusted model) 
Mean SDQ 
total difficulty 
score at 
follow-up 
(unadjusted) 
Unadjusted 
mean 
difference/ 
coefficient 
 Fully 
adjusted 
mean 
difference/ 
coefficient 
Mean SDQ 
total difficulty 
score at 
follow-up 
(unadjusted) 
 Unadjusted 
mean 
difference/ 
coefficient 
 
Fully adjusted 
mean 
difference/ 
coefficient 
No  contact 5.6 
(5.4 to 5.8) 
Reference Reference 8.6 
(7.1 to 10.2) 
Reference Reference 
Contact 2004 
only 
7.6 
(7.2 to 8.1) 
2.6 
(2.1 to 3.1) 
-0.1 
(-0.5 to 0.5) 
11.7 
(10.3 to 13.0) 
3.0 
(1.0 to 5.0) 
0.9 
(-0.9 to 2.8) 
Contact 2007 
only 
9.8 
(9.4 to 10.2) 
4.6 
(4.2 to 5.1) 
2.7 
(2.3 to 3.1) 
15.7 
(13.8 to 17.6) 
7.0  
(4.6 to 9.5) 
5.9 
(3.5 to 8.3) 
Contact 2004 
and 2007 
11.5 
(10.9 to 12.1) 
8.4 
(7.8 to 9.0) 
2.6 
(2.0 to 3.2) 
18.1 
(17.0 to 19.2) 
9.5 
(7.6 to 11.3) 
4.3 
(2.5 to 6.1) 
p value for 
association 
between 
service contact 
and outcome 
 p<0.001 p<0.001  p<0.001 p<0.001 
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Contact with CAMHS 
Table 3.38 displays the model for CAMHS contact as a predictor of parental total 
difficulty score in 2007, for children  who did not have a DAWBA diagnosis at 
baseline (on the left) and children who did have a diagnosis on the DAWBA at 
baseline (on the right).  For both groups of children, there was an association 
between CAMHS contact as a categorical variable, and total difficulty score in 2007 
(p<0.001) in the unadjusted and the fully adjusted models. Unlike in the any-service 
model, both for children with a diagnosis at baseline and for children without a 
diagnosis, service contact in 2004 only was associated with a reduction in total 
difficulty score in 2007. However, the 95% confidence interval for the coefficient 
included zero. For children without a diagnosis at baseline, being in contact only in 
2007 with CAMHS was associated with the greatest increase in the total difficulty 
score in 2007, compared to children who had contact at both time points, which 
might be related to their upward trajectory of difficulty. On checking both models by 
examining the distribution of the standardised residuals and plotting them against the 
fitted values, there was no evidence of significant heteroscedasticity.
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Table 3.38: Association of child mental health service contact 2004-2007 and parental total difficulty score in 2007 - results 
of linear regression analysis 
 
 
 
 
Predictor: 
Contact with 
CAMHS 
Outcome: Parental SDQ total difficulty score in 2007, (with 95% confidence intervals) 
Children without a DAWBA diagnosis at baseline 
(n=3636 in adjusted model) 
Children with a DAWBA diagnosis at baseline 
(n=291 in adjusted model) 
Mean SDQ 
total difficulty 
score at 
follow-up 
(unadjusted) 
Unadjusted 
mean 
difference/ 
coefficient 
Fully adjusted 
mean 
difference 
/coefficient 
Mean SDQ 
total difficulty 
score at 
follow-up 
(unadjusted) 
Unadjusted 
mean 
difference/ 
coefficient 
 
 Fully adjusted 
mean 
difference/ 
coefficient 
No  contact 6.9 
(6.7 to 7.0) 
Reference Reference 13.5 
(12.6 to 14.5) 
Reference Reference 
Contact 2004 
only 
11.0 
(9.2 to 12.7) 
4.1 
(2.4 to 5.9) 
-0.1 
(-1.9 to 1.7) 
14.7 
(12.4 to 17.1) 
1.2  
(-1.4 to 3.8) 
-1.5 
(-3.4 to 0.5) 
Contact 2007 
only 
13.8 
(12.5 to 15.2) 
6.9 
(5.6 to 8.3) 
4.8 
(3.5 to 6.2) 
19.0 
(16.8 to 21.1) 
5.4 
 (3.1 to 7.8) 
3.1 
(1.3 to 4.8) 
Contact 2004 
and 2007 
15.0 
(11.2 to 18.8) 
8.1 
(6.7 to 7.1) 
1.9 
(-2.9 to 6.7) 
22.6 
(20.8 to 23.4) 
9.0 
(7.0 to 11.1) 
4.3 
 (1.9 to 6.7) 
p value for 
association 
between 
service 
contact and 
outcome 
 p<0.001 p<0.001  p<0.001 p<0.001 
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3.5 Discussion 
 
This section places the findings of the secondary analysis of BCAMHS in the context 
of the literature, policy and practice. The findings from each of the three research 
questions are first considered individually, followed by a discussion of the strengths 
and limitations of the analysis, and a summary of key implications for research and 
practice.  
 Mental health related contact with services 
The first question in this study was: ‘What services do children with psychopathology 
have contact with over a three-year period?’ The analysis of data on service contact 
demonstrates that a high proportion of children with difficulties had contact with any 
service over the study period. Overall, levels of service contact in BCAMHS 2004-
2007 appeared higher than in the previous BCAMH Survey 1999-2002; 85% of 
children with a disorder at baseline in 2004  reported service contact in this analysis, 
compared to 57% in the earlier survey (Ford et al. 2007b).  
Nonetheless, half of children with disorders still did not report being seen by a 
specialist service in this latest survey, and levels of contact with CAMHS were not 
markedly higher; 30% had contact with CAMHS in 2004-2007 compared to 23% in 
1999-2002 (Ford et al. 2005). Just under half (49%) of those with a persisting 
disorder in 2004 and 2007 had not been in touch with CAMHS at all; the 
corresponding figure in the 1999 survey was 62%, suggesting a small increase in 
contact amongst children with more enduring psychopathology (Ford et al. 2005). 
There are no directly comparable surveys examining service contact amongst adults 
with psychiatric disorders; although the findings of the 2007 Adult Psychiatric 
Morbidity Survey (National Centre for Social Research, 2007) imply that specialist 
services are also used by a minority of adults with common mental disorders 
(CMDs). In the survey, 38% of those with a CMD reported GP contact within the past 
year, but only 18% reported using a specialist or community service. 
Levels of service contact in children with emerging diagnoses are also important to 
track as they may provide an indication of how quickly new disorders are recognised, 
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which may have a bearing on the possibilities for early intervention. Again, reported 
contacts were higher in this group than in the previous BCAMHS. Just 23% of those 
with an emerging disorder reported not being in touch with any service over the 
study period in 2004 – 2007, compared to 40% in 1999-2002 (Ford et al. 2005). This 
increase in contact with any service however did not translate into a rise in contact 
with specialist CAMHS; the percentages not in contact in 1999-2002 and 2004-2007 
were 79% and 81% respectively (Ford et al. 2005). These findings about contact with 
CAMHS may be influenced by the timescale of referral from frontline to specialist 
services, especially in the emerging disorder group. Whilst there are no data on 
waiting times from the period when BCAMHS was carried out, the most recent 
CAMHS Benchmarking Survey in 2014/15 reported an mean average wait of 32 
weeks (2014/15), with considerable variation around the country (NHS 
Benchmarking Network 2015).  
Children who had an emotional disorder at any time point reported lower levels of 
contact with services than those with externalizing disorders, and those with ADHD 
in particular. When interpreting these results it is important to consider the different 
courses of these disorders. Emotional disorders more typically follow an episodic or 
relapsing and remitting course, although some children may experience chronic 
difficulties (Chaiton et al. 2013, Legerstee et al. 2013). In contrast, ADHD and PDD 
are neurodevelopmental disorders and by definition these children would be 
expected to have persistent problems. Examining only those with persisting 
disorders partially addressed this issue, and suggested that the difference in contact 
was not as marked as unstratified analysis initially suggested. Children with ADHD 
remained more likely than those with anxiety disorders to have been in touch with 
every individual service except social services, although this was not statistically 
significant, possibly due to the small numbers of those with persisting disorders. This 
is in keeping with other studies reporting lower levels of contact amongst children 
with anxiety disorders (Zachrisson et al. 2006, Ford et al. 2007b, Costello et al. 
2014), and may reflect barriers to the identification and referral of emotional 
disorders. Front line professionals such as GPs have reported feeling uncomfortable 
with recognising and managing emotional disorders and highlighted the need for 
more training (Roberts et al. 2013). Teachers cite similar concerns, and also report 
competing pressures to manage more disruptive behaviours in the classroom; finally 
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young people themselves may be more reluctant to initiate help-seeking for such 
disorders (Gulliver et al. 2010, Kidger et al. 2010, Papandrea and Winefield 2011). 
When involvement with more than one service amongst children with a disorder was 
examined, those reporting teacher contact were found to be the least likely to be 
involved with other services. In particular, just over a third reported CAMHS contact 
as well, compared to over half of those seen by GPs. These findings are in line with 
work from the previous 1999 BCAMHS where the biggest overlaps in service use 
between front line and specialist services reported were between GPs and CAMHS 
and paediatrics, and separately between teachers and specialist education(Ford et 
al. 2007b). There was less overlap in service use between the health and education 
systems. In the US Great Smoky Mountain Study of service use, education was the 
point of entry ‘least likely to be followed by involvement by other sectors’(Farmer 
2003).  It is possible that many of these children with disorders who had mental 
health related contacts only within the education sector may have received entirely 
appropriate education-focussed assessment and intervention, and the involvement 
of other sectors may not have been indicated. Similarly, although all children 
examined had a disorder according to the DAWBA, children reporting teacher 
contact on average had lower mean parent rated total difficulty scores, which were 
not adjusted for at this point. However, these findings may also be influenced by 
reported teacher preference for exploring educational resources for help rather than 
refer to health, and uncertainty about what support from health might be required 
(Ford 2000, Moor et al. 2007, Papandrea and Winefield 2011). This is likely to be 
perpetuated by a perceived mismatch between the expectation that schools will 
address and refer these problems, and the availability of mental health consultation 
and services as discussed further in the Overarching Conclusions chapter (Rothì et 
al. 2008, Taggart and McDonald 2014). 
Overall, findings suggest that levels of contact with all services may have grown over 
time, without a corresponding increase in the prevalence of mental health problems 
(Green et al. 2005). There are various explanations for this possible increase and it 
is necessary to consider whether this is likely to be broadly representative of service 
contact in the wider population. The similarity in methods and measures between the 
two BCAMH surveys do enable comparisons to be made, although analyses were 
slightly different, as many of the secondary analyses of BCAMHS 1999 focussed on 
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children who had a disorder at baseline (Ford et al. 2005, Ford et al. 2007b). Both 
were weighted to be representative of the British child population at the time each 
respective survey was carried out. In such a large sample it is also unlikely that the 
overall levels of service contact were a chance finding, although there were very 
small numbers  and wide confidence intervals in some categories e.g. children with 
depressive disorders. 
The figures on service contact were also dependent on parental recall and as 
BCAMHS 2004 asked about service contact over a whole year, this is an important 
factor which could contribute to under- or over-estimation. Parents appear to recall 
their previous health concerns about their children with a high degree of accuracy 
over long time periods, for example, recalling concerns from ten years ago in one 
study by Russell et al. (2014).  Studies validating service use instruments suggest 
that parents are likely to accurately recall that they used a service, but that their 
memory of the exact service type may be less reliable. Bean et al. used the Services 
Assessment for Children & Adolescents (SACA) to interview parents about mental 
health service contact over the period of a year, and found overall agreement with 
case notes was high at 91%, but that recall of type of service was much more 
variable(Bean et al. 2000). Validation of the Children’s Services Interview (CSI) also 
suggested that parental recall was moderately reliable over a three month period, 
although their recall of which professional/service was seen was less so, particularly 
for teachers and the voluntary sector (Ford et al. 2007a). Another consideration is of 
course that parents may be unaware of service contacts by their child, for instance if 
these occur at school. Older teenagers may also attend services on their own or 
without informing their parents which could lead to underestimation or misattribution 
of service contact (Ford et al. 2007b).  
If this represents a true increase in contact to some extent, it is likely to be due to a 
combination of changes in demand for help with mental health problems, and 
changes in supply such as expanded availability and accessibility of services. Activity 
levels overall in the NHS have increased in terms of GP appointments and also 
referrals and appointments in CAMHS (NHS Benchmarking Network 2015, King's 
Fund 2016). These findings would also be in keeping with international trends, such 
as reports from the US national comorbidity surveys which found an increase in the 
proportion of children with disorders in contact with services from 2003 to 2012  
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(Merikangas et al.  2011, Costello et al. 2014). Policy changes may reflect growing 
awareness of mental health problems, leading to increased recognition and demand; 
they are also likely to have widened the availability of services since 2002.   The 
National Service Framework in 2004 prioritised a comprehensive CAMH service and 
emphasised increased accessibility of services (Department of Health 2004). The 
2008 CAMHS Review also reported a number of improvements in provision since 
2005, which overlaps with the time period of the second BCAMHS survey 
(Department of Health 2008a). However, since 2010, austerity is likely to have had 
an impact on services, and the possible implications of this as they relate to the 
findings of this thesis are discussed further in the Overarching Conclusions chapter 
(Young Minds 2015). 
Predictors of service contact  
The second study question focussed on the factors that predict contact with services. 
Here the results were generally in line with other studies, including the previous 
BCAMHS. An exception to this was the finding that those in the younger age group 
of lower socioeconomic status had reduced odds of any service contact, and of 
teacher contact relative to the reference higher managerial and professional group, 
something not reported in the previous BCAMH Survey in 1999 (Ford et al. 2008b). 
However, in the unadjusted models these groups had equal odds of contact 
compared to the baseline group. This would suggest that children from lower socio-
economic groups are as likely to contact services as those in higher groups, but that 
once psychopathology and other factors are adjusted for the effect is reversed – i.e. 
they may be less likely to be in contact relative to markers of need. This is known as 
the inverse care law (Tudor Hart 1971) and is not a new phenomenon in mental 
health; reduced access to mental health services relative to need in lower-income 
groups has been reported elsewhere, particularly in the United States (Newacheck et 
al. 2003). 
Non-white ethnicity was also found to be negatively associated with service contact 
in this analysis, for any service in all age groups and with teacher contact in younger 
children. Under-representation of children from ethnic minorities in child mental 
health services has been previously observed in the UK, by Bradby et al. (2007) and 
Messent and Murrell (2003) amongst others, who propose that this may result from 
the influence of more traditional community structures or from different views on the 
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role of services in mental health. Referral patterns also seem to reflect ethnic 
differences; recent examination of referral pathways to CAMHS in England found 
that children from ethnic minorities were less likely to be referred to child mental 
health from primary care than white children; instead the more frequent referral route 
was via education or social services (Edbrooke-Childs et al. 2015b).  
These results also indicated an interaction between age group and gender on 
service contact, which is in line with other population studies of service contact 
reviewed in Chapter Two (Young et al. 2011, Reijneveld et al. 2014).  In the adjusted 
analyses, younger boys were more likely than younger girls to report contact with 
any service overall, and with special education, teachers and CAMHS specifically. In 
the older age group, those aged 11 to 15 at baseline, girls were more likely to report 
contact with a GP than boys. As these analyses were adjusted for DAWBA diagnosis 
at baseline and SDQ, these differences are not likely to relate to major differences in 
psychopathology, but may be influenced by gender differences in symptom 
recognition and referral patterns. For example, a number of studies have suggested 
that girls with ADHD and autism may be less likely to be referred to services than 
boys with the same conditions (Novik et al. 2006, Ford et al. 2008a, Bussing et al. 
2012, Lai et al. 2015). 
Trajectories and outcomes 
Question Three related to examining the trajectories of psychopathology and 
outcomes in terms of psychopathology in 2007 of children in contact and not in 
contact with services. Analysis demonstrated that children in contact with services 
had consistently higher levels of difficulty over time than children without service 
contact, even when only children who met criteria for psychiatric diagnoses were 
included. Correspondingly, those who were in contact with services at both time 
points had on average more severe difficulties as measured by parental SDQ total 
difficulty and impact scores than any of the other three groups. Such children had 
sustained high total difficulty scores over the four time points of the study, although a 
small decrease in impact score was observed. Those who were in contact with 
services only in 2004 on average improved, whereas children who were in contact 
only in 2007 displayed a trajectory of increasing difficulty  prior to their contact with 
services. However, as service contact was only measured at two time points, this 
study was unable to collect data post service contact for this group, which would help 
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to determine whether this upward trajectory was maintained, or arrested by service 
contact, as suggested by Angold et al. (2000). In keeping with the examination of 
trajectories, in the regression analysis service contact only at follow-up in 2007 or at 
both time points (2004 & 2007) was associated with worse psychopathology than no 
reported service contact, even after adjusting for psychopathology at baseline. 
The explanation for these findings is probably multifactorial, as the relationship 
between service contact and psychopathology is complex. Costello and Maughan’s 
review (2015) discusses optimal outcomes for children with disorders and 
acknowledges that there is likely to be great individual variability in what might 
constitute the best possible outcome for any given child. In BCAMHS, children in 
contact with services experienced higher levels of psychosocial adversity in the 
baseline survey, some of which have been associated with greater persistence of 
difficulties and poorer outcomes (Costello and Maughan 2015). However, the 
association between service contact and outcome remained even after adjusting for 
such covariates. 
One contributing factor to this finding is likely to be that children with poor mental 
health are on different trajectories in terms of their psychopathology, which is 
supported by many of the studies quoted in Chapter Two (Zwaanswijk et al. 2006, 
Dekker et al. 2007, Pingault et al. 2011, Chaiton et al. 2013) . Children with a 
persisting disorder are likely to experience more enduring and chronic problems that 
may have worsened even further without contact with services, consequently, 
avoiding deterioration in this group may in fact represent a ‘gain’. Conversely, 
children with more transient difficulties, who were not seen at all or only seen in 
2004, may have improved without service contact. The 2007 only contact group 
demonstrated an upward trajectory of worsening problems before they came in 
contact with services. This may have explained the adjusted association with poorer 
outcomes in 2007 in these children and also replicates previous findings by Angold 
et al. who reported deterioration in symptoms before children used specialist 
services in the multi-wave Great Smoky Mountains Study (Angold et al. 2000). 
Angold et al. (2000) also observed a positive effect of service use on symptoms only 
after controlling for pre-treatment trajectory. This was unfortunately which not 
possible in BCAMHS where service contact was measured at two points only.  
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The results of this trajectories analysis are similar to those of the TRAILS study 
which reported poorer outcomes in terms of psychopathology at follow-up in those in 
contact with mental health services and in particular among those who were in 
contact over a longer period (Jörg et al. 2012). TRAILS were able to adjust for 
service contact in the past, a potential predictor of poorer outcomes (Visser et al. 
2003) which was not possible in BCAMHS. A number of other observational studies 
of ‘real world’ services have also reported no change in psychopathology over time 
(Zwaanswijk et al. 2006). In Warren et al.’s (2010) retrospective study of community 
mental health settings, 24% of children even experienced an increase in symptoms 
by the end of their treatment episode. Deterioration on various measures in up to 
30% of transition-aged young people receiving general mental health services was 
also reported by Manteuffel et al. (2008). Some of these studies were set in 
specialist mental health services and most of the included samples experienced an 
intervention of either therapy or medication. In contrast in BCAMHS, there was no 
available data on whether interventions were offered and if so, what they were. 
In BCAMHS, parents were asked about contact with services rather than whether 
their child had been assessed or treated, and what management they received.  The 
information on service contact is therefore not fine grained. Children who reported 
contact with services may still have been on a waiting list, have received only a brief 
assessment or not yet completed an intervention. Others may have been offered 
short or prematurely terminated therapies, which some have argued could be 
detrimental (Angold et al. 2000). Some children may have been offered evidence 
based interventions and completed courses of therapy. This heterogeneity is of 
course more likely to obscure any influence of effective intervention, whereas this 
model found the association to be statistically significant.  Repeating the analysis for 
individual groups, for example examining CAMHS contact in children with ADHD, 
may have produced different results, but small numbers meant that these analyses 
were inappropriate due to a lack of power. 
As BCAMHS is an observational study rather than a randomised trial set up to 
examine service contact, the findings are likely to have been influenced to some 
extent by confounding by indication. That is, that there were factors not measured 
which influenced both the final outcome in 2007 and the probability of service 
contact. Jörg et al. (2012) proposed that the clinical opinion of service gatekeepers 
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could constitute such a factor. Another might be educational achievement, as whilst 
estimates of IQ or learning disability were included as covariates both in the TRAILS 
study and this secondary analysis, neither study included a specific measure of 
school progress. Furthermore, resilience is increasingly recognised as playing a role 
in the development and response to mental disorders (Rutter 2013), although it is 
also a complex and dynamic concept which would not be captured by our measures, 
with possibly the most relevant being the prosocial rating on the SDQ. All could act 
as confounding factors. However, it is unlikely that confounding by indication would 
explain the entire association that persisted after adjustment for multiple 
characteristics. 
Strengths and limitations 
BCAMHS 2004-2007 had a number of strengths that made it appropriate for 
answering the research questions. It reported naturalistic patterns of contact with a 
wide variety of public sector services and is representative of the British population 
of school age children. The range of services included was not limited just to 
specialist mental health but also included education and social work, reflecting the 
wider range of contacts which families have and their broader needs. BCAMHS also 
employed well-validated measures of psychopathology, which are increasingly used 
in services today, such as the Strengths and Difficulties Questionnaire (Goodman 
and Goodman 2009). In addition, the multi-informant methodology increased the 
validity of ratings of children’s difficulty, as did the use of total difficulty and impact 
scores on the SDQ. 
The follow-up period of three years with the interim contact points also allowed the 
trajectory of children to be followed over time, rather than just as a ‘snapshot’ of 
psychopathology at two time points. This was valuable in examining the differences 
between service contact groups and also added context to the regression models. 
Overall the size and level of detail in the dataset was sufficient to explore the broad 
research questions. 
There are various limitations, both to the dataset and the methods of analysis used. 
A number of these have already been outlined above, such as the lack of detail on 
the nature of service contact which precluded more detailed analysis of aspects such 
as duration which may be associated with outcome. In addition, although the sample 
124 
 
size was large enough that analysis of the most common diagnostic groups was 
feasible, the small numbers of those with less common disorders such as depression 
meant that results for these children were reported with low precision. Due to tiny 
numbers, analyses of data on children with rarer diagnoses such as eating disorders 
were not appropriate. There was also a high proportion of missing data on teacher 
SDQ ratings and accordingly the extent to which multi-informant data could be used 
was restricted. 
The naturalistic community sample of BCAMHS made it very appropriate for an 
examination of ‘real world’ service contact but as this was an observational study, 
there were attendant limitations. Considerable heterogeneity was introduced by the 
timing of follow-up. Whilst trials and routine outcome studies measure 
psychopathology pre and post intervention, BCAMHS measured difficulties at a 
variety of points, depending on when parents were surveyed in relation to the service 
contact. The time points when parents were surveyed were therefore unlikely to 
relate directly to before or after experiencing an intervention. Some children may 
have accessed effective interventions and experienced reduced psychopathology 
that was not detected by the study as data collection did not correspond with the end 
of their treatment. 
Furthermore, as discussed above, the effects of residual confounding in the logistic 
and linear regression models cannot be excluded, despite the use of multivariable 
models. The analysis also adjusted only for baseline circumstances, so changes in 
socio-demographic variables occurring after 2004 will have influenced the outcome 
in 2007 but would not be accounted for in the regression model. Consequently, the 
results of the service contact and outcomes analysis should be interpreted with 
caution as representing an association between service contact and outcome that 
has been adjusted for common measured confounding factors at baseline. 
The decision to use parent rated SDQ scores as outcomes in this analysis may also 
have restricted the extent of change that was detected. Whilst the SDQ total difficulty 
score and impact score are broad and well validated measures that can be 
aggregated across groups, the SDQ may underestimate the effectiveness of 
services. Recent analysis of outcome measurement in a small cohort of children 
attending child mental health services in the UK found that although the SDQ 
showed change over time, this was to a lesser extent than more individualised 
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measures such as goal based progress (Edbrooke-Childs et al. 2015a). These 
findings replicate an earlier study in a specialist service for Obsessive Compulsive 
Disorder, where the SDQ detected a smaller effect size than more specialist 
questionnaires (Lee et al. 2005). Combining more specific measures such as SDQ 
subscales may have increased the sensitivity of the analysis and detected 
improvements that the total difficulty and impact scores did not. On the other hand, 
this would have involved multiple analyses or the development of a latent score 
which would have been more methodologically complicated and potentially created a 
lack of clarity.  
Finally, this BCAMHS dataset now dates from the previous decade. Changes in 
service supply and demand may mean that these results under- or over-estimate the 
extent of service contacts or the association between contact and outcome. Some 
changes, such as the introduction of Improving Access to Psychological Therapies 
(NHS England, 2016) for children and young people in 2011 may have increased the 
availability and effectiveness of services.  The Targeted Mental Health in Schools 
programme (TaMHS) which took place between 2008-2011 was also shown to have 
increased mental health input into schools during this time period (Wolpert et al. 
2013). Conversely, concerns continue to be raised over high barriers for entry to 
CAMH services and over the impacts of austerity. Recent figures from a Freedom of 
Information request by the charity Young Minds (2015) reported that the majority of 
NHS Clinical Commissioning Groups and local authorities had cut or frozen their 
budgets. Nonetheless, whilst the broad configuration of services remains the same 
these results may also serve as a useful benchmark for assessing the impact of 
changes between 2007 and the future 2016 BCAMHS. 
Summary 
The results of the secondary analysis suggest that a high proportion of children with 
difficulties were in contact with services during the period between 2004 and 2007. 
Nonetheless, there remained a significant number who were missing out on 
opportunities to have their problems assessed and managed, who might feel and 
function better with support and who may accrue secondary difficulties without it 
Findings on the association of contact and outcomes are broadly in line with other 
studies, but raise a number of questions which require more detailed study designs 
to address, and which link with an emerging emphasis on measuring outcomes in 
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mental health services. The final Overarching Conclusions chapter aims to consider 
and integrate the findings of all three studies together, and will discuss in more detail 
the clinical and research implications. The next chapter, Chapter Four, focusses on 
young people with ADHD and examines primary care prescribing over the transition 
period. 
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Chapter Four: Primary care prescribing of 
ADHD and psychotropic medication in young 
people with ADHD in the Clinical Practice 
Research Database 2005-2013 
4.1 Introduction 
 
This chapter explores primary care prescribing of medications for ADHD and other 
psychotropic medications in young people with ADHD. It focusses in particular on 
cessation of ADHD medication from the age of 16 onwards, in order to study what 
happens to prescribing as young people move on from child to adult services. The 
study uses a dataset from the Clinical Practice Research Datalink, a large UK 
database containing primary care records. 
ADHD was once considered to be a condition only of children and younger 
adolescents. It is increasingly accepted that this is not the case, with follow-up 
studies estimating that 40-60% of those with ADHD experience persistence of 
symptoms at age 25 (Faraone et al. 2006). However, it was only in 2008 that NICE 
first recommended appropriate assessment and management services, including 
medication, for adults affected by ADHD (NICE 2008b).  NICE guidance reflected 
increasing evidence that stimulants are effective in reducing symptoms in adults as 
well as children, and that outcomes for treated ADHD are likely to be better across a 
spectrum of health, occupational and educational domains, although poorer than for 
those without ADHD at all (Faraone and Glatt 2010, Shaw et al. 2012). Furthermore, 
pharmacological treatment has also been associated with a reduced risk of serious 
road traffic accidents and criminal convictions in males with ADHD (Lichtenstein et 
al. 2012, Chang et al. 2014).  
Previous UK studies of primary care prescribing have reported that the majority of 
young people with ADHD stop medication before the age of 18 (Wong et al. 2009, 
McCarthy et al. 2012a). In the 1999-2006 CADDY study, the peak age for 
discontinuation of medication in young people with ADHD was 16-17 years, which 
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coincides with the period of transition from child to adult services (Wong et al. 2009). 
The rate of cessation reported by the CADDY study up to 2006 was far greater than 
the estimated rate of persistence of ADHD in Faraone et al.’s (2006) meta-analysis 
of follow-up studies. Consequently, persisting symptoms may affect a young 
person’s functioning; and the impact of stopping medication at the time of transition 
may be intensified by the vulnerability of adolescents during this crucial 
developmental stage (Young et al. 2011, McGorry et al. 2013). In addition to the 
multiple challenges of leaving school, starting employment or further education and 
moving away from the family home, this transition from adolescence to early 
adulthood is also the time when substance misuse, personality disorders and severe 
mental illnesses may emerge (Singh et al. 2010, Copeland et al. 2011). 
Young people may themselves choose to stop taking medication as they move on 
from school or college, having assessed the trade- off between benefits and adverse 
effects and taking the opportunity to exert their autonomy (McCarthy 2014). It is 
nonetheless the case that there are a number of external barriers to continuation of 
medication during this vulnerable transition period. These include the acknowledged 
lack of services for adults with ADHD where medication may be monitored and 
attitudes amongst clinicians, who may not yet be fully accepting or knowledgeable 
about ADHD in adults as a valid diagnosis (Young et al. 2011, Hall et al. 2013, 
Matheson et al. 2013, Coghill 2015, Hall et al. 2015).  
During the transition from adolescence to adulthood, the clinical presentation of 
ADHD may also lead to under-treatment, or to substitution of other psychotropic 
medication for ADHD medication if the symptoms are mistaken for the signs of other 
common psychiatric disorders (Asherson et al. 2007).  Conversely, failure to 
recognise and treat existing psychiatric comorbidities, which are common in ADHD 
can also lead to sub-optimal management and increased impairment (Sobanski 
2006, Kooij et al. 2010, Jensen and Steinhausen 2015).   
Given the considerable impact of ADHD, discussed in Chapter Two, improving the 
availability and accessibility of appropriate management is central to improving the 
outcomes of people with the condition. The examination of recent patterns in both 
the prescription of medications for ADHD and of other psychotropic medications will 
facilitate greater understanding of current practice in treating ADHD and its 
comorbidities, and enable exploration of the hypothesis that medication substitution 
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may be taking place. Earlier studies of ADHD prescribing using primary care 
databases in the UK have covered the periods 1999-2006 (Wong et al. 2009) and 
2003-2008 (McCarthy et al. 2012a & 2012b), and concentrated on the prescribing of 
ADHD drugs rather than also examining other psychotropic medication. New 
guidance on prescribing in transition and in adults was released by the British 
Association for Psychopharmacology in 2007 (Nutt et al. 2007) and later by NICE in 
2008 (NICE 2008b). Exploring recent trends in a time period covering the changes in 
guidance will both complement and add to previous studies, as well as directing 
future research. In terms of wider benefit, better understanding of primary care 
prescribing in ADHD should feed into recommendations for practice and training, 
leading to improved assessment and treatment of this condition.  
4.2 Aims & Research Questions 
 
This was a study of primary care prescribing of ADHD medication and other 
psychotropic medications between 2005 and 2013 in a cohort of people with ADHD 
aged 10-20 at baseline in 2005.  
The objective of this study was to examine trends in prescribing of ADHD and 
psychotropic medications in this cohort as they cross the transition boundary, 
describing prescribing from early adolescence into the mid-twenties in order to 
capture prescribing over the transition period and beyond. Specifically, it aimed to 
answer the following main questions: 
1. What is the prevalence and incidence of prescribing of ADHD medication 
amongst people with ADHD aged 10-27? 
2. What is the prevalence and incidence of prescribing of other psychotropic 
medications in people with ADHD between the ages of 10 -27? 
3. What is the prevalence of comorbid psychiatric diagnoses and referrals to 
mental health services in people with ADHD between the ages of 10-27? 
4. What is the prevalence of ADHD medication cessation within each age band? 
5. What is the time to cessation of medication amongst young people aged 16 
with a prescription, and what factors (including prescription of other 
psychotropic medications) are associated with cessation? 
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4.3 Methods 
 
4.3.1 Study design 
Description of the Clinical Practice Research Datalink 
The Clinical Practice Research Datalink (CPRD) is a large UK clinical database run 
by the Medicines and Healthcare products Regulatory Agency (MHRA)(Herrett et al. 
2015). The primary care section of the database contains the records of over 11 
million patients and is contributed to by more than 670 GP practices across the UK, 
covering over 6% of the population. CPRD uses software to extract anonymised data 
from participating practices’ IT systems. Records of each patient are coded by GPs 
and practice staff according to NHS coding schemes; chiefly Read codes (NHS 
Health and Social Care Information Centre 2016b). Read codes are a hierarchical 
clinical classification system containing over 96, 000 codes based on a system of 
standard clinical terminology and mapping to the International Classification of 
Diseases (World Health Organisation 1992). Records include information on the 
following: 
 Patient registration details, including status, dates and gaps 
 Consultations 
 Clinical events including diagnoses and symptoms (coded using Read 
medical codes, referred to as medical codes) 
 Referrals e.g. to secondary or specialist care 
 Prescriptions issued in primary care (coded using CPRD product codes and 
British National Formulary (BNF) (Joint Formulary Committee 2015) codes 
 Records of immunisations and vaccinations 
 
Ethical approval 
All protocols using patient level data from the CPRD are reviewed for scientific 
quality and approved by the Independent Scientific Advisory Committee (ISAC) on 
behalf of the National Research Ethics Service Committee. This study protocol 
131 
 
(13_213) was granted ISAC approval in January 2013 (please see Appendix One for 
protocol). 
Overview of study design and research population 
Study design 
The study design was a cohort study, including cross-sectional and yearly analysis of 
prescribing prevalence of ADHD and other psychotropic medication in people aged 
between 10 and 27 during the study period (2005-2013). These age ranges allowed 
the study of patterns of prescribing before and during the transition period as well as 
into early adulthood. Analysis of referrals to mental health services and of recorded 
psychiatric diagnoses was also included, to give context to the prescribing and to 
examine the influence of recorded comorbidities. Prescribing was also explored by 
gender. 
In addition, the design included a brief descriptive analysis of age at cessation of 
medication. This was followed by a survival analysis of time to cessation in a 
subsection of the cohort who were prescribed ADHD medication at the age of 16. 
This age was chosen as it marks the beginning of the formal transition period from 
education and from children’s health services, including CAMHS, and would capture 
the period where cessation rates were highest in older studies (Wong et al. 2009, 
McCarthy et al. 2012a).  Early estimates from CPRD obtained in 2012 suggested 
that there would be approximately 1100 cases meeting the study criteria, with follow-
up data available for 8 or more years on 80% of these. Power calculations suggested 
this sample size would be large enough to allow inclusion of up to 13 predictors in 
multivariable Cox regression models without concerns about stability of the 
estimated confidence intervals and p-values. 
Study period 
The study period was defined as running from the 1st January 2005 until 1st January 
2014. This covered a nine year period encompassing the changes to prescribing 
guidance by NICE in 2008 and also including the most recently available data. 
Study population 
 In order to answer the research question, two populations were identified 
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1. Cases who had ADHD and were aged between 10 and 20 at baseline in 
2005, in order to study the prevalence & incidence of prescribing of 
ADHD medication and psychotropic medications, psychiatric diagnoses 
and referrals over the study period (research questions 1,2, 3  & 4 
above). 
Cases were therefore selected for the dataset if they had a medical code in their 
Clinical record at any point during the study period that was ADHD-related (see 
Appendix One for list of codes). This population would be refined further prior to 
analysis but a wide definition was used initially, as once received the dataset could 
not be changed. 
2. Cases that were prescribed ADHD medication and were aged between 
10 and 20 at baseline in 2005. This population would allow the 
identification of people aged 16 with a prescription at any point for the 
survival analysis (research question 5)  
To initially identify this population, cases were selected who had at least one 
prescription for an ADHD medication (defined as medication licensed for ADHD i.e. 
stimulants such as methylphenidate or non-stimulants included in Section 4.4. of the 
BNF, see Appendix One for list of codes) in their prescription records during the 
study period. Figure 4.1 below illustrates the age range of participants during the 
study period and those who would be eligible for the survival analysis. 
 
Figure 4.1: Cohort of patients in dataset: age of cases in each year of the cohort* 
 
Year Age of cases 
2005 10 11 12 13 14 15 16 17 18 19 20 
2006 11 12 13 14 15 16 17 18 19 20 21 
2007 12 13 14 15 16 17 18 19 20 21 22 
2008 13 14 15 16 17 18 19 20 21 22 23 
2009 14 15 16 17 18 19 20 21 22 23 24 
2010 15 16 17 18 19 20 21 22 23 24 25 
2011 16 17 18 19 20 21 22 23 24 25 26 
2012 17 18 19 20 21 22 23 24 25 26 27 
2013 18 19 20 21 22 23 24 25 26 27 28 
*Grey shading indicates subset of participants eligible for survival analysis 
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Dataset specification 
Following approval of the research protocol by ISAC, the dataset specification was 
agreed in conjunction with MHRA staff. All patients included needed to have Up-to-
Standard (UTS) data within the study period, which is a CPRD term to define 
‘research-quality’ data and is identified by computer algorithm (Herrett et al. 2015). 
Dataset specifications were as follows: 
Table 4.1: Dataset specification 
Specification CPRD definition 
Study period 01/Jan/2005 to 31/Mar/2014 
Source Population The extraction population will comprise of 
all acceptable patients in CPRD (from the 
most recent snapshot available; May 
2014) 
Cohort definition • Patients have had a record of an 
ADHD diagnosis found in the clinical, 
referral or test files recorded at any point 
before the end of the study. ADHD will be 
found using the medical codes specified 
in Appendix 
• Or who have a record of any 
ADHD prescription as specified in 
Appendix, found in therapy files, and who 
have at least one record during the study 
period 
• Patients have above events within 
their up-to-standard follow-up period 
• Patients will have at least one day 
of up to standard follow-up following their 
index date (either the ADHD diagnosis or 
the ADHD prescription) 
• Patients will have a minimum age 
of 10 years at the study start 
• Patients will have a maximum age 
of 20 years at the study start 
Follow-up period Follow-up will be defined as the latest of 
the patient registration date, the practice 
UTS date and 01/01/2005. The end of 
follow-up will be defined as the earliest of 
the patient transfer out date, the practice 
last collection date and 1/1/2014 
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Applying these criteria in CPRD resulted in a total number of 27,502 eligible patients 
in dataset, whose records were supplied and constituted the initial dataset for the 
study.  
 
4.3.2 Data Analysis 
Dataset preparation and checking 
Stata SE13(Statacorp 2015) was used for all data analysis. The initial dataset 
supplied by CPRD was checked and read into Stata, and two new datasets were 
prepared from this original source: 
 Dataset for the descriptive analysis, addressing questions 1,2 3 & 4 (the 
descriptive dataset) 
 Dataset for the survival analysis (the survival dataset) 
Checking patient registration 
Patient registration dates and status were checked in the Patient file, and cases 
were excluded from the new datasets if their registration end date was before 1st 
January 2005 or their registration start date after 1st January 2014. 
Identifying cases with ADHD 
Using the Clinical file, a new variable termed ‘ADHD’ was created whereby any 
record with an ADHD related medical code had a value of 1, and any without a value 
of 0. Of codes identified this way, 99% were classified as a ‘Diagnosis’ consultation 
type, indicating that they related to a diagnosis rather than symptom or presentation. 
The codes used to create this variable included all 22 CPRD medical codes/ GP 
Read terms (based on ICD-10 categories) which related to an ADHD diagnosis e.g. 
‘Attention Deficit Hyperactivity Disorder’, ‘Child Attention Deficit Disorder’ ‘Attention 
Deficit Disorder’ etc. These codes are listed in Appendix One. Terms related to 
general behaviour problems and disorders, such as ‘Behavioural Disorder’ and 
‘Reduced concentration’ were coded as 0. This was done to avoid an over-inclusive 
definition of ‘ADHD’ which could result in an artificially low estimation of prevalence 
of medication use. However, as explored in greater depth in the Discussion, this 
definition of an ADHD related medical code has a number of limitations, including a 
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reliance on the GP to enter a diagnosis code if the child is assessed and diagnosed 
elsewhere, for example in CAMHS.  
Identifying cases with an ADHD prescription during the study period 
Using the Therapy file, a new variable termed ‘ADHD medication’ was created 
whereby any prescription record which had an ADHD related medical code within the 
study period had a value of 1, and any without a value of 0. The codes used to 
create this variable included all 74 CPRD product codes referring to BNF categories 
of stimulants and non-stimulants for ADHD such as Atomoxetine. 
Assigning age band 
The CPRD did not supply dates of birth for most cases, for 96% of the sample only 
year of birth was available. Therefore, for the descriptive analysis, age bands were 
assigned. For example, those born in 1990 would be in the age band 15/16 in 2006. 
For the survival analysis, where it was necessary to designate a fixed point as the 
case’s 16th birthday, the date of birth was therefore assumed to be 1st July for each 
case, which minimised the error each way to a maximum of 6 months, and as 
transition is a process rather than a single event happening on the 16th, 17th or 18th 
birthday, this assumption did not affect the ability of the study to encompass the 
relevant time period of transition. 
Excluding narcolepsy 
A very small number of cases (n<20) had a prescription for ADHD medication, no 
ADHD related medical code but instead a narcolepsy diagnosis code. As stimulant 
medication is on occasion prescribed for narcolepsy, a very rare condition, these 
cases were excluded from the analysis. 
Creating new variables 
A number of new variables were created for the analyses. The key variables and 
their definition are listed in Appendix One. 
Missing data 
Data from the CPRD undergoes quality checks and cases included in a research 
dataset are required to have at least a day of ‘up-to-standard’ data, which is defined 
by a metric examining continuity of recording by a practice and recording of events in 
a patient record (Herrett et al. 2015). However, the recording of variables, especially 
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over time, may still be incomplete and therefore require further checking by the 
researcher. Checks were therefore carried on the key variables required for the 
proposed analysis. There were no missing data on basic demographics such as 
gender or year of birth, or on records of registration status. Prescriptions issued by 
the GP are automatically recorded with a product name and British National 
Formulary code, alongside the dosage instructions and quantity, so data on the type 
of prescription issued were complete. However, one field that was not always 
completed by the GP were the number of treatment days prescribed for a specific 
therapy event (e.g. the number of days that each ADHD prescription was meant to 
cover). This required making some assumptions about prescription length for the 
purposes of the survival analysis, explained further below. 
Descriptive analysis 
The descriptive analysis aimed to answer the first four research questions: 
1. What is the prevalence and incidence of prescribing of ADHD 
medication amongst people with ADHD aged 10-27? 
2. What is the prevalence and incidence of psychotropic medications in 
people with ADHD between the ages of 10 -27? 
3. What is the prevalence of comorbid psychiatric diagnoses and referrals 
to mental health services in people with ADHD between the ages of 10-27? 
4.  What is the prevalence of ADHD medication cessation within each age 
band? 
This was based on the descriptive dataset, which included only those cases who had 
an ADHD medical code within the study period. 
Question 1: What is the prevalence and incidence of prescribing of ADHD 
medication amongst people with ADHD aged 10-27? 
1a Prescribing prevalence 
The percentage of all cases that had a prescription for ADHD medication over the 
study period was calculated, with 95% confidence intervals. Pearson’s Chi-squared 
test was used to examine whether an association existed between prescription and 
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gender. More detailed analysis of prevalence of prescribing was performed in two 
ways: 
i. By age e.g. for all patients in the age band 15/16 at any point. This was 
calculated by summing all the patients aged 15/16 with a prescription for 
ADHD medication in the year they were aged 15/16, with the denominator 
being all patients who had data for the year they were 15/16. This was 
expressed as a percentage with the attendant 95% confidence interval. 
ii. By age and year e.g. patients aged 15/16 in 2005 that had at least one 
prescription record during the period 1st January 2005 to 31st December 
2005, with the denominator being all patients whose assigned age band in 
2005 is 15/16. This was expressed as a percentage with the attendant 95% 
confidence interval. 
 
In order to produce an accurate denominator, only cases who had data within the 
CPRD for the study period in question, e.g. the year 2005, were included in the 
calculation. If the case transferred out before the end of a year - i.e. before 31st 
December 2005, then that was counted as an incomplete year and the case was not 
included in numerator or denominator. 
1b Prescribing incidence 
Incidence was calculated by age band and defined as the number of cases within 
each age band that began their first spell of medication in that age band, i.e. had 
their first ADHD prescription. Re-initiation of medication, such as second and third 
spells of medication with gaps of over a year was not examined in this analysis. 
Question 2: What is the prevalence and incidence of prescribing of other 
psychotropic medications in people with ADHD between the ages of 10-28? 
2a Psychotropic prescribing prevalence 
The percentage of all cases with a prescription for other psychotropic medications 
(i.e. not medication for ADHD) at any point over the study period was calculated, with 
95% confidence intervals. Prescribing prevalence was also presented by 
psychotropic type according to the main BNF categories: antidepressants (BNF 
section 4.3), anxiolytics (section 4.2.1) and antipsychotics (section 4.2), and by 
gender, using the Chi-squared test.  
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Prevalence of prescribing was then examined by age e.g. for all patients in the age 
band 15/16 at any point. This was calculated by summing all the patients aged 15/16 
with a prescription for a psychotropic medication in the year they were aged 15/16, 
with the denominator being all patients who had data for the year they were 15/16.  
This was expressed as a percentage with the attendant 95% confidence interval. 
As with ADHD medication prescribing, in order to produce an accurate denominator, 
only cases who had data within the CPRD for the study period in question, e.g. the 
year 2005, were included in the denominator. If the case transferred out before the 
end of a year, i.e. before 31st December 2005, then that was counted as an 
incomplete year and the case was not included in numerator or denominator. 
2b Psychotropic prescribing incidence 
Incidence was defined as the number of those in an age band who had their first 
prescription for other psychotropic medication, with the denominator being all of 
those in that age band, at any point. 
Question 3: What is the prevalence of psychiatric diagnoses and referrals to 
mental health services in people with ADHD between the ages of 10-27? 
3a Prevalence of comorbid psychiatric diagnoses 
The prevalence of comorbid psychiatric diagnoses was calculated for all cases with 
an ADHD medical code by diagnostic category and for any diagnosis, as a 
percentage with 95% confidence intervals. The numerator was those who had the 
diagnostic code at any point, the denominator all cases with an ADHD code, i.e. all 
study participants. The diagnostic categories included were based on ICD-10 
classification and groups of READ codes and were:  Autism spectrum disorder 
(ASD), Anxiety or depression related disorder, Conduct/oppositional defiant disorder, 
Substance/alcohol misuse related disorder, Any tic disorder, Any personality 
disorder, and Bipolar affective disorder or psychoses. Prevalence was also 
compared by gender, with the Chi-squared test. 
The prevalence of learning disability (mild, moderate and severe) was also 
calculated as a percentage with 95% confidence intervals. 
3b Psychiatric diagnoses and prescribing 
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The percentage of those with any comorbid psychiatric diagnosis who had an ADHD 
medication prescription at any point or a psychotropic prescription at any point was 
reported for all cases and by gender, with 95% confidence intervals. The percentage 
of all cases and of cases with a comorbid diagnosis that had a concurrent 
prescription (in the same year) for a psychotropic and an ADHD medication was 
calculated, over the study period and by age band. 
3c Prevalence of referrals to mental health services 
The percentage of all cases with a code for a new referral to a mental health service 
was calculated for all cases as a percentage with 95% confidence intervals, for all 
mental health referrals and by specific service (e.g., adult mental health). This 
percentage was also calculated separately for cases with and without a psychiatric 
comorbidity. 
Question 4: What is the prevalence of ADHD medication cessation within each 
age band? 
Prior to the survival analysis of time to cessation, a brief descriptive analysis of 
cessation was carried out. For this purpose, cessation was defined as taking place in 
the last year of recorded prescription in the database. Age at cessation was 
therefore the age band of the case in the year in which cessation occurred. However, 
where the last year of prescription was also the last year of the study period, or the 
case’s last year in the CPRD due to transferring out of the practice, the case was 
regarded as censored rather than having stopped medication (and therefore not 
categorised as having experienced cessation), because the case was not followed 
up to determine whether or not medication was stopped or continued (see also 
section on Censoring below). 
Cessation was described in two ways: 
i. First, as the percentage of those stopping medication in each band (i.e. 
who had their last prescription in that age band) as a percentage of all 
cases prescribed ADHD medication during the study period. 
ii. Second,  as  a percentage of those who had a prescription for an ADHD 
medication in each age band for whom this was their last prescription 
Cessation over the transition period from age 16 onwards was then explored more 
fully in the Survival Analysis. 
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Survival analysis 
The survival analysis was set up to analyse the time to cessation of ADHD 
medication, from the subject’s 16th birthday. It aimed to answer the following 
research question: 
Question 5: What is the time to cessation of ADHD medication amongst young 
people aged 16 with a prescription, and what factors (including prescription of 
new psychotropic medications) are associated with cessation? 
Criteria for entry into survival analysis 
In order to be eligible to be entered in the survival analysis, each case had to meet 
certain criteria. Cases needed to: 
• Have data within the study period 2005-2013 
• Have at least six months of consecutive prescriptions for an ADHD 
medication for the time period up to and including the 1st July of the year of 
their 16th birthday. A gap of up to 6 months between prescriptions was 
allowed. 
 Have at least one day of follow up following 16th birthday 
Cases were excluded if: 
 They had a gap in their registration with the practice for more than 6 months 
after their 16th birthday, meaning that data was not available for analysis 
 They had less than 6 months of consecutive prescriptions for ADHD at the 
time of their 16th birthday 
Defining cessation 
Cessation was defined as a gap of more than six months in prescriptions for ADHD 
medication. This was chosen to allow for error or uncertainty in estimating 
prescription length, as well as to allow for medication ‘breaks’ which may occur 
during school holidays, or, for example, due to delays in obtaining new prescriptions 
due to administrative or other reasons such as starting University. The intention was 
for the definition of cessation to represent stopping medication, rather than a brief 
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interruption.  Data were not recorded on the length of a prescription in 98% of cases; 
where it was recorded the most common values were 28 or 30 days. Consequently, 
where data were missing as to the length of a prescription it was assumed to last 30 
days. This was also chosen as methylphenidate preparations are controlled drugs, 
and in many localities may only be prescribed for a month at a time (Bolea-Alamanac 
et al. 2014). 
Setting up the survival analysis 
Cases meeting the survival criteria detailed above were transferred into a survival 
dataset. The survival analysis was set up using the Stata command stset and was 
based on the following definitions shown in Table 4.2 below. 
Table 4.2: Definitions used in survival analysis 
 Entry point/start Observation 
period/time at risk 
Failure 
Definition 16th birthday - 
assigned as 1st 
July 
From 16th birthday 
until cessation or 
censoring occurs 
or study period 
ends (1st Jan 2014) 
The first period of 
cessation of 
medication for more 
than six months 
following the case’s 
16th birthday 
 
Censoring 
Censoring occurred in the dataset where there were no further prescribing records 
for a case within the study period, and the outcome – i.e. whether and at what point 
cessation occurred, is unknown. This would be the case where a person was 
transferred out of the CPRD, e.g. moved or otherwise left the practice but had not yet 
experienced cessation. Cases that were censored therefore are those who still had a 
prescription at the time of transferring out and being lost to follow-up. This was 
defined as having a prescription dated within 40 days of the date of transfer out of 
the CPRD. A sensitivity analysis was also carried where this definition was changed 
to 90 days (i.e. approximately three months). 
Analysing time to cessation 
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The initial survival analysis involved several steps: 
 Calculating the number of events and total number remaining in the survival 
analysis at each time point and the consequent survival function – the 
probability of remaining on medication at each time point. This was displayed 
in years rather than months/days to simplify reporting. 
 Calculating the median time to cessation and the interquartile range, with 95% 
confidence intervals 
 Calculating the rate of cessation per year, with 95% confidence interval 
 Producing a Kaplan-Meier curve of time to cessation using years as the 
timescale 
 
Explanatory variables 
The next stage was to explore the variables which might be associated with 
cessation of ADHD medication, including year of birth, which was chosen to examine 
secular trends. Most of these were pre-specified in the protocol (see Appendix One) 
but a number were revised in light of the dataset which was received, such as the 
comorbid psychiatric diagnoses, as this depended partially on their prevalence within 
the survival analysis dataset. 
These categorical variables were: 
 Gender 
 Prescription for another psychotropic medication in the age 15/16 age band or 
older 
 Referral to adult psychiatry at any point 
 Anxiety or depression related diagnosis at any point 
 Conduct or ODD diagnosis at any point 
 Autism spectrum disorder diagnosis at any point 
 Learning disability 
 Year of birth – binary variable (1989, 1990, 1991 & 1992 vs 1993, 1994, 1995) 
 Smoking 
 Time on ADHD medication before 16th birthday  (Less than 2 years, 2-3 
years,3 or more years) 
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Univariate analysis 
Each of the predictor variables above was initially explored by producing a Kaplan-
Meier curve to examine the shape of the survival function for each group.  In order to 
determine whether an association existed with cessation, the log rank test for 
equality of survivor functions was performed. Finally, each variable was also entered 
alone as a predictor in a Cox regression model, in order to produce a hazard ratio 
and 95% confidence interval 
Two methods were used to test for non-proportional hazards (a key assumption of 
the Cox regression model) for each predictor: 
 A Nelson-Aalen plot of cumulative hazard estimates to graphically examine 
the proportionality of hazards over time in the groups 
 Using Schoenfeld (1982) residuals saved in each Cox regression to test 
proportionality 
 
Multivariable analysis using Cox proportional hazards regression 
All predictors with a p value of 0.05 or under were then entered into the multivariable 
Cox regression analysis. Schoenfeld residuals were saved and used to test for non-
proportionality of hazards in the final model. Testing for interactions was theory 
driven. For example, an interaction between adult psychiatry referral and comorbid 
psychiatric diagnosis might be present on cessation, if a comorbid diagnosis had a 
different effect in those referred to adult psychiatry than in those not referred. This 
situation might occur if different prescribing practices occur in primary and secondary 
care.  Interactions were therefore tested where considered feasible using likelihood 
ratio tests. The fit of the final model was then tested by producing a graph of Nelson-
Aalen cumulative hazard function against Cox-Snell residuals. 
Sensitivity analyses 
Sensitivity analyses were also carried out to assess the effect of excluding the cases 
censored before the end of the study, and of extending the definition of censoring to 
include cases that had a prescription within 90 days of transferring out of CPRD. 
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4.4 Results 
 
4.4.1 Descriptive analysis 
Sample characteristics 
There were 9,390 cases with an ADHD medical code at any point and data within the 
study period. Of these, 83.9% were male. Cases were born between 1985 and 1995, 
and their ages ranged from 9-10 to 19-20 in the start year of 2005 (see Table 4.3 
below). The majority of the cohort was born from 1993-1995. The age bands 
included in the analysis were from 9/10 to 26/27; this is due to the small numbers for 
whom there were data in the 27/28 age band (only those born in 1985), as well as 
the stated aim to examine prescribing up to the mid-twenties. 
Table 4.3: Year of birth and age band at start and end of cohort in descriptive 
analysis 
Year of birth Age band at 
start  
(2005) 
Age band at 
end 
(2013) 
Frequency (n) Percent 
1985 19/20 27/28 235 2.5 
1986 18/19 26/27 306 3.3 
1987 17/18 25/26 385 4.1 
1988 16/17 24/25 590 6.3 
1989 15/16 23/24 707 7.5 
1990 14/15 22/23 840 9.0 
1991 13/14 21/22 1,108 11.8 
1992 12/13 20/21 1,148 12.2 
1993 11/12 19/20 1,359 14.5 
1994 10/11 18/19 1,389 14.8 
1995 9/10 17/18 1,323 14.1 
Total   9,390 100 
 
 
Cases were required to have had an ADHD diagnosis coded at any point in order to 
be included.  More than three-quarters of cases included had their first medical code 
for ADHD recorded before the age of 15 (n=7,167, 77.2%). 
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In the descriptive dataset, two-thirds of cases had data for 5 or more years of the 
study period (Table 4.4). Only 8.7% had follow-up data for less than a year. 
 
Table 4.4: Time in study 
Study time Frequency (n) Percent 
0-1 yrs  813 8.7 
1-2 yrs  774 8.2 
2-5 yrs  1,595 17.0 
5-8 years 6208 66.1 
Total 9,390 100 
 
 
Findings 
 
Question 1: What is the prevalence and incidence of prescribing of ADHD 
medication amongst people with ADHD aged 10-27? 
 
Prevalence of prescribing of ADHD medication 
For all cases over the study period 
61.6% (n=5780/9390) had at least one ADHD prescription at any point during the 
study period (95%CI: 60.6% to 62.5%). Prescribing prevalence was 61.8% 
(n=4866/7876, 95% CI 60.7 to 62.9%) amongst males and 60.4% (n= 914/1514, 
95% CI 57.9 to 62.8%) amongst females, with no significant difference (p=0.301) 
between the genders. Fewer than half of those with a prescription at any point 
(45.3% n=2618/5780, 95% CI 44.0-46.6%) had a prescription at the age of 17/18 or 
over. 
The most commonly prescribed drugs were all methylphenidate preparations. 
Concerta XL 36mg was the most commonly prescribed, with 39.5% of all patients 
with a prescription having received the drug at any point, this was followed by 37.8% 
who had been prescribed Methylphenidate 10mg, and 35.3% who had been 
prescribed Concerta XL 18mg. 
By age band (all years pooled) 
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Prescribing by age band is displayed in Figure 4.2 with 95% confidence intervals. 
The highest prevalence of ADHD prescribing in the sample was amongst the 13/14 
age band, where 41.2% (95% CI 40.0 to 42.4%) had at least one prescription. Over 
the transition period there was evidence of falling prevalence. Amongst 15/16 year 
olds, the prevalence of prescriptions for ADHD medication was 37.8% (95% CI: 36.6-
38.9%) whereas in the 17/18 age band less than a quarter had a prescription 
(23.7%, 95% CI: 22.7-24.6%). The lowest prevalence of prescriptions was in the 
21/22 age band (14.2%, 95% CI: 12.9-15.4%). The decline in prescribing appeared 
to tail off after this, but the small numbers in the older age bands meant that there 
were wider confidence intervals around these estimates. 
Figure 4.2: Percentage of cases with ADHD at each age with an ADHD 
medication prescription (all years 2005-2013, with 95% confidence intervals) 
 
 
 
By age band and study year 
As Figure 4.3 below demonstrates, patterns of prescribing followed a similar pattern 
in each year of the study period, with the sharpest drop in prescribing consistently 
seen between16 and 18 years of age. However, there did appear to be a possible 
trend over time for increasing prevalence of prescribing for people in their mid-
twenties, although small numbers of those in the older age bands in each individual 
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year meant that there were very wide confidence intervals around these estimates 
(not shown in Figure for clarity). 
 
Figure 4.3: Percentage of cases with an ADHD prescription, by age band and 
study year. 
 
 
 
Incidence of new prescriptions of ADHD medication, by age band 
Figure 4.4 below displays the percentage of cases in each age band that had their 
first prescription of ADHD medication within the study period during that year. The 
highest incidence of medication initiation was among the younger age bands, with 
almost a fifth of those aged 10/11 with ADHD beginning medication. Incidence then 
drops quite sharply from 10.5% in the 14/15 age band to 5.4% in the 16/17 age 
band. The lowest rates of initiation were in the early twenties from 19/20 to 21/22. 
Re-initiation (i.e. stopping and re-starting months or years later) was not explored in 
this analysis but is likely to have occurred in some cases, particularly amongst older  
participants. 
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Figure 4.4:  Percentage of cases with ADHD at each age with a first ADHD 
medication prescription (all years 2005-2013) 
 
 
 
Question 2: What is the prevalence and incidence of prescribing of other 
psychotropic medications in people with ADHD between the ages of 10-27? 
Prescribing prevalence 
All cases 
A quarter of all cases  (n=2336/9390, 24.9%, 95% CI 24.0 to 25.8%) had at least one 
prescription for another psychotropic medication at some point during the study 
period, with the most commonly prescribed category being antidepressants (Table 
4.5).  Females had a markedly higher level of antidepressant and anxiolytic 
prescriptions. In total, over a third of females had a psychotropic prescription at any 
point (36.4%, 95% CI 34.0 to 38.9%) compared to just over a fifth of males (22.7%, 
95% CI: 21.7 to 23.6). 
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Table 4.5: Psychotropic prescribing (excluding ADHD medication) 2005-2013, 
for all cases, and by gender 
Medication 
category 
(according to 
BNF category) 
Percentage (95% confidence intervals) with at least one 
prescription during study period 
% All cases 
(n=9390) 
% By gender 
% Males 
(n=7,876) 
% Females 
(n=1,514) 
p value 
for Chi-
squared 
test 
Antidepressants 16.0 (15.3-16.8) 13.6 (12.8-14.4) 28.7 (26.5-31.0) p<0.001 
Anxiolytics 5.8 (5.3-6.2) 5.1 (4.6-5.6) 9.2 (7.7-10.6) p<0.001 
Antipsychotics 10.7 (10.1-11.3) 10.5 (9.7-11.2) 11.4 (9.8-13.0) p=0.31 
Any 
psychotropic 
medication 
24.9 (24.0-25.8) 22.7 (21.7-23.6) 36.4 (34.0-38.9) p<0.001 
 
By age band 
When calculated by age band, less than 1 in 20 of those aged 16 and under had a 
non-ADHD psychotropic prescription. From the ages of 16/17 onwards there was a 
clear rise in the prevalence of psychotropic prescribing (see Figure 4.5 for 
illustration) so that at the age of 23/24 almost 1 in 10 (9.5%, 95% CI 8.1 to 10.9%) 
had a prescription. The prevalence of prescriptions for other psychotropics continued 
to rise with age, however due to small numbers in the older age groups, there was 
more uncertainty around these estimates. 
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Figure 4.5: Percentage of cases with ADHD at each age with a psychotropic 
medication (non-ADHD) prescription, with 95% confidence intervals (all years 
2005-2013) 
 
 
Prescribing incidence, by age band 
Overall, the incidence of new psychotropic prescriptions was low for all age bands 
(Table 4.6). Incidence rose from under 2% in the under-17s to 2.7% in 17/18 year 
olds and then to a peak of 4.0% amongst the 20/21 age band. Again, wider 
confidence intervals were found around point estimates for incidence in older cases, 
making interpretation of trends more uncertain. 
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Table 4.6: Percentage of cases with ADHD at each age with a new psychotropic 
medication prescription (all years 2005-2013) 
Age Band Frequency n/total n Percentage 
(95% CI) 
10/11 46/2647 1.7 (1.2-2.2) 
11/12 56/3931 1.4 (1.1-1.8) 
12/13 74/4954 1.5 (1.2-1.8) 
13/14 99/5903 1.7 (1.3-2.0) 
14/15 103/6528 1.6 (1.3-1.9) 
15/16 100/6981 1.4 (1.2-1.7) 
16/17 134/7263 1.8 (1.5-2.2) 
17/18 197/7308 2.7 (2.3-3.1) 
18/19 212/6307 3.4 (2.9-3.8) 
19/20 179/5235 3.4 (2.9-3.9) 
20/21 160/4048 4.0 (3.4-4.6) 
21/22 96/3130 3.1 (2.5-3.7) 
22/23 71/2249 3.2 (2.4-3.9) 
23/24 39/1610 2.4 (1.7-3.2) 
24/25 41/1073 3.8 (2.7-5.0) 
25/26 21/648 3.2 (1.9-4.6) 
26/27 10/377 2.7 (1.0-4.3) 
 
Prescribing summary: Comparison of ADHD and psychotropic prescribing  
Figure 4.6 plots the prescribing prevalence of both psychotropic and ADHD 
medications together by age band. 
Key points to note include: 
 There was a higher prevalence of ADHD prescribing than other psychotropic 
prescribing until age 24/25 onwards 
 Psychotropic prescribing increases continually over time from a very low base 
 ADHD prescribing prevalence peaks in the early teenage years, then declines 
steeply from age 15/16 onwards to 20/21,  
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 The two lines begin to converge in the mid- twenties, although the smaller 
numbers in the higher age bands mean there is more uncertainty around 
these estimates 
 
Figure 4.6: Percentage of cases with ADHD at each age with an ADHD or other 
psychotropic medication prescription (all years 2005-2013) 
 
 
Figure 4.7 below plots the incidence of new prescriptions of both psychotropic and 
ADHD medications together by age band. 
Key points to note include: 
• The highest incidence of ADHD prescribing is in the youngest age bands, and 
until the age of 17/18 years, is far higher than the incidence of psychotropic 
prescribing 
• Prescribing incidence of other psychotropic medication rises continually over 
time from a very low base, peaking in the early twenties 
• In the 18/19 age band, the lines converge; and in the 19/20, 20/21 and 21/22 
age bands, a higher percentage of the sample have new psychotropic prescriptions 
than ADHD prescriptions. However, confidence intervals overlap for most of these 
data points. 
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Figure 4.7: Percentage of cases with ADHD at each age with a first ADHD or 
other psychotropic medication prescription (all years 2005-2013) 
 
 
Concurrent prescribing of ADHD and psychotropic medication 
Less than 1 in 10 cases (8.8%, 95% CI 8.3 to 9.4%) had a prescription for an ADHD 
medication and another psychotropic medication within the same calendar year. This 
figure was higher among females (11.1%, 95% CI 9.5 to 12.7%) and rose to 17.8% 
(16.3 to 19.4%) in cases with a comorbid psychiatric disorder. In cases who ever had 
a psychotropic prescription at any point, over a third had a concurrent prescription 
with ADHD medication at any point (35.5%, 95% CI 33.5 to 37.4%). The prevalence 
of concurrent prescribing rose slightly by age. 
Question 3: What is the prevalence of psychiatric diagnoses and referrals to 
mental health services in people with ADHD aged 10-27? 
Psychiatric diagnoses 
All cases 
Over a quarter of cases in the sample had a psychiatric diagnosis at any point 
(26.0%, n=2440/9390), see Table 4.7 below. The most common categories of 
psychiatric disorder in the sample were autism spectrum disorders (ASD) (9.9%) and 
anxiety or depressive disorders (9.3%), followed by conduct and oppositional defiant 
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disorders (5.2%). Fewer than 3% of the sample had diagnoses coded for tic 
disorders (2.1%), substance or alcohol disorders (2.1%), or personality disorders 
(1.9%). The least common diagnostic category was bipolar affective disorders and 
psychoses (0.46%). 
Psychiatric comorbidity was more prevalent in females with almost 30% having any 
disorder at any point, and 15.9% having an anxiety or depressive diagnosis. 
Personality disorders were also more common in females, whereas ASD, conduct 
disorders and tics were significantly more common in males. 
Table 4.7: Prevalence of comorbid psychiatric disorders coded at any point, 
for all cases and by gender 
Disorder category N in 
dataset 
 
Percentage (95% confidence intervals) of cases 
with the disorder recorded at any point 
All cases 
% 
(n=9390) 
 
By gender 
Males % 
(n=7876) 
Females 
% 
(n=1154) 
p value 
for Chi-
squared 
test 
Any comorbid 
psychiatric disorder 
2,335 26.0 
(25.1-26.9) 
25.3 
(24.4-26.3) 
29.4  
(27.1-31.7) 
p<0.01 
Autism spectrum 
disorder (ASD) 
927 9.9 
(9.3-10.5) 
10.3 
 (9.6-11.0) 
7.7 
(6.3-9.0) 
p<0.01 
Anxiety or 
depression related 
disorder 
876 9.3 
(8.7-9.9) 
8.1 
(7.3-8.7) 
15.9 
 (14.1-
17.7) 
p<0.001 
Conduct/oppositional 
defiant disorder 
490 5.2 
(4.8-5.7) 
5.5 
(5.0-6.0) 
3.8 
(2.9-4.8) 
p<0.01 
Substance/alcohol 
misuse related 
disorder 
199 2.1 
(1.8-2.4) 
2.0 
(1.7-2.3) 
2.6  
(1.8-3.5) 
p=0.12 
Any tic disorder 198 2.1 
(1.8-2.4) 
2.3 
 (2.0-2.7) 
1.0 
 (0.5-1.5) 
p<0.01 
Any personality 
disorder 
179 1.9 
(1.6-2.2) 
1.5 
(1.2-1.8) 
4.0 
 (3.0-5.0) 
p<0.001 
Bipolar affective 
disorder or 
psychosis 
43 0.46 
(0.32-0.59) 
0.50 
(0.34-0.65) 
0.26 
(0.01-0.52) 
p=0.22 
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Prescribing and psychiatric comorbidity 
Table 4.8 presents the prevalence of prescribing of ADHD and other psychotropic 
medication at any point in those who did and did not have a psychiatric comorbidity 
(i.e. another psychiatric disorder in addition to ADHD). Of all cases with comorbidity, 
49.1% had a prescription for a psychotropic medication at any point, versus 16.8% of 
those without recorded comorbidity.  The prescribing prevalence of psychotropic 
medication was significantly higher (p<0.01) among females with a comorbid 
disorder than in males with such a disorder; almost two-thirds (64.5%, 95% CI 59.8 
to 68.9%) had a prescription compared to under half of males (45.8%, 95% CI 43.5 
to 48.0%). When including only those with a diagnosis of anxiety or depressive 
disorders, this pattern remained, with 67.8% (95% CI: 64.0 to 71.3%) of males 
having a psychotropic prescription versus 76.3% (95% CI: 70.4 to 81.2%) of females 
(not shown in Table 4.8), although the difference was not significant at the p<0.05 
level. 
In contrast to the findings on psychotropic prescribing, females with a comorbid 
psychiatric disorder had a lower prevalence of ADHD medication prescribing than 
males (60.7% vs. 63.5%, see Table 4.8), although again this difference was not 
significant at the p<0.05 level (p=0.3). 
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Table 4.8: Prescribing of ADHD and psychotropic medication in those with and 
without psychiatric comorbidities 
 Cases without 
recorded 
psychiatric 
comorbidity 
Cases with any psychiatric comorbidity  
 
All All Males Females 
Percentage 
prescribed 
psychotropic 
medication 
(95% 
confidence 
interval) 
16.8% 
(16.0-17.7%) 
49.1% 
(47.1-51.1%) 
45.7% 
(43.5- 47.9%) 
64.4% 
(60.0-68.9%) 
Percentage 
prescribed 
ADHD 
medication 
(95% 
confidence 
interval) 
61.0% 
(60.0-62.2%) 
63.1% 
(61.0-64.9%) 
63.5% 
(61.3-65.6%) 
60.7% 
(56.2-65.2%) 
 
Learning disability and ADHD: prevalence and prescribing 
Prevalence 
513 cases (5.5%, 95% CI 5.0 to 5.9%) had a code for a learning disability (including 
mild, moderate and severe categories). The prevalence was similar amongst 
females (5.7%, 95% CI 4.7 to 7.0%) and males (5.4%, 95% CI 4.9 to 5.9%, p=0.6). 
ADHD Prescribing 
68.6% (95% CI 64.5 to 72.5%) of cases with a learning disability (LD) had an ADHD 
prescription, compared to 61.2% (95% CI 60.1 to 62.2%) of those without (p=0.01). 
Prescribing prevalence was higher amongst girls with LD; 72.4% (95% CI 61.9 to 
80.9%) were prescribed an ADHD medication compared with 67.8% (95% CI: 63.2 to 
72.1%) of males. However, this analysis may have lacked power due to small 
numbers and the confidence intervals overlapped (p=0.4) 
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Psychotropic prescribing 
Almost half of cases with LD had a psychotropic prescription at some point during 
the study period (44.6%, 95% CI 40.4 to 50.0%). Again, females with LD had a 
higher prevalence (p=0.02) of psychotropic prescribing than males; 56.3% (95% CI 
45.6 to 66.5%) had a prescription versus 42.3% (95% CI 37.6 to 47.0%) of males. 
Psychiatric referrals 
Over the study period, only a fifth of cases had a recorded new referral to mental 
health services for any reason, which included CAMHS, adult psychiatry, clinical 
psychology and community psychiatric nurses (n= 1,894, 20.2%, 95% CI 19.3 to 
21.0%). A higher percentage of females had referrals recorded (24.1%, 95% CI 22.0 
to 26.3%) than males (19.4%, 95% CI 18.5 to 20.3%, p<0.001). This figure rose to 
26.4% (95% CI 24.6 to 28.2%) amongst cases with a comorbid psychiatric disorder, 
and fell to 16.6% amongst those with a learning disability (95% CI 13.6 to 20.1%). 
The most common service that young people were referred to was CAMHS. 
Approximately, 1 in 10 had a referral recorded (see Table 4.9). Very small numbers 
were specifically coded as being referred to clinical psychology or to community 
psychiatry nurses. 
Table 4.9: Psychiatric referrals by type over study period in cases with an 
ADHD code 
Referral 
Frequency 
n/total n 
Percentage 
(95% CI) 
No recorded referral 7,496/9390 79.8 (19.4-21.0) 
CAMHS 1,017/9390 10.8 (10.2-11.3) 
Adult psychiatry 816/9390 8.7 (8.1-9.3) 
Clinical psychology 168/9390 1.8 (1.5-2.1) 
Community Psychiatric Nurse 76/9390 0.81 (0.63-1.0) 
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Question 4: What is the prevalence of ADHD medication cessation within each 
age band? 
Time on medication and cessation 
The median number of years between first and last prescription for ADHD 
medication for all cases was 3 (interquartile range 1.0 to 6.0). Of the 5,780 cases 
who had an ADHD prescription at any point, 60.1% (n=3476, 95% CI 58.9 to 61.4%) 
had their last prescription recorded before the end of the study period (i.e. between 
2005 and 2012). Only 22.8% (n=1316, 95% CI 21.7 to 23.9%) were still on 
medication at the end of the study period in 2013. The remaining 17.1% (n=988, 
95% CI 16.1 to 18.1%) transferred out of the CPRD whilst still with a prescription for 
medication before the end of the study, hence their outcome was unknown. 
Age at cessation 
Figure 4.8 below shows the percentage of those stopping medication in each band 
(i.e. who had their last prescription in that age band) as a percentage of all cases 
prescribed ADHD medication during the study period. The highest frequency of 
cessation was at 15/16 years (15.4%) followed by 16/17 years (12.2%). Cessation 
over the transition period from age 16 onwards is explored more fully in the following 
section on Survival Analysis.  
Figure 4.8: Percentage of cases with an ADHD medication prescription 
stopping medication in each age band 
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Cessation as a proportion of prevalence 
Figure 4.9 displays the percentage of those who had a prescription for an ADHD 
medication in each age band for whom this was their first prescription (incidence) or 
last prescription (cessation) recorded in the database. Pre-transition, incident 
prescriptions are more frequent than cessation, but from the 15/16 age band 
onwards this pattern is reversed, 28.3% of prescriptions were stopped, compared to 
19.2% of prescriptions being new. For cases in their twenties trends in cessation and 
incidence are more unclear due to smaller numbers introducing more uncertainty 
(e.g. there were only 99 cases with a prescription in the 25/26 age band, and only 55 
in the 26/27 age band). 
Figure 4.9: Cessation* and incidence as a proportion of prevalence: 
percentage of cases in each age band on ADHD medication for who this was 
their first or last recorded prescription 
 
*Cessation is defined as the last year of recorded prescription, not counting cases in 
the numerator who were censored – i.e. for whom this was their last year in study – 
(see Methods) 
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4.4.2 Survival analysis 
Question 5: What is the time to cessation of ADHD medication amongst young 
people aged 16 with a prescription, and what factors (including prescription of 
new non-ADHD psychotropic medications) are associated with cessation? 
The survival analysis dataset 
1,620 cases met the criteria for entry into the survival analysis. Of these cases, 
87.6% (n=1419) were male. 
The total amount of time at risk (i.e. time from 16th birthday to censoring or 
cessation) for cases in the dataset was 3099.1 years. The minimum time at risk was 
0.08 years and the maximum 8.7 years, with the mean being 1.9 years. It is 
important to note that cases had their 16th birthdays from 2005 to 2011, meaning that 
for those turning 16 in 2011, there was less than 3 years of follow-up until the study 
end on 1st Jan 2014. 
390 cases, or 24.1% of the dataset did not experience cessation by the end of the 
study period. 302 were still on medication at the end of the study, 1st Jan 2014. 88 
were censored during the study period; i.e. they were lost to follow-up whilst still on 
medication before the end of the study. These cases were not significantly different 
to uncensored cases with respect to starting time, duration of medication, or year of 
birth. 
Time to cessation 
Time to cessation 
The median time to cessation was 1.5 years (95% CI 1.4 to 1.7), with the 
interquartile range being 0.67 years to 3.4 years.  
Rate of cessation 
75.9% (n=1230/1610, 95% CI 72.8 to 78.0%) of cases experienced cessation during 
the follow-up period. The rate of cessation per year was 0.40 (95% CI 0.38 to 0.42), 
or 396.9 per 1000. 
Survival function/probability of remaining on medication 
The survival function, which is the cumulative proportion of cases surviving up to the 
respective time interval at each year of follow up, is presented in Table 4.10 below. It 
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represents the probability of remaining on medication up to a given time point.  The 
survival function at 1 year (i.e. at the age of 17) was 0.63, but by two years, the 
probability of remaining on medication had fallen to 0.41. By 3 years this had fallen 
further to 0.30. At 6 years, only 39 cases remained on medication in the study, the 
rest having been censored by reaching the end of the study period or being 
transferred out; or having experienced cessation. Figure 4.10 displays the 
accompanying Kaplan-Meier plot of survival function over time.  
Table 4.10: Survival function at each year of follow-up 
Time post 16th 
birthday 
in years  
(age) 
N in the 
analysis 
N experiencing 
cessation 
Survival 
function/probability of 
remaining on 
medication* 
(95% CI) 
0 (16) 0 0 1 
1 (17) 1016 590 0.63 (0.61-0.65) 
2 (18) 646 343 0.41 (0.39-0.43) 
3 (19) 337 159 0.30 (0.28-0.32) 
4 (20) 165 91 0.21 (0.19-0.23) 
5 (21) 75 30 0.16 (0.14-0.19) 
6 (22) 39 11 0.13 (0.1 -0.16) 
7(23) 11 6 0.11 (0.08-0.14) 
8 (24) 11 0 0.11 (0.08-0.14) 
*Note, the survivor function is calculated over days and evaluated at indicated times; 
it is not calculated from aggregates shown at left of the table – therefore numbers 
censored are not shown 
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Figure 4.10: Kaplan Meier plot of survival function over time from age 16 years 
 
 
Figure 4.11 displays the Kaplan-Meier curve with censoring, with vertical marks 
representing multiple censored cases; note that there are fewer censored cases after 
6 years as only 39 cases remained on medication after this point. 
Figure 4.11: Kaplan Meier plot of survival function over time, showing 
censored cases 
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Factors associated with cessation/Explanatory variables 
The results for this question are presented in two parts; firstly the findings of the 
univariate analysis, and secondly the model for the multivariable analysis. 
Univariate analysis 
The findings displayed below in Table 4.11 suggest that there is an association at 
the p<0.05 level between a number of variables and cessation of medication. Having 
a prescription for another psychotropic medication at the age of 16 or over, being 
born later in the cohort, referral to adult psychiatry, comorbid ASD / LD and being on 
medication for 3 or more years prior to 16th birthday all appear to be associated with 
a reduced hazard of cessation. Smoking at any point was associated with an 
increased hazard. There was no strong evidence of non-proportionality of hazards 
over time, the test suggested weak evidence for non-proportionality of hazards for 
ASD (p=0.08) but on further examination of the graphed Nelson-Aalen estimates this 
was more marked at extremes of time where the model was more unstable. 
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Table 4.11: Predictors of cessation of ADHD medication: univariate analysis 
Variable Univariate Cox regression 
 
Test for non-
proportionality 
of hazards 
P value 
p value 
(derived from 
log-rank test) Hazard 
ratio 
95% CI P value 
Female 
gender 
 0.93 0.78 to 1.10 0.38 0.58 p=0.38 
Psychotropic 
prescription 
post 16 
0.77 
 
0.66 to 0.90 <0.001 0.75 p<0.001 
Anxiety or 
depression 
diagnosis 
 0.94 
 
0.75 to 1.18 0.60 0.59 p=0.60 
Conduct/ODD 
diagnosis 
1.04 0.81 to 1.32 0.77 0.61 p=0.77 
Autism 
spectrum 
disorder 
(ASD) 
0.62 0.51 to 0.76 <0.001 0.08 p<0.001 
Learning 
disability 
0.56 0.43-0.71 <0.001 0.30 p<0.001 
Adult 
psychiatry 
referral 
0.68 
 
0.55 to 0.83 <0.001 0.82 p<0.001 
Year of birth 
1993-1995 
(vs 1989-
1992) 
0.79 
 
 
0.71 to 0.89 <0.001 0.84 p<0.001 
Smoking at 
any point 
 1.17 
 
1.05 to 1.31 0.005 0.38 p=0.005 
Time on 
medication 
prior to 16th 
birthday: 
Less than 2 
years 
2-3 years 
3 or more 
years 
 
 
 
 
Reference 
 
1.03 
0.76 
 
 
 
 
Reference 
 
0.89 to1.20 
0.67 to 0.97 
 
 
 
 
<0.001 
 
 
 
 
0.27 
 
 
 
 
p<0.001 
 
Multivariable analysis 
Factors associated with cessation were entered into a multivariable Cox regression 
analysis. The results are presented in Table 4.12 below. Having a learning disability, 
an ASD diagnosis and being referred to adult psychiatry at any point were the 
strongest predictors of remaining on medication, with a hazard ratio for cessation of 
0.60, 0.68 and 0.67 respectively. Having a prescription of psychotropic medication at 
the age of 16 or over was also an independent predictor of remaining on medication 
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(HR 0.79). Those born later in the cohort, between 1993 and 1995, had a reduced 
hazard of cessation compared with those born earlier (HR 0.88), even after adjusting 
for all other variables, but the association was (just) not significant at the p<0.05 level 
(p=0.05). Having an ADHD prescription for 3 or more years prior to the age of 16 
was also associated with remaining on medication. Smoking, coded at any point 
during the study period, was associated with an increased hazard of cessation (HR 
1.10), although the 95% confidence interval included unity. 
Table 4.12: Fully adjusted multivariate Cox regression model of factors 
associated with cessation (n=1620) 
Variable Hazard ratio 95% confidence 
interval 
p value 
Psychotropic 
prescription aged 
16 or over 
0.79 0.67 to 0.91 p<0.01 
Autistic Spectrum 
Disorder 
0.68 0.55 to 0.83 p<0.001 
Learning disability 0.60 0.47 to 0.77 p<0.001 
Referral to adult 
psychiatry 
0.67 0.54-0.83 p<0.001 
Smoking 1.10 0.98-1.24 p=0.1 
Birth year 1993-
1995 
(vs 1989-1992) 
0.88 0.77-1.00 p=0.05 
Time on 
medication prior 
to 16th birthday: 
Less than 2 years 
2-3 years 
3 or more years 
 
 
 
Reference 
1.04 
0.81 
 
 
Reference 
0.89 to 1.21 
0.70 to 0.94 
 
 
p<0.01 
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Interactions 
There was no strong evidence of any interaction between the variables included in 
this model. There was weak evidence of an interaction between ASD diagnosis and 
psychotropic prescription over 16 (p=0.06); in people with a diagnosis of ASD, a 
psychotropic prescription over the age of 16 did not significantly change the hazard 
of cessation, and vice versa. Similarly, there was weak evidence of an interaction 
between ASD diagnosis and LD (p=0.08).  
Testing the model 
The p value for the global test of non-proportionality was 0.55, which suggested that 
the assumption of proportional hazards was reasonable. Testing the fit of the model 
by plotting Nelson-Aalen cumulative hazard function against Cox-Snell residuals 
(Figure 4.12) indicated that the model was a good fit overall with the hazard function 
following the 45 degree line. For larger values of time there was some deviation from 
the line, which is likely to be due to the increasing amount of censored data. 
Figure 4.12: Testing fit of multivariable model tested by plotting Nelson-Aalen 
cumulative hazard function against Cox-Snell residuals 
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Sensitivity analysis 
The planned sensitivity analyses to assess the effect of excluding the cases 
censored before the end of the study, and of extending the definition of censoring, 
did not appreciably alter the estimates obtained, and did not improve the fit of the 
model. 
 
4.5 Discussion 
 
ADHD and other psychotropic prescribing  
The first aim of this study was to examine prescribing of ADHD medication in cases 
with ADHD aged between 10 and 27.  Overall, 61.6% of cases had an ADHD 
prescription at any point during the study period. NICE guidelines (2008b) state that 
medication is a second-line treatment for children with moderate ADHD (following 
interventions such as referral to parent training groups) and a first line intervention 
for those with severe ADHD. Approximately 40% of children with ADHD have the 
severe form, and a further 35% have the moderate form (Kessler et al. 2005). We 
might therefore expect between 40% and 75% of those with ADHD to be treated with 
medication at some point. 
In this sample, the highest prescribing prevalence in any age band was at 13/14, 
where two-fifths had a prescription.  When examining prescribing by year, even for 
2012 and 2013, prevalence of prescribing never exceeded 44%. Although concerns 
have been raised about the rising number of ADHD prescriptions in the UK (Thomas 
et al. 2013), these findings do not suggest that children diagnosed with ADHD in this 
sample were being over-treated with medication, and are in keeping with UK 
population estimates of pharmacologically treated ADHD being lower than population 
estimates of prevalence (Ford et al. 2003, McCarthy et al. 2012b). The figures from 
this analysis are also lower than the reported prescribing prevalence in CAMHS 
samples described by Ford et al. (2008a) (up to 93% of those with ADHD reporting 
ever having had medication), although these would represent a more severely 
affected and complex population. 
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Fall in prescribing over the transition period 
Results clearly demonstrated a decline in prescribing from the age of 15/16 to 20/21 
years, with a fall of 23.1% over the study period.  Despite the secular trend for slowly 
increasing prescribing in all age bands, this fall was still evident in more recent years 
(2012 and 2013) within the study period.  Incidence of new prescriptions mirrored 
prevalence in this age group - dropping from 10.5% in the 14/15 age band to 5.4% in 
the 16/17 age band, with the lowest rates of initiation from 19 to 22.  
 As expected, parallel to the decline in ADHD prescribing, there was an increase in 
prevalence of psychotropic prescribing with increasing age, particularly over the 
transition period. This is of course the peak age for emergence of new mental health 
diagnoses whilst ADHD symptoms decline with age (Faraone et al. 2006, Kessler et 
al. 2007), however it does not contradict the hypothesis that these prescribing trends 
might equally represent substitution of one medication by the other in some cases. 
Prescribing in early adulthood  
Fewer than one in five of those aged 21/22 or over had an ADHD prescription. In the 
24/25 age band, 14.5% were on medication. Such figures are markedly lower than 
the estimates of persistence of symptoms at the age of 25 (40-60%), even for the 
most recent years in the study period, and add to the body of findings suggesting 
adults remain under-treated for their ADHD (Faraone et al. 2006, McCarthy et al. 
2012b, Ginsberg et al. 2014).  
Interestingly, there was a suggestion of a slight rise in incident and prevalent 
prescribing of ADHD medication from the mid-twenties onwards, although estimates 
had wide confidence intervals. This would require replication and further exploration, 
but may imply a trend for people with ADHD finding their way back to services and 
onto medication to manage their ADHD in the context of professional and family life 
as an adult. Such help-seeking may be facilitated by increasing awareness and by 
an expansion in shared care prescribing arrangements and new services for adult 
ADHD in England and Scotland (Crimlisk 2011, Health Improvement Scotland 2012, 
Magon at al. 2015).  
Pharmacologically treated adult ADHD appears to have risen over time. In 2008, 
NICE estimated that only 1.24% of adults with ADHD were currently receiving 
medication (NICE 2008a), in contrast, the current study found that 14-15% of adults 
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in in each age band between 20 and 27 had an ADHD prescription.  Prescribing in all 
age bands gradually rose over the course of the study, with prevalence in the older 
age bands (24/25, 25/26, 26/27) increasing from 2010 to 2013. This trend has been 
found in previous studies covering earlier and overlapping time periods, such as. 
McCarthy et al.’s (2012b) research using the Health Improvement Network (covering 
2003-2008) in the UK, as well as a number of European studies ( Zetterqvist et al. 
2013, Geirs et al. 2014) 
Comorbid psychiatric disorders and psychotropic prescribing 
Just over a quarter of all cases had an additional psychiatric diagnosis coded at any 
point. Approximately one in ten had a code for ASD and a nine per cent had anxiety 
or depressive disorders diagnosed. Overall the prevalence of other disorders in this 
sample was lower than estimates from comorbidity studies, although these estimates 
will not be directly comparable as comorbidity studies screen for psychiatric 
diagnoses using diagnostic instruments and clinical interviews, and in this study 
diagnoses were recorded by GPs. A review of comorbidity studies (Sobanski 2006) 
suggests that approximately 16-26% of children with ADHD will have a comorbid 
depressive syndrome and 15% will have an anxiety disorder. Lifetime prevalence of 
depressive episodes in adults with ADHD stands at 35-50%, with 40-60% for anxiety 
disorders, however comparison is more difficult as people in this study were followed 
up only until age 28. Whilst a quarter of the whole sample had a prescription for 
another psychotropic (i.e. non-ADHD medication)  at any point, this rose to half of 
those who had a psychiatric comorbidity, with the most commonly prescribed class 
being antidepressants. 
The relationship between gender, comorbidity and prescribing 
There was a clear gender difference both in the prevalence of other psychiatric 
diagnoses and of other psychotropic prescribing. Lifetime prevalence rates of anxiety 
and depression are higher amongst females with ADHD than with males, although 
externalizing disorders are more common amongst males (Levy et al. 2005, Elkins et 
al. 2011). This pattern was evident in the results of the current study; anxiety and 
depression were more commonly coded in relation to females and conduct and 
oppositional defiant disorders amongst males. 
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Females were more likely to be prescribed a psychotropic than males. This is not 
fully explained by the higher prevalence of emotional disorders amongst females, as 
even amongst those with a coded disorder of anxiety or depression, prescribing 
prevalence was higher amongst females (76%) than males (65%). The findings imply 
that females are more likely to be pharmacologically treated in primary care for 
comorbidities with ADHD, although without other information such as severity or 
details of other management, it is not possible to say whether this represents under- 
or over-treatment for either gender. 
Although females were more likely to be prescribed medication for comorbidities in 
this study, it has been suggested that they are less likely to receive medication for 
their ADHD itself (Coles et al. 2012, Garbe et al. 2012, Quinn and Madhoo 2014). 
This analysis found that women and girls with comorbidities were possibly less likely 
to be prescribed ADHD medication than males, although the difference was not 
significant at the p<0.05 level. This finding may still imply pharmacological under-
treatment of females,  as they may face higher barriers to receiving a diagnosis 
which are documented in the literature, including attitudes amongst teachers and 
parents (Maniadaki et al. 2006, Groenewald et al. 2009, Ohan and Visser 2009).  
Referral rates for girls have been found to be disproportionately lower than boys 
across Europe, even given the estimates of the gender ratio in ADHD (Novik et al. 
2006). Barriers to identification may be even higher where ADHD exists alongside 
comorbid depression and anxiety, which may be diagnosed and treated in 
preference to ADHD (Quinn and Wigal 2004, Quinn and Madhoo 2014). As all cases 
in this dataset had diagnosed ADHD, the females may have represented a more 
severely affected group than the males in order for their ADHD to have been 
clinically recognised and referred. Consequently, even this non-significant difference 
might represent under-treatment, although there were no data on severity and 
impairment to explore this hypothesis further.  
Cessation of ADHD medication 
In this sample, the majority of participants had stopped medication by their 18th 
birthday; the probability of still being on ADHD medication by then was 0.41, and 
0.30 by 19 years. These estimates are in line with McCarthy et al.’s (2012a) findings 
using the THIN database that approximately 40% of those starting medication in 
childhood or adolescence remained on medication at 18 or over. Whilst a direct 
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comparison should not be made with the earlier CADDY study due to slightly 
different methods, the populations are similar enough to note that the estimates of 
persistence on medication from this analysis are higher than those reported in the 
previous study, (54% at age 17, 36% at age 18, 24% at age 19) (Wong et al. 2009). 
The probability of remaining on treatment after the age of 19 was comparable in both 
studies (0.21 by age 20 versus 22% in CADDY), although the small numbers 
remaining after  censoring  by this time point meant that these estimates were more 
unstable and less reliable. Cases born later in this cohort, between 1993 and 1995, 
who turned 16 between 2009 and 2011 had a reduced hazard of cessation 
compared with those born earlier even after adjusting for all other variables, and the 
probability of remaining on medication at one year was highest amongst those born 
in 1995 (0.72).  These findings may reflect changing prescribing practice over the 
transition period, the development of adult services and an increasing acceptance 
that ADHD continues to merit pharmacological intervention after the age of 16, 
possibly influenced by the new NICE guidelines in 2008 (NICE 2008b, Crimlisk 2011, 
Magon et al. 2015).  
Less positively, the rate of cessation remains greater than the estimated persistence 
of symptoms.  Faraone et al.’s (2006) meta-analysis of follow-up studies found the 
persistence of ADHD meeting the full criteria for the condition 1 year later to be 83%, 
whereas the probability of medication persistence in our study was 0.63. The authors 
also place the persistence of symptomatic ADHD at age 20 at 69%, and a more 
conservative estimate of persistence of the full ADHD syndrome at 28%; both in 
excess of the probability of remaining on medication by 20 in this study (0.21).  
Predictors of cessation 
In contrast to the CADDY study, this analysis found associations between both 
referral to adult psychiatry and psychotropic prescribing, and cessation (Wong et al. 
2009). Being referred to adult psychiatry at any point was the strongest predictor of 
remaining on medication (probability 0.73 versus 0.62 for those with no referral). This 
may reflect a greater willingness of GPs to continue prescribing ADHD medication if 
the patient is being seen or referred to a psychiatrist, as guidelines recommend 
specialist oversight of prescribing (NICE 2008b, Bolea-Alamanac et al. 2014). It may 
also be due to these patients having more severe or persistent ADHD symptoms for 
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which we were unable to adjust, which would mean they were both more likely to be 
referred and to continue medication. 
The prescription of psychotropic medication at the age of 16 or over predicted 
remaining on medication. The association remained even after adjusting for possible 
confounders in the Cox regression including having a psychiatric diagnosis, and 
being referred to adult psychiatry. These findings do not support the original 
hypothesis for exploration, that psychotropic medications may be substituted for 
ADHD medication in patients transitioning into adulthood. It is possible that the 
relationship between psychotropic prescription and ADHD medication cessation may 
be confounded by other factors. For example, other psychotropic medication 
prescription may be a marker for severity of ADHD (Simon et al. 2013), or for 
variables such as social class or other patient factors influencing help seeking 
behaviour and engagement with services. The substitution hypothesis would require 
a more detailed analysis including these potential confounding variables to examine 
this further, and/or could be explored using qualitative methods such as interviews 
with GPs. 
Smoking at any point was associated with a small (but non- significant at the p=0.05 
level) increased risk of cessation, which may be explained by young people using 
smoking to self-medicate post cessation, as there is some evidence for an 
association between consistent ADHD medication and reduced risk of tobacco 
smoking (Schoenfelder et al. 2014). However, this analysis examined smoking only 
as a binary variable as ever-smokers and non-smokers and relied on primary care 
coding at consultation. This meant that it was not possible to define the order in 
which cessation and smoking occurred, or to conclude that any kind of causal 
relationship exists. 
This analysis did not find an association between cessation and gender, in contrast 
to the CADDY study, which reported a 27% lower hazard of cessation in females 
after 6 months(Wong et al. 2009). In this study the hazard ratio in females compared 
to males was less markedly reduced (0.93), with the 95% confidence interval 
spanning unity. The difference is unlikely to be due to power; 12.1% (201/1620) of 
the sample were female, compared to 9% (74/983) in CADDY, but may have been 
influenced by the younger starting age in CADDY, or be due to secular changes.  
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The only comorbid psychiatric diagnosis significantly associated with remaining on 
medication was ASD. Explanations for this finding are varied; people with ASD may 
be more likely to adhere to medication, or to have more severe ADHD and 
experience greater impairment increasing their desire to continue with 
treatment(Leitner 2014). Due to their dual neurodevelopmental disorders they may 
also be managed and monitored in different services from young people without 
ASD, such as paediatrics or learning disability, where transition may occur later or 
where there may be a greater acceptance of the use of medication. A similar 
explanation is likely to apply to the association between learning disability and 
remaining on ADHD medication. 
Strengths and limitations 
The chief strength of this analysis is the use of high quality and recent data from a 
national database capturing primary care prescribing until the end of 2013. The 
dataset covered a period following the introduction of the NICE guidance on 
prescribing for adults and an expansion in awareness of adult ADHD. The cohort 
design of the sample enabled both secular trends and trends by age to be examined. 
The size of the sample eventually eligible for analysis exceeded that required from 
the initial power calculation allowing multiple predictors of cessation to be examined, 
in contrast to previous studies with smaller numbers.   
Identification of prescriptions 
Increasing use of shared care means that primary care prescriptions are likely to 
provide the fullest available picture of prescribing without using data linkages, or 
dispensing records which may offer limited details. A 2008 study of young people 
seen in CAMHS found that GPs were prescribing for 82% of the sample (Ford et al. 
2008a). Some Mental Health Trusts also have shared care prescribing protocols for 
ADHD in adults; a 2013 audit found 35% of the 68% of Trusts that responded had 
such a protocol (Hall et al. 2015). Nonetheless primary care records will fail to 
capture prescribing taking place in specialist services, which might relate to shorter-
term trials of medication, or be for more severe and complex cases.   
Medication in most cases will be initiated by CAMHS, paediatrics or adult mental 
health services, according to NICE guidance (NICE 2008b). However, once a patient 
is established on medication, prescribing is often transferred to primary care. Short-
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term trials of medication may therefore not appear in the CPRD if the prescriptions 
were only issued in specialist care. Where prescriptions are initiated outside primary 
care then transfer over to the GP, the length of time that a case has been on 
medication may be underestimated, although the date of cessation which was 
central to this analysis would be unaffected. As Adult ADHD services may not 
provide ongoing prescribing for the condition but pass this responsibility to primary 
care (Magon et al. 2015), it is reasonable to assume that the proportion of 
prescriptions not captured in primary care for over 18s would have been minimal.  
 Findings from other studies in Europe and the US also suggest that the decline in 
prescribing over the transition period found in the current study is unlikely to be 
artefactual.  A European study by Zetterqvist et al. (2013) using data on all 
dispensed (i.e. from all prescribers) medication also reported the highest rate of 
treatment discontinuation amongst 15 to 21 year olds, suggesting that the pattern of 
discontinuation exists regardless of where medication is prescribed. A recent study 
from the US of self-reported ADHD medication use from the Medical Expenditure 
Panel Survey revealed a more gradual decline in prescribing between the age of 12 
and 23 years, although there were considerable geographical, ethnicity and gender 
related variations in prevalence rates amongst adolescents and young adults 
(Johansen et al. 2015). It is possible that the sharper decline in the UK and 
European studies might be a function of different health systems, service 
configurations and attitudes towards ADHD within between countries, although it 
may also be influenced by the self-report design of the US study. 
Identification of patients 
Cases were included if they had a Read code for ADHD at any point during their 
records. These Read codes map to ICD-10 chapters. This might contribute to 
overestimation of prescribing prevalence if cases with diagnosed ADHD received 
only a general code of behavioural disorder or concentration problems without an 
ADHD diagnosis recorded. However, estimates of validity of diagnoses in the CPRD 
are generally high (Herrett et al. 2010, Khan et al. 2010), particularly for non-acute 
conditions. Diagnoses made in specialist care (which would include all ADHD 
diagnoses) would usually be recorded and coded from letters sent to the patient’s 
GP. There is a possibility that occasional diagnoses may be missed due to poor 
communication between primary and specialist care, or through being coded as free 
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text (Herrett et al. 2010) . Furthermore, relying on coded diagnoses of ADHD to 
select cases might also contribute to overestimation of prescribing prevalence if 
recording of diagnosis was more complete among those who were prescribed drugs 
than those who were not. 
Assumptions 
There were two main areas which necessitated assumptions to be made. As the day 
and month of birth were not included in the dataset, it was necessary to assume a 
July birthdate (see Methods). Participants therefore entered the survival analysis on 
their ‘assumed’ 16th birthday, resulting in a potential variation of up to 6 months 
between the actual and the assumed date. Time to cessation from 16th birthday 
therefore includes a margin of error, but one which is unlikely to have affected the 
overall estimation, or its implications as transition is a period rather than a specific 
event happening on a 16th or 18th birthday. Secondly, where data was missing as to 
the length of a prescription it was assumed to last 30 days, as this was the most 
common prescription duration. This may have underestimated the time to cessation 
in a minority of cases, but as six months without a prescription was required for 
cessation to be declared, such an assumption would not have led to error in 
assigning the outcome. 
Confounding 
The dataset did not contain information on socio-economic status and severity of 
ADHD related symptoms, which would have been of interest both as variables 
related to prescription or cessation and as potential confounders. The potential effect 
of these variables in particular should be considered in interpreting the findings of the 
Cox regression analysis, as discussed above.  For example, it is probable that young 
people with more severe ADHD are also more likely to continue medication, and to 
be referred to adult psychiatry services, meaning that the true effect of adult 
psychiatry referral alone on cessation may not be as marked as in this analysis. 
Censoring 
There were fewer than 200 cases remaining after 4 years of follow-up in the survival 
analysis. Those cases turning 16 in 2010 and 2011 had less than 4 years of follow-
up until the study end on 1st Jan 2014, and a small proportion of all cases (5.5%) 
were censored during the study period. The result was greater uncertainty around 
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the probability of remaining on medication beyond the age of 20.  Cases censored 
during the study period may also have affected the results if the censoring was 
informative; that is, if what causes a case to be censored is related to what would 
cause them to experience an event (Leung et al. 1997). This could apply to cases 
that were still on medication but had transferred out of the CPRD before the study 
end. Transferring out could be related to moving away, which feasibly could be 
related to stopping medication, if it is not continued in another area. Alternatively, 
such a transfer might relate to moving to higher education and indicate a higher 
propensity to continue medication for the purpose of studying. Nonetheless, when 
these cases were removed in a sensitivity analysis, there was no significant effect on 
the findings, suggesting that the influence of informative censoring was minimal. 
Implications 
Young people with ADHD remain at high risk of cessation of medication over the 
transition period, despite the publication of guidance on prescribing in over-18s 
(NICE 2008b, Bolea-Alamanac et al. 2014). The decision to stop medication may be 
appropriate and reflect patient choice for reasons of adverse effects, personal 
preference or use of other management strategies (McCarthy 2014), but the 
continuing disparity between symptom persistence as reported by follow-up studies 
and medication persistence suggests that many are stopping medication that they 
could still benefit from (Faraone et al. 2006). Relating to providing optimal care, a 
study of ADHD medication doses in a cohort of transitional patients in the North of 
England found that patients appeared to be prescribed much less than the 
recommended dose despite experiencing severe symptoms (Adamou and Bowers 
2011). Whilst this is a single small study, the findings suggest that a larger scale 
analysis of ADHD medication dosage may be warranted; and although such analysis 
was outside the scope of this thesis, the CPRD dataset would be a potential 
resource to explore this further, alongside service audits.  
The findings must also be considered in the context of reports of inadequate 
provision of services for people with ADHD in transition, and an identified need for 
training for professionals in both primary and specialist care (Marcer et al. 2008, 
Ahmed et al. 2009, Hall et al. 2013, Hall et al. 2015). No evidence was found of a 
direct substitution of psychotropic medication for ADHD medication, but the high 
levels of comorbidity in ADHD make this a complex question. The potential gender 
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differences in prescribing suggested by this analysis also strengthen the case for 
further training not only on ADHD in adolescents and adults, but on the identification 
and management of comorbidities in the context of ADHD in both genders. 
Clinicians’ beliefs and knowledge regarding their prescribing practices in young 
people and adults with ADHD could also be better understood (and the substitution 
hypothesis explored) by methods such as qualitative interviews and structured 
questionnaires with GPs. 
Furthermore, results also suggest that a higher proportion of adults with ADHD are 
now being pharmacologically treated, and that some who have previously stopped 
medication or never taken it may be presenting to services in their mid-twenties. This 
could be initially explored by using this CPRD dataset to examine the pattern and 
prevalence of re-initiations of medication amongst adults. Sustainable service 
models are therefore needed both to optimise management of ADHD over the 
transition period, and to support adults who continue to experience impairing 
symptoms. Services should also not be confined to providing pharmacological 
oversight, but also take a holistic approach to assist people to manage their 
condition, considering complementary psychological or behavioural strategies 
appropriate for this age group, such as Cognitive Behavioural Therapy (NICE 2008b, 
Bolea-Alamanac et al. 2014, Coghill 2015). Different approaches to delivering care 
for older adolescents and adults with ADHD include youth services models and 
specific adult ADHD services; but investment by commissioners should be made on 
the basis of robust evaluation of the cost-effectiveness, outcomes and acceptability 
of such configurations.   
As many common themes are identified from the findings of this prescribing analysis 
which also relate to the findings of the following qualitative analysis in particular, 
more specific implications for policy, practice and research are discussed further in 
the final Overarching Conclusions Chapter. 
Summary 
This analysis found a sharp decline in the prescribing of ADHD medication in young 
people with ADHD over the transition period, which exceeded estimates from follow-
up studies of the expected decline of symptoms. The majority of young people with 
ADHD on medication at the age of 16 years had stopped medication by the age of 
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18 years. In contrast, the prescribing of other psychotropic medication increased 
over the same time period, although no evidence was found from the survival 
analysis that other psychotropics were associated with cessation of ADHD 
medication. 
The next chapter presents a qualitative interview study of young people with ADHD 
about their experiences of service use and transition. 
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Chapter Five: The experiences of young people 
with ADHD in transition from child to adult 
services 
Chapter Four focussed on psychotropic prescribing in primary care over the 
transition period among young people with ADHD. This chapter presents the third 
study in the thesis, which complements the previous analysis of ADHD prescribing 
by using qualitative methods to examine the experiences of young people with 
ADHD in transition. 
5.1 Introduction 
 
The importance of the transition period in people with ADHD has been discussed 
previously in Chapters Two and Four, and is therefore summarised only briefly here 
to avoid excessive repetition. In the UK, most services for children with ADHD will 
stop at the age of 18 (Young et al. 2011). Possible pathways from child services may 
involve referral to Adult Mental Health Services, referral to a specialist Adult ADHD 
clinic, or the transfer of all care back to the GP. This ultimate destination will be 
influenced by multiple factors including the young person's wishes, whether they 
continue to need medication, the persistence and severity of their symptoms, their 
comorbidities and the available services locally. A number of factors have been 
identified by professionals that may also adversely affect transition in this group, 
such as gaps in services, different organisational cultures in child and adult services, 
and a lack of knowledge and training regarding adult ADHD (Ahmed et al. 2009, 
Hovish et al. 2012, Hall et al. 2013, McLaren et al. 2013, Belling et al. 2014, Coghill 
2015). 
However, there has been a paucity of studies exploring the perspectives of young 
people with ADHD in the UK on the transition period, with only one recent qualitative 
study directly seeking their experiences (Swift et al. 2013). This may be influenced 
by a perception of young people in general, and those with ADHD in particular, as 
groups which may be ‘hard to reach’ in terms both of services and of recruitment for 
research (Wong et al. 2009, Flanagan and Hancock 2010, Singh et al. 2010). A clear 
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gap therefore exists in understanding young people’s vision of what services would 
help them and why might they disengage, which is directly relevant in creating 
functional and acceptable transition pathways. Greater understanding of the 
personal experiences of service users also assists in interpreting the findings of 
population studies. For example, whilst the primary care dataset analysis in the 
previous chapter illustrated trends in prescribing over the transition period, this 
qualitative interview study was designed in order to explore transition from the 
viewpoint of young people themselves. 
Qualitative methods are a particularly appropriate way to examine the perspectives 
of these service users, as the methods lend themselves to exploring experiences 
and meaning(Strauss and Corbin 1990). As this is a little-studied field, qualitative 
methods also allow for an inductive approach to the data, rather than presupposing 
what concerns and experiences young people may have. The semi-structured 
interview format was specifically chosen as it allows the interview to be structured 
around the areas of service use and transition whilst enabling participants to 
volunteer their views and perspectives. 
 
5.2 Aims and Methods 
 
5.2.1 Aim 
The aim of this study was to explore the experiences of young people with ADHD in 
transition from child to adult services in the South West Peninsula using qualitative 
interviews. This included their experience of using child services, their experiences 
of transition, and their perception of unmet needs and what services might help them 
in future. 
5.2.2 Study design and setting 
The study used qualitative semi-structured interviews to seek the experiences of 
young people with ADHD in transition regarding the services they were using. 
Service users going through transition were recruited from Child and Adolescent 
Mental Health Services (CAMHS), Child Health, and Adult ADHD services in Devon 
and Cornwall. Services for young people with ADHD in the Peninsula are provided 
by a variety of NHS Trusts and social and private enterprises. Due to time and 
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resource constraints, including the need to engage clinicians in person at 
geographically distant sites and to seek approvals from many separate providers, it 
was not possible to include all such services in the study.  Settings were therefore 
chosen to encompass urban and rural populations across the Peninsula with 
different service configurations, and where links could be established with clinicians. 
Table 5.1 below displays the services which agreed to assist in recruitment. These 
include five children’s services providing care for children with ADHD, and the only 
specialist Adult ADHD service in the Peninsula, which takes referrals from both 
CAMHS and Child Health in the Devon area. In the other areas of the Peninsula, 
there is no specialist Adult ADHD service, meaning that young people may return 
either to GP care, or potentially be referred to a general Adult Mental Health Service 
if they met local service thresholds. The aim was to recruit participants currently in 
the process of transition, including both those making the transfer to an adult ADHD 
service and those who were not transferring to any adult service, to gather young 
peoples’ experiences of these different transition processes. 
Table 5.1: Services involved in recruiting participants 
Area Name of service 
(provider) 
Type of service Notes 
Cornwall Cornwall CAMHS 
(Cornwall Partnership 
Foundation Trust) 
Child and Adolescent Mental 
Health Service 
No Adult ADHD 
service in area 
Torbay Torbay CAMHS (Torbay 
and South Devon NHS 
Foundation Trust 
Child and Adolescent Mental 
Health Service 
No Adult ADHD 
service in area 
Torbay Child Health 
Services (Torbay and 
South Devon NHS 
Foundation Trust) 
Child Health/paediatrics No Adult ADHD 
service in area 
Devon Devon CAMHS (Virgin 
Care) 
Child and Adolescent Mental 
Health Service 
Can refer to DANA 
(below) 
Devon Adult ADHD and 
Autism Service (DANA) 
(Devon Partnership NHS 
Trust) 
Specialist Adult ADHD and 
Autism service 
Accepts referrals from 
Devon CAMHS and 
from Child 
Health/paediatric 
services in Devon 
Plymouth Plymouth CAMHS 
(Plymouth Community 
Healthcare) 
Child and Adolescent Mental 
Health Service 
No Adult ADHD 
service in area 
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5.2.3 Sample and sampling strategy 
The sample frame for this study included young people aged between 17 and 19 
years with a clinical diagnosis of ADHD. The gender ratio in ADHD is estimated at 
between 1:3 and 1:6 in epidemiological studies depending on subtype, although girls 
appear to be less likely to be referred for treatment (Novik et al. 2006). 
Consequently, the aim was for the sample to include males and females, although it 
was planned that fewer females would be recruited due to these ratios. In order to 
gain a variety of perspectives, the sampling strategy was therefore to recruit young 
people both from the Transition Pathway of the local Adult ADHD service and from 
CAMHS and Child Health services locally that did not have access to this service 
(i.e. from Cornwall, Plymouth and/or Torbay). 
Inclusion and exclusion criteria 
For inclusion, participants were required either to be on the caseloads of CAMHS or 
Child Health Services (see Table 5.1 above for list of Trusts) and be due to leave the 
service within the following six months; or to be on the Transition Pathway of an 
Adult ADHD service and have left child services within the previous six months. This 
timescale was chosen for two reasons; firstly to gain the perspectives of people 
going through different stages of transition, and secondly, to increase flexibility by 
allowing for the fact that participants were often seen by clinicians and identified for 
the study at different time points in the process.  
The study did not exclude service users who might have other psychiatric 
comorbidities, as these are common amongst those with ADHD and their exclusion 
would lead to a sample that did not share characteristics with others in this situation. 
The chief exclusion criteria related to exclusions on the grounds of significant 
vulnerability or difficulties in communication which might make participation 
challenging. The clinicians identifying patients for the study were responsible for 
judging whether an otherwise eligible patient should be excluded on these criteria. 
Inclusion and exclusion criteria are presented in Box 5.1 and Box 5.2 below.  
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Box 5.1: Inclusion criteria 
 Young people aged 17 to 19 years with a clinical diagnosis of ADHD, 
including those in partial remission 
 On the caseloads of CAMHS or Child Health services (Tier 2 or 3), or the 
transition pathway of the Adult ADHD service 
 Currently in active treatment (with or without ADHD medication) 
 May be in education, work, training or other 
 Participants may have other psychiatric co-morbidities, but must have the 
capacity to consent to take part in the study 
 Either: 
o Due to leave CAMHS or Child Health within the next six months and 
cross the transition boundary regardless of whether referral made or 
accepted to Adult Mental Health Services (AMHS) 
Or: 
o Currently on the transition pathway of the Adult ADHD service and 
having left CAMHS or Child Health within the previous 6 months  
 
 
Box 5.2: Exclusion criteria 
 Young people were excluded if there was a significant language barrier which 
meant that the interview could not be completed without an interpreter 
 Young people were excluded from the study if their care co-ordinator or other 
clinician felt that taking part will be detrimental to their mental health, or if they 
were otherwise considered to be particularly vulnerable  
 Young people with moderate or severe learning disability. This group were 
excluded as they represented a somewhat different population from those 
with mild or no learning disability in terms of their needs and the services they 
use. They are also more likely to be using specialist learning difficulty services 
rather than mainstream CAMHS. 
 
5.2.4 Recruitment strategy and procedure 
Identification of participants 
I visited clinicians and managers within the included services to discuss and seek 
feedback on the study protocol and identification of participants. Clinicians, including 
doctors, specialist nurses and clinical psychologists were provided with information 
sheets detailing the inclusion and exclusion criteria for the study. They were then 
asked to identify eligible patients from their caseloads. The majority of services did 
not have a central list of ADHD patients, and therefore most participants were 
identified by clinicians only when attending clinics.  Clinicians were asked to verbally 
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introduce the study to eligible patients, and to give out a pack containing the 
Participant Information Sheet (see Appendix Two), and a contact details form with a 
stamped addressed envelope for returning the form which indicated that the patient 
consented to being contacted regarding the study. Full consent for taking part in the 
study was obtained following supply of further information, and a consent form being 
completed (see below). The forms supplied by the clinician also included my 
telephone number and email address in case the young person preferred to make 
contact directly.  
Making contact and seeking informed consent 
Once the young person agreed to be contacted by me, they received a telephone 
call, text message, email or letter depending on their indicated preferred contact 
method. Several attempts were made to contact potential participants, but if they 
then indicated that they were no longer interested, their contact details were 
destroyed. On making contact, I offered to discuss the research further and answer 
any questions in person or by phone or email. The potential participant was also 
encouraged to discuss taking part with family members or close friends if 
appropriate.  
Where the young person was then interested in participating, I reviewed the Consent 
form (in Appendix Two) with them in person or over the phone, and took informed 
consent. The participant was required to read and sign all sections of the form to 
ensure they were aware of aspects such as the need to audio-record the interview, 
and how their data would be stored. 
5.2.5 Interview procedure and contents 
Participants were interviewed using a semi-structured topic guide (see Table 5.2 
below). I carried out all interviews, which took place either on University premises, or 
at the participant’s home if requested, and were digitally audio-recorded. Parents 
were present if the young person wished them to be, although it was made clear that 
this was intended primarily to be an interview with the young person about their 
personal experience. The length of interviews ranged between 15 and 45 minutes, 
with an average length of 25 minutes. The duration of the interview was influenced 
by engagement and rapport with the participant, and by their ability to concentrate, 
as well as by the home environment. Questions covered the participant’s past and 
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present experience of using services for their ADHD, including how the transition 
process could be improved, as well as asking about what their ‘ideal service’ would 
look like. Due to the nature of qualitative research the exact questions varied and 
evolved as the first interviews were analysed, and the questions were modified 
slightly depending on how far along the process of transition participants were; 
however the structure and question areas remained the same. The key questions 
(shown in Table 5.2 below) covered experiences of services in the past, the present, 
and asked participants what ‘ideal services’ would look like in the future. 
Table 5.2: Key question areas from the interview Topic Guide 
Topic Area 
Past Present Future 
Could you tell me a bit 
about your experience of 
Child and Adolescent 
Mental Health 
Services/Child Health 
services in the past? 
Could you tell me a bit 
about the services you are 
using now (if any)? 
How do you see your 
ADHD affecting you in the 
future (if at all)? 
Could you tell me what it 
was like leaving 
CAMHS/Child Health? 
Is there anything you find 
helpful at the moment 
about services? 
Is there anything you find 
unhelpful? 
In an ideal world, what 
tools, services or support 
do you think would be 
available for you in the 
future to help you manage 
with your ADHD? 
How did / do you feel about 
moving on into adult 
services? 
In an ideal world, what 
services or support do you 
think would be available for 
you now to help you 
manage with your ADHD? 
 
Was there anything that 
could have made this 
process easier/better? 
  
 
Amendments to procedure 
A number of amendments were made to these procedures during the study due to 
slow recruitment of participants. In the first six months of the study, only two 
participants were recruited, one of whom subsequently dropped out prior to 
completing the interview. Initially, it was intended to complement the qualitative 
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interviews with supplementary parallel quantitative data collection about service use 
pre-transition and post-transition from questionnaires. However, this slow start 
indicated that there would be considerable challenges both in recruiting participants 
in the first place, and in retaining them in the study long enough to complete both 
questionnaires alongside the qualitative interview. The decision was therefore taken 
to focus on the qualitative interviews alone. Feedback was also sought from 
clinicians identifying patients, who thought that one problem was likely to be the 
reliance on young people to take the initiative in terms of returning the contact details 
form to me or emailing or telephoning me themselves if interested. The procedure 
was therefore amended so that clinicians briefly introduced the research in clinic and 
sought consent at the same time to pass on the details of eligible patients to me 
directly. In order to avoid the study information being lost or overlooked by patients 
or clinicians, brightly coloured study materials and envelopes were also introduced. 
Clinicians involved with the project also suggested that young people and their 
parents might want to discuss the research with me in person after their clinic 
appointment if they were interested in hearing more, and that this might improve 
recruitment. Unfortunately, this was not possible for CAMHS clinics, as there was not 
a system to alert me in advance when an eligible case might be attending. However, 
in the Adult ADHD service, one new patient was seen in the transition pathway clinic 
on most weeks, and on several occasions I was able to be available in person in 
case interested service users wanted to discuss the project once it had been 
introduced to them by their clinician. 
5.2.6 Ethical and risk considerations 
Ethical approval for the study was granted by the South West Research Ethics 
Committee (reference: 13/SW/0162, see Appendix Two for copy of letter), and 
approval was also sought and obtained for substantial amendments to the protocol. 
Research and Development (R & D) permissions were also obtained for all sites 
involved in the study. Specific considerations related to this study involved informed 
consent, data protection, impact on participants and safeguarding. 
Informed consent 
Each young person involved in the study received the Participant Information Sheet 
and was given the opportunity to discuss the study with me before deciding whether 
187 
 
they would like to take part. All participants were also made aware that they could 
withdraw from the interview or study at any time without needing to give a reason 
and without affecting their care in any way. Written, informed consent was obtained 
from each participant.  
Data protection and confidentiality 
All interview recordings and transcripts were kept separated from contact details and 
personal information, and unique codes were assigned as identifiers for participants. 
All hard copies of contact details and consent forms, recordings of qualitative 
interviews and data analysis were kept in a locked drawer in a locked university 
office in accordance with the Data Protection Act and Good Clinical Practice in 
research (HM Government 1998, European Medicines Agency 2002). Research data 
was kept on the university server which is automatically backed up and protected by 
secure password. Data will only be kept for as long as required by the data 
protection policy of the funder (NIHR) and the University of Exeter, which is currently 
a period of five years and subsequently completely destroyed according to the policy 
using the prescribed IT procedures. 
Risk management   
Clinicians were responsible for identifying eligible young people. If they considered 
any patients as being particularly vulnerable in terms of their mental health or other 
circumstances then they were not approached to take part in the study. Those taking 
part had the contact details of the researcher in case they should experience any 
aspect of the interview as distressing (this did not occur in any of the interviews). The 
researcher had a prepared list of local sources of support which were also detailed 
on the Participant Information Sheet, which also included appropriate contacts in 
case the participant wished to complain either about the study or about aspects of 
care that they received. 
As the research involved direct contact with young people, some under 18 years, the 
study followed the Child Mental Health Research Group’s Child and Vulnerable Adult 
Safeguarding Policy. The study protocol also incorporated actions to be taken in the 
event that participants disclosed other information about risk to themselves, for 
example, ideas about self harm or suicidal ideation, although this situation did not 
arise during any interview. These actions were adapted from the Mood Disorders 
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Centre at the University of Exeter’s Risk Protocol, which has been used for various 
trials involving participants with mental health difficulties (for example the 
Mindfulness Based Cognitive Behavioural Therapy for Parents trial). A statement 
was included in the information sheets to make participants aware that their details 
might be disclosed if the researcher had concerns either regarding safeguarding or 
about risk to the participant or other people. Finally, in order to address any potential 
risks due to interviewing participants at their home, the study protocol followed the 
Child Mental Health Research Group’s Safe Conduct of Fieldwork Policy. 
5.2.7 Data analysis 
Approach to analysis 
Digital copies of recorded interviews were kept separated from contact details and 
personal information, and uploaded onto the secure university server. Each interview 
was anonymised and assigned a number, and each participant was given a 
pseudonym. Interviews were then transcribed by me or by another member of staff 
with transcribing experience, and then checked against the recording for meaning 
and accuracy. NVIVO software, version 10 (QSR Software Ltd 2012) was used as a 
tool to manage and catalogue the data.  
The qualitative method used in this study was thematic analysis, which is described 
by Braun and Clarke (2006, p.6) as: “a method for identifying, analysing and 
reporting patterns (themes) within data”.  Thematic analysis was chosen as it 
represents a clear and sequential method for analysing qualitative interviews where 
there is no intention to generate new theory, but instead to describe participant 
experiences relating to a defined area – i.e., going through transition. The approach 
taken to the analysis was a realist one, meaning that the study aimed to “report 
experiences, meanings and the reality of participants” (Braun and Clarke 2006, p.9). 
I also took a predominantly inductive approach to the data; although the interview 
was structured around transition, the actual coding and development of themes was 
guided by the content. 
Initial coding 
The interview transcripts were read repeatedly in order to become familiar with the 
material. I then carried out initial coding of all transcripts, generating descriptive 
labels for sentences, paragraphs or sections to produce a first iteration of a coding 
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frame. Material from the parent, where present at the interview, was marked out 
clearly as being parental material in order to distinguish them from data from the 
young person themselves.  Extracts were coded more than once if they fitted several 
code definitions. Next, extracts from all interviews with the same code were collated 
together and compared to determine whether re-coding or merging of codes was 
required.  In this way, a coding frame was produced describing and defining all the 
codes used across all transcripts. To enhance quality, coded examples of text were 
discussed with a supervisor, who was asked to code sections independently and 
compare.  These discussions informed subsequent coding. 
Generation of themes and development of narrative 
The relationships between the different codes were mapped, in order to create 
categories arising from the coding frame (see Appendix Two for mapped Coding 
Frame). Extracts of interviews in each category were reviewed and analysed in order 
to develop overarching themes relating to the research questions. A description was 
written of each ‘candidate’ theme, all of which were then judged by Patton’s (1990) 
criteria of external heterogeneity and internal homogeneity to determine whether 
they were sufficiently different from each other, and whether data within each theme 
was coherent and/or sufficiently demonstrated the theme. If this was not the case, 
themes were discarded or created, or extracts were moved between themes. This 
process resulted in four final overarching themes. 
Finally, each theme was written up as a narrative to tell the ‘story’ of transition. 
Quotes from the data were selected to demonstrate meaning and provide examples 
of the theme under discussion. In writing up this narrative, care was taken to include 
extracts which might contradict one another and to ‘deviant cases’ where one 
participant might hold a completely different view to the others, in order to illustrate 
and account for differences in experience. 
Consideration of reflexivity 
Mays and Pope (2000, p.51) define reflexivity as: “sensitivity to the ways in which the 
researcher and the research process have shaped the collected data, including the 
role of prior assumptions and experience”. They also highlight the impact that the 
researcher’s personal and professional characteristics can have on the interview and 
on the interpretation of the data. During the process of the interviews and of the 
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analysis it was therefore important for me personally to be aware of how my 
experience might influence this research. 
I have previously trained in child psychiatry and worked in some of the services from 
which participants were recruited. I did not however make reference to any clinical 
background when introducing myself to young people in order to prevent replicating 
a doctor-patient relationship, which might affect the young person’s willingness to 
volunteer their views, and also place me in a position of already ‘knowing’ about 
ADHD and transition. I attempted to be conscious of other ways in which this clinical 
background might affect the interview or my response to the data, for example, if I 
were to feel defensive about criticism of former professional colleagues. 
On the other hand, this previous clinical experience was in contrast to the position of 
being a ‘new’ qualitative researcher and a PhD student.  My status as a student 
allowed me to be curious and ask questions without my clinical advice being sought 
by participants, and therefore facilitated interviews. It was more difficult to avoid the 
temptation to use familiar methods of conducting a more directive ‘clinical’ interview 
instead of a qualitative interview. This challenge is also discussed by McNair et al. 
(2008), in their paper on clinician researchers, who suggest that those trained initially 
in medical interviewing are more prone to pitfalls such as excessive control over 
time, inappropriate paraphrasing and inadequate probing for feelings and meanings. 
Slow recruitment meant I also felt considerable pressure for early interviews to be 
detailed and ‘rich’, which heightened anxieties about technique. As proposed in 
McNair et al.’s (2008) paper, my supervisor and I reviewed the first interview 
transcripts closely in order to identify any of the pitfalls described above, and to 
consider how to take a more open approach to the interview. I also attempted to 
remain aware of these potential influences on interviewing and analysis by using 
memos attached to the data, and through the discussion of transcripts and 
interpretations with my primary qualitative supervisor as part of the analysis process.    
 
 
 
191 
 
5.3 Results 
 
5.3.1 Description of sample 
Recruitment took place from December 2013 to September 2015. Over this time 
period, a total of 22 young people were identified by clinicians as being eligible to 
take part in the study, who also consented to being contacted regarding the 
research. Of these, only 12 responded to repeated attempts to contact them by 
email, text message, phone and post. Four of the young people who were 
successfully contacted decided that they did not wish to take part in the interview, 
citing lack of interest and lack of time as reasons. One agreed to take part but 
subsequently stopped responding to contact, and therefore no interview was carried 
out. Qualitative interviews were therefore carried out with seven participants. 
Characteristics of participants 
The characteristics of the participants are presented in Table 5.3 below. Five of the 
seven participants were male, and all were aged 17 or 18. There was some success 
in interviewing young people from across the Peninsula, with interviews being 
achieved with service users from Devon (n=4), Plymouth (n=1) and Cornwall (n=2). 
Five participants had already left child services, with the remaining two still being 
seen by CAMHS. Three young people had Autism Spectrum Disorder as well as 
ADHD, and one had borderline and specific learning difficulties. In four cases, 
interviews took place with a parent present. 
For the purposes of the analysis, participants were given a pseudonym and number, 
shown in Table 5.3. Throughout the Results section, participants are referred to by 
these pseudonyms and participant numbers (e.g. David, P1), in order to show the 
gender of the participant.  
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Table 5.3: Characteristics of participants 
Participant 
number and 
pseudonym 
Age and 
gender 
On ADHD 
medication? 
Psychiatric 
co-
morbidities 
Transition 
stage 
Parent 
present at 
interview  
P1 David 18 M Yes None 
reported 
Care 
transferred to 
GP from 
CAMHS 
No 
P2 Joe 18 M Yes Borderline 
and specific 
learning 
difficulties 
Leaving 
CAMHS 
No 
P3 Rebecca 17 F Yes None 
reported 
Leaving 
CAMHS 
Yes – 
mother 
 
P4 Sam 18 M Yes ASD Care 
transferred to 
Adult ADHD 
service, from 
Paediatrics 
Yes – 
mother 
 
P5 Lauren 18 F Yes ASD Care 
transferred to 
GP from 
CAMHS 
Yes – 
mother 
 
P6 Patrick 18 M Yes None 
reported 
Care 
transferred to 
GP from 
CAMHS 
Yes – 
mother 
 
P7 Owen 17M Yes ASD Care 
transferred from 
Adult ADHD 
service from 
CAMHS 
No 
 
5.3.2 Themes 
Four key themes pertinent to the perceptions of transition emerged from analysis of 
these seven interviews: professionals’ roles and relationships with young people; the 
role of ADHD medication, uncertainties around transition, and identified needs and 
increasing independence.  The first two themes describe more general experiences 
regarding professionals and medication, but which were highly relevant to the 
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process of transition, whereas the second two themes relate to specific aspects of 
transition. All are presented in turn below, and then discussed in further detail and in 
the context of current policy and literature in the final Discussion section of this 
Chapter.  
Theme: Professionals’ roles and relationships with young people 
When asked about their experience of using services for their ADHD, participants 
volunteered their thoughts about a number of professional groups that they had had 
contact with. The main groups referred to were teachers, GPs, and specialists, 
including psychiatrists, paediatricians and mental health workers. They discussed 
these professionals and services in terms of the role they considered them to have, 
their perceived attitudes towards and knowledge of ADHD, and the relationships that 
they, the participant, experienced with the professional. Participants’ experiences 
with each group are described in turn below. 
Teachers and other education professionals 
Interactions with schools and teachers were discussed as a core part of young 
peoples’ experience of ADHD. Experiences appeared to be framed more in terms of 
the attitudes and attributes of staff rather than the academic role of the school: 
 
 They [are] just understanding and they just say the right things and… they’re 
just all really nice people there, all seem happy and that cheers you up as well 
(Sam, P4) 
 
This shows that the relationship with and personal characteristics of members of 
staff were important to young people. Positive attitudes were valued, particularly 
when accompanied by an understanding of the person and their ADHD. 
Consequently, participants also identified situations where they did not feel they or 
their ADHD were accepted or understood:  
 
…they would say that you’re a trouble-maker… what quite a lot of teachers 
think…I find that most mainstream schools don’t get educated in ADHD and 
things like that…so I think all the teachers should like go on a course about it 
(Rebecca, P3) 
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Rebecca’s experience was that attitudes towards ADHD varied from school to 
school, and where there was a lack of knowledge about the condition, teachers 
might quickly assign the child the status of ‘naughty’ or ‘trouble-maker’, sometimes 
without reading any notes about the child and their condition first.   
Other interviewees had a mixed reaction to the help on offer at their schools. One 
participant (Patrick) had been offered extra time for his exams, but a greater concern 
for him was the crowds at school, which he found harder to cope with. Another had 
been given one-on-one support in school and access to separate learning areas, but 
his perception of this was that it served to differentiate him and hindered his ability to 
make friends: 
 
…what that meant was that for the entirety of my lunches and breaks I had to 
go to this room, secluded from everyone else, which was 
embarrassing…Whereas I would’ve liked rather than to do that to go out and 
make friends without one to one support, that was rubbish (Owen, P7) 
 
Such comments perhaps indicate that although support was available it was not 
necessarily tailored to what students with ADHD felt they wanted or needed, 
illustrating differences in the perception of needs between the school and the pupil.  
Whilst schools appeared to concentrate on accommodating academic requirements, 
the less obvious social aspects of the school experience were similarly important to 
the young people interviewed.   
Participants’ experiences of primary and secondary education highlighted occasions 
where their needs were perceived to be unmet, or had to be fought for; for example 
by moving schools. Consequently the move to further education and training 
alongside the transition taking place in health services was also associated with 
anxieties regarding the availability of support and getting to know the new system. 
This is discussed further under the final theme of ‘Identified needs and increasing 
independence’. 
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GPs 
All participants discussed their experiences with primary care, past and present. For 
the young people interviewed, the GP’s role was often very limited, and primarily 
seen as to provide prescriptions for medication. 
 
…we [just] go to the GP to order the repeat and then collect it (Sam, P4) 
 
This distant relationship that participants felt they had with their GP was sometimes 
contrasted with the more personal and developed relationship with CAMHS or Child 
Health (see section below). Such limited contact informed concerns about a transfer 
of care from CAMHS to primary care: 
 
It’s a bit iffy …..cos doctors [the GP]… just don’t really know …if I’ve got 
CAMHS I know they know what I’m not like and what I’m like… Doctors don’t 
really know.… I’ve seen them…in the last two years, like twice no more” (Joe, 
P2) 
 
Interviewees perceived contact with their GP to be an infrequent event, meaning that 
their GP did not know them, or and indeed perhaps had not so far needed to know 
them as CAMHS dealt with their ADHD management.  Consequently, young people 
did not necessarily feel they had a relationship with the GP that could be built on 
after transition.  
Two of the young people interviewed had recently made the transfer from CAMHS 
back to the care of their GP at the age of 18. In both cases, the GP agreed to 
continue providing a prescription, but the participants still had concerns. One young 
woman felt that her GP did not know her at all, and had been told that he would see 
her only once or twice a year for standard medication checks: 
 
I’ve only seen him once…just walked in and [he] changed my prescription 
(Lauren, P5) 
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This described encounter was experienced as being perfunctory and functional, 
focussing only on medication. The implication is that there was no time for 
discussion, which might represent an abrupt change from the style of appointments 
participants were used to in CAMHS, and leave the young person feeling cast adrift 
and let down; these feelings are discussed further under the theme ‘Uncertainties 
around transition’. 
Another participant who had also recently left CAMHS was particularly concerned 
that the GP would not provide help in managing medication, such as tailoring the 
dose, or being available to answer questions in the same way as CAMHS were. He 
described an appointment where he had discussed medication with his GP: 
 
He’s not really qualified, he wouldn’t, he didn’t want to change it because he 
doesn’t really know what he’s doing as much as the specialists did, so he 
wouldn’t change it (Patrick, P6) 
 
This encounter appears to reflect a similar feeling from the participant of lack of 
engagement from primary care with their specific case.  In addition, perhaps 
because the participants have had so little contact with the GP to date, the GP is not 
seen as being informed about ADHD, and this led to doubts about whether the GP 
was ‘qualified’ to manage their medication. 
The experiences of participants suggest that where the GP’s role has been limited 
(both in terms of time and input into care), naturally the relationship between the 
doctors and the young person and their family is not one of mutual trust and 
understanding.  There was a lack of trust from participants that their GP would be 
knowledgeable about their ADHD and to manage it appropriately. Meanwhile, from 
the other side, the GP may be suddenly faced with a patient at the age of 18 that 
they do not know well enough to feel able to tailor prescription requirements to their 
needs.  This is a difficult context for transition, setting the scene for the later theme 
‘Uncertainties around transition’. 
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CAMHS and Child Health/paediatrics 
Overall, most of those interviewed appeared to value a number of aspects of their 
relationships with specialists from CAMHS and Paediatrics. Appointments were often 
seen as being the opportunity to see clinicians who understood ADHD and who 
knew them, with whom they could build a relationship: 
 
 I was on good terms with doctor [name]. She said just drop her an email if I 
wanted to talk about anything (David, P1) 
 
The fact how nice they were and everything, it was just really good (Sam, P4) 
 
It was nice to talk to someone….it was always the same guy… Yeah, it was 
cool, we always had like a quiz session at the end about things we liked…  
(Owen, P7) 
 
The positive aspects of the encounters with CAMHS therefore were about 
availability, approachability, responsiveness and time to talk through any issues 
required, which also seemed to contribute to building a bond and even a sharing of 
interests. 
Participants also discussed how, unlike primary care, specialist care helped them to 
manage their medication and to change the dosage to suit them. Young people saw 
drug doses as something that might need to be reviewed quite frequently, and that 
this medication change might be a tool to help them cope with daily activities or 
academic schedules: 
 
 I’d say to them like… I need more medication and they’d give it to me and if 
they say you need less medication I say yeah, they give me less…but if I ever 
needed medication I’d just ring up saying I need more medication, I need 
more dosage...they’d give it to me (Joe, P2) 
 
She [the paediatrician] was really good… ‘cos I was saying that the tablets 
don’t last the whole day, they kind of wear off in the evenings and sometimes 
for example when during exams it can be… quite important for me… to be 
able to concentrate throughout the evening and she came up with the idea of 
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top up once in the evening like… a lower dose, and that’s been quite useful to 
just be able to do more work in the evenings when I need to (Sam, P4) 
 
In these quotes young people describe an interactive system that is flexible and 
responsive to their requests. There is also a sense of partnership whereby either the 
young person or the professional could initiate changes in medication in response to 
a perceived need, showing trust in the reality of the patient’s experience in 
recognising and managing their symptoms.  
Nonetheless, not all clinicians were seen as being equally helpful in this regard. One 
of the same participants quoted above contrasted one paediatrician with another that 
he had seen who was reluctant to add an extra dose, and who was therefore 
perceived as “not supportive” (Sam, P4). Other interviewees also recounted 
occasions where they had not been able to see their regular clinician, due to 
rotations, sickness or the staff member leaving: 
 
Been difficult, cos like I thought I’d be seeing the same one, but then I go 
there, there’s a different one… so it’s difficult, difficult to say to one person, 
then to another person, then to another person (Joe, P2) 
 
This disrupted their positive view of services and made it harder for them to build up 
trust and good relationships. The turnover of staff was also seen as having a 
negative effect on transition, as discussed in more detail under ‘Uncertainties around 
transition’.  
There was also a feeling that gaps between appointments were often long, or did not 
correspond with expectations:  
 
Erm when they say they’ll… review in a couple of months it takes 6-7 months 
to even get the letter through (Owen, P7) 
 
This implies that service users were aware of a gap between the expected or 
promised care and what was actually delivered. This might be heightened by an 
expectation of more frequent or intensive review in specialist care compared to 
primary care. 
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Summary of theme 
This theme describes the experiences young people had with professionals involved 
in the care of their ADHD, in relation to their roles, attitudes and relationships, which 
form the backdrop for their transition from child to adult services. In particular, 
participants discussed perceived differences in roles, understanding, knowledge and 
relationships between primary care and CAMHS/paediatrics. Given that participants 
were all leaving these child services, either for an Adult ADHD clinic or for primary 
care, such narratives are highly relevant to their expectations and experiences of this 
transition. 
Theme: The role of ADHD medication 
Medication was mentioned far more often than non-pharmacological ADHD 
management by the young people interviewed, and was largely discussed in terms 
of medication effects, and medication purpose. To illustrate this, participants gave 
examples of what happened when they did not take their medication: 
 
I have a note not to forget… to take them when going to school and it was in 
physics lesson I remember… normally I can get it quite quickly and I 
understand it and I’m able to concentrate and  I just  wasn’t able to … well 
concentrate and… I started thinking ‘What! well normally I get this’ and it was 
a lot harder than it was normally and I realised I forgot to take them and that 
was when I realised… made me think about how difficult it actually is 
sometimes when I don’t take them (Sam, P4) 
 
well we had a trial [of stopping medication], and within the first couple of days 
I was on the steps outside [school] and I was just in tears because I was just 
felt like everyone was having a go at me, it just felt all of a sudden everyone 
was just shouting at me, do this, do that, that’s not how you do it, that’s not 
how you do this, and I was just… I felt almost suicidal… I just felt everyone 
was having a go at me (Patrick P6) 
 
Occasions where medication was stopped accidentally or deliberately had a marked 
impact on some participants, and they were able to remember and describe these 
events in some detail as shown above. In Sam’s quote, the impact of a forgotten 
dose was felt in a marked deterioration in concentration and understanding at 
school, but in Patrick’s case a trial of cessation was actually a highly distressing 
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experience.  The role of ADHD medication was therefore seen not only in terms of 
concentration and focus in the academic environment, but also in terms of emotional 
impact and ability to function. For some, just the thought of stopping medication was 
anxiety-provoking.  One interviewee had been very concerned that when he moved 
to adult services they would stop his medication. However, on further thought he 
reassured himself that professionals would be unlikely to do this whilst he was still 
attending school:  
 
 I felt kind of protected if you will… by the fact that I was [still] going to school 
next year (Sam, P4) 
 
The use of the word ‘protected’ suggests that medication may be seen as both a 
literal, and a symbolic, safety net for some participants, and that being still at school 
would provide protection against enforced cessation. Most of the young people 
interviewed made this link between medication and education:   
 
 I don’t usually stay medicated when I’m not doing academic work …I see it as 
an aid in situations when I need to concentrate ‘cos I’m not that bad. I’m not 
awful without it. But I do find it hard to get on with things when I’m not 
medicated (David, P1) 
 
I know people who like have taken Ritalin like that, they often, when they 
finish the exams, they stop taking it, and then some people carry on taking it, 
but then they don’t know how long they can take it for and whether they can 
carry on taking it while in college or they have to stop it when eighteen… 
(Rebecca, P3) 
 
The first quote from David frames medication as being a specific tool that he 
chooses to use for academic work, whereas the second quote from Rebecca also 
links medication and education but voices more uncertainty about the exact purpose 
of the drugs. She suggests that medication might be for taking exams, although 
possibly only for those at school and not those at college. This implies that in her 
mind the appropriateness of taking ADHD medication might be directly related to age 
or stage of the education system instead of whether or not the treatment is needed 
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to function academically. The uncertainties that she talks about also relate to the 
third theme of ‘Uncertainties around transition’. 
Although education was seen as being the most important purpose of medication, 
participants also discussed other positive effects. One interviewee reported that 
medication was essential for him to safely ride his motorbike. However, the most 
highly valued and commonly cited ‘non-educational’ effect of medication was 
experienced by young people as the benefit to social and family relationships: 
 
It [the medication] does help for other things – I’m normally giving my mum, 
like, attitude all the time if I don’t take it, if she p** me off I just tell her to shut 
up, but if I do take them I just walk out of the room … like to calm myself down 
(Joe, P2) 
 
And…I’m able to kind of have more of a conversation with people than…just 
being set on speed and just telling them what I think all the time…I’m able to 
help out a bit more [at home] …and yeah… I’m able to be a lot more switched 
on …, when I need to focus to help out (Sam, P4) 
 
 
Interviewees therefore valued the effects of medication on relationships; both in the 
home environment in terms of reducing conflict and being able to play a ‘helpful’ role; 
and in the wider sense of improving social skills and interactions with other people.  
Negative aspects of medication mentioned included a dislike of swallowing large 
tablets, or decreased appetite. Only one interviewee suggested that he would prefer 
not to take the drugs. For this young person, the decision to take medication 
appeared from his point of view to be heavily influenced by his parents’ perceptions. 
He felt they were looking for specific behaviour changes from him: 
 
Erm being, normal, blending in with people…Not jumping off roofs, things like 
that…I didn’t feel the need to take it [the medication]. Like, I thought I could 
just be myself (Owen, P7) 
 
For Owen, his idea was that his parents wanted him to be ‘normal’ and conform, the 
implication being perhaps that he was in some way abnormal, although he also 
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refers to engaging in risky behaviour which indicates that he might recognise 
legitimate concerns on their part. Owen also reported that taking medication made 
him feel more tired and depressed. His words suggest he felt that he was not himself 
on medication, and that it affected his feelings of identity. His motive for taking ADHD 
drugs seemed therefore to be at least partially to show his parents that he could be 
responsible, and go out without getting into trouble, rather than because he valued 
the benefits of the treatment. This was one of the only occasions in the interviews 
where there appeared to be tension between the views about treatment between 
parents and children; although it was one of three interviews where no parent was 
present.  
Summary of theme 
This theme represented young peoples’ experiences of the role and effects of ADHD 
medication, past and present. The majority of participants reported pharmacological 
therapy as being central to their ability to manage ADHD in an academic 
environment, and for some this appeared to be the primary and possibly only 
purpose of medication.  However, despite saying that they took medication ‘for 
school’, the positive effects on social interactions and daily life at home and with 
other people were also highly valued by most interviewees, which suggests that 
motivation to use medication is likely to be more complex. These perceptions about 
the purpose and value of pharmacological therapy are relevant as they directly 
informed their views on needs over the transition period and beyond, which are 
discussed in detail in the next two themes. 
Theme:   Uncertainties around transition 
All the young people interviewed voiced a number of uncertainties and concerns 
around the process of transition. This included both those who had already left 
CAMHS or paediatrics, and those who were still being seen by child services. As 
described in the previous theme, for many participants, medication played an 
important role in helping them manage daily life at home and at school or college. 
Consequently, for those who were only just leaving CAMHS, a central area of 
uncertainty was how their medication would be continued, and who would prescribe 
it. One young woman had had previous difficulties with her GP refusing to prescribe 
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ADHD medication, and did not think they might prescribe it after the age of 18 even 
though she wanted to continue. This was because: 
 
I would think ‘cos it’s for kids more than anything (Rebecca, P3) 
 
This suggested a clear link between age and medication, rather than functioning and 
medication, as discussed under the previous theme. It was unclear though whether 
this idea about medication being ‘for kids’ had come from other young people with 
ADHD that she knew, or from professionals.  
Another participant was more confident that his medication would be continued 
somehow: 
 
Now I’m headed off to university and switching GPs and everything and I’m 
not entirely sure where to go from there…I think I need to have an 
appointment, I’ve been told I need an appointment with the GP when I get 
there just to make sure the prescription’s fine to stay on (David, P1) 
 
David’s quote above mentions the added complication of going to University and 
changing his GP, but although he appears to expect that his medication will continue 
to be prescribed there is still an element of doubt present. 
Most of the young people interviewed specifically wished to continue medication 
beyond the age of 18, and they linked this to their ongoing education and training at 
college or University. Those who had not yet left child services talked about their 
anxieties about the impact of stopping medication on their plans: 
 
If I don’t take them it’d be …I… don’t get on with work I’ll be clumsy , if I do 
take them, I’ll be concentrating all the time. I know if I stop taking them and I’ll 
just be kicked out of college, just won’t be able to handle myself… (Joe, P2) 
 
For participants who had found medication crucial to functioning in an academic 
environment, concerns about whether they would be “allowed” to stay on medication 
were evident.  To them, the potential consequences of stopping were envisaged as 
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being potentially severe, including being “kicked out” of their course, and being 
unable to continue with education and training.  
The account of one interviewee, who had recently made the transfer to an Adult 
ADHD service, of his last appointment with paediatrics suggested he found this final 
appointment an anxiety-provoking experience. He had seen a different doctor than 
usual, who had implied that his medication might be stopped. Prior to his first 
appointment with the Adult ADHD service he then became worried that the fact he 
was doing well at school might mean that the adult clinic would decide he did not 
need his medication: 
 
I was kind of worried that they [the adult ADHD service] were going to say 
‘Ok, I think you’re doing well and so I think that, you know, you can probably 
do without [the medication]’ (Sam, P4) 
 
This first appointment with adult services was therefore framed almost as a 
‘judgement’, with his medication, and consequently his success at school, hanging in 
the balance.  In particular, Sam thought that his educational success so far might 
count against him in that adult services might decide he could cope without the 
drugs.  
The sense of uncertainty experienced by some participants was further heightened 
by what they perceived as a lack of preparation for leaving child services, with no or 
little notice given or much idea of what to expect. The last appointment at child 
services did not always appear to be part of a planned transition, but often an 
afterthought: 
 
It just felt like any other meeting. Apart from towards the end she said ‘oh um, 
er we won’t be having any more meetings’. I mean, I was surprised at the time 
because I didn’t realise that was coming up, um cos I’ve had it since I was 
young, I just got used to them… it was just so sudden….’Oh you’re 18 now, 
goodbye’ (Patrick, P6) 
 
Yeah, you get dropped when you’re 18…  [They said] ‘you go to your GP 
now…Fill some forms in and we’re leaving you’ (Lauren,P5) 
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The language used by Patrick and Lauren above suggests that this final appointment 
was experienced as dismissal, or even abandonment: ‘we’re leaving you’ ‘goodbye’; 
leaving a sudden gap. Furthermore, their accounts imply that young people found 
the approach to the encounter rather rushed and lacking in care, with the issue of 
leaving addressed suddenly, or only at the end of the appointment. 
Only one of those who had left child services appeared to have been notified well in 
advance: 
 
 Yeah, they sent me a letter about 6 months before, so I knew it was coming 
(Owen, P7) 
 
This participant appeared to experience less concern and uncertainty over leaving 
CAMHS than many over the other participants, which might relate to his more 
ambivalent attitudes towards medication which were discussed under the previous 
theme. He was satisfied with being notified about transition by letter and not during a 
meeting. The letter also informed him about the option to be assessed by the Adult 
ADHD service, which he thought was something useful to do, ‘in case’ he did need 
help later on.  
Summary of theme 
In this theme the participants’ narratives highlighted the uncertainties around 
transition that most experienced to some degree. These uncertainties aroused 
anxieties; in particular regarding the continuation of medication post-transition. Their 
accounts of leaving child services also suggested that sometimes this was perceived 
as a sudden event for which they were unprepared.  Consequently, this theme of 
uncertainty leads into the final theme which elaborates on the needs identified by the 
young people interviewed. 
 
Theme Four: Identified needs and increasing independence 
Participants’ responses highlighted several areas where they felt services did not 
meet their needs over the transition period. These subthemes included: information 
about transition, timing of transition, and specific needs post transition such as 
medication management and support in higher education. In conversations around 
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transition, there was also a common theme of independence and responsibility, both 
in terms of growing independence of child from parent, and, to a lesser extent, in 
terms of increased self-management of ADHD and less reliance on services. These 
aspects are discussed and illustrated further below. 
Information about transition 
As described in the previous theme, leaving CAMHS or paediatrics was often 
perceived to be a sudden event, rather than part of a process of moving between 
child and adult services. Consequently, most of the interviewees therefore expressed 
a desire for more information further in advance in order to prepare: 
 
I would’ve just liked to know a bit more about what it was going to be like [the 
Adult ADHD service] and everything ‘cos I didn’t really have a clear idea and 
the way we kind of left the last session…I just kind of, I didn’t know what to, I 
just didn’t know what to expect.  But yeah, if I would’ve known what it was 
going to be like I would’ve been so much more relaxed (Sam, P4) 
 
Like if they said it last year before I was chucked off…this time next year, this 
would be the last appointment, I’d be like ‘OK I can prepare myself in 
whatever ways’ (Patrick, P6) 
 
Just, I suppose that at this age you would be expected to get on with it, see 
your GP and ask for advice but some kind of informative thing, a pamphlet or 
something to tell you the steps to take before moving away, would have been 
helpful (David, P1) 
 
 
These quotes do not appear to suggest that participants required detailed or 
complex information, but instead a clear indication of what happens next, where they 
are expected to go and contact points. This lack of information led to considerable 
anxiety, which young people thought could have been avoided in some cases by 
better communication. The extracts from Patrick and David also imply that they were 
willing to take on some responsibility for preparation and finding information 
themselves (which also relates to the next sub-theme below on increasing 
independence), but that they perhaps needed some advance help or encouragement 
to do so. 
207 
 
 
Timing of transition and increasing independence 
The timing of transition was discussed by participants and parents in relation to 
increasing independence and responsibility. It was suggested that transition might 
occur too early, and might be better in the early twenties, for example at the age of 
21: 
 
 …like CAMHS up to age of twenty-one and then change …‘cos you’re an 
adult but you’re not adult adult (Rebecca, P3) 
 
I think it may be nice to extend to 21 ‘cos… if I’ve still got any questions I can 
ask [CAMHS] (Patrick, P6)  
 
These quotes came from young people who were not moving into an Adult ADHD 
service. The first quote suggests that it is the young person’s age, or maturity that 
dictates the timing of transition, i.e. when they are an ‘adult adult’; whereas the 
second quote implies that it should be decided by needs. Patrick’s quote also 
suggests that he feels most confident in CAMHS to meet those needs, in this case, 
by answering questions. 
Parents still appeared to be accompanying their children to ADHD-related 
appointments in many cases, but the degree to which young people took control of 
ADHD management also varied: 
 
They [parents] make sure that I take them ‘cos after, the whole month and a 
half thing of me not taking them, they wanted to make sure I was. So they 
make sure I take them every morning…I think I’ll take it…as long as people 
see a problem with me not taking it. But if people start not seeing a problem 
with me not taking it I’ll stop taking it (Owen, P7) 
 
I mean I’m getting better at determining whether or not I need medication, if I 
feel… sort of really out of it and I can’t concentrate on something, or I think 
hang on a minute I would not normally do this, like metaphorically climbing up 
the walls, just things out of character, then I’d say right I’m going to have one 
of my meds now (Patrick, P6) 
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I’m trying to get into the habit of also thinking ‘Ok, I’ve got a week left, I need 
to order them [the tablets] in again and pick them up in time’ otherwise I’ll go 
on without them for a bit and that’s not really good (Sam, P4) 
 
Owen makes reference here to a time where he did not take the ADHD medication 
which he had been prescribed, which meant that his parents took over the 
responsibility of monitoring his adherence. This seems to be related to the fact that 
he himself did not greatly value the effects of the medication. Therefore, because 
others viewed him as a ‘problem’ when he did not take medication the onus was on 
them to oversee the drugs. Even though Owen is shortly to have his 18th birthday, he 
also appears to feel that the decision whether or not to even continue medication 
does not rest with him, but rather with others and is externally controlled. Patrick on 
the other hand discussed becoming more aware of his symptoms, recognising when 
he might benefit from taking a dose, and therefore making his own decisions about 
his treatment schedule. The third quote is from a participant who was shortly leaving 
for University. He was already thinking about the need to start preparing for taking 
control of his condition when away from home, but this responsibility appeared very 
practical in terms of taking on tasks such as ordering and collecting prescriptions. 
These quotes therefore illustrate varying levels of independence and responsibility 
as young people and their families undergo the process of transition. Such 
differences seem naturally to closely relate to participants’ own beliefs about the 
benefits and purpose of pharmacological therapy, as discussed in an earlier theme, 
but are also likely to be influenced by family dynamics, symptom severity and 
general functioning.  All these accounts nonetheless supported a general narrative in 
which independence was seen by participants to refer to managing their own ADHD 
medication, rather than in a wider sense of taking charge of their interactions with 
services, but might represent the first step on this journey. 
Needs post transition 
Two participants who had made the transfer to an Adult ADHD service locally had 
already had their first appointments. These appointments with specialist nurses and 
psychologists were perceived as being helpful experiences: 
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 It was a surprise it was really nice… when I went there… I didn’t know what it 
was going to be like but if I’d known beforehand how kind of nice they 
would’ve been and how relaxed it would have been I would’ve been maybe… 
a little bit better (Sam, P4) 
 
Therefore, in contrast to his anxieties about adult services, this participant was 
actually pleasantly surprised. He may have been expecting staff in adult services to 
be more judgemental and unfriendly, compared to the atmosphere in child services, 
but found that this was not the case.  
 
He and his mother also valued the advice given by Adult ADHD services regarding 
the support available in higher education, as it seems that the clinic had experience 
in managing patients who were away at university. The importance of support for 
ADHD in further and higher education was mentioned by other participants too: 
 
It seems they’ve [the University] got a good department in place that will offer 
support if you need it. They’ve got counsellors, both very central to the 
university and within your accommodations and colleges. So I think that’s 
quite nice and you’ll have someone to go to that, you know, who’s just there 
(David, P1) 
 
In this case support was perceived not necessarily to be ADHD-specific, but also to 
relate to counselling and advice generally for any issues that might arise. 
The predominant focus of need identified by young people was active management 
and monitoring of medication post-transition. This seemed to be more of a 
preoccupation for those who had left CAMHS, and returned to the care of their GP, 
without any specialist ADHD input. These participants often perceived people with 
ADHD as having particular needs which might not be served by ‘routine’ primary 
care check-ups.  One of these young people explicitly felt this arrangement did not 
meet his needs: 
 
…I used to look forward to the meetings ‘cos they used to be able to change 
my dosage and see what the doctor recommends, but I can’t really go and 
see her anymore to ask questions, [like] If I lower my meds down by 5 or 10 
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[what will happen]? but I don’t know, well then… just stay on the same dosage 
then. So, I can’t… I’ve got no one to ask anymore…and it feels a bit… 
awkward really (Patrick, P6) 
 
Patrick’s concern seems particularly to relate to having no-one to consult regarding 
his medication, in contrast to the highly valued specialist appointments he had in 
CAMHS. By saying that he has no-one to ask, Patrick implies that he cannot 
approach his GP with questions, which is linked to his earlier statement where he 
perceived GPs as not being qualified to help with ADHD. The result in this case is 
that he feels quite lost, and unable to test out changing his dosage as he would like 
to do.  
Another participant, David, was also not transferring into an Adult ADHD service and 
was planning to continue medication for the present: 
 
Well, I still need a height weight blood pressure review at least annually if I 
stayed…on medication (David, P1) 
 
However, in contrast to Patrick above, David did not appear to want closer oversight 
of his medication. Instead, he identified his needs as being annual reviews of the 
physical health aspects of his treatment, perhaps seeing this as being within the 
GP’s remit. 
Summary of theme 
This final theme describes participants’ perceptions of their needs over the transition 
period and beyond.  Young people identified a number of elements which would help 
them manage their ADHD, including better information and preparation for transition, 
ongoing specialist medication management, and advice and support with further and 
higher education options. The narratives present in this theme related to young 
people’s increasing independence over the period of transition, but also indicated the 
complex negotiations between child and parent which formed part of the process. 
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5.4 Discussion 
 
This study directly explored the experiences of young people with ADHD who are 
undergoing transition from child services. The findings add to the very limited body of 
research in this area, despite considerable difficulties in recruitment. There is only 
one published UK study which has previously interviewed service users with ADHD 
in transition, which was set in Nottinghamshire and included young people making 
the transition from CAMHS to Adult Mental Health Services (Swift et al. 2013). In the 
current study described in this chapter, participants came from different areas of the 
South West Peninsula with varying service configurations. Consequently, the 
research was able to include the experiences of transition both of those who made 
the transfer to an Adult ADHD service, as well as of those who were returning to 
primary care management of their ADHD.  As there is known to be considerable 
variation in the services commissioned for adult ADHD across the country, 
particularly in whether an adult ADHD service is provided, this research may 
therefore serve to illustrate themes which have a wider relevance to services outside 
the Peninsula (Hall et al. 2015, Coghill 2015).  
The four themes which arose from the analysis were: professionals’ roles and 
relationships, role of medication, uncertainties around transition and finally identified 
needs and increasing independence.  These findings chime in many respects with 
other qualitative literature, but also highlight aspects of young peoples’ experiences 
which have not been previously explored or reported.  
Discussion of themes 
Professional roles and relationships 
The importance of relationships with professionals is a theme commonly arising from 
qualitative research with people using mental health services ( Jones et al. 
2009,Swift et al. 2013, Plaistow et al. 2014), which was also the case in this study. 
Positive qualities such as understanding, being ‘nice’ and non-judgemental were 
frequently identified when discussing experiences with professionals. On the other 
hand, despite these attributes of individual staff members, young people referred 
frequently to a lack of continuity in medical and other staff within child services (as 
opposed to continuity of staff between services over the transition period). This was 
212 
 
seen as having a negative effect on relationships and also consequently on their 
experience of transition, for example, seeing a new clinician on their last 
appointment with child services. In Swift et al.’s (2013) interviews with young people 
with ADHD in transition, both service users and parents also viewed these 
relationships with CAMHS as having a ‘pivotal impact’ on transition.  Lack of 
continuity and depersonalised transition between teams is also reported as 
undermining patient satisfaction and wellbeing in research with adult service users 
by Jones et al. (2009). 
However, one of the most highly valued roles professionals in CAMHS and 
paediatrics were perceived to have was that of an expert in ADHD who would help 
them manage and optimise their medication; this was sometimes contrasted with the 
role of primary care (discussed further below). Professionals from CAMHS and 
paediatrics were generally considered by participants to understand ADHD. This was 
not the case with all professional groups. Whilst some young people had a positive 
experience of ADHD support in schools, other interviewees reported encountering 
negative attitudes, such as an assumption that children with ADHD would be ‘trouble 
makers’.  These quotes are mirrored on a much larger scale by a recent systematic 
review which suggested that many teachers held polarised views about ADHD 
(Richardson et al. 2015). The review found some teachers tended to perceive the 
disorder as being of a wholly sociological origin rather than being of multifactorial 
aetiology, relating it to ‘naughtiness’ and to the environment in the home. In the 
review, attitudes towards ADHD were also found to influence classroom 
management of ADHD. Similarly, the help offered to some participants in this study 
was perceived as not being tailored to their needs, and even as being stigmatising; 
experiences which were also reported in the review. Such findings are concerning 
given the increasing policy emphasis placed on school-based mental health and on 
the role of teachers in identifying and managing disorders (see Chapters Two and 
Three for policy details).  
The GP’s role in managing ADHD, both pre- and post-transition was discussed 
across the majority of interviews, and extracts relating to primary care were relevant 
to all the key themes. This was unsurprising as much prescribing for children with 
ADHD takes place under shared care arrangements with primary care (Ford et al. 
2008a). Primary care also takes on care for adults with ADHD, either under shared 
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care arrangements with specialist services or even without specialist oversight 
(although this is not recommended under NICE guidelines) (NICE 2008b, Bolea-
Alamanac et al.  2014). The contrast between primary care and specialist services 
was explicitly made by young people in this study. Understandably, some young 
people compared the closer relationship they had with their psychiatrist or 
paediatrician with the fact that they ‘never saw’ their GP, and felt that they did not 
know, or perhaps trust them. Indeed, their only ADHD-related encounters with 
primary care may have been in the process of referral for their initial diagnosis 
(which may also have represented a ‘fight’ or ‘battle’ for the parent), and when 
collecting repeat prescriptions, encounters which would not build a trusting and 
understanding base for the therapeutic relationship in adulthood. 
Participants expressed little confidence in their GP’s ability to help them manage 
their medication post transition, again in contrast to this specific support that they 
valued from specialists. This lack of confidence may be influenced by various factors 
such as the absence of a longstanding therapeutic relationship with the GP, and real 
and practical constraints such as limited GP time. Furthermore, interviews also 
suggested that many young people and parents naturally took on the role of ‘expert 
patients’, having built up years of experience of managing their condition, similarly to 
young people with other chronic health conditions.  They may therefore have been 
more critical of primary care, and the knowledge or qualifications of GPs relating to 
ADHD.  Potentially, the perceptions of participants might also reflect wider 
misunderstandings about primary care; other research amongst young adults has 
found that this group report issues with trust and communication in primary care, with 
some believing that GPs dealt exclusively with physical disorders and lacked training 
in or understanding of psychiatry (Biddle et al. 2006, Davey et al. 2013).  
Misunderstandings and stigma surrounding ADHD itself as a condition, as well as 
controversies around ADHD medication (see Introduction and Background) might 
further contribute to difficulties in the therapeutic relationship with primary care, 
where participants encountered ‘unsupportive’ attitudes or refusals to prescribe. This 
attitude towards prescribing chimes with the reports of adults with ADHD interviewed 
by Matheson et al. (2013) who described GPs being reluctant to prescribe, and 
pharmacists being unwilling to dispense, treating the medication like ‘plutonium’; with 
periods of enforced cessation being the result.   
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From the perspective of professionals themselves, comments made by 
paediatricians in a survey of those treating ADHD cases suggested that some also 
felt that GPs might not have the time, skills or interest to manage young people with 
ADHD (Marcer et al. 2008); something that was also raised by the small number of 
psychiatrists and paediatricians interviewed in the qualitative part of the CADDY 
study (Wong et al. 2009). Perhaps surprisingly, given their key role, to date in the UK 
there have been no published studies of GP attitudes towards ADHD in this age 
group. Evidence does suggest that many may feel uncomfortable and unprepared in 
taking responsibility for the management of young people with mental health 
problems. For example, GPs interviewed by Roberts et al. (2013) expressed anxiety 
in communicating with young people. They reported finding the mental health 
presentations of young adults highly variable and unpredictable, and felt they lacked 
the training to deal with them. Furthermore, GPs considered that their practice was 
hampered by guidelines limiting what they could do without specialist support or 
access to psychotherapies; and at the same time were frustrated by problems in 
gaining access to such specialist services for their patients.  
The question of guidelines is of course very salient to ADHD; as NICE guidance 
(2008b) currently recommends that ADHD medication requires occasional review by 
a specialist, and where such services are not available (see section below on 
Transition) this will limit the GP’s ability to prescribe, or to offer non-pharmacological 
interventions even where they might wish to do so.  In addition, relationships with the 
patient may affect the GP’s own confidence and willingness to prescribe, given that 
they themselves may be suddenly faced with a patient at the age of 18 who has 
always previously been seen by specialist services. GPs may therefore be cautious 
in taking on prescribing responsibilities in ADHD after patients reach 18 years, 
especially given that stimulants are controlled drugs (Bolea-Alamanac et al. 2014).  
The role of medication 
A commonly expressed idea by the young people interviewed was a strong link 
between medication and education. They described the purpose of medication in 
various ways: as helping them to be calm in the classroom, to concentrate, to 
complete homework, and to take exams. This, of course, is possibly the most 
common reason for taking medication cited across the literature (Travell and Visser 
2006, Wong et al. 2009, Brinkman et al. 2012). Young people interviewed by 
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Brinkman et al. (2013, p.57) in the US “recalled that medication was recommended 
by teachers and/or physicians in order to achieve academic success” . There was 
also the suggestion from Travell and Visser’s (2006) study of medication that many 
adolescents thought that the end of school (i.e. age 16 or 18 years) was the time to 
stop medication, which might relate to the comment from one participant in this 
current study that ‘medication is for kids’; although it is not known whether this was 
their own idea or something heard from clinicians or teachers. If it is a commonly 
held belief amongst professionals, both clinicians and teachers, that medication is 
just for children, or just for school, this is a view that may need exploring or 
addressing in future research. Although education appeared to be considered to be 
the ‘purpose’ of medication, the benefits of medication on social relationships were 
also prominent in young peoples’ accounts.  Indeed, in Singh et al.’s (2010) 
qualitative study with young adolescents with ADHD, participants reported that 
medication had more of a beneficial effect on their social relationships than on their 
academic work. Interestingly, although the interviewees in the current study seemed 
to value these effects on social relationships, no participant gave them as the main 
reason for wanting to continue medication. It is possible that education was seen by 
young people and parents as being the most worthy or acceptable purpose for 
medication; and one that would be harder for professionals to argue with, especially 
given their uncertainties regarding whether their medication would be continued after 
leaving child services. 
Transition 
Two of the themes focussed on experiences and needs around transition and 
beyond: ‘uncertainties around transition’ and 'identified needs and increasing 
independence’. Participants’ views on medication, discussed above, contributed to 
the uncertainties around transition that they faced.  A major anxiety expressed by 
some participants appeared to be the fear that if their medication was stopped, their 
training and education might consequently suffer, even to the extent of being 
expelled from college, or having to leave University.  Most interviewees (although not 
all) also appeared keen to continue to take their medication after the age of 18. This 
contrasts to some degree with other qualitative studies with adolescents about 
ADHD medication where a significant number of participants perceived that the 
negatives of medication outweighed the positive, and where many reported making 
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their own decision to stop medication (Wong et al. 2009, Brinkman et al. 2012, 
Charach et al. 2014). The findings may differ due to the sample interviewed; the 
young people interviewed in this current study were all still on medication; which 
suggests both that these participants recognised the need for medication and 
remained engaged with healthcare services. The majority also planned to remain in 
some form of education or training after the age of 18. This is important to 
acknowledge when considering all the study findings and is discussed further under 
Limitations below.  
The need to prepare young people for transition is well recognised from previous 
research and forms a key part of the guidance on optimal transition across physical 
and mental health services (Department of Health 2008b). Consequently, one of the 
more striking findings was how important information was to participants; and that 
this remained a central unmet need identified by interviewees in this study. Even 
young people who were otherwise satisfied with the service they received felt that 
extra attention and information around the time of transition in terms of what to 
expect and next steps to take would have helped them. The feeling of being 
unprepared, being suddenly ‘dropped’ and the experience of not being kept informed 
suggest guidance may not have been followed (see Implications below). Being 
informed was linked with the concept of becoming an adult and taking increased 
responsibility. The negotiation of a transfer of responsibility from parent to child 
appeared to be a stage that families were undergoing alongside transition. The 
extent of the transfer and the type of parent involvement naturally varied between 
participants who had differing levels of functioning, family structure and 
comorbidities, a finding also reported amongst young people with life-limiting health 
problems interviewed by Beresford et al. (2014). 
The second major unmet need identified relating to care over the transition period 
and beyond was for support in managing ADHD medication. In particular, 
participants who were not transferring to an Adult ADHD service to appeared to have 
concerns about lack of specialist advice and review. They felt that they required 
regular review of dosage and type of drug in order to optimise the management of 
their symptoms. Similarly, in Matheson et al.’s (2013) study of adults with ADHD, 
those that received only repeat prescriptions from their GP wanted extra support with 
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adjusting their medication and dealing with adverse effects, suggesting this might not  
be a role that primary care is always able to fulfil. 
In contrast to the anxieties voiced regarding medication, needs for non-
pharmacological management were less prominently expressed during interviews. 
Non-pharmacological interventions were generally referred to in more vague terms 
such as ‘someone to talk to’ or ‘support’ with further or higher education. Given that 
those interviewed had only just left child services, the issue of medication may have 
been a more urgent concern; but the relative lack of emphasis placed on other 
interventions might also reflect uncertainty about the role of non-pharmacological 
management. Adolescents interviewed by Singh et al. (2010) reported the view that 
medication was the most efficacious treatment for ADHD; and many also could not 
recall memorable or helpful non-pharmacological interventions. Such perceptions 
may indicate both a lack of awareness and a lack of availability of non-
pharmacological options for young people with ADHD, leaving medication as their 
only ‘safety net’ over the transition period. 
Strengths and limitations 
One of the strengths of this study was that the design involved interviewing young 
people using a variety of services across the South West Peninsula, encompassing 
four different service providers and configurations. It therefore describes the 
perspectives of service users from both CAMHS and paediatrics that transferred to 
Adult ADHD services as well as those for whom no such service was available and 
who were returning to GP care. Their experiences may therefore be applicable to 
young people in other areas of the country where similar arrangements are in place. 
The sample was also quite diverse. Although no young people from black or minority 
ethnic backgrounds were identified as being eligible, the sample included young men 
and women, with different co-morbidities, and who had varying destinations following 
transition such as vocational training, further education and higher education. The 
inclusion of young people with comorbidities (in particular Autism Spectrum Disorder) 
is likely to have meant that these wider needs would also have influenced their 
responses and experiences of service use; nonetheless this inclusion also resulted 
in a sample that reflected the ‘real-life’  complexities of clinic populations to a greater 
extent. 
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There were also potential strengths and limitations relating to the interview. Firstly, 
as a first time qualitative researcher, there were challenges in adapting a clinical 
interview technique to a more open technique suitable for qualitative interviewing, 
meaning that early interviews could potentially have been deeper and richer in data. 
On the other hand, as considered under Reflexivity earlier in the chapter, there were 
also advantages of having previous interviewing experience, and regular supervisory 
meetings allowed the discussion of transcripts and the development of techniques.  
One of the requirements of ethical approval was to explain to the participant that a 
parent or carer could be present at the interview if they wished. Accordingly, four of 
the seven participants were also interviewed with parents present. This may have 
carried the potential to inhibit the participant, but on the other hand may also have 
allowed them to feel more comfortable in being interviewed by a stranger. Although 
data from the parent where present forms part of the ‘contextual’ information given in 
the analysis, data from the parent was not reported as part of the thematic analysis. 
This decision was taken because the original intention was for this study to 
concentrate on the perspectives of the young people themselves. There were of 
course varying levels of parental involvement in the interview itself; in some cases 
this was only at the level of factual information given to remind the child, in others 
parents wanted to contribute to the narrative, for example, discussion of how they 
had fought or battled to get into the ‘system’. On analysis there appeared to be no 
major differences in how the themes were represented across the data from young 
people in interviews with and without parents present. Nonetheless, it is important to 
acknowledge the influence that parents may have had, and consider that the findings 
of the study may not ‘purely’ represent the views of young people alone. 
One of the key limitations was the difficulty in recruiting this hard-to-reach group, 
despite adapting the study design on several occasions (described in Section 5.2 
Aims and Methods). Although qualitative studies are not predicated on reaching a 
specific sample size (Mays and Pope 2000) the small number of young people 
interviewed means that the data may not reflect the full range of experiences of 
transition, and therefore should be generalised with some caution. Nonetheless, few 
studies have successfully managed to recruit to plan when carrying out research with 
this population. For example, both the large TRACK and CADDY studies reported 
very low response rates (Wong et al. 2009, Hovish et al. 2012); in TRACK, only 11 
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service users out of a planned 20 were interviewed. Problems with a low response 
rate and a high drop-out rate prior to interview were also noted by Swift et al. (2013) 
(who identified initially over 80 cases but could interview only 10) and Matheson et 
al. (2013), both studies involving adolescents and adults with ADHD. 
Young people in general can be hard to engage with, and the nature of ADHD 
involved added challenges in recruitment and retention. Those with the disorder 
generally experience problems with organisation and attention, both issues which 
would make it harder for them to respond to invitations and reminders. Indeed, most 
of those who eventually took part required repeated contacts, sometimes over the 
course of weeks or even months. Young people with ADHD may also have comorbid 
ASD or associated difficulties with social skills, meaning that telephone contact, for 
instance, may have been anxiety provoking (the reason given by one non-
participant), as may taking part in an actual interview.  Engaging young people often 
required repeated attempts at contact, and many seemed nervous or reluctant to 
speak on the telephone. Online ‘chat-room’ style discussions have previously been 
used with ‘hard to reach’ groups’ (Wilkerson et al. 2014) and might represent an 
alternative acceptable option for some participants, especially given the high 
prevalence of autism or social skills difficulties in those with ADHD (Murray 2010, 
Green et al. 2015). The fact that the study design involved making contact with 
service users at the disruptive and potentially chaotic time of transition is likely to 
have been yet another barrier to recruitment. 
Another point for consideration is that the young people interviewed in this current 
study were all still being seen in specialist services at the age of 17-18 years and 
were all on medication; which suggests that these participants both recognised the 
need for medication and were engaged with healthcare services.  The study is 
therefore unable to reflect the experiences of young people who might disengage 
from services earlier in adolescence; a group who may face different challenges and 
report different priorities and needs.  
Implications 
Although this study presents the experiences of a small number of young people at a 
specific point in time, their stories suggest that best practice around transition is not 
always being followed. Transition planning should begin at least six months in 
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advance of leaving child services, and, in order to provide as much continuity as 
possible should include joint working and meetings between child and adult services 
(Department of Health 2008b, NHS England 2015). The NICE guidance on ADHD 
(2008b) recommends that the patient be given ‘full information’ about adult services, 
and that they should be involved in the planning of transition. Similarly, the NHS 
England Service Specification (2015) for transition from CAMHS places emphasis on 
keeping the young person and family informed throughout the process, with access 
to multi-media information resources, copies of care pathways, and regular 
meetings. Furthermore, arrangements for the continuation of medication described 
by participants in this study did not always appear to be optimal, or accord with 
current guidelines.  A number of young people seemed to be continuing medication 
after leaving CAMHS under the sole care of their GP. This is in contrast to guidance 
from NICE (2008b) and the British Association for Psychopharmacology which 
suggests that, if continuation of treatment is required this should take place with the 
oversight of specialist clinicians (Bolea-Alamanac et al. 2014). 
Whilst this research does not in any way represent an audit of care, a gap 
nonetheless appears to be present between the guidance on transition, and what is 
experienced by the young people themselves. This relates not only to potentially 
more complex and resource-intensive provision (such as access to adult ADHD 
specialists) but to what would seem initially to be simple and cheap measures such 
as providing information, which was highly valued by young people.  Such a gap 
does not seem likely to be a local problem, but instead to reflect national 
shortcomings in delivering services for those in transition. The findings are in 
keeping with those of the 2010 TRACK evaluation of transition from CAMHS to 
AMHS, which found that ‘basic principles of good practice identified in transition 
protocols’ were not implemented, and that only 5% of cases experienced ‘good 
transition’ (Singh et al. 2010a). This gap between policy and practice is also evident 
in recent mapping surveys of healthcare professionals and mental health trusts in 
England, which highlighted a lack of transition protocols and care pathways for 
young people with ADHD (Hall et al. 2013, Hall et al. 2015). 
Implications for research 
The findings suggest a number of priorities for future research; in particular regarding 
knowledge and attitudes of professional groups towards managing young people 
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with ADHD in transition. The potential gap between policy and service user 
experience is another area requiring further exploration. Mapping transitions on a 
national scale is also likely to assist in service planning and provision by defining the 
scale of potential unmet need. The experience of conducting this study helped gain 
insight into the challenges of engaging this ‘hard-to-reach’ group.  Key points of 
learning included the need to allow sufficient time for recruitment and to build 
relationships with clinicians, as well as flexibility in the methods of contacting young 
people to take account of their anxieties and preferences. Some of the experiences 
from this study have therefore contributed to the protocol for a mixed methods 
project using surveillance, qualitative and mapping studies entitled “Children and 
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) in transition from 
children’s services to adult services (CATCh-uS)” (Ford et al. 2015) on which the 
author is a co-applicant, and which takes forward some of the work from this thesis. 
The CATCh-uS study and other recommendations for research are considered 
further in more detail in the Overarching Conclusions chapter as they are also 
relevant to the overall findings of the thesis.  
Summary 
This chapter described a qualitative interview study with young people with ADHD 
recruited from various service configurations across the South West Peninsula, who 
discussed their experiences and concerns about the transition process, such as 
anxieties about managing medication, and the need for better preparation. The key 
themes from the data were professional roles and relationships, the role of 
medication, uncertainties around transition, and identified needs and increasing 
independence.  
Many of the implications for research and practice arising from these interviews are 
common to one or both of the other studies in this thesis, and in particular the study 
of primary care prescribing in Chapter Four. Further implications are therefore 
discussed in greater depth in the final Overarching Discussion and Conclusions 
chapter. 
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Chapter Six: Overarching discussion and 
conclusions 
6.1 Introduction 
 
This final chapter aims to draw together the findings of the three studies which form 
the thesis. While the strengths and limitations, issues and implications which are 
specific to each study have been discussed in the relevant section of the chapter 
devoted to that study, this over-arching discussion will draw out the common themes 
and points of agreement or contrast.  This chapter will then consider what the overall 
implications might be for further research, for policy and for practice. 
All the studies in this thesis examined contact with services and/or treatment for 
children and young people with psychiatric disorders from different perspectives and 
using different methodologies. The first study (in Chapter Three) analysed mental 
health related service contacts in school aged children across the range of disorders. 
The second and third both focused on the transition from child to adult services in 
young people with ADHD.  The large dataset analysis (in Chapter Four) described 
changes in primary care prescribing of ADHD and other psychotropic medication 
during the ages in which transition from child to adult services occurs, and the 
complementary qualitative study (in Chapter Five) explored the experience of service 
users going through this transition. 
6.2 Common themes and findings 
 
Findings from all three studies suggested gaps between the need for healthcare and 
the provision of services.  Whilst the majority of children with a disorder in BCAMHS 
2004 reported some contact with at least one service regarding their mental health, 
only a minority had contact with a specialist mental health service. In line with the 
previous 1999 BCAMHS, this work found that teachers were the most commonly 
approached source of help and support for children with mental health problems 
(Ford et al. 2007b). However, there was an increase from the earlier survey in the 
proportion of children reporting contact with education professionals, which might 
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relate to the expansion of school based mental health initiatives and overall 
awareness of mental health over the intervening period. In contrast, the proportion of 
children reporting CAMHS contact did not show such a marked increase, with little 
change amongst children with more enduring psychopathology; only half of those 
with persisting disorders reported CAMHS contact in 2004-2007. Such findings may 
indicate reliance on less specialist services to provide assessment and management 
of psychiatric disorders, which may not meet the more complex needs of these 
children; as discussed further under Implications below. 
Similarly, the analysis of primary care prescribing in young people with ADHD also 
suggests unmet needs. This study is to date the first survival analysis of persistence 
of ADHD medication in the UK which includes a significant period of time after the 
introduction of the NICE guidelines on ADHD in 2008. The survival analysis revealed 
ongoing discrepancy between estimates of symptom persistence from taken from 
follow-up studies, such as the meta-analysis by Faraone et al. (2006) and medication 
persistence. Although there are caveats, such as the inclusion of only primary care 
prescriptions, the implication remains that many adolescents with ADHD may not be 
continuing treatment that they could potentially benefit from. Analysis of recorded 
psychiatric comorbidities against prescribing of psychotropic medication also 
suggested some gender differences in prescribing patterns which would warrant 
further investigation (see Chapter Four). Associations with gender were also evident 
in the BCAMHS analysis; where younger boys were more likely than younger girls to 
have mental health related contact with special education, teachers and CAMHS, 
and older girls more likely to have GP contact. Gender differences in service contact 
and referral patterns, particularly for ADHD and ASD, have been reported in other 
studies and might represent unmet need in both males and females (Novik et al. 
2006, Staller and Faraone 2006, Ford et al. 2008a, Bussing et al. 2012). 
Finally, in the qualitative interviews with young people that complemented this large 
dataset analysis, participants expressed needs for support and information that were 
not always being met by current services. Two inter-related themes emerging from 
the data were of particular relevance: concerns regarding stopping medication, and 
the role of and relationship with GPs.   Participants discussed the importance of 
medication for education, with an attached assumption from some young people that 
as the purpose of medication was to concentrate at school or college, there might be 
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no need to continue once leaving, or after having finished exams. This might indicate 
a considered choice by young people in the wider population to stop their medication 
at 16 or 18 years and may be relevant to the steep decline in prescribing at this age 
found in the prescribing analysis using the CPRD. However, those interviewees that 
planned for college or apprenticeships expressed uncertainty about who would 
prescribe their medication after the age of 18 and had concerns about what 
cessation might mean for them in terms of continuing their education and training 
and performing at their best. This related to participants’ experiences of problems 
with prescriptions such as the reluctance of GPs to prescribe; and a feeling that GPs 
did not know them as well as CAMHS or were ‘not supportive’ of ADHD. Such 
perceptions may well reflect external influences on cessation and might constitute 
another explanation for our findings of ‘premature’ cessation in the second study. In 
this respect these findings also resonate with the experiences of adults with ADHD 
interviewed by Matheson et al. (2013) who recalled experiencing ‘enforced 
cessation’ and described problems gaining access to prescriptions for medication, 
with psychiatrists and pharmacists treating it like ‘plutonium’.   
6.3 Implications for further research 
 
Whilst the specific limitations of this work and implications for research are discussed 
in the individual chapters, the overall findings of the thesis suggest key general and 
more focussed areas for development, including evaluation of interventions, use of 
large datasets and data linkages; and the need for complementary research into 
knowledge, attitudes and policy implementation.   
In discussing the findings of this thesis, reference has often been made to 
uncertainties and controversies surrounding interventions in child mental health and 
their efficacy. Accordingly, as recognised by recent reports from the Chief Medical 
Officer (Davies 2014) and the CAMHS Taskforce (Department of Health 2015), 
good-quality trials and evaluations of interventions and services continue to be a 
central priority in order to improve outcomes. However, an associated implication is 
the corresponding need for balanced reporting of research, as care for those with 
ADHD in particular may be adversely affected by controversy surrounding the 
condition and its treatment. Media reporting of the results of a recent systematic 
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review of methylphenidate (Storebo et al. 2015) was highly variable, with some 
newspaper headlines implying that methylphenidate may not help with ADHD or be 
unsafe (Rhodes 2015). Media portrayal of such uncertainties may contribute to 
stigma felt by parents of children with ADHD (DosReis et al. 2010).  It is even 
possible that the polarised media presentations of ADHD medication as discussed 
by Clarke (2011) might contribute to reluctance to fully treat ADHD with medication 
by professionals (Wang et al. 2015), although this is not a well- studied area. 
Consequently, well designed research needs to be accompanied by dissemination of 
the results that is balanced and informative.  
Linking back to the qualitative work done for this thesis, it was also notable that 
participants gave little emphasis to non-pharmacological treatments for ADHD, in line 
with other qualitative studies suggesting that adolescents may have little knowledge 
of or confidence in such interventions (Singh et al. 2010b). Similarly, the effects of 
non-pharmacological interventions in ADHD could also be better understood. 
Systematic reviews suggest beneficial effects, but again restate the importance of 
rigorous evaluation that takes into account the context in which interventions 
happen, as well as the mapping of intervention components and approaches to 
outcomes(Fabiano et al. 2015, Richardson et al. 2015). 
‘Big Data’ and data linkages 
The large dataset analyses examining service contact (in BCAMHS) and prescribing 
(in CPRD) were able to answer the research questions, but were limited by using 
single sources of routinely collected and survey data. Further context and 
understanding could be gained by using ‘Big Data’, a term used to describe data that 
is high volume and uses a variety of data types, which may involve large dataset 
linkages or data mining (Belle et al. 2015). For example, the Clinical Record 
Interactive Search (CRIS) programme at the South London and Maudsley NHS 
Foundation Trust allows access to pseudonymised clinical records with free text 
available. Programmes are being developed to extract and analyse such free text, 
which could be highly valuable in adding detail and nuance that is not coded (Downs 
et al. 2015a). CRIS is also being linked with the National Pupil Database, a 
longitudinal dataset containing educational and census information, which will allow 
examination of education outcomes using individual level longitudinal data (Downs et 
al. 2015b). 
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Therefore, developing linkages with existing administrative datasets across health 
and education would provide even greater opportunities to study access to services, 
interventions and outcomes for children with psychiatric disorders; and ideally to 
study access and outcomes in individual disorders. Correspondingly, focussing on 
young people with ADHD, data linkages with CAMHS and AMHS records and with 
routine outcome collection would allow exploration of the relationship between ADHD 
severity, functioning and prescribing. This would provide more detail on where and 
consequently, how the management of those with ADHD and associated 
comorbidities could be optimised over the transition period and beyond. 
Research with primary care 
A number of findings suggested the need for further research in primary care. GPs 
were the second most commonly contacted service in BCAMHS 2004; as well as 
playing a key role in the management of young people with ADHD in transition. 
Whilst research has examined GP attitudes towards some psychiatric disorders 
(Roberts et al. 2013, Roberts et al. 2014); the knowledge and attitudes of UK GPs 
regarding ADHD in older adolescents and adults has not been well studied. This is 
surprising given that GPs may take over the management of ADHD patients leaving 
child health services, and that the NICE guidance on ADHD recommends that GPs 
can prescribe for adults with ADHD under shared care arrangements with 
specialists(NICE 2008b). The British Association for Psychopharmacology suggests 
a number of components which should be included under such an arrangement; 
including defining the role of the specialist as being available for medication reviews, 
and trigger points for referral back to specialist care (Bolea-Alamanac et al. 2014). 
However, as reviewed in Chapters Four and Five, fewer than half of English Trusts 
surveyed by Hall et al.(2015) in 2013 had a shared care protocol, and the majority 
had no specialist service. Given that this qualitative study also suggests that young 
people prefer their ADHD medication to be actively managed and regularly reviewed, 
primary care professionals are likely to experience tensions between the needs of 
their patients, best practice guidance, and what they are able to deliver and are 
trained to provide. Therefore, as part of examining potential barriers to the 
implementation of guidance and policy (see also section on Policy below) it is 
important to understand how GPs make prescribing decisions in treating patients 
with ADHD, their attitudes towards the disorder, and their training needs. Both 
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primary care questionnaires and qualitative interview studies could address these 
questions, and identify priorities to support GPs in caring for their patients with 
ADHD.  
Further research into transition 
The research described in this thesis illustrates recent prescribing patterns for ADHD 
over the transition period on a national level; and also presents the direct 
experiences of young people with ADHD using local services. The themes arising 
from these qualitative interviews may reflect aspects of the experiences of service 
users across the country, and will also serve to inform local commissioning. 
However, this work also highlights the need for better understanding of the national 
picture of demand and supply.  Surveys by Hall et al.(2013, 2015) of mental health 
Trusts and professionals, have begun to fill in some of this gap, but there remains no 
comprehensive national map of transition in ADHD which might help commissioners 
identify the likely numbers using and/or needing services.  
The forthcoming CATCh-uS (Children and adolescents with ADHD in transition 
between children’s services and adult services) study of transition in ADHD  may 
assist in quantifying the scale of ongoing need in young people with ADHD leaving 
both CAMHS and paediatric services, as well as describing the provision of adult 
ADHD services nationwide(Ford et al.  2015). The study will also aim to complete 
qualitative interviews with various groups of professionals and people with ADHD, 
including two groups not included in the qualitative study for this thesis: young 
people attending CAMHS or paediatric services prior to the age when maximal drop-
out from services is thought to occur (14-16 years old), and young adults who return 
to services in their mid-twenties after a period without secondary health care. 
Research by Matheson et al. (2013) also suggests that some adults with ADHD may 
re-initiate medication after a break in early adulthood or adolescence, but little is 
known about this group or about the potential scale of this population’s needs. 
Exploring the perspectives of those returning to services would therefore be 
complemented by future study of re-initiation of medication following cessation using 
sources such as the CPRD. 
Furthermore, there are likely to be other specific groups of young people with 
psychiatric disorders who may be especially vulnerable to the disruptions of 
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transition. According to the TRACK study, those with other neurodevelopmental 
disorders such as ASD and those with emotional disorders were also less likely to 
experience ‘optimal transition’ (Singh et al. 2010a). There is consequently the 
potential to use similar methods, e.g. mapping and surveillance, complemented by 
interview studies, to examine their experience of transition and identify barriers and 
facilitators. 
Tracking young people in transition and mapping provision is an important first step 
in understanding the need for services, yet questions remain regarding the evidence 
on the best service models of transition. A systematic review in 2015 by Paul et al. 
(2015) examined 19 studies, mostly surveys and semi-structured interviews, 
intervention studies and case notes reviews, and concluded that there was currently 
no ‘high quality’ evidence to support the use of any particular transition care models. 
Evaluation of transition models should be embedded in services and involve the use 
of standardised measures of outcomes such as transfer rates, service satisfaction 
and functioning to allow more meaningful comparison and conclusions. The Europe-
wide Milestone study, which will randomise CAMHS teams to control groups or 
managed transition intervention groups, may also provide evidence on the outcomes 
and cost-effectiveness of transition models, as well as identifying and validating 
potential outcome measures (Milestone 2015). 
6.4 Implications for policy 
 
Chapters One and Two of the thesis discussed the policy background in terms of 
child mental health and transition. Consideration of the overall findings of the thesis 
in the light of current policy suggests that another theme of this research may be the 
gap between policy and practice, resulting from complex factors including conflicting 
policies, lack of oversight, attitudes and beliefs, and possibly deteriorating access to 
services. As recognised by Tudor-Hart’s inverse care law, problems in gaining 
access to services may particularly affect the most vulnerable (Tudor Hart 1971, 
Goddard 2008). 
For children and for young people making the transition to adult services, the model 
of local commissioning by Clinical Commissioning Groups (CCGs) in a climate of 
resource scarcity is likely to have influenced service delivery. The change in 
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economic climate since the 2007 BCAMHS follow-up means that the impact of 
austerity will not have been captured in the analysis presented by this thesis, and 
equity of access for those from lower socio-economic groups may have further 
deteriorated. Child mental health policy has placed considerable emphasis on the 
roles and responsibilities of the education system; however devolved budgets and 
more fragmented oversight of schools have led to concern about variation in the 
service delivered, and the potential impact on children with special educational 
needs in particular(Muir and Clifton 2014). At the same time there has been a lack of 
investment in specialist CAMHS for front line services to refer on to.   Indeed, a 
recent Freedom of Information request from the charity Young Minds (2015) found 
that 75% of Mental Health Trusts, 67% of CCGs and 65% of Local Authorities had 
frozen or cut their CAMHS budgets between 2013/14 and 2014/15. Waiting times for 
CAMHS have also increased, with a mean maximum wait standing at 32 weeks in 
2015 compared to 22 weeks in 2013/14 (NHS Benchmarking Network 2015). Whilst 
extra investment has been promised for CAMHS, it needs to be carefully channelled 
into services that can demonstrate benefit. Unfortunately, the levers to monitor and 
enforce service provision are weak. This situation is compounded by complex 
commissioning arrangements for child mental health with multiple budgets and 
systems, and therefore a lack of clear leadership and accountability (Department of 
Health 2015). This fact has also been acknowledged by the Health Select Committee 
(2014) who suggested an increase in monitoring of service variation and standards 
in their recent review of CAMHS, and a return to a greater degree of national 
oversight from NHS England and the Department of Health. 
More positively, the findings of the CPRD study in this thesis suggested that the 
2008 NICE guidance had some impact on practice. Analysis suggested a rise in 
prescribing for adolescents and adults over time,  consistent with research using the 
Health Improvement Network in the UK, as well as a number of European studies 
(McCarthy et al. 2012b, Zetterqvist et al. 2013, Geirs et al. 2014). In this more recent 
analysis, young people appeared to remain on medication for longer than in the older 
CADDY study, although the studies are not directly comparable (Wong et al. 2009). 
This was particularly the case for those in the later age cohort, suggesting that 
practice may have gradually changed. However, both the continuing gap between 
symptoms and medication persistence and the experiences of the young people 
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interviewed imply that  guidance from NICE and the British Association for 
Psychopharmacology on ADHD is not being fully implemented (NICE 2008b, Bolea-
Alamanac et al. 2014). Hall et al.’s (2015) 2013 survey of a number of mental health 
trusts confirmed that many Trusts did not have a transition protocol that clinicians 
were aware of, and that half had no commissioned service for adults with ADHD. 
The recently introduced NHS England (2015) transition service specification sets out 
best practice, which is welcome but suggests only that clinicians take up matters with 
commissioners if suitable post-18 services are not provided. As well as studying 
barriers to policy implementation, as discussed above, the inclusion of ‘good 
transition’ as an outcome in the NHS Outcomes Framework might serve to 
encourage and monitor the implementation of transition best practices.  
6.5 Implications for professionals and services 
 
Implications for primary care 
Primary care plays a crucial role in caring for children and young people with mental 
health problems, and GPs were the second most frequently contacted professional 
group in BCAMHS. Qualitative research with GPs suggests that they themselves 
identify opportunities to improve their management of mental health conditions and 
often feel especially unprepared to address their patients’ emerging emotional 
disorders, a target area for professional development (Roberts et al. 2013). A study 
of GPs referring to a CAMH service by Hinrichs et al. (2012)  also found that they 
were more likely to have a referral rejected than other agencies, and that GPs  
experienced care pathways and referral criteria to be unclear; suggesting a need for 
more ‘GP-friendly’ systems and interfaces. The findings of the qualitative study and 
of the prescribing analysis in this thesis also suggest that GPs may experience 
specific training needs in relation to ADHD (as discussed in Implications for research 
above), and on the identification and management of comorbidities in the context of 
ADHD in both genders. Opportunities should be explored to integrate teaching on 
specific aspects of child mental health, including ADHD, but also on other under-
served conditions such as emotional disorders, in the training scheme for GP 
registrars. 
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There are also implications for the interface between primary care and specialist 
care in the case of ADHD. As reported in surveys of Trusts and GPs, there appears 
to be little consistency in local policy on the role of GPs in managing adult ADHD 
(McCarthy et al. 2013, Hall et al. 2015). The British Association for 
Psychopharmacology also identify added complications in terms of the prescribing 
regulations on controlled ADHD drugs, which may be implemented differently across 
localities and create further complexity in commissioning and in shared care 
arrangements (Bolea-Alamanac et al. 2014). Therefore, GPs are also likely to 
require further clarification of their remit in ADHD, along with appropriate support 
from specialist services where indicated. 
Implications for education 
Teachers were the professional group most contacted regarding mental health in the 
BCAMHS analysis, and children that reported teacher contact had a high prevalence 
of psychiatric disorder and difficulties. Education was also a central theme for young 
people with ADHD interviewed in the qualitative study, some of whom felt strongly 
about teacher misconceptions about their condition. A recent Health Technology 
Assessment review of ADHD in schools found that levels of conflict relating to ADHD 
between teachers, pupils and parents were often high (Richardson et al. 2015). Both 
the classroom environment and stigma related to ADHD were seen as having a role 
in aggravating symptoms, and a number of training needs were identified.  Another 
key concern of participants in the interviews was the potential impact of medication 
cessation on their studies and future educational achievements, which highlights 
their feelings of vulnerability and might suggest they lacked other forms of support. A 
number of young people also indicated that they valued advice from schools about 
managing their ADHD in further and higher education, including how to choose 
supportive Universities. Therefore, teachers and lecturers have the potential to play 
a major part in helping students through these multiple simultaneous transitions.  
However, educational professionals face a number of potential obstacles to fulfilling 
their role on the front line of mental health in schools and colleges. These challenges 
are not confined to ADHD. More generally, teachers also report feeling ill-equipped 
to deal with the responsibility of recognising mental health problems, with emotional 
disorders being a particular area of concern (Connelly et al. 2008, Rothì et al. 2008, 
Kidger et al. 2010). The various competing demands on teachers’ time are 
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acknowledged to be a barrier to their ability to recognise problems and intervene; a 
recent survey of head teachers in England reported that workload was a key factor 
preventing early identification of mental health problems in schools (Taggart et al. 
2014). The emotional wellbeing of professionals themselves can also be affected by 
working with children and young people in distress without proper time or training to 
do so, and in turn have an impact on their response  to their pupils’ needs (Kidger et 
al. 2010). 
Despite more than a decade of policy focus on the role of schools in mental health, 
beginning with Every Child Matters in 2003, teachers surveyed by the National 
Foundation for Educational Research in 2015 still reported gaps in support and 
training (Harland  et al. 2015). Whilst a small majority (62%) felt equipped to identify 
potential mental health problems in pupils, a minority (32%) thought that they had 
received appropriate training in schools in this area, and just over half (52%) 
reported feeling confident in assisting their students to access appropriate support 
(Harland et al. 2015). This is especially concerning, as in line with previous research, 
the BCAMHS analysis also found that education may be the first or only point of 
contact for many children with clinical and diagnosable levels of difficulty.  Evaluation 
of the Targeted Mental Health in Schools (TaMHS) programme, which took place 
between 2008 and 2011, also reported that much of the increase in mental health 
support in schools resulting from the initiative was provided by teachers rather than 
specialists (Vostanis et al. 2013). Consequently, in line with the concerns raised by 
these surveys, training for teachers across the range of psychiatric disorders, 
including ADHD should remain a priority. Teachers and lecturers should also be 
aware of the needs that their students might have for support over the transition from 
school to college or university; and in particular the fact that symptoms of disorders 
such as ADHD may not necessarily stop at the age of 16 years. E-learning 
programmes such as MindEd (Street and Mainey 2015) may represent useful 
starting points for education professionals, but training also needs to be 
accompanied by adequate support, time and resources for schools and teachers to 
effectively carry out their mental health role.  
Nonetheless, even with improved training, schools should not be relied upon to deal 
alone with complex mental health problems. With concerns raised repeatedly about 
access to child mental health services by front line professionals as well as in 
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national policy reviews (Department of Health 2008a, Kidger et al. 2010, Health 
Select Committee 2014), timely access to specialist help is essential. 
Implications for mental health services  
Child mental health services 
A significant proportion of children with emerging and persisting psychiatric disorders 
reported no contact with CAMHS in the 2004 survey. Concerns have been 
repeatedly raised over high barriers for access to CAMHS, not least by those in 
education who may seek to refer on children with problems that they have identified 
(Kidger et al. 2010, Taggart et al.  2014). Aside from the problems of investment 
discussed above, recommendations by the recent Mental Health Taskforce include 
dissolving the tiered system and greater integration of services to remove artificial 
barriers and enable earlier intervention (Department of Health 2015). 
In the analysis of data from BCAMHS, children that did come into contact with 
CAMHS had high levels of disorder and difficulty, and did not experience on average 
a significant improvement as measured by the SDQ after three years. For optimal 
outcomes, further focus is needed not just on access to CAMHS, but on the effective 
implementation of appropriate interventions once children are seen in services, as 
recommended by the Chief Medical Officer report (Davies 2013). At present, the 
extent to which children are receiving evidence based interventions remains 
unknown, and there is still uncertainty about which interventions are effective for 
which groups of children, and to what extent (Hoagwood et al. 2001, Davies 2013). 
Linking to the theme of data discussed above, outcomes monitoring therefore has an 
important part to play in gathering data on the implementation of evidence based 
practice, and in allowing ‘real-world’ outcomes of interventions to be measured.  The 
forthcoming CAMHS Minimum Dataset is likely to have a major role in this, as it will 
contain indicators on outcomes and on the use of evidence based interventions. 
However, outcome data needs to be used and interpreted with caution. Costello and 
Maughan’s review (2015) discusses optimal outcomes for children with disorders 
and acknowledges that there is likely to be great individual variability in what might 
constitute the best possible outcome for any given child. Services and 
commissioners will also need to consider the gathering and interpretation of 
outcomes data carefully, perhaps using the ‘MINDFUL’ framework outlined by 
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Wolpert et al. (2014) for examining outcome data; which emphasises the use of 
multiple perspectives, triangulation of data, the consideration of outliers, and the 
appreciation of uncertainty. 
Transition 
As discussed in the sections on research and policy above, the provision of services 
over the transition period has been identified as sub-optimal for young people with a 
variety of psychiatric diagnoses, such as for young people with ADHD, ASD and 
emotional disorders (Singh et al. 2010a).The findings from this PhD and from other 
studies such as TRACK  support the implementation of best practice guidance 
relevant to all conditions, such as transition planning and the importance of providing 
timely and appropriate information to young people approaching 
transition(Department of Health 2008b, NHS England 2015). Transition pathways 
also need to be appropriate and accessible for young people moving on from both 
CAMHS and paediatrics; as some paediatricians will routinely see children with 
ADHD but perhaps have less well established links with adult mental health(Marcer 
et al. 2008). 
Nonetheless, although improving transition in existing service structures is an 
important step forward, there are strong arguments for investing in changing the 
structures themselves to suit the needs of the young people using them. Participants 
in this PhD qualitative study also questioned the current leaving age for child 
services of 18 years, suggesting that “you’re an adult, but not adult adult”. For those 
moving to further or higher education, transition at the ages of 21 or older was 
considered to better suit their needs and allow continuity whilst they established 
themselves in adult life. Furthermore, the majority of people with ADHD are likely to 
still meet full syndrome criteria at 18, but this is estimated to fall to under 40% by the 
age of 20 (Faraone et al. 2006). Consequently, an extended service to the age of 21 
or 25 would provide support for those who continue to experience impairing 
symptoms, allow improved identification of any emerging comorbidities, and 
potentially address the sharp drop in medication prescribing between the ages of 16 
and 19.  
The potential benefits of youth or ‘extended’ service are likely to be applicable across 
the range of psychiatric disorders; McGorry et al. (2013, p.s30) in their review of 
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youth services suggest that the current age boundary may be one of the worst 
possible times in which to transfer between services, arguing that “the system is 
weakest where it needs to be strongest”, given the instabilities inherent in this 
developmental phase, the emergence of risk-taking behaviours such as substance 
misuse, and the high incidence of new disorders which all together have lasting 
functional impacts on young peoples’ life chances (Gibb et al. 2010).  Youth services 
up to the age of 25 could provide more acceptable and integrated mental health 
care, as well as social and vocational support for young people during this time when 
they are more likely to disengage from sources of help (Green et al. 2012, Ogundele 
and Omenaka 2012, Cappelli et al. 2014). The emergence of youth services might 
also allow for the concentration and continuity of expertise in neurodevelopmental 
conditions that participants in this qualitative study valued highly. For example, in 
Birmingham the new 0-25 community mental health service includes streams for 0-
14 and 15-25 year olds; with the aim of providing ‘seamless’ care, enabling 
continuation of medication, and early intervention in emerging disorders (Forward 
Thinking Birmingham 2016). In Australia, the Headspace programme goes a step 
further to integrate mental and physical healthcare provision for this age group. The 
evaluation suggested that co-locating physical health services served to minimise 
stigma associated with attending a specific mental health service, as well as 
addressing co-morbidities such as substance misuse(Muir et al. 2009).  Both local 
authorities and child and adult clinical commissioners should therefore review the 
results of evaluations of such service models; and consider which configurations 
might best meet the local needs identified in their Joint Strategic Needs 
Assessments (Department of Health 2013). 
Adult mental health services 
Focussing specifically on adults with ADHD, these findings implied that more adults 
are now continuing to take medication into their mid-twenties and beyond than was 
previously the case, yet there is still likely to be a gap between prescribing and 
prevalence of adult ADHD. This should not necessarily be interpreted as 
representing under-treatment, as people with ADHD may prefer to find their own 
management strategies and not to use medication. Nonetheless, a sustainable 
model for assisting adults with ADHD to manage their condition is needed, in terms 
both of medication (the first line in NICE guidance) and of other psychological or 
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behavioural strategies. Any model is likely to involve a role for AMHS in providing 
specialist oversight and advice and supporting and liaising with primary care, 
depending on the severity and complexity of the case. Specialist input may involve 
specialist nurse prescribers as well as psychiatrists and psychologists(Mangle et al. 
2014). The service provided by AMHS may involve an integrated model whereby 
ADHD management forms part of general adult psychiatry, or may constitute a 
separate specialist service. Both have advantages and disadvantages, for example 
in terms of the benefits of specialist care versus splitting off ADHD into a ‘silo’ which 
may further distance the condition from the rest of psychiatry (Bolea-Alamanac et al. 
2014, Coghill 2015).  Furthermore, the existence of a specialist adult clinic does not 
necessarily mean that all the patients’ needs are met; audit of adult ADHD clinics in 
East Anglia found that the service lacked a rounded programme to provide 
psychological, behavioural and educational support, although compliance with NICE 
standards on assessment and pharmacological treatment was good (Magon et al. 
2015). In order for commissioners to invest in improving ADHD management, the 
various models of delivering services for people with ADHD from transition onwards 
must consequently be evaluated in terms of cost-effectiveness, acceptability and 
sustainability. 
6.6 Conclusions 
 
In summary, the findings of these three linked studies suggest common themes in 
terms of unmet needs and gaps between policy and practice in the care of children 
with psychiatric disorders, and for those with ADHD making the transition between 
child and adult services. Given the impact of psychiatric disorders in childhood on 
multiple domains including education, relationships and general health, there are 
considerable public health gains to be made by optimising the identification and 
management of these conditions and the transition to adulthood.  One of the chief 
implications of this research is the need for oversight and policy levers to ensure the 
implementation of best practice and that resources are allocated to meet unmet 
needs, especially in the most vulnerable. This should be accompanied by 
complementary efforts to better understand and overcome other barriers to providing 
optimal care, including research into knowledge and attitudes of different groups and 
the provision of targeted training. 
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Protocol 13_213 for Study Two approved by ISAC: version 4 
10/12/13 
 
 
 PROTOCOL: version 4 10/12/13 
With minor amendments dated 7/4/14, 11/4/14 and 17/4/14 
Psychotropic prescribing for young people with ADHD in the Clinical Practice 
Research Datalink: a cohort study 
Funder Reference NIHR-DRF-2012-05-221 
1. Lay Summary 
Attention Deficit Hyperactivity Disorder (ADHD) is not only a condition of children, but can 
also persist into adulthood. Previous research suggests that although those over 18 could 
benefit from medication, many stop receiving prescriptions for their treatment at the age of 
16/17, which is also the time when most young people will stop having contact with Child 
and Adolescent Mental Health Services (CAMHS).  This study aims to describe what 
happens to prescribing of ADHD medication and of medication for other mental health 
problems in primary care over time in a group of young people with ADHD in the Clinical 
Practice Research Datalink (CPRD), from the age of 16/17 to 23/24. The study will report on 
how many of these young people stop being prescribed their medication after the age of 16 
or 17, as well as on factors such as gender which might affect how likely they are to stop. It 
will also look at how many are prescribed other medications for different mental health 
disorders over this time period.  Understanding recent trends in prescribing in this group will 
help in identifying where health needs might not be met and in planning and improving 
services for people with ADHD. 
 
2. Background 
This study addresses primary care prescribing in young people with Attention Deficit 
Hyperactivity Disorder (ADHD) aged between 16 and 24. This age range has been chosen in 
order to study what happens to prescribing as young people move on from CAMHS into 
adult services, which historically has happened between the ages of 16-18. ADHD is often 
thought of as just a condition of children and younger adolescents – however, evidence 
suggests that this is not the case. A meta-analysis of data from follow-up studies of ADHD 
reported the persistence of symptoms in 40-60% (Faraone, Biederman, & Mick, 2006), 
although persistence of the disorder meeting the full diagnostic criteria at age 25 was only 
15%.  It is estimated that there are over 400,000 adults in the UK with ADHD. (NICE, 2012). 
Over a lifetime, over three-quarters of those with ADHD are likely to experience psychiatric 
co-morbidity, with depression and anxiety being most common(Sobanski, 2006). Smoking, 
substance misuse and criminal behaviour are also increased in this population, who 
underachieve educationally and occupationally(Shaw et al., 2012). 
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2.1 Medication in adult ADHD 
The role of medication in adults has historically been controversial. However, there is now 
evidence that stimulants are effective in reducing symptoms in adults as well as children and 
in 2008 the National Institute for Health and Clinical Excellence (NICE) first recommended 
appropriate assessment and management services, including medication, for adults affected 
by ADHD(NICE, 2012). A systematic review of long term outcomes found that without 
treatment, outcomes ranging from academic attainment to social functioning were worse in 
people with ADHD compared to those without(Shaw et al., 2012). Outcomes were better in 
treated as opposed to untreated ADHD, although still poorer than for people without the 
diagnosis. However, despite the potential benefits of treatment, NICE estimated that in 2008 
only 1-2% of adults were receiving medication.  Recent qualitative research indicates that 
prescribing for adults with ADHD is still not well established and accepted amongst many 
professionals.(Matheson et al., 2013). 
 
2.2 Existing UK studies of prescribing 
Young adults are most at risk of premature discontinuation of treatment as they leave Child 
and Adolescent Mental Health Services (CAMHS) or shortly afterwards. This is the case 
even with GP prescribing of ADHD medication, as treatment prescribed in primary care is 
often monitored by CAMHS teams. The CADDY study (Cessation of Attention Deficit 
Hyperactivity Disorder Drugs in the Young) specifically looked at 15-21 year olds over the 
period 1999 to 2006 using the General Practice Research Database (Wong et al., 2009). 
This study used survival analysis to examine rates of cessation of ADHD medication, finding 
the most noticeable reduction between the ages of 16 and 17. The rate of cessation was 
greater than the estimated rate of persistence of ADHD, suggesting that medication may be 
being prematurely terminated. Whilst young people may themselves choose to stop taking 
medication as they move on from school or college, the inappropriate cessation of 
medication during this time may contribute to the psychological, social and personal 
difficulties experienced by this age group.  The Health Improvement Network database has 
also been used to examine the persistence of ADHD medication prescribing into adulthood 
for patients who started the drugs in childhood or adolescence (McCarthy et al., 2012a). Of 
those starting treatment before the age of 12, 38.5% remained on treatment beyond their 
18th birthday. Of those starting between 13 and 17, the rate of persistence was 42.8%. 
 
Prescribing in older adults with ADHD in the UK has been an under-examined area until 
recently. Another 2012 study using the Health Improvement Network database  examined 
the prevalence and persistence of ADHD prescribing in over-18s over the period 2003-
2008(McCarthy et al., 2012b). An increase in the prevalence of prescribing in adults was 
reported over this period, potentially due to increasing awareness of adult ADHD. However, 
total prescribing in 2008 in 18-24 year olds in this database stood at 1.122 per 1000, and at 
0.079 per 1000 in 25-45 year olds. Despite the fact that many adults may prefer not to use 
medication or may be prescribed medication by specialist services outside of primary care, 
these figures are markedly lower than even the most conservative estimates of adult ADHD 
prevalence, ranging from 0.4% to 4% (Simon, Czobor, Bálint, Mészáros, & Bitter, 2009), 
suggesting a considerable unmet need. 
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2.3 Prescribing and comorbidities 
Psychiatric disorders which have higher rates of prevalence in ADHD include depression, 
anxiety, substance misuse, sleep disorders and personality disorder(Sobanski, 2006). In 
addition to true co-morbidity, in clinical practice there may also be an element of 
misdiagnosis, whereby the symptoms of ADHD, particularly in adults, are mistaken for the 
signs of another disorder. For example, mood instability may lead to diagnoses of mood or 
personality disorders, when this may be actually be a feature of the patient’s ADHD 
(Asherson, Chen, Craddock, & Taylor, 2007). Whilst this may occur with any medical 
diagnosis, historical stigma and misconceptions relating to ADHD increase the likelihood of 
such misdiagnoses.  
 
It is therefore feasible to suggest, as clinicians may be more familiar with prescribing for 
depression or anxiety and see these conditions as more ‘acceptable’, other psychotropic 
medications may be inappropriately substituted for ADHD treatment. The result may be 
missed opportunities to treat ADHD, as well as the use of other ineffective management 
strategies(Asherson et al., 2007). 
 
3. Rationale 
Given the considerable impact of ADHD, improving the availability and accessibility of 
appropriate management is central to improving the outcomes of people with the condition. 
Part of addressing this should involve understanding recent patterns in prescribing and 
diagnosis. Earlier studies of ADHD prescribing using general practice databases have 
covered the periods 1999-2006 (Wong et al., 2009) and 2003-2008(McCarthy et al., 2012a), 
and largely concentrated on the prescribing of ADHD drugs rather than also examining other 
psychotropics . New guidance on prescribing in transition and in adults was released by the 
British Association for Psychopharmacology in 2006(Nutt et al., 2007), and later by NICE in 
2008 (NICE, 2008). Capturing a picture of recent trends in a time period covering the 
changes in guidance will both complement and add to previous studies. In terms of wider 
benefit, better understanding of primary care prescribing and comorbidities in ADHD should 
feed into recommendations for practice and training, leading to improved assessment and 
treatment of this condition.  
 
4. Study design 
This is an observational study using a retrospective cohort design.  
 
5. Research objective 
To estimate the use of ADHD and other psychotropic medications over time in young adults 
aged 16-24 
 
6.  Specific aims 
The three specific aims of the study are to: 
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 Describe the how the percentage of young people prescribed  ADHD medication 
in primary care in this cohort changes between the ages of 16/17 and 23/24 
 Describe the prescribing of other psychotropic medications in primary care over 
the same time period and analyse the relationship between the prescription of 
ADHD medication and other psychotropics 
 Describe the new psychiatric diagnoses and psychiatric service referrals that 
occur 
The study will collect the following data on the cohort: 
 Prescription of ADHD medication  
 Prescription of other psychotropic medication to include antidepressants, 
antipsychotics and anxiolytics 
 New mental health diagnoses  
 New mental health service referrals  
 
7. Study population 
The cohort will be defined as follows. It will include all cases with primary care records in the 
CPRD in 2005 who: 
 Are aged 16 or 17 years of age as of 1st January 2005 
 Have a recorded prescription for an ADHD medication (Methylphenidate, 
Dexamphetamine or Atomoxetine), and have been prescribed this medication for 
at least 6 months as of 31st January 2005 
 Have had at any point a diagnosis of ADHD coded 
 Are not classed as ‘temporary residents’ 
 
All cases meeting these criteria will be included. 
The time period of the study will be from 1st January 2005 until 31st December 2012 
(availability of CPRD data permitting). 
 
8. Sample size 
 
 Early estimates from GPRD obtained in 2012 suggested that there would be approximately 
1100 cases meeting the study criteria, with follow-up data available for 8 or more years on 
80% of these – i.e., around 900 participants. This sample size is large enough to estimate 
the percentage of the cohort that remains on medication in adulthood with a margin of error 
no greater than +/-3.3 percentage points based on the width of the 95% confidence intervals. 
The sample size for the regression analyses is most easily considered by treating the 
outcome as binary (whether remains on medication versus ceases medication) rather than 
time to event (i.e., time until cessation of medication). If 15%  remain on medication to the 
age of 24/25 then around 135 will continue using medication and 765 will cease. This is 
large enough to allow inclusion of up to13 predictors (135 divided by 10) in multivariable Cox 
regression models without concerns about stability of the estimated confidence intervals and 
p-values. The sample size is also large enough to detect a difference of a third of a standard 
deviation unit on a continuous predictor between those who remain on medication and those 
who cease medication in adulthood with 85% at the 5% level of significance, assuming that 
90 remain on medication and 810 cease medication 
 
9. Exposures, outcomes and covariates 
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9.1 Outcomes: 
 Cessation of ADHD medication from the study start date (primary outcome) – 
defined as greater than a 6 month gap in prescriptions 
 Percentage of participants who receive a new prescription of other psychotropic 
medication since the study start date 
 Percentage of participants who receive a new psychiatric diagnosis recorded in 
the CPRD since the study start date  
 Percentage of participants who have a new mental health service referral 
recorded in the CPRD since the study start date 
9.2 Covariates: 
A number of covariates will be examined using Cox proportional hazards regression to 
determine their effect on the primary outcome (cessation of ADHD medication). These are 
likely to include: 
 Age (i.e. whether aged 16 or 17 at start of the study) 
 Gender 
 Comorbidity with other psychiatric disorders 
 Referral to mental health services 
 Prescription of other psychotropic medication 
 
10. Data analysis plan 
Data will be analysed using Stata SE version 12 (Statacorp, 2011). The extent of missing 
data will be described.  The method of addressing significant missing data will depend on 
how missing data are associated with key variables and the likelihood of introducing bias, 
but any assumptions made and methods used (such as multiple imputation) will be justified 
and fully described. 
10.1 Cessation of medication 
All participants will be prescribed ADHD medication in 2005 (as this is one of the inclusion 
criteria for the study). Kaplan-Meier curves will be used to examine the time until cessation 
of ADHD medication in this cohort over the following time period to 2012. The median (inter-
quartile range) time until cessation will be reported assuming a sufficiently large number 
cease medication in order for these statistics to be calculated. Cessation will be defined as a 
minimum of 6 month’s gap in prescriptions from the last medication prescription. Factors 
potentially associated with cessation will be examined using Cox proportional hazards 
regression. These will include: age, prescription of new psychotropic medication, new 
psychiatric diagnosis, mental health services referral and gender. 
As with the CADDY study, informative censoring (where loss of the patient from the 
database is associated with the outcomes of interest) is likely to occur. This will be taken into 
account when interpreting the data. However, recent correspondence from the CPRD 
suggests that over 8 years of follow-up data is available for almost 80% of eligible cases in 
the database. 
10.2 Prescription of new psychotropic medications, psychiatric diagnoses and mental 
health service referrals. 
The incidence and prevalence of the above will be described for each year of the study 
period: 
1. Prescription of new medication: 
The percentage of participants that have been prescribed a new psychotropic medication 
(since 1st January 2005) will be reported as below: 
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  The percentage who have been prescribed a new psychotropic over the 
whole of the study period 
 In each year of the study, the percentage that are prescribed a new 
psychotropic medication since 1st January of that year 
 The above will be presented for any psychotropic medication, and by 
medication groups e.g. antidepressants, antipsychotics etc. 
 
2. New diagnoses: 
We will report the percentage of participants that have received a new psychiatric diagnosis 
(since 1st January 2005). 
 The percentage who received a new psychiatric diagnosis over the whole of 
the study period 
 The percentage receiving a new diagnosis in each year of the study period 
(since 1st January of each year) 
  The above will be presented for any psychiatric diagnosis and for individual 
diagnostic groups. 
 
3. New referrals: 
We will report the percentage of participants that have been newly referred to mental health 
services since 1st January 2005. We will report: 
 The percentage who were newly referred over the whole of the study period 
 The percentage referred in each year of the study period (since 1st January 
of each year) 
 
11. Limitations 
As with other studies using primary care databases, this study will not capture prescriptions 
issued in specialist services or other secondary care, which is likely to result in some under-
estimation of the prescription of ADHD medication and other psychotropics. Where ADHD or 
other comorbidities are more severe, this increases the likelihood of prescriptions being 
issued outside primary care. In particular, some psychotropic medications are more likely to 
be initiated and monitored in specialist care than others, e.g. Lithium or certain 
antipsychotics. However, over time where medication is to be prescribed over a longer 
period and the patient is to be maintained on it, then in the majority of cases prescribing will 
be transferred to primary care. This is increasingly likely to happen under shared care 
arrangements and as specialist appointments become used more for assessment than more 
lengthy follow-up care. This will need to be taken into account when considering the 
interpretation of the planned analysis.  
Information on severity and impairment is also not recorded in CPRD records, meaning that 
the association between these factors and cessation and other outcomes of interest cannot 
be examined. Similarly, there is also the potential for limited available data on new 
psychiatric diagnoses and mental health service referrals, which may result in lower 
statistical power for these analyses.  
Finally, as reasons for cessation of ADHD medication or prescriptions of new psychotropics 
will not be recorded, it will not be possible to confirm whether these prescribing decisions 
were appropriate. However, it will be possible to comment on whether rates of cessation or 
new prescriptions exceed what we would expect to see from epidemiological studies of 
ADHD and comorbidities, and to comment on changes from previous research covering 
earlier time periods. 
 
12. PPI 
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This study, along with 2 others which form part of an NIHR Doctoral Research Fellowship 
held by the Chief Investigator, has a small budget for PPI and has recruited advisors who 
have personal experience of having ADHD or being a carer for someone with the condition. 
Advisors will be invited to attend meetings or contribute by telephone or email throughout the 
Fellowship and will be reimbursed for their time. Specific areas where PPI advice and input 
will be sought include identification of important research questions and how best to present 
and disseminate the results. 
 
13. Dissemination/communication 
This study forms part of a PhD which is funded by a NIHR Doctoral Research Fellowship. 
There is a small budget for presentation of the research through conferences as well as 
through open access publication as required by NIHR. In addition to dissemination through 
conferences, publication etc., the results will also be communicated through NIHR networks 
and via the production of the completed PhD thesis. As described above, the input of PPI 
advisors will be used to determine how best to communicate relevant findings to the public, 
service users and carers – this is likely to involve presentations to support group networks, 
newsletters and the use of social media.  
 
14. Amendments 
 
In order to study the most recent trends in prescribing the study period will be extended from 
01/01/2005 to 31/12/12 to cover a longer period of 01/01/2005 to 31/3/2014.  
 
Widening of study cohort definition 
We will include all those aged 10-20 at the start in 2005 who have a recorded diagnosis of 
ADHD or a prescription event during the study period. This will enable us to study 
prevalence of ADHD medication prescribing and other psychotropic medication prescribing 
from the age of 16/17 onwards as originally envisaged, and will allow examination of the 
prevalence of prescribing of ADHD medication and other psychotropic medications into the 
mid-twenties.  The restriction on having at least 6 months of prescriptions of ADHD 
medication will therefore be removed.  All those from within this cohort with a current 
prescription at the age of 17 will be entered into the survival analysis to study medication 
cessation.  
  
This wider definition will require the identification of genuine ADHD patients from those who 
are only given a prescription (but no diagnosis). For this group of drugs the major indication 
is ADHD. Much rarer indications include narcolepsy, or epilepsy (to counter toxic effects of 
anticonvulsants). The initial plan to deal with this would be to check each patient record 
where there was a prescription but no diagnosis coded for codes related to these much rarer 
indications – if they had another recorded indication and no codes relating to ADHD 
problems they would therefore be excluded. It is not anticipated that there would be many 
such cases which would make this feasible to carry out. 
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16. APPENDIX: CPRD Codes 
 
15.1 Proposed CPRD medical codes to identify ADHD diagnosis 
 
Eu90011 [X]Attention deficit hyperactivity disorder 
E2E0.00 Child attention deficit disorder 
1BR..00 Reduced concentration 
E2E..00 Childhood hyperkinetic syndrome 
Eu9y700 [X]Attention deficit disorder 
E2E0100 Attention deficit with hyperactivity 
ZS91.11 ADD - Attention deficit disorder 
1BR0.11 Short attention span 
ZS91.00 Attention deficit disorder 
Eu90.00 [X]Hyperkinetic disorders 
E2E0z00 Child attention deficit disorder NOS 
Z7C5312 Short attention span 
E2E2.00 Hyperkinetic conduct disorder 
ZS91.12 [X]Attention deficit disorder 
Eu90100 [X]Hyperkinetic conduct disorder 
E2E0000 Attention deficit without hyperactivity 
Eu90z00 [X]Hyperkinetic disorder, unspecified 
E2Ez.00 Hyperkinetic syndrome NOS 
Eu90111 [X]Hyperkinetic disorder associated with conduct disorder 
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Eu90y00 [X]Other hyperkinetic disorders 
Eu90z12 [X]Hyperkinetic syndrome NOS 
 
 
16.2 Proposed CPRD product codes to identify ADHD medication 
 
Product 
code 
Product name 
5811 
Concerta XL 36mg tablets (Janssen-Cilag Ltd) 
576 
Methylphenidate 10mg tablets 
5810 
Concerta XL 18mg tablets (Janssen-Cilag Ltd) 
2679 
Ritalin 10mg tablets (Novartis Pharmaceuticals UK Ltd) 
7101 
Methylphenidate 5mg tablets 
9738 
Dexamfetamine 5mg tablets 
6169 
Methylphenidate 36mg modified-release tablets 
35159 
Concerta XL 27mg tablets (Janssen-Cilag Ltd) 
6868 
Equasym XL 20mg capsules (Shire Pharmaceuticals Ltd) 
6107 
Methylphenidate 18mg modified-release tablets 
14331 
Equasym XL 30mg capsules (Shire Pharmaceuticals Ltd) 
14512 
Dexedrine 5mg tablets (Auden McKenzie (Pharma Division) Ltd) 
14346 
Equasym XL 10mg capsules (Shire Pharmaceuticals Ltd) 
6643 
Atomoxetine 40mg capsules 
11733 
Methylphenidate 20mg tablets 
6644 
Atomoxetine 60mg capsules 
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6645 
Atomoxetine 25mg capsules 
7100 
Atomoxetine 10mg capsules 
13914 
Equasym 5mg tablets (Shire Pharmaceuticals Ltd) 
13946 
Equasym 10mg tablets (Shire Pharmaceuticals Ltd) 
11536 
Methylphenidate 20mg modified-release capsules 
35658 
Medikinet XL 30mg capsules (Flynn Pharma Ltd) 
35659 
Medikinet XL 20mg capsules (Flynn Pharma Ltd) 
13212 
Methylphenidate 10mg modified-release capsules 
37658 
Medikinet XL 40mg capsules (Flynn Pharma Ltd) 
14848 
Methylphenidate 30mg modified-release capsules 
35469 
Methylphenidate 27mg modified-release tablets 
14129 
Atomoxetine 18mg capsules 
36628 
Medikinet XL 10mg capsules (Flynn Pharma Ltd) 
17014 
Strattera 40mg capsules (Eli Lilly and Company Ltd) 
16949 
Strattera 25mg capsules (Eli Lilly and Company Ltd) 
40279 
Atomoxetine 80mg capsules 
17588 
Strattera 60mg capsules (Eli Lilly and Company Ltd) 
37237 
Medikinet 10mg tablets (Flynn Pharma Ltd) 
14119 
Strattera 10mg capsules (Eli Lilly and Company Ltd) 
37097 
Medikinet 5mg tablets (Flynn Pharma Ltd) 
6804 
Equasym 20mg tablets (Shire Pharmaceuticals Ltd) 
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35515 
Methylphenidate 40mg modified-release capsules 
18832 
Strattera 18mg capsules (Eli Lilly and Company Ltd) 
13238 
Dexamfetamine 1mg/ml oral liquid 
46593 
Medikinet XL 5mg capsules (Flynn Pharma Ltd) 
36910 
Medikinet 20mg tablets (Flynn Pharma Ltd) 
46607 
Methylphenidate 5mg modified-release capsules 
41492 
Strattera 80mg capsules (Eli Lilly and Company Ltd) 
21399 
Equasym xl 20mg Capsule (Celltech Pharma Europe Ltd) 
54504 
Methylphenidate 20mg modified-release tablets 
24116 
Durophet 12.5mg Capsule (3M Health Care Ltd) 
47609 
Dexamfetamine 5mg modified-release capsules 
56336 
Elvanse 50mg capsules (Shire Pharmaceuticals Ltd) 
55987 
Lisdexamfetamine 30mg capsules 
31623 
Dexedrine 15mg Spansules (Imported (United States)) 
16185 
Dexamfetamine 15mg modified-release capsules 
51453 
Dexamfetamine 5mg/5ml oral solution 
55635 
Atomoxetine 100mg capsules 
18998 
Durophet 7.5mg Capsule (3M Health Care Ltd) 
55495 
Dexamfetamine with amfetamine 10mg with 10mg capsules 
55747 
Elvanse 30mg capsules (Shire Pharmaceuticals Ltd) 
47481 
Dexamfetamine 10mg modified-release capsules 
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52233 
Methylphenidate 54mg modified-release tablets 
56742 
Elvanse 70mg capsules (Shire Pharmaceuticals Ltd) 
18996 
Durophet 20mg Capsule (3M Health Care Ltd) 
23173 
Tranquilyn 10mg tablets (Genesis Pharmaceuticals Ltd) 
47099 
Dexamfetamine with amfetamine 10mg with 10mg modified-release capsules 
49392 
Amfetamine 10mg / Dexamfetamine 10mg modified-release capsules 
55169 
Lisdexamfetamine 50mg capsules 
56576 
Elvanse 30mg capsules (Shire Pharmaceuticals Ltd) 
47679 
Dexamfetamine 15mg modified-release capsules 
23161 
Tranquilyn 5mg tablets (Genesis Pharmaceuticals Ltd) 
52461 
Equasym XL 10mg capsules (Waymade Healthcare Plc) 
54804 
Equasym XL 10mg capsules (Doncaster Pharmaceuticals Ltd) 
53527 
Equasym XL 30mg capsules (Waymade Healthcare Plc) 
56713 
Ritalin-SR 20mg tablets (Imported (United States)) 
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Table A1.1 List of ADHD codes included in the dataset 
CPRD 
medical 
code 
Read 
code 
Read term 
1363 E2C..11 Behaviour disorder 
11054 1B1X.00 Behavioural problem 
6519 Eu90011 [X]Attention deficit hyperactivity disorder 
5565 E2E0.00 Child attention deficit disorder 
10741 1BR..00 Reduced concentration 
14650 13Z4C00 Behavioural problems at school 
3775 E2E..00 Childhood hyperkinetic syndrome 
10918 1P00.00 Hyperactive behaviour 
10378 1BW..00 Poor concentration 
26285 Eu9y700 [X]Attention deficit disorder 
9715 E2E0100 Attention deficit with hyperactivity 
101067 6A61.00 Attention deficit hyperactivity disorder annual review 
24808 ZS91.11 ADD - Attention deficit disorder 
28543 ZS91.00 Attention deficit disorder 
1458 Eu90.00 [X]Hyperkinetic disorders 
24546 Ry13.00 [D]Overactivity 
20467 E2E0z00 Child attention deficit disorder NOS 
45263 E2E2.00 Hyperkinetic conduct disorder 
24753 ZS91.12 [X]Attention deficit disorder 
42988 1BR0.00 Reduced concentration span 
33505 Eu90100 [X]Hyperkinetic conduct disorder 
37994 ZS9..00 Disorders of attention and motor control 
34199 E2E0000 Attention deficit without hyperactivity 
50015 Eu90z00 [X]Hyperkinetic disorder, unspecified 
41769 E2Ez.00 Hyperkinetic syndrome NOS 
37894 ZS94.00 Minimal brain dysfunction 
46551 Z7C5313 Short concentration span 
58069 E2E1.00 Hyperkinesis with developmental delay 
45799 Eu90111 [X]Hyperkinetic disorder associated with conduct disorder 
6510 Eu90y00 [X]Other hyperkinetic disorders 
96770 Eu90z12 [X]Hyperkinetic syndrome NOS 
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28394 1BR0.11 Short attention span 
22789 Z7C5312 Short attention span 
 
Table A1.2 List of ADHD medication codes eligible for 
inclusion in the analysis 
5811 Concerta XL 36mg tablets (Janssen-Cilag Ltd) 
576 Methylphenidate 10mg tablets 
5810 Concerta XL 18mg tablets (Janssen-Cilag Ltd) 
2679 Ritalin 10mg tablets (Novartis Pharmaceuticals UK Ltd) 
7101 Methylphenidate 5mg tablets 
9738 Dexamfetamine 5mg tablets 
6169 Methylphenidate 36mg modified-release tablets 
35159 Concerta XL 27mg tablets (Janssen-Cilag Ltd) 
6868 Equasym XL 20mg capsules (Shire Pharmaceuticals Ltd) 
6107 Methylphenidate 18mg modified-release tablets 
14331 Equasym XL 30mg capsules (Shire Pharmaceuticals Ltd) 
14512 Dexedrine 5mg tablets (Auden McKenzie (Pharma Division) Ltd) 
14346 Equasym XL 10mg capsules (Shire Pharmaceuticals Ltd) 
6643 Atomoxetine 40mg capsules 
11733 Methylphenidate 20mg tablets 
6644 Atomoxetine 60mg capsules 
6645 Atomoxetine 25mg capsules 
7100 Atomoxetine 10mg capsules 
13914 Equasym 5mg tablets (Shire Pharmaceuticals Ltd) 
13946 Equasym 10mg tablets (Shire Pharmaceuticals Ltd) 
11536 Methylphenidate 20mg modified-release capsules 
35658 Medikinet XL 30mg capsules (Flynn Pharma Ltd) 
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35659 Medikinet XL 20mg capsules (Flynn Pharma Ltd) 
13212 Methylphenidate 10mg modified-release capsules 
37658 Medikinet XL 40mg capsules (Flynn Pharma Ltd) 
14848 Methylphenidate 30mg modified-release capsules 
35469 Methylphenidate 27mg modified-release tablets 
14129 Atomoxetine 18mg capsules 
36628 Medikinet XL 10mg capsules (Flynn Pharma Ltd) 
17014 Strattera 40mg capsules (Eli Lilly and Company Ltd) 
16949 Strattera 25mg capsules (Eli Lilly and Company Ltd) 
40279 Atomoxetine 80mg capsules 
17588 Strattera 60mg capsules (Eli Lilly and Company Ltd) 
37237 Medikinet 10mg tablets (Flynn Pharma Ltd) 
14119 Strattera 10mg capsules (Eli Lilly and Company Ltd) 
37097 Medikinet 5mg tablets (Flynn Pharma Ltd) 
6804 Equasym 20mg tablets (Shire Pharmaceuticals Ltd) 
35515 Methylphenidate 40mg modified-release capsules 
18832 Strattera 18mg capsules (Eli Lilly and Company Ltd) 
13238 Dexamfetamine 1mg/ml oral liquid 
46593 Medikinet XL 5mg capsules (Flynn Pharma Ltd) 
36910 Medikinet 20mg tablets (Flynn Pharma Ltd) 
46607 Methylphenidate 5mg modified-release capsules 
41492 Strattera 80mg capsules (Eli Lilly and Company Ltd) 
21399 Equasym xl 20mg Capsule (Celltech Pharma Europe Ltd) 
54504 Methylphenidate 20mg modified-release tablets 
24116 Durophet 12.5mg Capsule (3M Health Care Ltd) 
47609 Dexamfetamine 5mg modified-release capsules 
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56336 Elvanse 50mg capsules (Shire Pharmaceuticals Ltd) 
55987 Lisdexamfetamine 30mg capsules 
31623 Dexedrine 15mg Spansules (Imported (United States)) 
16185 Dexamfetamine 15mg modified-release capsules 
51453 Dexamfetamine 5mg/5ml oral solution 
55635 Atomoxetine 100mg capsules 
18998 Durophet 7.5mg Capsule (3M Health Care Ltd) 
55495 Dexamfetamine with amfetamine 10mg with 10mg capsules 
55747 Elvanse 30mg capsules (Shire Pharmaceuticals Ltd) 
47481 Dexamfetamine 10mg modified-release capsules 
52233 Methylphenidate 54mg modified-release tablets 
56742 Elvanse 70mg capsules (Shire Pharmaceuticals Ltd) 
18996 Durophet 20mg Capsule (3M Health Care Ltd) 
23173 Tranquilyn 10mg tablets (Genesis Pharmaceuticals Ltd) 
47099 Dexamfetamine with amfetamine 10mg with 10mg modified-release capsules 
49392 Amfetamine 10mg / Dexamfetamine 10mg modified-release capsules 
55169 Lisdexamfetamine 50mg capsules 
56576 Elvanse 30mg capsules (Shire Pharmaceuticals Ltd) 
47679 Dexamfetamine 15mg modified-release capsules 
23161 Tranquilyn 5mg tablets (Genesis Pharmaceuticals Ltd) 
52461 Equasym XL 10mg capsules (Waymade Healthcare Plc) 
54804 Equasym XL 10mg capsules (Doncaster Pharmaceuticals Ltd) 
53527 Equasym XL 30mg capsules (Waymade Healthcare Plc) 
56713 Ritalin-SR 20mg tablets (Imported (United States)) 
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Table A1.3 List of ADHD codes eligible for inclusion in the 
analysis 
CPRD 
medical 
code 
Read 
code 
Read term 
6519 Eu90011 [X]Attention deficit hyperactivity disorder 
5565 E2E0.00 Child attention deficit disorder 
26285 Eu9y700 [X]Attention deficit disorder 
9715 E2E0100 Attention deficit with hyperactivity 
101067 6A61.00 Attention deficit hyperactivity disorder annual review 
24808 ZS91.11 ADD - Attention deficit disorder 
28543 ZS91.00 Attention deficit disorder 
1458 Eu90.00 [X]Hyperkinetic disorders 
24546 Ry13.00 [D]Overactivity 
20467 E2E0z00 Child attention deficit disorder NOS 
45263 E2E2.00 Hyperkinetic conduct disorder 
24753 ZS91.12 [X]Attention deficit disorder 
33505 Eu90100 [X]Hyperkinetic conduct disorder 
37994 ZS9..00 Disorders of attention and motor control 
34199 E2E0000 Attention deficit without hyperactivity 
50015 Eu90z00 [X]Hyperkinetic disorder, unspecified 
41769 E2Ez.00 Hyperkinetic syndrome NOS 
37894 ZS94.00 Minimal brain dysfunction 
58069 E2E1.00 Hyperkinesis with developmental delay 
45799 Eu90111 [X]Hyperkinetic disorder associated with conduct disorder 
6510 Eu90y00 [X]Other hyperkinetic disorders 
96770 Eu90z12 [X]Hyperkinetic syndrome NOS 
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Table A1.4 List of new variables created for analysis 
Variable Definition Values 
Study psychotropic At least one recorded 
prescription for a 
psychotropic medication 
(anxiolytic, antidepressant, 
antipsychotic etc )during the 
study period 
 0 –None prescribed 
1 – one or more prescriptions 
Psychotropic in X year At least one recorded 
prescription in a given 
calendar year 
0 –None prescribed 
1 – one or more prescriptions 
Psychotropic aged X At least one recorded 
prescription in the year that 
case was in that age band 
(e.g. 15/16) 
0 –None prescribed 
1 – one or more prescriptions 
ADHD medication in X year At least one recorded 
prescription for ADHD 
medication in a given 
calendar year 
0 –None prescribed 
1 – one or more prescriptions 
ADHD medication at X age At least one recorded 
prescription in the year that 
case was in that age band 
(e.g. 15/16) 
0 –None prescribed 
1 – one or more prescriptions 
Concurrent medication At least one prescription for 
ADHD medication and 
psychotropic medication in 
the same calendar year 
during the study period 
0 – No concurrent 
prescriptions 
1 – one or more years with 
concurrent medication during 
the study period 
Referral to  any mental 
health service 
 
Recorded referral at any 
point during the study period 
to any mental health services 
(defined as: 
Adult psychiatry 
CAMHS 
Clinical psychologist 
Forensic psychiatry 
Community Psychiatric 
Nurse, psychotherapy) 
0 –No referral 
1 – one or more referrals 
Referral to adult psychiatry Recorded referral at any 
point during the study period 
to adult psychiatry 
0 –No referral 
1 – one or more referrals 
Transfer out Case transferred out/left the 
practice before the end of the 
study period. 
0 – Not transferred out 
1 – transferred out 
Study time category Number of years of data that 
0-1 year 
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case has in the study period  
1-2 years 
2-5 years 
5-8 years 
 
Depression or anxiety related 
diagnosis 
Depression or anxiety related 
code 
coded in clinical file  
0 – No code 
1 – Coded at least once 
Bipolar affective disorder or 
psychosis related diagnosis 
 Bipolar affective disorder or 
psychosis code 
coded in clinical file 
0 – No code 
1 – Coded at least once 
Substance or alcohol misuse 
diagnosis 
Any code relating to 
substance or alcohol misuse 
coded in the clinical file at 
any point 
 0 -No code 
1– Coded at least once 
Any personality disorder 
diagnosis 
Any code relating to a 
personality disorder coded in 
the clinical file at any point 
0 – No code 
1 – Coded at least once 
Autism spectrum disorder 
diagnosis 
(ASD) 
Any code relating to Autism, 
Asperger’s or another 
pervasive developmental 
disorder coded in the clinical 
file at any point 
0 – No code 
1 – Coded at least once 
Conduct or oppositional 
defiant disorder (ODD) 
diagnosis 
Any code relating to a 
conduct or oppositional 
defiant disorder coded in the 
clinical file at any point 
0 – No code 
1 – Coded at least once 
Learning disability Any code relating to learning 
disability; mild, moderate, 
severe or profound 
0 – No code 
1 – coded at least once 
Tic disorder Any code relating to a tic 
disorder coded in the clinical 
file at any point 
0 – No code 
1 – Coded at least once 
Smoking Smoking related medical 
code coded in clinical file at 
any point. 
0 - No code 
1 - Coded at least once 
Time on medication prior to 
16th birthday 
Number of years where an 
ADHD prescription was 
coded prior to the year of 
16th birthday 
(for survival analysis dataset 
only) 
0  - Less than 2 years 
1 -  2-3 years 
2 -  3 or more years 
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APPENDIX TWO 
Documents relating to Study Three in Chapter Five: The experiences of young people 
with ADHD in transition from child to adult services 
List of contents 
1. Latest letter of ethical approval for study and amendments 
2. Sample Participant Information Sheet for participants from Adult ADHD 
Clinic (v3) 
3. Sample Participant Information Sheet for participants from CAMHS (v2) 
4. Sample Consent form 
5. Coding frame for qualitative analysis  
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Latest letter of ethical approval for study and amendments 
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Sample Participant Information Sheet for participants from 
Adult ADHD Clinic (v3) 
 
 
 
Young people with ADHD in transition: 
Participant information sheet for qualitative interview 
 
Version 3 (17/04/15) – For use with participants from Adult ADHD services 
 
 
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you.   Please read this information sheet carefully. If you are interested in 
finding out more or taking part, one of our researchers will go through the sheet with 
you and answer any questions that you might have. Thank you! 
 
What is the purpose of this study? 
This study is about people with ADHD moving on from Child and Adolescent Mental 
Health Services (CAMHS) or other children and young people’s services. This period 
is often referred to as ‘transition’, and can be a difficult or challenging time. We are 
interested in hearing about the experiences of people who have been through 
transition.  
 
We are asking if you would be willing to take part in an interview with the researcher 
to tell us about your experiences. There is more information about this below. 
 
Why have I been chosen? 
We are looking to interview people aged 17-19 who have ADHD and have been 
through transition and left CAMHS or other child services, and who are now being 
seen in Adult ADHD services. We are trying to interview a wide range of people to 
understand and learn from their experiences. 
 
Do I have to take part? 
It is entirely up to YOU whether you would like to take part. Taking part is voluntary 
and you can withdraw from the study at any time without any disadvantage. We 
would encourage you to discuss taking part in the study with your parents, carers or 
other close family or friends. The researcher is not a part of CAMHS, Devon Autism 
& ADHD (DANA) Service or any other clinical services and the decision to 
participate in or withdraw from the study will NOT influence how you are treated.  
 
What do I have to do if I take part in the study? 
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If you decide that you would like to take part in the researcher will talk through what 
will happen, and you will need to sign a consent form if you are willing to join the 
study.  If you agree to take part, we will arrange a convenient time and place to come 
and talk to you. If you need to travel in order to take part in the interview, we will 
refund you for any reasonable travel costs. 
We will want to ask you about your experiences of transition in a one-to-one 
interview somewhere private, lasting up to 30 minutes. To help us remember what 
you say we would like to make an audio-recording during the interview. This would 
only be used as a record of the conversation to help the researcher write about what 
you have said, and the recording would be kept securely. We might also want to use 
direct quotes from what you have said in published work, but these quotes would be 
anonymous and no-one would be able to identify you from them.  
If you would like to bring someone along to the interview with the researcher for 
support (such as a family member), you would be very welcome to do so. 
 
 
What are the possible risks or disadvantages of taking part? 
It will take approximately 20-30 minutes of your time. We don’t expect that taking 
part in the interview will be upsetting, but you would be able to stop at any time if you 
do find it distressing or for any other reason. You would not be disadvantaged in any 
way in deciding not to go ahead with the interview. You will also be able to contact 
the researcher at any point if you have concerns, and if necessary they will link you 
up with sources of help and support (please see What is there is a problem? at the 
end of this sheet) 
 
What are the advantages of taking part? 
The aim of this research is to improve services for people with ADHD, in particular 
for those aged 17-19. The information that you have given may help other young 
people in future, although we don’t expect that there will be any direct advantages to 
you as a result of taking part. 
 
What will happen to the results of this study? 
This study is a student study. The results will be published as part of a PhD thesis 
and in academic journals. We will produce a summary for young people in the study 
and for ADHD support groups, and share what we find with services working with 
people with ADHD to discuss how services can be improved. You will not be 
identified in any publication from this work. 
 
Will my taking part be kept confidential? 
Everything that you say will be kept private unless what you say suggests that you or 
anyone else may be at risk. If this happens, we have a legal duty to discuss what 
has been reported with professionals who know you to see how we can help you and 
reduce any risk to you or anyone else. No one will be identified in any reports that 
come out of this research. Both the recording of the interview and any other 
information about you will be kept securely. Only the research team will have access 
to the data and it will be stored securely in accordance with the relevant guidelines, 
and destroyed after 5 years. We will ask for your permission to inform your GP 
that you are taking part in this project, but will only share information about 
you with professionals with your written permission. 
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Who has reviewed this study and who is funding it? 
All research within the NHS is looked at by an independent group of people called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed and given favourable opinion by NRES Committee South 
West-Exeter. The study is being funded by the National Institute for Health Research 
(NIHR) as part of a Doctoral Research Fellowship, and is being carried out by the 
University of Exeter Medical School. 
 
What if there is a problem? 
 
If you have any complaints about the way in which this study has been carried out 
please contact the Patient Advice and Liaison Service on 0800 0730741 
 
If you become distressed at any point in the study and need support, please do get 
in touch with your adult mental health team if you are in contact with them, or with 
any other keyworker if you have one. If you are not currently in contact with any 
services you may want to speak to your GP or to NHS Direct on 0845 4647 for 
advice. 
Childline also offer confidential telephone or webchat advice and counselling for 
people under 19 and can be contacted on 0800 1111 or at 
http://www.childline.org.uk 
Young Minds is a charity which offers information to young people about emotional 
health and wellbeing, and has useful information available on its website including 
how to look after yourself, get support and find out about your rights or complain. 
http://www.youngminds.org.uk/for_children_young_people 
 
 
If you have any questions or need any further information, please feel free to 
contact: 
 
Tamsin Newlove-Delgado 
Doctoral Research Fellow 
University of Exeter Medical School 
Email : t.newlove-delgado@exeter.ac.uk 
Telephone : 01392 726083 
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 Sample Participant Information Sheet for participants 
from CAMHS (v2) 
 
 
Young people with ADHD in transition: 
Participant information sheet for qualitative interview 
 
Version 2 (17/7/13) 
 
 
We would like to invite you to take part in our research study. Before you decide we would 
like you to understand why the research is being done and what it would involve for you.   
Please read this information sheet carefully. If you are interested in finding out more or 
taking part, one of our researchers will go through the sheet with you and answer any 
questions that you might have. Thank you! 
 
What is the purpose of this study? 
This study is about young people with ADHD moving on from Child and Adolescent 
Mental Health Services (CAMHS) or other children and young people’s services. 
This period is often referred to as ‘transition’, and can be a difficult or challenging 
time. We are interested in hearing about the experiences of people who have been 
through transition.  
 
We are asking if you would be willing to take part in an interview with the researcher 
to tell us about your experiences. There is more information about this below. 
 
Why have I been chosen? 
We are looking to interview people aged 17-19 who have ADHD and have been 
through transition and left CAMHS or other child services. We are trying to interview 
a wide range of people to understand and learn from their experiences. 
 
Do I have to take part? 
It is entirely up to YOU whether you would like to take part. Taking part is voluntary 
and you can withdraw from the study at any time without any disadvantage. We 
would encourage you to discuss taking part in the study with your parents, carers or 
other close family or friends. The researcher is not a part of CAMHS or any other 
clinical services and the decision to participate in or withdraw from the study will 
NOT influence how you are treated.  
 
What do I have to do if I take part in the study? 
If you decide that you would like to take part in the researcher will talk through what 
will happen, and you will need to sign a consent form if you are willing to join the 
study.  If you agree to take part, we will arrange a convenient time and place to come 
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and talk to you. If you need to travel in order to take part in the interview, we will 
refund you for any reasonable travel costs. 
We will want to ask you about your experiences of transition in a one-to-one 
interview somewhere private, lasting up to 30 minutes. To help us remember what 
you say we would like to make an audio-recording during the interview. This would 
only be used as a record of the conversation to help the researcher write about what 
you have said, and the recording would be kept securely. We might also want to use 
direct quotes from what you have said in published work, but these quotes would be 
anonymous and no-one would be able to identify you from them.  
We would encourage you to let your parents or carers know that you are taking part, 
and if you would like to bring someone along to the interview with the researcher for 
support (such as a family member), you would be very welcome to do so. 
 
 
What are the possible risks or disadvantages of taking part? 
It will take approximately 20-30 minutes of your time. We don’t expect that taking 
part in the interview will be upsetting, but you would be able to stop at any time if you 
do find it distressing or for any other reason. You would not be disadvantaged in any 
way in deciding not to go ahead with the interview. You will also be able to contact 
the researcher at any point if you have concerns, and if necessary they will link you 
up with sources of help and support (please see What is there is a problem? at the 
end of this sheet) 
 
What are the advantages of taking part? 
The aim of this research is to improve services for people with ADHD, in particular 
for those aged 17-19. The information that you have given may help other young 
people in future, although we don’t expect that there will be any direct advantages to 
you as a result of taking part. 
 
What will happen to the results of this study? 
This study is a student study. The results will be published as part of a PhD thesis 
and in academic journals. We will produce a summary for young people in the study 
and for ADHD support groups, and share what we find with services working with 
people with ADHD to discuss how services can be improved. You will not be 
identified in any publication from this work. 
 
Will my taking part be kept confidential? 
Everything that you say will be kept private unless what you say suggests that you or 
anyone else may be at risk. If this happens, we have a legal duty to discuss what 
has been reported with professionals who know you to see how we can help you and 
reduce any risk to you or anyone else. No one will be identified in any reports that 
come out of this research. Both the recording of the interview and any other 
information about you will be kept securely. Only the research team will have access 
to the data and it will be stored securely in accordance with the relevant guidelines, 
and destroyed after 5 years. We will ask for your permission to inform your GP 
that you are taking part in this project, but will only share information about 
you with professionals with your written permission. 
 
Who has reviewed this study and who is funding it? 
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All research within the NHS is looked at by an independent group of people called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed and given favourable opinion by NRES Committee South 
West-Exeter. The study is being funded by the National Institute for Health Research 
(NIHR) as part of a Doctoral Research Fellowship, and is being carried out by the 
University of Exeter Medical School. 
 
What if there is a problem? 
 
If you have any complaints about the way in which this study has been carried out 
please contact the Patient Advice and Liaison Service on 01752 211818. 
 
If you become distressed at any point in the study and need support, please do get 
in touch with your adult mental health team if you are in contact with them, or with 
any other keyworker if you have one. If you are not currently in contact with any 
services you may want to speak to your GP, or to NHS Direct on 111 for urgent 
advice. 
Childline also offer confidential telephone or webchat advice and counselling for 
people under 19 and can be contacted on 0800 1111 or at 
http://www.childline.org.uk 
Young Minds is a charity which offers information to young people about emotional 
health and wellbeing, and has useful information available on its website including 
how to look after yourself, get support and find out about your rights or complain. 
http://www.youngminds.org.uk/for_children_young_people 
 
 
If you have any questions or need any further information, please feel free to 
contact: 
 
Tamsin Newlove-Delgado 
Doctoral Research Fellow 
University of Exeter Medical School 
Email : t.newlove-delgado@exeter.ac.uk 
Telephone : 01392 726083 
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Sample Consent form 
 
 
Young people with ADHD in transition: 
Participant consent form for qualitative interview 
Version 3 (26/7/13)  
 
I understand/agree that: (please read each statement fully and ask the 
researcher if you have any questions or concerns. Please sign with your 
initials in each box and sign in full at the bottom of the sheet) 
    
  Please 
initial 
each 
box 
1.  I confirm that I have read the Participant Information Sheet (version 3: 17/4/15) 
concerning this study and understand what it is about.  All my questions have 
been answered to my satisfaction.  I understand that I can request any further 
information at any stage or contact the researcher with any other questions or 
concerns.  
 
2. I am aware that taking part is entirely voluntary and I am free to leave the study 
or stop the interview at any time without any disadvantage; 
 
 
3 I agree to the interview being audio/tape recorded 
 
 
4 I agree to the use of quotes from my interview being used in papers or other 
publications – these will be anonymous and I will not be identifiable from them 
 
 
5  All the information collected about me for the study will be kept in secure 
storage, including audio recordings, and destroyed after 5 years. 
 
 
6 I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from regulatory authorities or 
from NHS Trusts, where it is relevant to my taking part in the research. I give 
permission for these individuals to have access to my records. 
 
7 My GP will be informed that I am taking part in this study and I consent to this 
 
 
 
8. The results of the study may be published, but my anonymity will be preserved.    
9. Everything I say will be kept confidential, but I understand that confidentiality 
may be broken if anything indicates that I or other people may be at risk. 
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10 I agree to taking part in this study  
 
Please give your telephone number if you are happy to be contacted by telephone 
call or text message: _______________________________ 
Please give your email address if you are happy to be contacted by email: 
__________________________________ 
 
 
______________________________ ________________  ____________________ 
Printed name of participant           Signature    Date 
 
 
______________________________ ________________  ____________________ 
Printed name of Researcher  Signature    Date  
 
 
Ethical Approval: All research within the NHS is looked at by an independent group of people called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed and given favourable opinion by NRES Committee South West-Exeter 
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Coding Frame of Themes, Categories and Codes 
 
ROLE OF ADHD MEDICATION: Categories 
Effects of medication :Codes Purpose of medication: Codes 
 
Education For kids 
Relationships College/school 
Driving Daily activities 
Going out So I can go out/ Difference of perception 
between child and parent 
Effects on emotions e.g. calmer Being normal 
Stops me being myself  
Physical effects Exams 
Helping out at home 
 
PROFESSIONALS: ROLES AND RELATIONSHIPS: Categories 
 
Attitudes and ideas: 
Codes  
Professional 
knowledge/lack of : 
Codes 
Relationships: 
Codes 
 
Role: Codes 
Child with ADHD as 
trouble-maker 
Managing medication Knowing the patient Managing 
medication inc 
changing dose 
Naughty 
families/broken 
families 
Qualifications Temporary staff/staff 
leaving 
Medication 
review 
Assumptions about 
ADHD 
Parent/YP as expert Understanding and 
judgement 
Prescribing vs 
problems with 
prescribing 
Understanding and 
judgement 
Doing own research Asking questions Physical 
monitoring 
 
UNCERTAINTIES AROUND TRANSITION: Categories 
Preparation by 
services: Codes 
Concerns: Codes Feelings: Codes 
Lack of information Who will prescribe? 
 
Getting ‘dropped’ at 18 
Expectations Who will manage? 
Timing of preparation Asking questions 
Impact of 
cessation/consequences 
of cessation 
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IDENTIFIED NEEDS AND INCREASING INDEPENDENCE: Categories 
Need for 
information: 
Codes 
Need for support with 
medication : Codes 
Becoming an 
adult/becoming 
independent: 
Codes 
Other 
needs/support:Codes 
Lack of 
information 
Who will prescribe? 
 
Preparation – 
handover between 
parent and child 
Support in further/ 
Higher education 
Expectations Who will manage? Parent 
management/parent 
expectations 
Choosing 
further/higher 
education 
Timing of 
preparation 
Asking questions Timing of transition – 
relates to ideal 
service 
 
Impact of 
cessation/consequences 
of cessation 
Changing needs vs 
too much/unwanted 
support 
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